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Abstract 
 
Acute phase proteins (APPs) are proteins synthesised predominantly in the liver, 
whose plasma concentrations increase (positive APP) or decrease (negative APP) 
as a result of infection, inflammation, trauma and tissue injury. They also 
change as a result of the introduction of immunogens such as bacterial 
lipopolysaccharide (LPS), turpentine and vaccination. While publications on APPs 
in chickens are numerous, the limited availability of anti-sera and commercial 
ELISAs has resulted in a lot of information on only a few APPs.  
Disease is a threat to the poultry industry, as pathogens have the potential to 
evolve, spread and cause rapid onset of disease that is detrimental to the 
welfare of birds. Low level, sub-acute disease with non-specific, often 
undiagnosed causes can greatly affect bird health and growth and impact greatly 
on productivity and profitability. Developing and validating methods to measure 
and characterise APPs in chickens will allow these proteins to be used 
diagnostically for monitoring flock health. Using immune parameters such as 
APPs that correlate with disease resistance or improvements in production and 
welfare will allow the use of APPs as selection parameters for breeding to be 
evaluated.   
For APPs to be useful parameters on which to evaluate chicken health, 
information on normal APP concentrations is required. Ceruloplasmin (Cp) and 
PIT54 concentrations were found to be much lower in healthy birds form 
commercial production farms than the reported normal values obtained from the 
literature. These APPs were found to be significantly higher in culled birds from 
a commercial farm and Cp, PIT54 and ovotransferrin (Ovt) were significantly 
higher in birds classified as having obvious gait defects.  
Using quantitative shotgun proteomics to identify the differentially abundant 
proteins between three pools: highly acute phase (HAP), acute phase (AP) and 
non-acute phase (NAP), generated data from which a selection of proteins, 
based on the fold difference between the three pools was made. These proteins 
were targeted on a individual samples alongside proteins known to be APPs in 
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chickens or other species: serum amyloid A (SAA), C-reactive protein (CRP), Ovt, 
apolipoprotein A-I (apo-AI), transthyretin (Ttn), haemopexin (Hpx) and PIT54.  
Together with immunoassay data for SAA, Ovt, alpha-1-acid glycoprotein (AGP) 
and Cp the results of this research reveal that SAA is the only major APP in 
chickens. Ovotransferrin and AGP behave as moderate APPs while PIT54 and Cp 
are minor APPs. Haemopexin was not significantly different between the three 
acute phase groups. Apolipoprotein AI and Ttn were significantly lower in the 
HAP and AP groups and as such can be classed as negative APPs.  
In an effort to identify CRP, multiple anti-sera cross reacting with CRP from 
other species were used and a phosphorylcholine column known to affinity purify 
CRP were used. Enriched fractions containing low molecular weight proteins, 
elutions from the affinity column together with HAP, AP and NAP pooled samples 
were applied to a Q-Exactive Hybrid Quadrupole–Orbitrap mass spectrometer 
(Thermo Scientific) for Shotgun analysis and CRP was not identified. It would 
appear that CRP is not present as a plasma protein constitutively or during an 
APR in chickens and as such is not an APP in this species.  
Of the proteins targeted as possible novel biomarkers of the APR in chickens 
mannan binding lectin associated serine protease-2, α-2-HS-glycoprotein (fetuin) 
and major facilitator superfamily domain-containing protein 10 were reduced in 
abundance in the HAP group, behaving as negative biomarkers. Myeloid protein 
and putative ISG(12)2 were positively associated with the acute phase being 
significantly higher in the HAP and AP groups. The protein cathepsin D was 
significantly higher in both HAP and AP compared to the NAP indicating that of 
all the proteins targeted, this appears to have the most potential as a biomarker 
of the acute phase, as it was significantly increased in the AP as well as the HAP 
group. 
To evaluate APPs and investigate biomarkers of intestinal health, a study using 
re-used poultry litter was undertaken. The introduction of litter at 12 days of 
age did not significantly increase any APPs measured using immunoassays and 
quantitative proteomics at 3, 6 and 10 days post introduction. While no APP was 
found to be significantly different between the challenged and control groups at 
anytime point, the APPs AGP, SAA and Hpx did increase over time in all birds. 
The protein apolipoprotein AIV (apo-AIV) was targeted as a possible APP and 
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because of its reported role in controlling satiety. An ELISA was developed, 
successfully validated and used to measure apo-AIV in this study. While no 
significant differences in apo-AIV plasma concentrations between challenged and 
control groups were identified apo-AIV plasma concentrations did change 
significantly between certain time points in challenged and control groups. 
Apoliporotein AIV does not appear to behave as an APP in chickens, as it was not 
significantly different between acute phase groups. The actin associated 
proteins villin and gelsolin were investigated as possible biomarkers of intestinal 
health. Villin was found not to be present in the plasma of chickens and as such 
not a biomarker target. Gelsolin was found not to be differentially expressed 
during the acute phase or as a result of intestinal challenge. Finally a proteomic 
approach was undertaken to investigate gastrocnemius tendon (GT) rupture in 
broiler chickens with a view of elucidating to and identify proteins associated 
with risk of rupture. A number of proteins were found to be differentially 
expressed between tendon pools and further work would enable further detailing 
of these findings.  
In conclusion this work has made a number of novel findings and addressed a 
number of data poor areas. The area of chicken APPs research has stagnated 
over the last 15 years with publications becoming repetitive and reliant on a 
small number of immunoassays. This work has sought to characterise the classic 
APPs in chickens, and use a quantitative proteomic approach to measure and 
categorise them. This method was also used to take a fresh approach to 
biomarker identification for both the APR and intestinal health. The 
development and validation of assays for Ovt and apo-AIV and the shotgun data 
mean that these proteins can be further characterised in chickens with a view of 
applying their measurement to diagnostics and selective breeding programs.  
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General Introduction  
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1.1 The innate immune system 
Multi-cellular organisms appeared about 525 million years ago and over time 
developed many specialized structures and biochemical pathways that constitute 
an innate immune response (IIR), which protected against pathogens before the 
adaptive immune response (AIR) appeared in jawed vertebrates about 75 million 
years later (Stavitsky, 2007). As a result, many aspects of the IIR are 
phylogenetically conserved among higher vertebrates with many genes and 
proteins of ancient vintage, conserved from invertebrate to vertebrate phyla 
(Stavitsky, 2007). As the first line of defence, the IIR is dedicated to 
containment, holding infections to a level that can be resolved by the ensuing 
development of the AIR. The IIR is non-specific and rapid, transpiring almost 
immediately after recognition of an invading pathogen. Consisting of both 
constitutive and inducible components the IIR is highly diverse and can directly 
control the replication or spread of bacteria and viruses through induction of 
phagocytosis or antimicrobial products (Kogut, 2009). The constitutive 
components include physical barriers (e.g. epithelial lining and mucus), 
neutro/heterophils, macrophages and other phagocytes, various antimicrobial 
peptides and proteins, complement and toll-like receptors which serve to 
prevent infection, eliminate potential pathogens, and initiate the inflammatory 
response (Klasing, 2004; Cray et al.,2009) 
The AIR in contrast is target specific but it takes longer to develop. Adaptive 
immunity mostly operates through communication between antigen presenting 
cells, B-cells and T-cells by direct cell to cell contact using MHC, T-cell 
receptors and immunoglobulins and/or cytokines (Zekarias et al., 2002; Kogut, 
2009). Innate immunity provides instruction for the AIR through the activation of 
intracellular signalling pathways that initiate cellular processes such as the 
production of pro-inflammatory and/or anti-inflammatory cytokines/chemokines 
and the production of co-stimulatory molecules required for antigen 
presentation to the acquired immune system (Swaggerty et al., 2006). 
Production of pro-inflammatory cytokines is stimulated by macrophages, 
following activation by bacterial products, they have a key role in initiating an 
IIR and assist in generating a local inflammatory response and the inducement of 
the acute phase response (APR) (Giansanti et al., 2006;  Swaggerty et al., 2008) 
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1.1.1 The acute phase response  
The inducible component of the IIR is the systemic APR (Klasing, 2004). The APR 
is observed across all animal species. It is a core part of the IIR with 
counterparts of the mammalian APR identified in invertebrates and fish, in 
which the APR is proposed to be more robust than that in mammals to 
compensate for a less-evolved adaptive immune response (Cray et al., 2009). 
The APR is the prominent and non-specific systemic reaction of the innate 
immune system to local or systemic disturbances caused by trauma, infection, 
stress, surgery, neoplasia or inflammation the goal of which is re-establishment 
of homeostasis and healing (Gruys et al., 2005; Cray et al., 2009; Eckersall and 
Bell, 2010).  
At the site of infection or place of tissue injury pro-inflammatory cytokines and 
chemokines are released by a variety of cell types, but mainly by macrophages 
(Murata et al., 2004; Gruys et al., 2005). Cytokines and chemokines are protein 
and peptide mediators that play a key role in immune and inflammatory 
responses through activation and regulation of other cells and tissues (Wigley 
and Kaiser, 2003). The cytokines that play a key role in the induction of the APR 
in both mammals and avian species are the pro-inflammatory cytokines. In 
chickens the pro-inflammatory cytokines are IL-1β, IL-6, IL-17 family and TNF-α 
(Giansanti et al., 2006). Cytokines and chemokines initiate and modulate the 
APR, and together with nitric oxide and glucocorticoids trigger the hepatic APR. 
Within the first few hours of an APR, protein synthesis within the liver and 
hepatocyte secretion is drastically altered and there are measureable changes in 
the plasma concentration of several plasma proteins referred to as acute phase 
proteins (APPs) (Gruys et al., 2005). Diffusing into the extracellular fluid and 
circulating in blood, cytokines also activate receptors on different target cells 
leading to a systemic APR and resulting activation of the hypothalamic–pituitary–
adrenal axis, reduction in growth hormone secretion and a number of physical 
changes clinically characterised by pyrexia, anorexia and catabolism of muscle 
cells. Other changes include decreased low and high density lipoproteins, 
leukopenia, increased ACTH, increased glucocorticoids, activation of 
complement and blood coagulation, decreased calcium, zinc, vitamin A and α-
tocopherol (Gruys et al. 2005). Bacterial infections usually lead to a strong 
systemic APR due to the reaction of the mononuclear-phagocytic system‟s cells. 
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TNF-α and IL-1β are induced in response to endotoxin. Thus endotoxins such as 
Lipopolysaccaride (LPS) from the cell wall of Gram negative bacteria are used to 
induce experimental APRs. Viral infections generally cause a milder APR (Gruys 
et al. 2005). 
1.1.2 Acute phase proteins  
The cytokines TNF-α, IL-1β and IL-6 are the major mediators of the APR with IL-6 
the major mediator for the hepatocyte secretion of most of the APP (Murata et 
al. 2004; Gruys et al. 2005; Cray et al. 2009). Hepatic mRNA of the APPs that 
increase during an APR is upregulated and there is a reduction of mRNA synthesis 
of those APPs that decrease during an APR (Gruys et al. 2005). These are termed 
positive APPs or negative APPs respectively. Albumin is the most abundant 
constitutive plasma protein (Murata et al., 2004) and represents a major 
negative acute APP. Due to selective loss by the renal and gastrointestinal 
systems or decreased hepatic synthesis, plasma albumin concentration decreases 
during an APR. In chickens, albumin concentrations decrease to 50 - 75 % of 
normal concentrations (Grieninger et al., 1986; Adler et al., 2001). The decrease 
in albumin synthesis is postulated to allow for the unused pool of amino acids to 
instead be used to generate positive APP and other important mediators of 
inflammation (Cray et al., 2009). 
Positive APPs are further classified as minor, moderate or major APPs according 
to the magnitude and duration of increase during the APR. Major APPs increase 
10 – 1000 fold, moderate APPs increase 4 - 10 fold and minor APPs represent 
those with only slight 2 – 3 fold increases. There are noted differences in the 
timing and duration of increase in positive APP.  Major APPs tend to increase 
markedly within the first 48 hours after of the triggering event and decline 
rapidly due to a short half life. Moderate and minor proteins tend to increase 
more slowly and have more prolonged duration (Cray et al, 2009 Eckersall and 
Bell, 2010).  
APPs are involved in the restoration of homeostasis and as such have varied 
functions that include opsonisation, activating complement, binding cellular 
remnants and neutralising enzymes, scavenging free haemoglobin, iron and free 
radicals, antibacterial, antiviral and anti oxidant and are modulators of the 
host‟s immune response. Acute phase proteins are involved in many crucial 
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metabolic and immune pathways and have roles that include scavenging 
extracellular haemoglobin, iron and free radicals and direct antibacterial and 
antiviral activity. The circulating concentrations of the APP are usually related 
to the severity of the disorder and the extent of the tissue damage. 
Quantification of their concentration can therefore provide diagnostic and 
prognostic information and assessment of the response to the triggering event 
(Murata et al., 2004; Gruys et al., 2005; Cray et al., 2009). Acute phase proteins 
are recognized for their application to human diagnostic medicine having value 
in the diagnosis and prognosis of cardiovascular disease, autoimmunity, organ 
transplant and cancer treatment (Cray et al., 2009), as well as providing general 
biomarker of health.  
The serum concentrations of pro-inflammatory cytokines increase within a few 
hours of an initiating stimulus and are usually cleared from the circulation within 
a few hours. The APP serum concentrations are detectable for longer periods, 
generally the maximum response is seen at 24 – 48 hours after the initiation and 
the decline coincides with recovery from the infection. As alterations in plasma 
APP concentrations tend to remain longer they have a better diagnostic 
potential than cytokines (Petersen, et al. 2004). Acute phase protein profiles of 
both companion and farm animal species are well documented, yet it was the 
early 1990s before the wider application APP in veterinary medicine was 
reported. Since then, APPs have been used in a variety of veterinary species for 
monitoring herd health and companion animal diagnostics, where these clinical 
parameters are used diagnostically and for understanding the pathogenesis of 
important diseases (Petersen et al., 2004; Cray et al., 2009; Eckersall and Bell, 
2010). Acute phase proteins, the degree to which they change during an APR, 
the cytokine profiles and the way these inflammatory mediators respond to 
various pathogenic challenges vary between species.  
1.1.3 Acute phase proteins in chickens  
The APR and the APP changes that occur in chickens in response to disease have 
been documented in a large number of studies as reviewed by O‟Reilly & 
Eckersall (2014). Table 1.1 details the chicken APPs documented to date, their 
reported basal concentrations and using the mammalian classification as 
described in Eckersall and Bell (2010) the reported change during an APR. This 
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table briefly lists the functions of these APPs together with the page number 
where these APPs are introduced in further detail in the relevant chapters. 
Similarly other APPs, not yet characterised in chickens are also detailed here. 
Chickens represent an important avian species owing to their importance as a 
food production animal and studies have sought to identify and quantify APPs in 
chickens with the aim of establishing how these APPs change during different 
disease processes. Table 1.2 details viral, bacteria, parasitic, immune mediated 
diseases in which APP have been studies in chickens. Studies that have studied 
APPs in relation to welfare and behaviour are also included.  
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APP Functions References 
Normal serum 
concentrations 
Reference Classification Page 
Albumin  
Al 
 Regulate plasma osmotic pressure 
 Bind /transport endo/exogenous compounds 
 Antioxidant 
Sitar et al. 2013 
11.08 ± 1.34 g/L 
20 g/L (Plasma) 
15 g/L (Serum) 
Inoue et al., 1997 
Hrubec and Whichard, 2002 
Hrubec and Whichard, 2002 
Negative - 
α1-acid 
Glycoprotein 
AGP 
 Anti-inflammatory 
 Inhibit heterophil activation  
 Clear LPS and neutralise toxicity 
 Immunomodulatory  
 Plasma transport  
Murata, et al. 2004; 
Ceciliani & 
Pocacqua, 2007 
161.8 ± 25.8 mg/L  
228 ± 20 mg/L  
Inoue et al., 1997 
Takahashi et al., 1998 
Moderate 131 
Ceruloplasmin 
Cp 
 Copper storage and transport 
 Antioxidant - prevents iron induced oxidative 
stress  
Floris et al., 2000 
30 mg/L  Disilvestro and Harris, 1985 
Minor / 
Moderate 
59 
Fibrinogen  
Fb 
 Coagulation  
 Pro-inflammatory 
Davalos & 
Akassoglou 2012 
0.99 (± 0.11) g/L 
3.379 (± 0.485) g/L 
2.8 (± 0.05) g/L 
Georgieva et al., 2010 
Nazifi et al., 2010 
Amrani et al., 1986 
Minor - 
Fibronectin  
Fn 
 Cell adhesion, migration, growth and 
differentiation in the extracellular matrix 
 Wound healing 
Labat-Robert, 2012 
0.31 (± 0.4) g/L Amrani et al., 1986 
Minor - 
Haemopexin 
Hpx 
 Sequester and transport haem 
 Iron homeostasis 
 Antioxidant  
Ascenzi et al., 2005; 
Tolosano et al., 
2010 
0.15 g/L  Buyse et al., 2007 
Minor 139 
Mannan binding 
lectin  
MBL 
 Bind microorganisms  
 Phagocytosis 
 Immunomodulatory 
 Immunoglobulin secretion.  
 Activate complement system through distinct 
MBL pathway  
Nielsen et al., 1999; 
Juul-Madsen et al., 
2003; Schou et al., 
2010 
0.4 – 37.8 mg/L (mean 
5.8 (± 4.0) mg/L) Over 
10 weeks old 
Laursen and Nielsen, 2000 
Minor 186* 
Ovotransferrin 
 Ovt 
 Sequester, store and transport iron  
 Antibacterial  
 Immunomodulatory 
Giansanti et al. 
2007; Xie, et al. 
2002b; 
0.90 ±0.06 g/L  
1.18 (± 0.13) g/L  
Xie et al., 2002b 
Rath et al., 2009 Moderate 64 
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Table 1.1: Basal levels of chicken APPs and their described behaviour in chickens together with functions of other APPs, not yet characterised in chickens. 
The thesis page number listed indicates where this APP is introduced fully or discussed*.
PIT54 
 Bind haemoglobin 
 Anti-bacterial  
 Anti-inflammatory 
 Potent antioxidant  
Iwasaki et al. 2001; 
Ceron et al., 2005 
0.100 (± 0.020) g/L 
1.2 g/L  
0.09 g/L 
0.05 g/L 
Georgieva et al., 2010 
Millet et al., 2007 
Nazifi et al., 2011 
Nazifi et al., 2010 
Minor 61 
Serum amyloid 
A  
SAA 
 Lipoprotein transport and metabolism  
 Prevent oxidative tissue damage  
 Recruit immune cells to areas of inflammation  
 Immunomodulatory 
Eriksen et al., 1993; 
Landman, 1998; 
Uhlar & Whitehead, 
1999) 
0.15 ± 0.02 mg/L 
0.166 ±0.17 mg/L  
1.590 ± 0.0041 mg/L 
1.56 ± 0.13 mg/L 
Alasonyalilar et al., 2006 
Sevimli et al., 2005 
Nazifi et al., 2010 
Nazifi et al., 2011 
Major 127 
APPs uncharacterised in chickens  
C-reactive 
protein 
CRP 
 Recognise and eliminate pathogens  
 Clear cellular and nuclear debris  
 Bind apoptotic cells  
 Amplify the classical pathway of complement 
activation 
Volanakis, 2001;Kravitz et al., 2005 
Major  
(Humans, pigs, 
dogs) 
 
Minor 
(ruminants) 
129 
Apolipoprotein 
AI 
Apo-AI 
 Antioxidant  
 Prevent lipid peroxidation  
 Cardioprotective 
 Redistribution of cholesterol 
Franceschini 2003; Kravitz et al. 2005; Roman et al., 2009 
 
Negative 135 
Apolipoprotein 
AIV  
Apo-AIV 
 Lipoprotein metabolism  
 Control satiety  
 Anti-oxidant 
 Anti-inflammatory 
 
Vowinkel et al., 2004; Tso & Liu 2004 
 
Positive (mice) 195 
Transthyretin   
Ttn 
 Bind thyroid hormones 
Yamauchi & Ishihara, 2009 Negative 137 
Fetuin  
 Regulates calcium metabolism  
 Anti-inflammatory 
Olivier et al., 2000; Gangneux et al., 2003; Dabrowska et al., 2015 
Negative 
 Positive   
186* 
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Infectious agent APP Reference 
Viral 
Infectious bursal disease virus Cp  
SAA 
PIT54 
Fb 
Ovt 
MBL 
Nazifi et al., 2010 
Nazifi et al., 2010 
Nazifi et al., 2010 
Nazifi et al., 2010 
Xie et al., 2002b 
Nielsen, et al., 1998a; 1999  
Infectious bronchitis virus SAA 
 
 
Ovt 
AGP 
MBL 
PIT54 
 
CRP 
Nazifi et al., 2011 
Asasi et al., 2013 
Seifi et al., 2014 
Xie et al., 2002b 
Nakamura et al., 1996 
Juul-Madsen et al., 2003; 2007  
Seifi et al., 2014 
Asasi et al., 2013 
Seifi et al., 2014 
Respiratory enteric orphan virus 
Fowl Poxvirus 
Ovt 
Ovt 
Xie et al., 2002b 
Xie et al., 2002b 
Infectious laryngotracheitis 
virus 
Ovt 
AGP 
MBL 
Xie et al., 2002b 
Nakamura et al., 1996 
Nielsen, et al., 1998b; 1999  
 
Low pathogenic avian influenza 
 
Newcastle disease virus  
AGP 
Ovt 
SAA 
PIT54 
Sylte & Suarez, 2012 
Sylte & Suarez, 2012 
Firouzi, et al., 2014 
Firouzi, et al., 2014 
Bacterial 
Escherichia coli (LPS) Cp 
 
Ovt 
 
AGP 
 
 
Hpx 
 
CRP 
Butler et al., 1972 
Takahashi et al., 2009 
Xie et al., 2002b 
Hallquist and Klasing, 1994 
Takahashi et al., 1994; 1995;  2009 
Nakamura et al., 1998 
Buyse et al., 2007 
Barnes et al., 2002 
Buyse et al., 2007 
Patterson and Mora 1964; 1965 
Salmonella ser Typhimurium 
(LPS) 
Cp 
 
Ovt 
Hpx 
PIT54 
MBL 
Song et al., 2009   
Koh et al., 1996 
 Xie et al., 2000 
Adler et al., 2001 
Millet et al., 2007 
Millet et al., 2007 
Salmonella ser Typhimurium 
 
Salmonella ser Gallinarum  
PIT54 
SAA 
Cp 
PIT54 
Ovt 
Hpv 
Yazdani et al., 2015 
Yazdani et al., 2015 
Garcia et al., 2009 
Garcia et al., 2009 
Garcia et al., 2009 
Garcia et al., 2009 
Staphylococcus aureus SAA 
 
CRP 
Chamanza et al., 1999 
Upragarin, 2005 
Patterson and Mora, 1964 
 
Pasteurella multocida  
 
Gallibacterium anatis 
MBL 
CRP 
Ovt 
Schou et al., 2010 
Patterson and Mora, 1964 
Roy et al., 2014 
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Streptococcus equi subsp. 
zooepidemicus 
Mycoplasma gallisepticum 
Ovt 
 
AGP 
Roy et al., 2014 
 
Peebles et al., 2014 
Parasitic 
Eimeria tenella Cp 
PIT54 
Fb 
Ovt 
Cp 
Georgieva et al., 2010 
Georgieva et al., 2010 
Georgieva et al., 2010 
Rath et al., 2009 
Richards and Augustine, 1988 
Eimeria maxima 
Eimeria acervulina   
Histomoniasis  
Ascaridia galli 
Ovt 
Cp 
CRP 
MBL 
CRP 
Rath et al., 2009 
Richards and Augustine, 1988 
Patterson  Mora, 1964 
Dalgaard et al., 2015  
Dalgaard et al., 2015 
Immune 
mediated 
Autoimmune vitiligo 
 
Ovt Rath et al., 2009 
Metabolic 
Tibial dyschondroplasia  
Pulmonary hypertension  
Femoral head separation 
Ovt 
Ovt 
Ovt 
Rath et al., 2009 
Rath et al., 2009 
Durairaj et al., 2009 
Welfare & 
Behaviour  
Egg laying system 
 
Broiler production system 
Stocking density  
 
 
Feed restriction  
AGP 
Al 
AGP 
Ovt 
Cp 
PIT54 
Ovt 
Cp 
PIT54 
Salamano et al., 2010  
Salamano et al., 2010 
Tuyttens et al., 2008 
Shakeri et al., 2014; Najafi et al., 2015  
Shakeri et al., 2014; Najafi et al., 2015  
Shakeri et al., 2014; Najafi et al., 2015  
Najafi et al., 2015  
Najafi et al., 2015  
Najafi et al., 2015   
 
Table 1.2: Studies of bacterial, viral, parasitic, immune-mediated and metabolic diseases and 
welfare in chickens that have measured APPs (adapted from O’Reilly & Eckersall, 2014). 
 
Research into animal APPs has followed a general trend of identifying known 
human APPs in animal sera, establishing validated methods of measurement and 
then determining the response these APPs have to an infection in that animal 
species. This approach has also been applied to chickens with all of the 
recognised APPs in chickens having been previously identified in humans and 
other animals. Many of the studies in APP in chickens in Table 1.1 and 1.2 utilise 
LPS to stimulate an APR, from which the changes in an APP concentration are 
then measured. Other studies describe the development of methods to measure 
an APP in chickens or cite papers that have. Some studies utilise commercially 
available immunoassay kits with stated cross reactivity to chickens. However 
there are published studies that have undertaken measurement of APPs in 
chickens using commercially acquired non-specific, usually human ELISA kits that 
have not been tested or validated in chickens, and the results of these studies 
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should be treated with caution. Table 1.3 describes the reported methods by 
which chicken APPs have been quantified.  
 
Table 1.3: Reported methods of quantifying chicken APP. 
 
More recently APPs have been used as a physiological marker for health and 
welfare in chickens. In different egg laying and broiler production systems, 
differences in APP concentrations were compared. The APP AGP was significantly 
different between egg laying systems (Salamano et al., 2010) and significantly 
higher in organic broilers compared to conventionally produced broilers, this was 
attributed to restriction of prophylactic medicines coupled with access to the 
outside (Tuyttens et al., 2008). Higher stocking density have also been found to 
increase serum concentrations of APPs (Shakeri et al., 2014; Najafi et al., 2015). 
Restricted feeding in female broilers however did not affect the serum 
concentration of APPs (Najafi et al., 2015).  
 
 
 
APP Measurement 
Cp 
Indirectly measured using p-phenylenediamine (PPD) oxidase activity (Sunderman 
and Nomoto 1970; Martínez-Subiela et al., 2007). 
Fb Heat precipitation method (Thrall et al., 2004)  
Fn ELISA (Lynagh et al., 2000)  
Ovt ELISA (Xie et al., 2002b; Rath et al., 2009)  
PIT54 
Commercially available kits for measuring haptoglobin are based on the 
haemoglobin binding activity (Eckersall et al., 1999) are effective with chicken 
PIT54. 
Hpx 
Rocket gel electrophoresis using a rabbit anti-chicken hemopexin (Adler et al., 
2001).  
SAA 
Mouse SAA antibody solid phase sandwich ELISA available from Tridelta (Ireland) 
(Nazifi et al., 2010). 
MBL Sandwich ELISA (Laursen et al., 1998).  
AGP 
Specific chicken single immunodiffusion test kit available using anti-chicken AGP 
antibodies of rabbit origin (ECOS Institute, Miyagi, Japan). 
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1.2 The Poultry industry  
Consumer demand for safe, healthy, competitively priced and readily available 
meat has resulted in a massive increase in the popularity of poultry meat over 
the last 50 years. The poultry industry has changed from small scale production 
to large scale units able to produce the large volume required to meet the 
growing consumer appetite for chicken. In 2014 109,000 metric tons of poultry 
meat was produced worldwide, and this figure is projected to reach 111,000 for 
2015 (WattAgNet, 2016). Advances in animal breeding and genetic selection have 
facilitated the advancement in scale of production of the broiler chicken (Gallus 
gallus) along with advances in nutrition, management and disease control. 
Through these advancements there have been improvements in feed conversion 
ratio (FCR) allowing for improved growth rates and an increase in breast yield. 
Selective breeding for increased body weight in broilers has brought about a 
reduction in the time required for a bird to reach processing weight. In 1953, 
10.5 weeks were required for a broiler to reach a final live weight of 1.45 kg; 
however, by 2001 birds were reaching 2.67 kg in only 6 weeks (Swaggerty et al., 
2009). 
Selection based heavily on growth characteristics and other phenotypic traits is 
reported to adversely affect immune competence, leaving chickens and turkeys 
more susceptible to disease (Swaggerty et al., 2009). Experimental genetic 
selection of poultry based on immunity or inherent resistance to a specific 
infectious agent, such as Marek‟s disease virus or avian leukosis virus, or to a 
vaccine, resulted in chickens resistant to specific pathogens with either poor 
growth characteristics or a poor response to other pathogens or vaccines 
(Zekarias et al., 2002; Swaggerty et al., 2009). As such broiler breeding 
companies approach the selection of the modern broiler chicken holistically 
where performance traits are combined with those associated with the health 
and robustness of the bird. The increased statistical and genomics technologies 
have enabled breeding programmes to evolve from selection for „simple‟ and 
„single‟ criteria to selection for multiple trait criteria that balance production, 
reproduction, product quality, and animal robustness characteristics to 
neutralise possible antagonistic effects (Neeteson, 2010). In order to achieve this 
balanced breeding broiler selection is through multi-environment selection and 
the inclusion of liveability and robustness traits within the selection process.  
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As poultry production continues to grow, infectious diseases remain a threat to 
the industry. Pathogens have the potential to spread and cause a rapid onset of 
disease, owing to the large homogeneous populations housed in close 
confinement. Sub-clinical disease is also detrimental, effecting FCRs, growth 
rates and negatively affecting productivity. As well as impacting negatively on 
production, disease is also detrimental to bird welfare. Historically 
antimicrobials were at the forefront of disease control in poultry production. 
Concern about the overuse of antimicrobials and the subsequent ban on the use 
of antimicrobial growth promoters in the EU, together with the threat of exotic 
and emerging diseases mean that there is a need to identify and implement 
alternatives to disease control (EC Regulation No. 1831/2003; Kogut, 2009). 
Focusing on the immune system of the bird is one of a number of approaches 
that can be taken to address these issues.  
Using immune parameters such as antibody production, lymphocyte 
proliferation, phagocyte activity or parasite load to describe immune 
responsiveness that is correlated with resistance or susceptibility to a pathogen 
(Zekarias, et al. 2002) allows measurable immune parameters to be applied to 
the selection of poultry. The IIR is non-specific, directs the AIR and has the 
ability to be augmented and stimulated. This makes the APR an appropriate 
target for research into immune competence in chicken with the aim of 
selecting poultry with an efficient innate immune response (Kogut, 2009; 
Swaggerty et al., 2009). Studies, undertaken with the aim of selecting poultry 
based on an effective and efficient IIR to produce a population of birds that have 
multivalent protection against diverse pathogens and increased livability in the 
field, have revealed that cytokine mRNA expression by heterophils, may be a 
useful selection tool (Swaggerty et al., 2006). In vitro heterophil function 
corresponds with increased in vivo resistance to Gram-positive and Gram-
negative bacterial infections and there are increased mRNA expression levels of 
pro-inflammatory cytokines/chemokines in heterophils isolated from resistant 
lines compared to susceptible lines. Measurable differences in innate 
responsiveness are under genetic control with strong pro-inflammatory cytokine 
and chemokine responses associated with increased resistance against disease 
(Swaggerty et al., 2009). 
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The inducible APR can also be evaluated by measuring serum APPs. The changes 
in the APP profile of an animal during an APR represent an immune parameter by 
which the degree of immune competence could be measured (Kogut, 2009). 
While many studies have detailed APPs in chickens, it is only the APP mannan 
binding lectin (MBL) that has been evaluated as a selection parameter. Mannan 
binding lectin belongs to a group of proteins called collectins which, upon 
recognition of infectious agents, activates a number of cellular defence 
mechanisms including phagocytosis, modulation of cytokines and immunoglobulin 
secretion (Nielsen et al., 1999; Juul-Madsen et al., 2003; Schou et al., 2010). 
Although classed as a minor acute phase reactant, MBL plays an active and 
prominent role in the immune response of chickens (Nielsen et al., 1998b) and 
expression of MBL has been shown to be genetically influenced. Selecting two 
lines of chickens for low and high levels of serum MBL concentration resulted in 
significantly higher MBL levels in the high line and lower MBL levels in the low 
line by the 6th generation. When experimentally infected with IB virus, there was 
a 1.6 fold and 2.3 fold increase in MBL in the low and high lines respectively 
(Juul-Madsen et al., 2007). 
Although the expression MBL is malleable to genetic selection, high levels of 
circulating APPs may not necessarily be optimal and desirable, because as 
effective as the APR is, it is costly in terms of energy expenditure and 
behavioural changes (Klasing, 2004). Studies in physiological ecology and 
theoretical immunology often refer to “cost” in terms of resources such as the 
energy needed to mount an immune response, or trade-offs between 
immunocompetence and other nutrient requiring functions (Read & Allen, 2000). 
The systemic APR that accompanies and IIR appears to be the most expensive 
component of immunity in young chickens (Klasing, 2004) 
Quantifying the changes in mass of leukocytes and protective plasma proteins in 
systemic (non-mucosal) components of adult chickens injected intravenously 
with dead E. coli reveals that individual components of the immune system 
respond to an infectious challenge at very different rates. The APPs are secreted 
in large amounts by the liver during the first days of most infections. 
Quantitatively, the increases in the weight of cells and antibodies due to E. coli 
were dwarfed by the increase in the weight of the liver and APPs. Thus the APR 
was markedly more costly than the subsequent adaptive response (Iseri & 
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Klasing, 2013). The production of APPs would therefore be nutritionally costly 
given that significant amount of nutrients are needed to support their de novo 
synthesis (Klasing, 2004). It has also been demonstrated that the mobilisation of 
skeletal muscle protein that occurs during immune stress response supplies the 
necessary amino acid precursors for APP synthesis (Liu et al., 2015) leading to 
further loss of FCR. 
Worldwide, the poultry industry faces numerous challenges to remain 
sustainable. These include the move to more extensive rearing systems and the 
potential withdrawal of prophylactic and many therapeutic antibiotics (Kogut, 
2009). With the rapid evolution of bacteria, viruses and parasites into more 
pathogenic or drug resistant forms, this means that other methods to reduce the 
impact pathogen related diseases have on production and welfare are required. 
The host immune response to pathogens in the earliest stages of infection is a 
critical determinant of disease resistance and susceptibility (Swaggerty et al., 
2009). The IIR is not pathogen-specific (Kogut, 2009), so studying the early 
immune response is highly relevant when considering the immunity of poultry. 
The relatively recent discovery that the IIR directs the acquired response 
supports efforts to select poultry with an efficient early IIR (Swaggerty et al., 
2009).  
Moving towards APPs as possible targets of the early IIR in chickens requires 
robust methods of measurements to evaluate these IIR parameters. Methods of 
measurement must be repeatable, relatively straight forward and capable of 
handling large throughput of samples. Commercially available ELISA kits are 
costly, and often have not been fully validated in chickens. Further work is 
required to investigate normal concentrations of APPs in commercial flocks. All 
the published data on chicken APPs are derived from small scale experimental 
studies. To use APPs as research, diagnostic or selective tools in chickens, more 
baseline data is required.   
It is also relevant that infections with less virulent pathogens affect productivity 
(Kogut, 2009) and a challenging microbial environment in itself can reduce 
growth and uniformity. Considering this, determining whether APPs are 
associated with non-specific poor performance in broilers would give further 
information on how these plasma proteins change with low level sub-clinical 
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disease. Taking steps to identify other biomarkers associated with poor 
performance would also widen the scope of assays available to deliverer 
information on the immune health and performance of broiler chickens. 
 
1.3 Enzyme Immunoassays  
 
1.3.1 Introduction 
Quantitative analytical methods that show antigen–antibody reactions through 
the colour change obtained by using an enzyme linked conjugate and enzyme 
substrate and that serve to identify the presence and concentration of molecules 
in biological fluids are generally called enzyme immunoassay (EIA) or enzyme-
linked immunosorbent assay (ELISA) (Aydin, 2015). Today these terms are 
synonyms, used interchangeably that originate from the two research methods 
that developed two assay techniques that differed in design but utilised the 
same principle.  
The enzyme immunoassay method was developed in the early 1970s when two 
groups independently developed the concept of labelling antigens or antibodies 
with enzymes for the detection and quantification of analytes. The EIA method 
using the enzyme bound horseradish peroxidise bound to IgG was published (Van 
Weemen & Schuurs, 1971) and in the same year a second group published details 
of an enzyme linked immunosorbant assay (ELISA) that utilised alkaline 
phosphatise as the reporter label (Engvall & Perlmann, 1971). Since then EIAs 
and ELISAs have become household names for medical laboratories, 
manufacturers of in vitro diagnostic products, regulatory bodies, and external 
quality assessment and proficiency-testing organizations (Lequin, 2005).  
The impact of diagnostic immunoassays on patients, clinicians, and the 
healthcare system is virtually unsurpassed, the number of analytical and clinical 
investigations relying on these measurement procedures worldwide is 
exceedingly large, the numbers of measurements and determinations using 
immunoassay for routine patient care are astronomical (Lequin, 2005). Prior to 
the development of EIAs and ELISAs, radioactively labelled antibodies and 
antigens were used. This required specialised facilities, posed a safety risk for 
operators and presented a problem of radioactive waste (Lequin, 2005). With 
the development of solid phase, with the antigen or antibody bound to 
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microtitre plates, commercialisation of EIAs and ELISAs has ensued and these 
products continue to dominate the diagnostics market. Immunoassay are readily 
available for the detection of a wide range of biomarkers in veterinary species 
where they are used both diagnostically and in research environments.  
1.3.2 Enzyme immunoassay (EIA) / Enzyme linked immunosorbant assay 
(ELISA) types 
Either the antigen or the antibody is sound to the solid phase, which is typically 
a 96 well microtitre made of rigid polystyrene, polyvinyl and polypropylene. The 
microplates used must be able to appropriately adsorb the antigen and the 
antibody, but not adsorb the components in the other phases (Aydin, 2015). 
Figure 1.1 details an example well for each type of ELISA and how it produces a 
result. For a direct ELISA, the antigen is coated to the plate and an enzyme 
linked antibody used for detection. Indirect ELISAs utilise two antibodies: a 
primary (unbound) antibody that binds with the antigen coated on the plate to 
form a complex and a secondary enzyme that binds the complex. This secondary 
antibody is raised against the same host the primary antibody was produced in 
and is typically an anti-IgG, antibody. This will bind to the primary antibody, but 
not the antigen or other analytes from the sample. A sandwich ELISA has the 
antibody coated to the plate and the antigen will bind to this. Antibody with the 
detection enzyme bound is then added and this will bind to the bound antigen. 
In a competitive ELISA, antigen in the form of the sample is added to a well that 
is coated with an antigen, specific to the same antibody. On addition of the 
antibody which is labelled, antibody bound to the sample antigen will be washed 
away, whereas antibody bound to the antigen on the plate will remain and be 
detectable. Direct ELISAs are reported to have the lowest sensitivity, with false 
positives an issue. Both indirect and competitive ELISA are highly sensitive and 
sandwich ELISAs are reported to have the highest sensitivity, 2–5 times more 
sensitive than all other ELISAs (Aydin, 2015). 
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Figure 1.1: Types of ELISAs 
 
 
1.4 Proteomics   
 
1.4.1 Introduction  
A proteome is the protein products of the genome, cell or tissue type (Wasinger 
et al., 1995) and proteomics the large-scale study of proteins, including their 
structures and functions (Ceciliani et al., 2014). Since the 1990s, the field of 
proteomics has become an intense area of research, quantitating the changes in 
protein expression levels and applying this to drug discovery, diagnostics and 
therapy (Westermeier et al., 2008). Studying disease at the protein level is 
challenging and proteins, as mediators of phenotype, require complete 
understanding if the molecular mechanisms of disease are to be fully understood 
(Friedman & Lilley, 2008). Proteomics has emerged as a field of research in less 
than two decades and has developed rapidly, driven by improvements in 
technology and by the need for analytic approaches that can deliver global 
protein characterization (Ceciliani et al., 2014).  
 
Mass spectrometry (MS) is one important analytical technique used in 
proteomics,  measuring the mass-to-charge ratio (m/z) of ions based on their 
46 
 
motion or magnetic field (Westermeier et al., 2008). Proteins undergo trypsin 
digestion, whereby peptide bonds at the carboxyl-terminal of lysine and arginine 
amino acid residues are cleaved, the peptide masses determined using the MS 
and a unique peptide mass fingerprint created that make it possible to infer the 
amino acid composition of those peptides (Lilley & Friedman, 2004). Currently, 
two major MS platforms are employed for proteomics, differentiated by the 
mechanism through which ions are generated: these ion sources are termed 
matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization 
(ESI) (Ceciliani et al., 2014).  
 
The complexity of the proteome has made developing methods for efficient 
separation and sensitive detection of proteins a critical component of this 
effort. Continued advances in MS technology have enabled the detection of 
proteins with much greater speed and sensitivity than previously possible (Issaq 
& Veenstra, 2008). To characterise proteins, the number that the MS is asked to 
analyze must be temporally limited and this is done by applying either 
electrophoretic or chromatographic fractionation. By spreading out the 
proteome, more proteins will ultimately be analyzed within an individual 
experiment (Issaq & Veenstra, 2008; Ceciliani et al., 2014). Combinations of 
electrophoresis and chromatography are among the most efficient fractionation 
systems. Generally, proteins are initially fractionated by electrophoresis, 
trypsinised to generate peptides that can be further fractionated by high-
performance liquid chromatography (LC) before analysis by an ESI-MS that is fed 
directly with the chromatography eluate (LC-MS). The MS will generally be 
capable of recording the mass of analytes and be able to isolate and fragment 
peptide ions (MS/MS, or tandem MS) to generate information about structure. 
The resulting data are fed to a search engine, such as Mascot (Matrix Science 
Ltd), which generates in silico MS data for the specified genome sequence 
database and looks for statistically significant matches with the experimentally 
generated MS data. The data output is a list of potential matches, ranked by 
confidence, to proteins that may be components of the sample (Ceciliani et al., 
2014). Although these efforts can result in the separation and identification of 
thousands of proteins, no single method can resolve all the proteins in a 
proteome due to the large number, concentration dynamic range, proteins 
present at levels below the threshold of detection and also because some 
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proteins are refractory to analysis or are not represented in the genome 
database (Issaq & Veenstra, 2008; Ceciliani et al., 2014). Quantitation in MS is 
based on isotopic or chemical labels that are introduced in a previous step into 
the organism, at the cellular level, by labelling the intact proteins or peptides, 
or performed in a label-free mode that requires high reproducibility of the 
analyses (Almeida et al., 2015). 
 
The application of proteomics centres on the elucidation of the mechanisms of 
disease and also the search for biomarkers of disease and potential therapeutic 
targets (Lilley & Friedman, 2004). Despite the potential, proteomic studies have 
been limited in animal and veterinary research (Almeida et al., 2015) where 
biomarkers for disease and further insight into the molecular mechanisms by 
which pathogens cause disease are sought.  
 
 
1.4.2 Gel based proteomics  
 
1.4.2.1 Two - dimensional sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (2DE) 
Developed by Laemmli, (1970) to separate and study bacteriophage proteins, gel 
electrophoresis remains at the forefront protein research, albeit with significant 
modifications and adaptations that have advanced the separation and resolution 
of proteins within a complex sample. Polyacrylamide gel electrophoresis has 
been extremely useful as an analytical tool for the separation and quantification 
of protein species as has the introduction of sodium dodecyl sulfate (SDS) to 
overcome the problem of protein solubility (Gordon & Jencks, 1963). The ionic 
detergent SDS favours amino acid-detergent interactions over amino acid-amino 
acid interactions, promoting the denaturation of proteins (Abdallah et al., 
2012). 
An important development in proteomics came when O‟Farrell, (1975) 
introduced  2-dimensional separation of proteins (2DE), which has since evolved 
to become the workhorse of protein separation and the method of choice for 
differential protein expression analysis (Abdallah et al., 2012). Proteins first 
undergo isoelectric focusing (IEF) in the first dimension to separate proteins 
based on their net charge (pH). The orthogonal second dimension is then used to 
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further separate proteins based on molecular weight in the presence of 
denaturing conditions. The resolution power is therefore derived from 
orthogonally combing two separation methods based on two independent 
parameters: charge and size (O‟Farrell, 1975; Lilley & Friedman, 2004; Unlu & 
Minden, 2002).  
Using an isoelectric focussing in the first dimension and a separation via SDS-
PAGE in the second dimension, thousands of protein spots can be separated, 
visualized and quantified in a single 2DE gel. Comparisons of 2DE gels allows for 
the detection of protein species that differ between the compared states (Unlu 
& Minden, 2002), with relative abundances of proteins in related samples such as 
diseased and control tissues, allowing the classes of proteins that differ between 
two to be determined (Lilley & Friedman, 2004).   
 
Protein spots of interest are removed from the gel digested, extracted from the 
gel and identified using MS. With a 2DE approach each proteome snapshot 
becomes a protein map on which hundreds and even thousands of proteins are 
fractionated and displayed (Unlu & Minden, 2002) making 2DE a powerful 
approach for descriptive and comparative proteome analysis. It remains the 
highest-resolution protein separation approach and is inherently quantitative. 
The separation of intact proteins by charge and mass can highlight post-
translational modifications that would not be evident in 1-dimensional 
electrophoresis or in peptide-based separations (Ceciliani et al., 2014) . 
 
1.4.2.2 Difference gel electrophoresis (DiGE) 
 
Poor resolution results in some classes of proteins, namely those that are of 
relatively low abundance, very large, or highly charged, being under-
represented when 2DE methods are utilised (Issaq & Veenstra, 2008; Ceciliani et 
al., 2014). While many advances in software alignment tools have been made, 
reproducibility remains a limitation for 2DE, as ensuring direct spot-to-spot 
comparison between two separate gels is challenging (Issaq & Veenstra, 2008). 
High levels of inherent technical and systematic variability will exist between 
gels affecting reproducibility of generated protein patterns and spot intensities. 
Gel-to-gel variations result in difficulties in spot detection, matching, and 
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ultimately distinguishing biological from technical variance (Arentz et al., 2015). 
Even if the quantification is very accurate and sensitive using 2DE, the relatively 
high amount of protein necessary for protein identification as well as multiple 
experimental steps are the major disadvantages of this technique (Megger et al.,  
2013). 
 
The development of 2D difference gel electrophoresis (DiGE) in 1997 overcame 
some of these limitations by labelling proteins within samples with spectrally 
distinct fluorescent dyes prior to electrophoretic separation. The dyes used are 
cyanine dyes (DiGE CyDye Fluor CyTM GE Healthcare) and there are three 
spectrally distinct CyDyes available: Cy2, Cy3, and Cy5. For samples to be 
compared quantitatively and the comparison to confer any statistical power a 
pooled internal standard comprising equal aliquots of every sample within the 
experiment is labelled with the Cy2 CyDye and ran on all gels. This pooled 
internal standard is labelled once in bulk to avoid variation. Two samples 
labelled separately to Cy3 and Cy5 and the pooled internal standard labelled 
with Cy2 are mixed and co-resolved in the same 2DE gel. The gel is scanned with 
a fluorescent imager at different wavelengths and each of the samples and the 
pooled standard is separately visible on the single gel. Having been ran together 
under identical condition with proteins migrating under the exact conditions the 
problems of reproducibility are overcome (Unlu & Minden, 2002; Lilley & 
Friedman, 2004; Westermeier et al. 2008; Friedman & Lilley, 2008).  
 
Use of the pooled internal standard ensures all proteins in the sample are 
represented assisting both inter and intra gel matching. Variation in spot 
volumes due to gel-specific variation will be the same for each sample in the 
single gel (Lilley & Friedman, 2004). The imaging software developed for the 
DiGE system: DeCyderTM (GE Healthcare) is used for quantitative analysis. 
Measurements are made relative to the Cy2 signal for each resolved protein 
(Friedman & Lilley, 2008) and as the Cy2 signal should be the same for a given 
protein across all the different gels because it came from the same bulk 
mixture, any differences represent gel-to-gel variation, which can be effectively 
neutralised by normalising all the Cy2 values for a given protein across all the 
gels (Friedman & Lilley, 2008). DeCyderTM uses a triple co-detection algorithm 
that allows simultaneous detection of labelled protein spots from images that 
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arise from the same gel and increases the accuracy in the quantification of 
standardised abundance. The standardised abundances can then be compared 
across groups to detect changes in the protein expression (Alban et al., 2003). 
The use of sufficient replicates and the presence of the same pooled standard 
present in each gel allows for the application of the students t-test and analysis 
of variance (ANOVA) statistical analysis despite the samples having been 
separated on different DiGE gels (Lilley & Friedman, 2004). 
 
1.4.3 The chicken proteome 
 
1.4.3.1 Introduction  
Proteomic samples can come from many different and varied sources. 
Investigations can utilise whole plasma or homogenised tissues from 
experimental or clinically affected animals. The excellent resolving powers of 
proteomics mean that sub-cellular proteins can be fractionated and identified to 
reduce the protein complexity (Lilley & Friedman, 2004). The use of proteomics 
to investigate disease and identify biomarkers in the field of animal health has 
gained huge momentum over the last 15 years and in poultry, as the areas of 
application widen, it has becomes possible to investigate more specific and 
varied areas of poultry health. Comparing the number of publications listed in 
Web of Science  that contain the words „proteome‟ or „proteomics‟ and 
„chicken‟ or „broiler‟ or „hen‟ in their title reveals that the study of chicken 
proteomes has grown steadily over the last 15 years. Figure 1.2 details this 
trend.   
 
51 
 
 
Figure 1.2: The number of publications listed in Web of Science that contain the words 
‘proteome’ or ‘proteomics’ and ‘chicken’ or ‘broiler’ or ‘hen’ in their title from 1999 to 
2015. No publications are listed prior to 1999. 
 
1.4.3.2 The effect of selection on the chicken proteome 
Detailing the proteomic differences between genetic lines of chickens which 
exhibit differential resistance and/or susceptibility to different diseases can 
reveal molecular mechanisms by which pathogens cause disease in their host and 
can reveal how a bird‟s immune system can affect a more efficacious response. 
One of the few research papers to compare protein expression between 
different broiler lines found that the serum proteome of two lines challenged 
orally with Eimeria (E.) acervulina, E. maxima or E. tenella identified a number 
of differentially expressed proteins. Several metabolic enzymes were identified 
as potential candidates for early diagnostic markers of E. acervulina infection 
including malate dehydrogenase 2, NADH dehydrogenase 1 alpha subcomplex 9, 
and ATP synthase. These proteins were detected only in Line A birds that were 
inoculated with E. acervulina. Increases of a protein in response to infection 
were detected mainly in E. acervulina and E. tenella infected birds in both lines 
(Gilbert et al., 2011).  
Comparing the proteomes of broiler breeds with different growth profiles can 
also elucidate to the molecular mechanisms by which some birds effectively 
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utilise and metabolise the nutrients available to them. Comparing the embryonic 
liver proteome of two breeds of broiler with different growth and fat deposition 
characteristics, identified thirty-seven differentially expressed proteins. The 
results suggest that lipid metabolic proteins and enzymes are inherent 
characteristics that contribute to the apparent differences in fat deposition 
between the two strains (Huang, et al., 2010). 
1.4.3.3 The chicken intestinal proteome  
The intestinal proteome has been a particular popular target in chicken 
proteomic studies owing to the importance of intestinal health in broiler 
chickens. Studies of the chicken intestinal proteome have found that proteins in 
the brush border involved in digestive function, maintenance of membrane 
potential, membrane trafficking and cytoskeletal organisation changed from day 
of hatch to 14 days post hatch over time and differed between genetic lines 
(Gilbert, et. al., 2010). Bacteriocins were found to trigger differential 
expression of metabolic-related proteins within the jejuna, many of which had 
antioxidant functions (Wang et al., 2013). The feeding of the probiotic 
Enterococcus faecium (E. faecium), differentially expressed forty-two intestinal 
mucosal proteins, four related to intestinal structure and seventeen related to 
immune and antioxidant systems of which six were abundant in the broilers fed 
E. faecium, which when taken with the other findings in this study indicated 
that the chickens employed less nutrients and energy to deal with immune and 
antioxidant stresses (Luo et al., 2013). The jejunal proteome sampled from 12 to 
22 days of age showed developmental changes and the introduction of re-used 
litter at 12 days resulted in the differential expression of a number of proteins. 
Many of these proteins were cytoskeletal proteins, particularly actin. Villin-1, an 
actin associated protein involved in apoptotic processes was shown to be 
reduced in expression in the challenged birds indicating that many of the 
changes in cytoskeletal protein expression in the challenged birds were as a 
result of an increased rate of apoptosis. A number of heat shock proteins were 
found to decrease in expression over time in the intestine and this was more 
pronounced in the challenged birds (O‟Reilly, 2013). High atmospheric ammonia 
exposure was found to differentially express forty-three intestinal mucosal 
proteins, up-regulating proteins related to oxidative phosphorylation and 
apoptosis and down-regulating proteins related to cell structure and growth, 
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transcriptional and translational regulation, immune response, oxidative stress 
and nutrient metabolism; indicating that exposure to ammonia triggered 
oxidative stress and interfered with nutrient absorption and immune function in 
the small intestinal mucosa of broilers (Zhang et al., 2015a). The results of these 
intestinal proteome studies in chickens are comparable with similar studies in 
other species and indicate that many of the responses to infection and 
inflammation in the small intestine are conserved among vertebrates.  
1.4.3.4 The chicken proteome during disease 
Proteomics has been applied to the study of a number of poultry diseases. 
Studying the splenic proteome over time as a result of Marek‟s disease infection 
in susceptible and resistant chickens revealed a number of differentially 
expressed proteins included antioxidants, molecular chaperones, proteins 
involved in the formation of cytoskeleton, protein degradation and antigen 
presentation, signal transduction, protein translation and elongation, RNA 
processing and cell proliferation (Thanthrige-Don et al., 2010). The peripheral 
blood mononuclear cell proteome during Newcastle disease virus infection 
revealed thirty-five proteins that consistently showed differential expression. 
These proteins functioned in macromolecular biosynthesis, cytoskeleton 
organization, metabolism, stress responses, and signal transduction (Deng et al., 
2014). The proteomic changes induced in host cells infected with avian reovirus 
(ARV), the etiological agent of several diseases, revealed the majority of protein 
expression changes occurred 72 hours post-infection and that fifty-one proteins 
had differential expression levels. All identified proteins involved in signal 
transduction, RNA processing, and the ubiquitin-proteasome pathway were 
downregulated in infected cells, whereas proteins involved in DNA synthesis, 
apoptosis, and energy production pathways were upregulated (Chen et al., 
2014). Metabolic diseases have also been the focus of proteomic studies with the 
hepatic proteome of broilers afflicted with ascites syndrome compared to their 
normal counterparts (Wang et al., 2012) and the protein extracts of cartilage 
from normal and tibial dyschondroplasia (TD) affected growth plates compared 
(Rasaputra et al., 2010). 
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1.4.3.5 Egg, meat and reproductive proteomes 
Proteomic methods are also readily applicable to poultry meat and egg quality 
with a number of studies investigating the proteome of muscle (Doherty et al., 
2004), carcass characteristics and meat quality (Zheng et al., 2014). Proteomic-
based methods have also been developed for the detection of chicken meat 
within mixed meat preparations (Sentandreu et al., 2010). The area of egg and 
egg shell research is undoubtedly the area of poultry research that has utilised 
proteomic technologies the most with a significant number of proteomic studies 
detailing the egg proteome and the egg shell/cuticle proteome. The eggshell is a 
barrier that plays an important role in the defence of the egg against microbial 
and other infections and it protects the developing bird against unfavourable 
impacts of the environment and is essential for the successful reproduction of 
birds. The extractable proteins of the eggshell matrix have been studied 
extensively and many of them have been identified (Mikšík et al., 2014). In other 
reproductive related areas semen quality has been assessed using proteomics 
(Labas et al., 2015) and the proteomic analysis of the muscularis complexus (the 
pipping muscle) in broiler chicken embryos has also been undertaken (Sokale et 
al., 2012). 
1.4.3.6 Other tissue proteomes in chickens  
The effects of heat stress (Tang et al., 2015) and ammonia toxicity (Zhang et 
al., 2015b) on the hepatic proteome have been investigated. Proteomic 
approaches have also been undertaken to study heart muscle development, 
studying the proteome of different heart structures at three stages of chicken 
embryonic development (Bon et al., 2010). The proteome of brain tissue form 
chickens infected by the neurovirulent avian influenza virus have also been 
detailed (Zou et al., 2010). The proteome of the bursa of Fabricius, an 
important gut associated lymphoid tissue where chicken B-cells develop has 
been detailed during embryonic and post-hatch development. One hundred and 
fifty three protein spots with significantly different intensities were identified 
with several proteins assigned to retinoic acid metabolism (e.g. retinal-binding 
protein 5) and the actin-cytoskeleton (e.g. vinculin and gelsolin) (Korte et al., 
2013). 
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1.5 Aims of study 
In veterinary species there is increasing emphasis on the identification of 
biomarkers for disease resistance, enhanced immunity and optimal vaccine 
response. Susceptibility to infection, sub-clinical disease and the emergence of 
drug resistant pathogens are major issues in poultry production and impact 
negatively on health, welfare and overall productivity making this is a timely and 
appropriate target for novel biomarker investigation. Acute phase proteins are 
widely used as disease biomarkers and these are an appropriate target on which 
to focus a study owing to their role in early IIR. Despite the number of 
publications on APPs in chickens, the variety of the research is low. Often the 
same APPs are studied and the immunogen LPS is typically used to initiate an 
APR. There are many APPs have not yet been confirmed as acute phase 
responders in chickens and there is a lack of reliable, specific and economically 
viable assays and the availability of commercial ELISA is limited. This in itself 
has somewhat distorted the research publications with many APPs not detailed 
at all and others over represented in the literature. Developing new 
immunoassays will broaden the spectrum of APPs measured in chickens.  
The development of immunoassays is lengthy and costly and to circumvent this a 
quantitative proteomic approach will allow the identification and measurement 
of a large number of proteins within a single series of experiments. For APPs to 
be used diagnostically or as a selective tool for breeding more baseline data is 
required on normal APP concentrations and on how baseline concentrations 
change on commercial farms. Looking at the APP concentrations from normal 
and culled chickens will give comparative data and contextualise other results.   
It is the further aim of this work to detail novel biomarkers of the APR that may 
not have been considered previously as such. Plasma biomarkers for intestinal 
health will also be studied. Acute phase proteins will be measured to determine 
whether an intestinal challenge, in the form of re-used litter, induces an APR. As 
a result of initial studies, the protein apolipoprotein AIV will be investigated and 
an ELISA developed. The application of APP measurement to a number of areas 
of poultry science is possible, but without robust and validated methods of 
measurement that are economical and capable of a high throughput of samples, 
the full extent to which these biomarkers can be utilised will not be recognised.   
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1.6 Thesis outline  
Chapter 2 measures the APPs Ovt, PIT54 and ceruloplasmin (Cp) in three 
separate studies. The first investigates Cp and PIT54 concentrations from 
broilers from a commercial unit. These broilers have been culled due to stunting 
or lameness or are healthy. The aim of this study was to look at the baseline 
data for these APPs and determine whether there was any difference between 
seemingly healthy broilers and culled birds from a normal production 
environment. In a second study APP concentrations are measured in broilers with 
experimental infections of E.tenella, E.coli and combinded E.tenella and E.coli 
infections. A 1DE gel is also undertaken to survey the proteins present. The third 
study compared the APP concentrations of broilers with different gait scores and 
also details the plasma proteome of using 2DE.  
Given the poor reproducibility of the Ovt assay described and used in Chapter 2, 
Chapter 3 sought to develop another Ovt assay utilising an antibody raised 
against egg derived Ovt. This chapter details the development of the assay and 
its validation.  
With the aim of widening the scope of this study to APPs that have not been 
previously detailed in the literature and investigating novel biomarkers of the 
APR in chickens, quantitative proteomics was utilised in Chapter 4 to determine 
the relative quantification of a number of APPs and proteins that appear to be 
differentially expressed between three different acute phase groups. Three 
pools were established initially, these were highly acute phase (HAP), acute 
phase (AP) and non-acute phase (NAP) pools. These pools underwent proteomic 
shotgun analysis and proteins found to be differentially expressed between the 
pools were identified and those with highest fold changes were selected for 
further measurement on individual samples.  It was the aim of this Chapter to 
identify and measure the APPs serum amyloid A (SAA) and C-reactive protein 
(CRP) in chickens and a number of enrichment steps, namely molecular weight 
fractionation and affinity chromatography, were undertaken to aid in the 
identification and measurement of these APPs.  
Chapter 5 uses the same proteomic approach as Chapter 4 to measure the 
protein apolipoprotein AIV (apo-AIV), a protein reported to have various 
functions including APP and a satiety protein. A further protein gelsolin, an actin 
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associated protein was also measured. An ELISA to measure apoAIV was 
developed and validated. A study to investigate the APR as a result of a 
microbial challenge, delivered in the form of reused litter was undertaken and 
the APPs determined by both ELISA and quantitative proteomics. The protein 
villin, found in a previous study to be a possible biomarker of intestinal health 
(O‟Reilly, 2013), was investigated using western blotting. 
Chapter 6 utilised DiGE technology to compare the tendon proteomes of broiler 
chickens with ruptured gastrocnemius tendons (GT). The aim of this work was to 
detail the GT proteome in chickens and identify differentially expressed 
proteins, which could elucidate to the pathophysiology of this condition. 
Chapter 7 summarises the work of the whole thesis and details areas in which 
improvement could be made and recommendations for future work.   
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Chapter  2 
Acute phase protein analysis in broiler chickens   
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2.1  Introduction  
A series of studies were utilised to investigate ceruloplasmin (Cp), PIT54 and 
ovotransferrin (Ovt) serum concentrations in broiler chickens. These APPs are 
the most widely measured APPs detailed in the literature. It is the aim of this 
chapter to determine whether broiler chickens, culled on farms due to lameness 
and stunting had higher APP concentrations than their healthy counterparts. 
Measuring APPs in healthy birds from commercial farms would aid in the 
establishment of baseline concentrations and reveal the normal variation among 
healthy birds. Detailing the APPs in culled birds would also reveal whether culled 
birds from commercial farms exhibit an APR at culling, and this may provide 
information as to the cause of non-specific conditions for which the birds were 
culled.  
Two further studies focus on lameness and Coccidiosis, two diseases that are 
widespread and cause significant financial loss to the poultry industry. Measuring 
APPs and utilising proteomic methods will gain further insight into the acute 
phases of these diseases. The APPs Cp, PIT54 and Ovt will be described in 
further detail in the following sections, being the APPs  this chapter focuses its 
attentions. Other APPs will be introduced in more detail in the following 
chapters where work on these APPs is described.  
2.1.1 Ceruloplasmin  
Ceruloplasmin (Cp) is a vertebrate plasma protein belonging to the multicopper 
oxidase family, a family characterised by their different copper sites (Floris et 
al. 2000). Ceruloplasmin is the only copper oxidase to occur in animal species 
(Calabrese et al. 1988) and contains over 95% of the copper found in the plasma 
(Martinez-Subiela et al. 2007). Avian blood is very low in copper compared to 
mammals and as such has lower serum levels of Cp (Disilvestro and Harris, 1985). 
Human serum contains approximately 30mg Cp per 100ml serum whereas chicken 
serum has 3mg Cp per 100ml (Disilvestro and Harris, 1985).  
2.1.1.1 Ceruloplasmin structure and function  
Ceruloplasmin is a multifunctional protein both storing and transporting copper 
within the body. Ceruloplasmin donates copper in a regulatory fashion with 
evidence of Cp receptors on the membranes of numerous different cell types, 
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supporting Cp‟s role as a cell signalling multifunctional enzyme within many 
different metabolic pathways (Floris et al., 2000). Ceruloplasmin is an 
antioxidant protein and historically preventing iron induced oxidative stress has 
been considered the principle role of the protein in vivo; as ferroxidation by Cp 
is a physiologically crucial event with Cp able to oxidise the divalent iron Fe (II), 
efficiently preventing iron induced oxidative stress (Floris et al., 2000). While Cp 
has been long recognised as a plasma protein synthesised by hepatocytes, there 
is evidence in other species to indicate that other cell types also synthesis Cp 
(Floris et al 2000).  
2.1.1.2 Ceruloplasmin and the acute phase response in chickens  
The first paper to describe Cp as an APP in chickens was Butler, et al. (1972) 
who noted that a single injection of endotoxin from E. coli increased serum Cp 
concentration by 2 – 5 fold, the degree of increase varying with the strain of E. 
coli used. The maximal increase in Cp was 24 hours post injection and increased 
levels were still detectable 48 hours after injection. Further studies have also 
described Cp as a positive acute phase reactant. Salmonella serotype Gallinarum 
delivered per os into the crop of chickens, showed Cp to increase the quickest of 
all the APPs measured in this study, with peak serum Cp levels measured 3 – 5 
days post infection. Serum concentration then progressively decreased (Garcia 
et al., 2009). 
Serum CP increased significantly in response to Eimeria (E.) tenella infection 
(Richards and Augustine, 1988; Georgieva et al., 2010) and combined E. coli and 
E. tenella infection (Georgieva et al., 2010). Infection with Eimeria (E.) 
acervulina did not significantly increase Cp concentrations (Richards and 
Augustine, 1988). Conversely chickens infected with infectious bursal disease 
virus (IBDV) had decreased serum Cp concentration, with the decrease even 
more pronounced in the most severely infected birds (Nazifi et al., 2010). 
Further work would be needed to confirm whether, during viral or IBDV 
infections Cp is indeed a negative APP.   
2.1.1.3 Quantification of Ceruloplasmin in chickens  
Disilvestro and Harris (1985) characterised chicken Cp using SDS PAGE and 
revealed Cp to have a molecular weight of 130kDa, a slightly smaller band was 
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also present, which the authors suggested could be minor fragments of the main 
component. Calabrese et al, (1988), found chicken Cp to have a higher 
molecular weight of approximately 140kDa. Disilvestro and Harris (1985) 
produced chicken Cp antibodies for immunoelectrophoresis and yielded a single 
band corresponding to Cp on western blots. Serum Cp concentration can be 
measured indirectly by measurement of the p-phenylenediamine (PPD) oxidase 
activity. Cp catalyses the oxidation of PPD to yield a purple coloured product 
whose rate of formation can be determined by spectrophotometry. The rate of 
formation of the coloured oxidation product is proportional to the concentration 
of serum Cp, if a correction is made for non enzymatic oxidation of PPD 
(Sunderman and Nomoto, 1970). The oxidase activity of chicken Cp assayed 
between pH 6 – 8 was found by Calabrese et al. (1988) to be five times higher 
than the value measured for mammalian Cp under the same experimental 
conditions with maximum at around pH 6.8. The PPD method is the most widely 
cited method for measuring Cp. 
2.1.2 PIT54 
Under certain pathological conditions such as infection the red blood cell (RBC) 
(erythrocyte) membrane can destabilise resulting in the lyses of the cell and 
leakage of haemoglobin (Hb) into circulation (Wicher and Fries, 2006). As 
evolution made Hb more efficient as an oxygen carrier within the RBC, the 
protein appears to have developed harmful properties outside the cell. 
Haemoglobin outside the cell is toxic, proinflammatory and pro-oxidative causing 
damage to cells and tissues and haem associated iron will support microbial 
growth (Ceron et al. 2005; Wicher and Fries, 2010). Plasma proteins have 
therefore evolved that bind free Hb or its haem group, blocking its detrimental 
effects and mediating its removal from the blood stream (Wicher and Fries, 
2010). Haemoglobin and haem scavenging in plasma involves a number of 
different proteins: haptoglobin (Hp), high and low density lipoproteins (HDL, 
LDL), serum albumin, Hpx, α-1 microglobulin (Ascenzi et al., 2005) and an avian 
species named PIT54 (Wicher and Fries, 2006). 
Historically the Hb binding protein in chickens was considered to be Hp or a 
haptoglobin-like protein until analysis of the Hb binding protein in chickens 
found that it binds avian and reptilian Hb but not mammalian Hb. In contrast 
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human Hp binds both chicken and human Hb with great affinity (Musquera et al., 
1979). A report by Delers et al., (1983) analysing mammalian Hp and the Hb 
binding protein in chickens revealed significant structural differences between 
the two proteins. Detailed analysis of the chicken genome found there to be no 
gene coding a protein similar to mammalian Hp. Instead the protein referred to 
as PIT54 was identified, which fulfils a similar role in chickens as Hp does in 
mammals (Iwasaki et al., 2001; Wicher and Fries, 2006). PIT54 is found only in 
avian species having been identified in geese, ostriches and emus. Although 
absent in chickens, Hp is found in paleognathus birds (ostriches and emus) where 
Hp has been conserved alongside PIT54 (Wicher and Fries, 2010). Despite the 
evidence, some of the literature still refers to chicken Hp as opposed to PIT54. 
Given the structural and functional similarities between the two proteins the 
following section details work conducted on both Hp and PIT54.   
2.1.2.1 Haptoglobin and PIT54 structure and function  
PIT54 is a soluble member of the family of scavenger receptor cysteine rich 
proteins (Wicher and Fries, 2006). Structurally PIT54 has been demonstrated to 
have three glycosylation variants that differ in their molecular weight and 
structure, though distribution of the glycosylation variants are not altered during 
an APR when induced in layer chickens with turpentine (Delers et al. 1988). 
Haptoglobin is an anti-inflammatory protein modulating prostaglandin synthesis 
and inhibiting granulocyte chemotaxis and phagocytosis (Ceron et al., 2005). 
PIT54 too has been shown to have potent antioxidant properties, inhibiting 
superoxide production by phagocytes, thus inhibiting the overproduction of 
reactive oxygen species that cause oxidative damage (Iwasaki et al. 2001). This 
supports the notion that PIT54 evolved from an anti-inflammatory protein which 
evolved Hb binding ability and, like Hp, retains these anti-inflammatory 
properties (Wicher and Fries, 2010).  
PIT54 and Hp are antibacterial proteins, binding free haemoglobin rendering it 
unavailable for bacterial growth. Haemoglobin iron availability and the 
susceptibility to infection are intimately linked with pathological iron overload 
predisposing to bacterial infection (Ascenzi et al., 2005). Haptoglobin also has a 
role in wound healing binding Hb in infected areas to prevent bacterial growth 
and sepsis and this may account for Hp expression in adipose tissue (Ceron et 
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al., 2005). Free Hb in systemic circulation will pass through the glomerular 
filter, causing renal damage. When Hp forms a soluble complex with Hb in 
plasma they are not filtered through the glomeruli but delivered to the 
reticuloendothelial system and after internalisation into liver parenchymal cells 
the complex dissociates into two subunits that are subsequently degraded 
(Langlois and Delanghe, 1996; Ascenzi et al., 2005) and the iron is reused. 
2.1.2.2 PIT54 and the acute phase response in chickens  
Haptoglobin is a positive APP and serum concentrations will increase during 
infection, inflammation and trauma and tissue damage. Measuring the serum 
concentration of Hp provides valuable diagnostic information in cattle and sheep 
where normal Hp values are <0.1mg/ml but increase 100 fold or more in 
response to infection, making Hp a major APP in these species. In dogs, cats and 
pigs more modest increases (2 – 5 fold) occur but these increases are still 
diagnostic (Eckersall et al., 1999).  
In chickens Nazifi et al., (2010, 2011) using a commercial Hp kit based on Hb 
binding affinity that also measures the concentration of PIT54, found that 
chickens had no significant increase in PIT54 during IBDV infection, yet had a 
significant increase as a result of infectious bronchitis (IB) infection.  
Investigating the effect of bacterial challenge on PIT54 serum concentrations 
Garcia et al., (2009) found that intra-crop inoculation of Salmonella enterica, 
serovar Gallinarum, resulted in a significant increase throughout the course of 
the 10 day challenge. As a result of parenteral administration of S. Typhimurium 
LPS, mean PIT54 serum concentrations significantly increased 1.5 fold (Millet et 
al., 2007). Georgieva et al., (2010) compared serum PIT54 after experimental 
infection with E. coli, E. tenella and combined infection of both pathogens. The 
increase in PIT54 was highly significant as a result of E. coli infections and 
combined infections, however serum PIT54 levels did not increase significantly 
as a result of E. tenella infection alone. The reported increases in PIT54 during 
an APR would classify it as a minor APP in chickens.  
2.1.2.3 Quantification of PIT54 in chickens  
Owing to the functional similarities between PIT54 and Hp, a commercially 
available assay based on the biochemical activity of Hp will work with PIT54 
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from chicken serum (Georgieva et al., 2010). For example Nazifi et al. (2010) 
measured PIT54 according to the preservation of the peroxidise activity of Hb 
which is directly proportional to the Hp (or PIT54) if using for chickens (Tridelta, 
Wicklow, Ireland). 
2.1.3  Ovotransferrin  
The transferrins are an extended family of metal binding transport proteins with 
an in vivo preference for binding ferric iron. They are single chain glycoproteins 
and are widely distributed in physiological fluids and cells of vertebrates 
(Aguilera et al., 2003). Mammals have serum transferrin, synthesised in the liver 
and lactoferrin a major milk protein, synthesised in the mammary gland. 
Melanotransferrin has also been identified in malignant melanoma cells (Aguilera 
et al., 2003). Chickens have neither transferrin or lactoferrin, instead 
synthesising ovotransferrin (Ovt) in the liver in response to proinflammatory 
cytokines and in the oviduct under the influence of oestrogen (Hallquist and 
Klasing, 1994). Historically the word conalbumin was used to describe both the 
egg and serum transferrin in chickens. Williams (1968) as well as advocating 
ovotransferrin as a more informative name to describe the egg protein, 
demonstrated that both serum and egg Ovt were the same protein differing only 
in their glycosylation. More recently serum transferrin has adopted the „ovo-‟ 
and the word ovotransferrin is widely used to describe both egg and serum 
transferrin in chickens. Ovotransferrin is a positive APP in chickens (Hallquist 
and Klasing, 1994; Xie et al., 2002a)  with a number of studies confirming that 
serum Ovt increases during an APR due to a variety of experimentally induced 
infections and inflammatory processes. This differs from mammals where serum 
transferrin is a negative APP with expression being down regulated during 
inflammation (Ceron et al., 2005). Synthesis of egg Ovt however responds in a 
negative fashion during an APR, with the oviduct magnum decreasing mRNA 
synthesis for egg Ovt with a resultant cessation to egg laying (Hallquist and 
Klasing, 1994).  
2.1.3.1 Ovotransferrin structure and function  
Ovotransferrin shows marked sequence and structural homologies with both 
mammalian serum transferrin and mammalian lactoferrin (Giansanti et al., 
2007). Sequence alignment (Figure 2.1) of chicken Ovt and human 
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lactotransferrin and serotransferrin shows 40.97% sequence homology between 
the three transferrin protein sequences. In chickens serum Ovt is synthesised by 
the liver and released into the blood stream in response to proinflammatory 
cytokines. Egg Ovt is synthesised by cells in the oviduct under the control of 
oestrogen. It is predominantly an egg white protein though it has also been 
found in the yolk, shell membranes and shell of the egg (Stevens, 1991). 
Ovotransferrin produced in the oviduct is incorporated into the egg white where 
it has an important antibacterial action on bacteria that enter through the 
porous egg shell.  
Chicken egg Ovt and serum Ovt have been identified as being the same protein 
that exists in two protein isoforms that have a similar amino acid sequence and 
differ only in their glycosylation patterns and composition of their carbohydrate 
moieties (Williams, 1968; Thibodeau et al., 1978; Xie et al., 2002a). The egg 
white Ovt glycosyl-group is present as a single oligosaccharide composed of 
residues of mannose and 8 residues of N- acetylglucosamine glycan. Serum Ovt is 
mostly composed of a single unit of 2 residues of mannose, 2 residues of 
galactose, 3 residues of N-acetylglucosamine  and either 1 or 2 residues of sialic 
acid (Williams, 1968).  
It is hypothesised that in birds, Ovt carries out the biological functions which in 
mammalian species are split between serum transferrin and lactoferrin. Like 
mammalian transferrin, serum OVT is involved with iron transport and delivery 
to cells and egg. Ovt displays many biological functions similar to that of 
lactoferrin related to innate immunity, carrying out in egg white the same 
protective antibacterial functions that lactoferrin carries out in mammalian milk 
(Giansanti et al., 2007). Ovotransferrin, like other members of the transferrin 
family, is an antibacterial protein, able to sequester, store and transport iron. It 
is Ovt‟s iron sequestering function that deprives bacteria of the iron essential for 
growth (Xie, et al., 2002b) and contributes to its antibacterial action. 
Ovotransferrin has been demonstrated to have a direct action on Gram negative 
bacteria as Ovt is able to permeate the outer membrane of E.coli, reach the 
inner membrane and cause selective permeation of ions. This results in 
dissipation of the electrical potential, which together with a change in 
membrane potential and alteration in pH, results in uncoupling of the 
respiration-dependant energy production resulting in bacteriostasis (Aguilera et 
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al., 2003). Transferrins also disrupt the bacterial type III secretion systems which 
promote bacterial attachment (Van Droogenbroeck, Beeckman et al., 2008). In 
vitro work is highly suggestive of a crucial role of Ovt against viral infection as 
both isoforms of Ovt (serum and egg white) have been shown to exert antiviral 
activity towards Marek‟s disease virus, an avian herpes virus (Giansanti et al. 
2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Sequence alignment of chicken Ovt (P02789), Human lactoferrin (P02788) and 
Human serotransferrin (P02787) using CLUSTAL O (1.2.1) multiple sequence alignment 
(Uniprot.org).   
SP|P02789|TRFE_CHICK MKLILCTVLSLGIAAVCFAAPPKSVIRWCTISSPEEKKCNNLRDLT----QQERISLTCV 56 
SP|P02788|TRFL_HUMAN MKLVFLVLLFLGALGLCLAGRRR-SVQWCAVSQPEATKCFQWQRNMRK---VRGPPVSCI 56 
SP|P02787|TRFE_HUMAN MRLAVGALLVCAVLGLCLAVPDK-TVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACV 59 
*:* . .:*  .  .:*:*   :  ::**::*. * .** . :             ::*: 
 
SP|P02789|TRFE_CHICK QKATYLDCIKAIANNEADAISLDGGQAFEAGLAPYKLKPIAAEVYEHTEGSTTSYYAVAV 116 
SP|P02788|TRFL_HUMAN KRDSPIQCIQAIAENRADAVTLDGGFIYEAGLAPYKLRPVAAEVYGTERQPRTHYYAVAV 116 
SP|P02787|TRFE_HUMAN KKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAV 119 
:: : ::**:*** *.***::**.*  ::* *** :*:*:.**.*   .   * ****** 
 
SP|P02789|TRFE_CHICK VKKGTEFTVNDLQGKTSCHTGLGRSAGWNIPIGTLLHRGAIEWEGIESGSVEQAVAKFFS 176 
SP|P02788|TRFL_HUMAN VKKGGSFQLNELQGLKSCHTGLRRTAGWNVPIGTLRP--FLNWTGP-PEPIEAAVARFFS 173 
SP|P02787|TRFE_HUMAN VKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLY----CDLPEP-RKPLEKAVANFFS 174 
***   * :*:*:* .****** *:****:*** *      :        :* ***.*** 
 
SP|P02789|TRFE_CHICK ASCVPGATIE--QKLCRQCKGDPKTK--CARNAPYSGYSGAFHCLKDGKGDVAFVKHTTV 232 
SP|P02788|TRFL_HUMAN ASCVPGADKGQFPNLCRLCAGTGENKCAFSSQEPYFSYSGAFKCLRDGAGDVAFIRESTV 233 
SP|P02787|TRFE_HUMAN GSCAPCADGTDFPQLCQLCPGCG-----CSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTI 229 
.**.* *      :**: * *        :    * .*****:**:** *****::.:*: 
 
SP|P02789|TRFE_CHICK NENAPD--QKDEYELLCLDGSRQPVDNYKTCNWARVAAHAVVARDDNK-VEDIWSFLSKA 289 
SP|P02788|TRFL_HUMAN FEDLSDEAERDEYELLCPDNTRKPVDKFKDCHLARVPSHAVVARSVNGKEDAIWNLLRQA 293 
SP|P02787|TRFE_HUMAN FENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQA 289 
*:  :  ::*:***** * :*:***::* *. *:* :*:****.     : **.:* :* 
 
SP|P02789|TRFE_CHICK QSDFGVDTKSDFHLFGPPGKKDPVLKDLLFKDSAIMLKRVPSLMDSQLYLGFEYYSAIQS 349 
SP|P02788|TRFL_HUMAN QEKFGKDKSPKFQLFGSPSG----QKDLLFKDSAIGFSRVPPRIDSGLYLGSGYFTAIQN 349 
SP|P02787|TRFE_HUMAN QEHFGKDKSKEFQLFSSPHG-----KDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRN 344 
*..** *.. .*:**. *       *********  : :**  :*: :***  * :**:. 
 
SP|P02789|TRFE_CHICK MRKDQLT--PSPRENRIQWCAVGKDEKSKCDRWSVVSNGDVECTVVDETKDCIIKIMKGE 407 
SP|P02788|TRFL_HUMAN LRKSEEE--VAARRARVVWCAVGEQELRKCNQWSGLSEGSVTCSSASTTEDCIALVLKGE 407 
SP|P02787|TRFE_HUMAN LREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGE 404 
:*:       : .   : ***:...*  **:.**  * *.: *  .. *:***  :::** 
 
SP|P02789|TRFE_CHICK ADAVALDGGLVYTAGVCGLVPVMAERYDDESQCSK----TDERPASYFAVAVA-RKDSNV 462 
SP|P02788|TRFL_HUMAN ADAMSLDGGYVYTAGKCGLVPVLAENYKSQQSSDPDPNCVDRPVEGYLAVAVVRRSDTSL 467 
SP|P02787|TRFE_HUMAN ADAMSLDGGFVYIAGKCGLVPVLAENYNKS------DNCEDTPEAGYFAIAVVKKSASDL 458 
***::**** ** ** ******:**.*...          *    .*:*:**. :. :.: 
 
SP|P02789|TRFE_CHICK NWNNLKGKKSCHTAVGRTAGWVIPMGLIHNRTGTCNFDEYFSEGCAPGSPPNSRLCQLCQ 522 
SP|P02788|TRFL_HUMAN TWNSVKGKKSCHTAVDRTAGWNIPMGLLFNQTGSCKFDEYFSQSCAPGSDPRSNLCALCI 527 
SP|P02787|TRFE_HUMAN TWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCM 518 
.*:.:********** ***** *****:.*:   *.***:**:.*****   * ** ** 
 
SP|P02789|TRFE_CHICK GSGGIPPEKCVASSHEKYFGYTGALRCLVE-KGDVAFIQHSTVEENTGGKNKADWAKNLQ 581 
SP|P02788|TRFL_HUMAN GDEQ-GENKCVPNSNERYYGYTGAFRCLAENAGDVAFVKDVTVLQNTDGNNNEAWAKDLK 586 
SP|P02787|TRFE_HUMAN GS---GLNLCEPNNKEGYYGYTGAFRCLVE-KGDVAFVKHQTVPQNTGGKNPDPWAKNLN 574 
*.     : *  ...* *:*****:***.*  *****::. ** :** *:*   ***:*: 
 
SP|P02789|TRFE_CHICK MDDFELLCTDGRRANVMDYRECNLAEVPTHAVVVRPEKANKIRDLLERQEKRFGVNGSEK 641 
SP|P02788|TRFL_HUMAN LADFALLCLDGKRKPVTEARSCHLAMAPNHAVVSRMDKVERLKQVLLHQQAKFGRNGSDC 646 
SP|P02787|TRFE_HUMAN EKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDC 634 
*: *** ** *  * :  .*.** .*.**** * :*   ::.:* :*:  ** * :: 
 
SP|P02789|TRFE_CHICK -SKFMMFESQNKDLLFKDLTKCLFKVREGTTYKEFLGDKFYTVISSLKTCNPSDILQMCS 700 
SP|P02788|TRFL_HUMAN PDKFCLFQSETKNLLFNDNTECLARLHGKTTYEKYLGPQYVAGITNLKKCSTSPLLEACE 706 
SP|P02787|TRFE_HUMAN SGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACT 694 
:* :*.*:.*:***.* * ** :::  .**:::** ::   : .*:.*. * :*: * 
 
SP|P02789|TRFE_CHICK FLEGK 705 
SP|P02788|TRFL_HUMAN FLRK- 710 
SP|P02787|TRFE_HUMAN FRRP- 698 
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Ovotransferrin has immunomodulatory effects, inducing respiratory burst activity 
and degranulation in heterophils and macrophages as well as stimulating the 
release of IL-6 a proinflammatory cytokine from these cells. Ovotransferrin also 
has an anti-inflammatory role through its inhibition of IL-1 and TNF-α (Xie et al., 
2002c). Ovotransferrin facilitates tissue remodelling and angiogenesis, aiding 
post inflammatory repair of tissues (Xie et al., 2002c). 
2.1.3.2 Ovotransferrin and the Acute Phase Response in chickens  
Chickens infected with a variety of pathogens, as well as immunostimulatory 
chemicals, have shown to have an increase in a 65kDa serum protein that Xie et 
al., (2002a) identified as Ovt. With reference to Table 2.1 and Figure 2.2 the 
majority of studies have confirmed that Ovt increases in response to a variety of 
experimentally induced infections and inflammatory processes.  
Infectious agent Reference 
Viral 
Infectious bursal disease virus Xie et al., 2002b  
Infectious bronchitis virus Xie et al., 2002b  
Respiratory enteric orphan virus Xie et al., 2002b 
Fowl Poxvirus Xie et al., 2002b 
Infectious laryngotracheitis virus Xie et al., 2002b  
Low pathogenic avian influenza Sylte and Suarez, 2012 
Bacterial 
Escherichia coli (LPS) 
Xie et al., 2002b 
Rath, et al., 2009 
Hallquist and Klasing, 1994 
Salmonella ser Gallinarum Garcia et al., 2009 
Parasite 
Eimeria tenella Rath et al., 2009 
Eimeria maxima Rath et al., 2009 
Immune mediated 
Autoimmune vitiligo Rath et al., 2009 
Metabolic 
Tibial dyschondroplasia separation 
(spontaneous) (6 weeks age) 
Rath et al., 2009 
Durairaj et al., 2009 
Pulmonary hypertension (ascites) 
(Induced) (6 weeks age) 
Rath et al., 2009 
Femoral head (6 weeks) Durairaj et al., 2009 
Table 2.1: Infectious, immune mediated and metabolic diseases in which Ovt has been 
measured in chickens.   
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Figure 2.2: Reported serum Ovt concentrations in experimentally induced and naturally 
occurring disease and vaccination (Table 2.1). * Base line concentration of Ovt Xie, et al., 
(2002), ** Durairaj et al., 2009, +Rath et al., 2009, ns not significantly different to respective 
controls. For the viral challenges Ovt was measured 7 days post infection (pi) (Xie et al., 2002) 
except for LPAI which was measured up to 96 hours pi (Sylte & Suarez, 2012). For E.coli and S. 
Gallinarium Ovt was measured 7 and 5 day pi respectfully (Xie et al., 2002; Garcia et al., 2009). 
Eimeria maxima results were obtained 7 days pi and the Autoimmune vitiligo (an autoimmune 
disease causes discoloured feathers, birds were 13 weeks of age when sampled (Rath et al., 
2009). The TD and femoral head separation disorder were naturally occurring, diagnosed at 
necroscopy at 6 weeks of age (Durairaj et al., 2009; Rath et al., 2009).  
Lipopolysaccharides (LPS) are cell wall components of Gram negative bacteria 
that cause inflammation and sickness and are known to induce an especially 
strong APR with resultant changes in APP (Xie et al., 2000). Escherichia (E.) coli 
LPS has been used to demonstrate that Ovt is a positive APP in chickens in a 
number of studies. Xie et al., (2000) showed that the administration of LPS from 
Salmonella (S.) typhimurium to broiler chickens resulted in significant elevations 
in IL-6 and a serum band shown to be Ovt. Garcia et al., (2009) used an oral 
infection route, infecting birds with Salmonella ser Gallinarum per os, as oppose 
to intra peritoneum and found conversely that Ovt responded negatively, 
decreasing in response to infection.  
Xie, et al., (2002b) quantified the serum Ovt levels in response to a number of 
viruses as well as E. coli. The highest Ovt concentration was detected in a viral 
ns
ns
ns
ns
0 1 2 3 4 5 6 7 8 9
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Pulmonary hypertention
Tibial dyschondroplasia**
Tibial dyschondroplasia+
Autoimmune vitiligo
Eimeria maxima
Eimeria tenella 10 days pi
Eimeria tenella 5 days pi
Salmonella Gallinarium
Escherichia coli 
Low pathogenic avian influenza
Infectious laryngotracheitis virus
Fowl Poxvirus
Respiratory enteric orphan virus
Infectious bronchitis virus
Infectious bursal disease virus
Base line concentration* 
Ovt Concentration g/L
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infection. The respiratory enteric orphan virus increased serum Ovt 
concentration 8.6 fold, while other viruses elevated serum Ovt concentration 2.6 
– 3.5 fold. Investigating the response of APPs to low pathogenic avian influenza 
(LPAI) vaccination and infection, Sylte and Suarez (2012) measured Ovt alongside 
AGP and found that chickens receiving a LPAI vaccine had significantly lower 
serum Ovt at 48 and 96 hours post infection than those chickens that did not 
receive the vaccine.  
Rath, et al., (2009) compared changes in the serum Ovt concentrations due to 
infectious diseases, metabolic diseases and autoimmune disease. In keeping with 
Xie et al., (2002b) the infectious diseases showed the biggest increases in Ovt, 
with E. coli and protozoal pathogens E. maxima and E. tenella, causing the 
greatest increases in Ovt. The autoimmune disease, autoimmune vitiligo, which 
is an auto-inflammatory disease that results in loss of melanocytes and resulting 
discolouration of the feathers, resulted in birds with increased in serum 
concentrations of Ovt. Birds with the metabolic diseases: tibial 
dyschondroplasia, pulmonary hypertension syndrome and femoral head 
separation disorders did not show elevations in serum Ovt. It was postulated 
from these results that as well as inflammation, infection or tissue injury was 
also needed to evoke a rise in OVT (Rath, et al., 2009). It appears that increases 
in Ovt are only evident with pathogenic challenge and the increases seen in birds 
with the autoimmune disorder was most likely due to the pathologically high 
levels of proinflammatory cytokines that are stimulatory to Ovt synthesis. 
Changes in the serum Ovt concentration over time have found that 6 hours post 
croton oil injection, serum concentrations dropped slightly, then continued to 
show a steady increase peaking 72 hours post injection before reducing to pre-
injection concentrations 240hours post injection (Xie et al., 2002b). 
2.1.3.3 Quantification of Ovotransferrin in chickens  
The most widely cited method to quantify Ovt in chicken serum is by 
immunoassay. Xie, et al., (2002b) describes a competitive ELISA method utilising 
rabbit α-chicken serum transferrin antibody (Accurate Chemicals) and 
biotinylated egg Ovt (Conalbumin Sigma C0755). Rath et al., (2009) describes a 
similar immunoassay, without the biotinylation step. A commercial immunoassay 
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ELISA kit is available (ICL Inc. Portland Oregan USA) and has been used with 
success (Roy et al., 2014).  
Other methods to quantify Ovt have utilised gel based methods running serum 
samples on SDS PAGE and using densitometric scanning to obtain a concentration 
(Xie et al., 2002a, Garcia et al., 2009). A method for measuring Ovt in birds has 
been adapted from Yamanishi, et al., (2002) by Horrocks, et al., (2011) and 
omits the need for an antibody and instead measures the total iron binding 
capacity (TIBC) in serum. Using three reactions steps, this method firstly 
involves saturating serum transferrin with ferric iron under alkaline conditions, 
before reducing unbound iron with absorbic acid and eliminating it by adding a 
chromogenic reagent that forms a complex with ferrozine. Finally the ferric iron 
is dissociated from transferrin and the formation of ferrozine-Fe2+ complex 
which is proportional to the TIBC under acidic conditions. The increase in 
absorbance is measured at 570 nm (primary wavelength) and 660 nm (reference 
wavelength) (Yamanishi, et al., 2002).  
2.1.4 Investigating acute phase proteins in broiler chickens  
To investigate and understand the behaviour of APPs in broiler chickens three 
studies were utilised (Table 2.2). The first examined the APPs Cp and PIT54 in 
healthy and culled broilers from a commercial farm. The second investigated the 
effect of gait score on the APPs Cp, PIT54 and Ovt. This study also looks at the 
effect of non-steroidal anti-inflammatory drugs (NSAIDs) on the same APPs. The 
third study compared the serum from birds experimentally infected with Eimeria 
tenella (E. tenella) and Escherichia coli (E. coli) to determine whether the APPs 
Cp and Ovt differed between groups. Proteomic investigations to examine 
differentially expressed protein bands was also undertaken. 
Study 1 Acute phase proteins in culled and healthy broilers 
Study 2 Effect of Gait score and NSAIDs on Acute phase proteins in broiler chickens 
Study 3 Coccidiosis and Acute phase proteins 
 
Table 2.2: Three studies on which APPs were measured. 
2.1.4.1 Acute phase proteins in culled and healthy broilers 
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All of the published data on chicken APPs has described specific and highly 
controlled experimental infections and challenges. There is no published 
information regarding APP concentrations from chickens on poultry units. Sick 
birds on a commercial unit may either die or be culled by stock personal if 
showing signs of ill health such as collapse, lameness and stunting. By obtaining 
serum from culled birds together with samples from healthy birds from the same 
unit the APPs can be measured to see if the non-specific diseases that result in a 
bird being culled result in changes in APP concentrations. The differences 
between a bird housed with thousands of other birds in a commercial 
environment compared to a small replicate pen in a scientific study are vast and 
this study may also indicate whether this affects base concentrations of APPs in 
healthy birds.  
2.1.4.2 Effect of gait score and NSAIDs on acute phase proteins in broiler 
chickens 
Gait abnormalities in broiler chickens and the diseases and disorders that cause 
them are major issues for the poultry industry affecting both productivity and 
welfare. Investigating alternative methods to identify, prevent and control the 
underlying causes of gait abnormalities in broilers would be welcomed. There 
has been no previous attempt to characterise the APP changes that occur as a 
result of gait abnormalities in broilers. The Bristol six point Gait Score (GS) 
system (Kestin et al., 1992) is a method of assessing walking style of individual 
birds and allocating a score of GS 0 (no detectable walking abnormality) through 
to GS 5 (unable to stand). This method has been widely employed in welfare 
studies to assess the walking ability of broilers. This is a qualitative method of 
assessing gait and determining the APP concentrations would determine whether 
the cause of a poor walking gait is purely mechanical or whether there are 
inflammatory factors associated with the cause of the poor walking gait. In this 
investigation, conducted by Dr. Vicky Sandilands at the Scottish Rural College 
(SRUC), birds were selected from commercial farms on the basis of having a gait 
score of 1 (GS1), a slight uneven gait typical of normal broiler walking, or GS3, 
an obvious gait defect affecting ability to move about (Kestin et al., 1992).  
Acute phase protein studies into specific causes of lameness in chickens are so 
far limited to Durairaj, et al., (2009) who measured Ovt in broilers with femoral 
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head separation and Rath et al., (2009) who also measured Ovt in chickens with 
tibial dyschondroplasia. Both of these studies found no significant elevations in 
Ovt in birds affected with these diseases, possibly because both of these 
diseases are metabolic diseases and in these studies did not evoke sufficient 
tissue damage and inflammation to cause an acute phase response. Looking to 
other veterinary species, lame cattle arriving at a clinic were found to have 
significantly elevated APPs (fibrinogen, haptoglobin and serum amyloid A) 
compared to clinically healthy cows (Jawor, et al., 2008). Lame sows were found 
to have higher haptoglobin and C-reactive protein concentrations than non-lame 
controls (Oravainen, 2008). By assessing birds with generalised non-specific 
lameness as determined by gait score, this study would determine whether 
lameness in chickens also causes elevations in APPs.   
Non-steroidal anti-inflammatory drugs are widely used analgesics for the 
treatment of inflammatory musculoskeletal diseases as well as fever, pain and 
other signs associated with inflammatory ailments (Peters et al., 2012). Non-
steroidal anti-inflammatory drugs target cyclooxygenases and subsequently 
inhibit the production of prostaglandins and thromboxanes, which are key 
mediators in the process of inflammation and thus provide a targeted approach 
to treating inflammation compared to their steroidal counterparts (Peters et al., 
2012). Meloxicam, though not licensed in birds has reported safety and efficacy 
in treating lameness, pain and joint inflammation in back yard chickens 
(Hadipour et al., 2011). It was also the aim of this study to determine if the 
administration of NSAIDs to both GS1 and GS3 birds also affected the 
concentration of APPs.  
There are few accounts describing APPs in relation to NSAIDs in veterinary 
species. Peters et al., (2012) investigating the RNA expression of inflammatory 
biomarkers in LPS treated pigs, found that the NSAID flunixin meglumine reduced 
the expression of serum amyloid A-2 48 hours post stimulation with LPS. In a 
clinical study (Bennett et al., 2013) found that osteoarthritic dogs treated with 
robenacoxib for 28 days had reduced concentrations of CRP in their synovial 
fluid, though serum concentrations of CRP were unchanged. These studies, like 
many cited in the human literature describe studies utilising NSAIDs in known 
cases of inflammatory diseases and at the therapeutic doses. It has been noted 
that at suprapharmacological doses NSAIDs will elicit pathology and gene 
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expression changes similar to LPS administration (Tugendreich, et al., 2006). 
Studies in rat models found the NSAIDs indomethacin and ibuprofen induced 
changes in the gastrointestinal tract that allow bacteria and LPS to leak into 
systemic circulation and alter hepatic expression of inflammatory genes resulting 
in an APR (Tugendreich et al., 2006). Determining whether meloxicam causes 
elevations in GS1 and GS3 birds could determine whether NSAIDs evoke a APR in 
this species, or whether the administration of NSAIDs causes no effect on the 
serum concentrations of APPs.  
2.1.4.3 Coccidiosis and acute phase proteins 
Coccidiosis is caused by protozoan parasites that are members of the genus 
Eimeria. Seven Eimeria species have been recognized to infect chickens: Eimeria 
acervulina, E. maxima, E. tenella, E. brunetti, E. necatrix, E. mitis and E. 
praecox (Vermeulen, et al., 2001; Swaggerty, et al., 2011). Each species is 
pathogenic to chickens in varying degrees, with E. acervulina, E. maxima, and E. 
tenella the most pathogenic and prevalent within the broiler industry (Swaggerty 
et al., 2011).  
Eimeria species infect the epithelial cells of the intestinal lining causing 
pathological changes varying from local destruction of the mucosal barrier and 
underlying tissue (often associated with some degree of inflammation resulting 
in endothelial lesions), to systemic effects such as blood loss, shock syndrome 
and even death (Vermeulen et al., 2001). Each Eimeria species targets a distinct 
region in the intestinal tract resulting in a characteristic pathology at this 
region: E. acervulina pathology is characterised by white lesions in the upper 
small intestine, E. maxima results in petechiae in the midgut, and E.tenella 
targets the caecal pouches and results in bloody faeces (Hammond & Long, 
1973). Coccidiosis is one of the most economically important diseases to affect 
commercial poultry production, costing the poultry industry upward of U$3 
billion worldwide annually (Swaggerty et al., 2011). At least 70% of that cost is a 
result of subclinical coccidiosis characterized by substandard flock performance, 
including decreased weight gain and increased feed conversion (Swaggerty et 
al., 2011).  
There is a great deal of interest therefore in control strategies as currently the 
only effective control strategy is the addition of anticoccidials to feed and 
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water. Vaccination development and intestinal and systemic immunity remain 
key areas in Coccidial research. The effect of Coccidial infection on APP 
concentration varies depending on the species involved. Georgieva et al., (2010) 
found Cp and fibrinogen (Fb) to increase significantly in birds infected with E. 
tenella, and found that in combination with E. coli, E. tenalla significantly 
increased serum concentration of Cp, PIT54 and Fb. This study found the 
increases in Fb concentration to be highly significant (P=<0.001). Rath et al., 
found Ovt to be significantly increased during E. tenalla infection both 5 and 10 
days post infection. Ceruloplasmin was found to only be significantly higher 6 
days post infection (Richards & Augustine, 1988). Looking at the response of Cp 
in response to E. acervulina infection, Richards & Augustine, (1988) found no 
significant increases in the serum concentration of this APP. Rath et al., (2009) 
examined E. maxima and found this species to also significantly increase Ovt 
concentrations. Table 2.3 details the serum concentrations of these APPs in 
response to Eimeria challenge.  
Coccidial 
species 
APP measured 
Control APP 
concentration g/L 
Post-infection 
APP 
concentration g/L 
Reference 
E. tenella 
Cp (8 days pi) 0.052 ± 0.01 0.098 ± 0.017* 
Georgieva et al., 2010 
PIT54 (8 days 
pi) 
0.100 ± 0.02 0.124 ± 0.007 
Fb (8 days pi) 0.99 ± 0.11 1.80 ± 0.17* 
Ovt (5 days pi) 
1.20 ± 0.16 
4.88 ± 0.37* 
Rath et al., 2009 
Ovt (10 days pi) 2.96 ± 0.32* 
Cp (3 days pi) 
0.12 ± 0.001 
0.12 ± <0.001 
Richards and 
Augustine, 1988 Cp (6 days pi) 0.20 ± 0.001* 
E. tenella 
& E. coli** 
Cp 0.052 ± 0.01 0.14 ± 0.03* 
Georgieva et al., 2010 PIT54 0.100 ± 0.02 0.150 ± 0.008* 
Fb 0.99 ± 0.11 3.35 ± 0.43* 
E. maxima Ovt (7 days pi) 1.12 ± 0.18 2.00 ± 0.24* Rath et al., 2009 
E. 
acervulina 
Cp (3 days pi) 
0.12 ±<0.001 
0.135 ± <0.001 Richards and 
Augustine, 1988 Cp (6 days pi) 0.134 ±0.001 
 
Table 2.3: Coccidial species and APP concentrations before and after infection.  
*significantly different from respective controls/pi – post infection/** Sample for APP analysis 
taken 8 days and 4 days post infection for E.tenella and E.coli respectfully. 
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2.1.5 Aims of study   
The aims of this chapter were to determine the APP response in chickens in 
three areas of poultry health. The APPs Ovt, Cp and PIT54 were targeted for 
measurement owing to the availability of these assays and previous validation 
steps undertaken for use in chickens. The first question addressed was whether 
culled birds had significantly different APP expression compared to healthy birds 
(study 1). By measuring the APPs Cp and PIT54 the normal basal values in birds 
from commercial farms can be established and used for future reference. The 
measurement of APPs in culled chickens from commercial farms has not been 
reported and although a basic undertaking in principle, determining whether 
generalised ill-health results in an elevation in APP concentrations would be 
advantageous to future applications of APP measurement in chickens. By 
measuring APPs and undertaking proteomic investigations in birds from studies 
investigating lameness and NSAIDs (study 2) and Coccidiosis (study 3), it was the 
aim of this chapter to determine what effect these diseases have on APP 
expression and acute phase sera. It was hypothesised that culled birds would 
have higher concentrations of circulating APPs (study 1) and that because 
lameness may be associated with pathological conditions it was hypothesised 
that an increased gait score would result in higher concentrations of APPs (study 
2). Previous studies focusing on APPs during Coccidial infections have found that 
these infections cause elevations in APPs in chickens, and so it was hypothesised 
that infection with E. tenella, particularly when associated with E. coli would 
cause significant increases in APP concentrations (study 3).   
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2.2 Materials and Methods 
 
2.2.1 Acute phase protein assay validation and measurement 
 
2.2.1.1 Reagents  
Chemicals and materials used were obtained from Sigma Chem. Co. Poole, UK 
and Bio-Rad Laboratories Ltd Hemel Hempstead UK. Unless otherwise stated. 
Double distilled water was used throughout. 
2.2.1.2 Bradford assay 
Bovine serum albumin (BSA), used as a standard was diluted in 0.9% NaCl from 
2mg/ml to 0.25mg/ml. Samples were diluted with 0.9% NaCl 1:5 , 1:10, 1:20 or 
1:40 as deemed necessary, and 5µl of sample and each standard were added in 
triplicate to wells of a 96 well plate (Falcon # 351172). Bradford reagent (Sigma 
#SLBC4590V) was warmed to room temperature and 250µl was added to each 
well. The plate was placed on a plate shaker for 30 seconds before incubating at 
room temperature for 5 minutes, after which the absorbance was read at 595nm 
on Flurostar optical density reader (BMG LABTECH, Ortenburg Germany).  
2.2.1.3 Ceruloplasmin assay 
Serum Cp was measured indirectly using p-phenylenediamine (PPD) oxidase 
activity. Cp catalyses the oxidation of PPD to yield a purple coloured product 
whose rate of formation can be determined by spectrophotometry. The rate of 
formation of the coloured oxidation product is proportional to the concentration 
of serum Cp (Sunderman and Nomoto, 1970). Before applying the PPD assay to 
chicken serum the optimum pH was established according to (Martinez et al, 
2007) and found to be pH 6.2. The PPD reagent was made by adding 61.5mg of 
p-phenylene di amine dihydrochloride (sigma P1519) to 25ml of 0.598M sodium 
acetate buffer pH 6.2. Porcine serum of a known Cp concentration (118mg/ml) 
was diluted 1:100 and serially diluted to achieve a standard curve. To each well 
of a 96 well plate 50µl of PPD and 15µl of serum sample or standard solution was 
added. This was left in the dark for 20 minutes and the read on a Flurostar 
optical density reader at 550nm (BMG LABTECH, Ortenburg Germany). A Pentra 
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biochemical auto analyser (Horiba Medical, Montpellier France) was used 
subsequently to measure large numbers of samples using the same method. 
Coefficient of Variants (CVs) for the Cp assay were calculated and are detailed in 
Table 2.4.  
Intra-assay 
CV 
Mean  
Concentration 
(n=3) 
SD CV 
Sample 127 
(low) 
1.85 0.27 14.62 
Sample 221 
(high) 
3.34 0.34 10.14 
 
Intra-assay  CV 12.37 
Inter-assay 
CV 
Sample run QC-low QC-high 
 
16.12.10 1.53 - 
 
29.09.11 1.41 2.58 
 
23.11.11 1.38 2.55 
 
17.12.13 0.5 1.96 
 
21.02.12 1.17 2.35 
 
27.06.12 1.31 2.39 
 
Mean 1.22 2.37 
 
SD 0.37 0.25 
 
CV 30.49 10.46 
  Inter-assay CV 20.47 
 
Table 2.4: Coefficient of Variants (CVs) for the Cp assay. Intra-assay CVs were calculated from 
the SD of the mean (n=3) to determine the within plate variation. Two samples were used: a high 
and low reading sample. The inter-assay CV was calculated from running two samples (a high and 
low) over six assay runs. The values of which were then used to calculate a CV to determine 
repeatability.  
 
2.2.1.4 PIT 54 assay 
Commercial assay methods for measuring haptoglobin, the haemoglobin binding 
protein in mammals, has been found to be effective for chicken PIT54 
(Georgieva et al. 2010). The peroxidise activity of haptoglobin (or PIT54 when 
measured in chickens) is directly proportional to the concentration of the 
protein (Eckersall et al., 1999). A Pentra biochemical auto analyser (Horiba 
Medical, Montpellier France) was used to measure this activity and calculate the 
concentration of PIT54. Table 2.5 details the calculated CVs for this assay. 
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Intra and Inter-assay Coefficient of Variants 
Intra assay  
High 17% 
Low 15% 
Inter-assay  
High  7% 
Low 7% 
Table 2.5: Coefficient of Variants (CVs) for the haptoglobin/PIT54 assay. Intra-assay CVs were 
calculated from the SD of the mean (n=12) to determine the within plate variation. Two samples 
were used: a high and low reading sample. The inter-assay CV was calculated from running two 
samples (a high and low) over twelve assay runs. The values of which were then used to 
calculate a CV to determine repeatability. 
 
2.2.1.5 Ovotransferrin Competitive ELISA 
An Ovt assay detailed by Narayan Rath (Rath et al. 2009; 2010, pers comm.) was 
modified and used to determine the concentration of Ovt. A 96 well plate was 
coated with chicken Ovt (Conalbumin Sigma C0755) at a concentration of 1µg/ml 
in 0.2M Sodium hydrogen carbonate and stored at 4°C overnight. Wells were 
washed with Tris buffered saline (18mM Tris . 123.2mM NaCl) (TBS) and blocked 
with 0.5% (v/v) fish gelatin (Sigma G7765) for 1 – 2 hours and removed before 
the addition of the test solutions.  
Ovotransferrin standards were made by serially diluting 32µg of OVT in 1 ml TBS 
to 0.125µg/ml. Rabbit anti-chicken transferrin (i.e. Ovt) antibody (Accurate 
Chemical AI-AG 8240) was diluted to a concentration of 0.2µg/ml in tris-buffered 
saline (TBS). Serum was diluted 1:20 in TBS. To wells 50 µl of diluted standards 
or samples were added in duplicate and to this 50 µl anti-chicken transferrin 
antibody was added, mixed and incubated by rocking for 2 hr. The wells were 
washed successively 4-5 times using TBS containing 0.05% tween-20 (TBS-T). To 
each well 100µl of 0.02% goat anti-rabbit IgG-HRP (abcam ab6721) was added. 
After 1 hour incubation by constant shaking, each well was aspirated and washed 
3-4 times with TBS-T. To each well 100µl of IMB peroxidase substrate (KPL 50-76-
00) was added and incubated for 4 – 5 minutes at room temperature as the wells 
turned blue. The reaction was halted with the addition of 100µl 1M HCl. 
Absorbance was measured at 450nm on a FLUOstar absorbance microplate 
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reader and analysed using associated MARS data analysis software (both BMG 
LABTECH, Ortenburg Germany) to determine OVT concentrations of samples.   
Coefficient of Variants (CVs) for the Ovt competitive ELISA were calculated using 
108 samples across 8 plates and 4 quality control samples and the results 
detailed in Table 2.6.  
Coefficient of Variants  SD CV 
Intra-assay CV 
 
10.71 14.91% 
 
 Sample   
Inter-assay CV 20 0.82 36.35 
 37 0.81 49.14 
 234 0.64 28.33 
 33 0.17 14.43 
 Average  32.06% 
 
Table 2.6: Coefficient of Variants (CVs) for Ovt competitive ELISA.  Intra-assay CVs were 
calculated from the SD of the mean of 108 samples measured in triplicate to determine the 
within plate variation. The inter-assay CV was calculated from running four samples over eight 
plates. The values of which were then used to calculate a CV to determine repeatability. 
 
2.2.2 Proteomics  
 
2.2.2.1 One and two dimensional electrophoresis SDS PAGE (1DE/2DE) 
To compare the protein profiles on one-dimension SDS PAGE (1DE) each serum 
sample was vortexed and diluted 1:10 with dH2O, 2µl of XT reducing buffer 
(BioRad #161-0788) and 10µl of XT sample buffer (BioRad #161-0791) was added, 
heated at 95°C for 4 minutes and pipetted into the well of a BioRad Criterion XT 
Bis-Tris precast 18 well gel (BioRad #345-0124). A molecular weight marker was 
added to one well and the gel was ran at 200V for approximately 25 minutes 
(just before the protein front reached the edge of the gel) in MOPS running 
buffer (BioRad #161-0788). The gel was removed from the cassette and stained 
in Coomassie blue G dye (Sigma-Aldrich, Dorset, UK) for an hour and de-stained 
in 10% (w/v) acetic acid in 25% (v/v) methanol overnight .  
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For two-dimensional (2DE) separation 200ug of protein at a concentration of 
1µg/µl was used on each gel. 200µg of protein was diluted in rehydration buffer 
(8M Urea, 2% CHAPS, 50 mM DTT, 0.2% Bio-Lyte® BioRad 163-2106) and loaded 
onto 11cm 3-10 pH non-linear IPG strip (BioRad ReadyStripTM) covered in 500µl 
of mineral oil and focused overnight with a combined rehydration - focusing step 
over 17 h totalling of 35,000 V-hr (PROTEAN IEF cell protocol, BioRad). For the 
second dimension IPG strips were firstly reduced for 10 minutes with 64.83 mM 
Dithiothreitol (DTT) dissolved in an equilibration buffer (0.374M Tris . 2.4M Urea 
. 13.68mM Glycerol . 69.36mM SDS) then 67.58 mM of acylated Iodoacetamide 
dissolved in that same equilibration buffer for 10 minutes, after which the strip 
was inserted into the well of a IPG+1 TGX precast 4-12% acrylamide gel (BioRad 
#567-1081). The gel was run for 50 minutes in MOPS buffer at 200V. Gels were 
stained in Coomassie for an hour and left to de-stain in acetic acid and methanol 
overnight for 24 hours.  
2.2.2.2 Western Blotting  
The gel (1DE or 2DE) for Western blotting was removed from the cassette and 
placed directly onto nitrocellulose paper (NCP) (Bio-Rad 162-0112) cut to size. 
Using a Criterion blotter (Bio-Rad 170-4070) the gel and NCP was placed between 
blotting paper and foam pads on both sides and sealed within a cassette holder 
and placed into the tank with two ice packs. Transfer buffer (25.012 mM Tris . 
191.82 mM Glycine . Methanol 20 % (v/v)) was added to the tank and the transfer 
made at 70V over 1 hour. The NCP was blocked overnight with 1% (w/v) non-fat 
milk protein in TBS. The following day the NCP paper was washed three times 
with TBS with 0.1% tween (TBS-T). The primary antibody was diluted in TBS-T 
and poured over the NCP paper and placed on the rocker for 1 hour. The NCP 
was washed three times with TBS-T before the addition of the secondary 
antibody conjugated to HRP and diluted with TBS-T and placed on the rocker for 
a further hour. The NCP was washed three times with TBS-T and developed with 
the addition of Opti-4-CN (BioRad #170-8235). The NCP was finally washed with 
dH2O to halt the development.  
2.2.2.3 Identification of proteins using mass spectrometry  
2.2.2.3.1 In gel digestion  
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Protein bands and spots of interest were excised from the gel, diced if necessary 
and placed into Eppendorf tubes and washed in 500µl of 100mM ammonium 
bicarbonate for 30 minutes. This wash was poured away and the gel pieces 
washed twice in 500µl of 50% acetonitrile in 100mM ammonium bicarbonate for 
30 minutes to de-stain the gel pieces. The gel pieces were finally washed in 50µl 
of 50% acetonitrile to shrink the gel pieces for 10 minutes, after which the 
solvent was removed and the gel pieces air dried completely in a vacuum 
centrifuge for 2 hours. In gel digestion was performed with sequencing grade 
trypsin (Promega, WI USA, V511A) which was re-suspended in 20µl of 25mM 
ammonium bicarbonate and added to the dried gel pieces. Once the trypsin has 
absorbed and the gel pieces fully rehydrated a further 20µl of 25mM ammonium 
bicarbonate was added over the gel pieces. The protein was allowed to digest 
overnight at 37°C. The following day the Eppendorf‟s were pulse centrifuged to 
pellet the gel pieces and the liquid transferred to a 96 well plate. To the 
remaining gel pieces, 20µl of 5% formic acid was added and allowed to incubate 
for 20 minutes on the shaker after which 40µl of acetonitrile was added and the 
incubation continued for a further 20 minutes. The gel pieces were pelleted and 
the liquid added to the 96 well. The combined extracts on the plate were dried 
down completely in a vacuum centrifuge.  
2.2.2.3.2 Protein identification   
Protein were identified using nanoflow HPLC electrospray tandem mass 
spectrometry (nLC-ESI-MS/MS), in Glasgow Polyomics, in collaboration with Dr. 
Richard Burchmore. Peptides were solubilised in 2 % acetonitrile  with 0.1 % 
trifluroacetic acid and fractionated on a nanoflow uHPLC system (Thermo 
RSLCnano) before online analysis by electrospray ionisation (ESI) mass 
spectrometry on an Amazon ion trap MS/MS (Bruker Daltonics). Peptide 
separation was performed on a Pepmap C18 reversed phase column (LC 
Packings). Peptides were desalted and concentrated for 4 min on a C18 trap 
column followed by an acetonitrile gradient for a total time of 45 min. A fixed 
solvent flow rate of 0.3 l / min was used for the analytical column.  The trap 
column solvent flow rate was fixed at 25 l / min using 2 % acetonitrile with 
0.1% v/v trifluroacetic acid. Mass spectrometric (MS) analysis was performed 
using a continuous duty cycle of survey MS scan followed by up to ten MS/MS 
analyses of the most abundant peptides, choosing the most intense multiply 
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charged ions with dynamic exclusion for 120s (Burchmore, pers comm. 2013). MS 
data was processed using Data Analysis software (Bruker) and the automated 
Matrix Science Mascot Daemon server (v2.4.1). Protein identifications were 
assigned using the Mascot search engine to interrogate protein sequences in the 
NCBI Genbank databases for Gallus gallus and bony vertebrates, allowing a mass 
tolerance of 0.4 Da for both MS and MS/MS analyses (Burchmore, pers comm. 
2013). Searches were made in both the Gallus gallus database and the bony 
vertebrate database, the latter being more extensive and therefore used to 
ensure that any proteins, not yet annotated for or identified in G.gallus could be 
putatively matched and identified.  
 
2.2.3 Investigating acute phase proteins in broiler chickens 
 
2.2.3.1 Study 1: Acute phase proteins in culled and healthy broilers 
To establish whether the APPs Cp and PIT54 were elevated in birds culled due to 
ill health and poor performance, two groups of chickens were sampled from a 
commercial broiler farm in Scotland. Blood samples (serum) were taken 
immediately post mortem from two groups of chickens: control chickens (n=20) 
with no obvious signs of disease and culled chickens (n=18), birds removed from 
the flock by stock personal due to poor growth rate, as evidenced by stunted 
growth, or lameness. These birds were culled and blood sample taken 
immediately post-mortem intracardially.   
2.2.3.2 Study 2: The effect of gait abnormality and NSAID on plasma acute 
phase protein concentration and plasma proteome.  
Bloods were received from collaborators Dr. V. Sandilands and Professor N. 
Sparks at Scotland‟s Rural College (SRUC) from their study conducted to 
investigate the effects of NSAIDs on the gait score of commercially reared 
broilers (approved by the SRUC ethics committee). At the SRUC, 132 male Ross 
and Cobb broiler chickens aged 35-36 days were selected from a number of 
commercial farms from the same company on the basis of  having a gait score of 
1 (GS1), a slight uneven gait typical of normal broiler walking, or GS3, an 
obvious gait defect affecting ability to move about (Kestin et al., 1992). Birds 
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were weighed and injected with either saline (S), 2mg/kg meloxicam (M2) or 
5mg/kg meloxicam (M5). Blood was recovered from the birds when culled 6, 30, 
54 or 78 hours after meloxicam injection and the serum concentrations of the 
APPs ceruloplasmin, PIT54 and ovotransferrin were determined. For analysis of 
the acute phase reactive plasma (APRP) proteome of the GS3 birds, samples 
were ranked according to plasma concentrations of Cp, PIT54 and OVT and the 
plasma samples (n=3) with the highest across all APPs selected. Acute phase 
protein results from the GS1 birds were also ranked and samples with the lowest 
APP concentrations selected (n=3) for further proteomic investigation (non-
APRP). The plasma proteomes was analysed using 2DE and spots were selected 
based on differential expression between the two gait groups.  
2.2.3.3 Study 3: Serum Ceruloplasmin and Ovotransferrin in chickens 
infected with Escherichia coli and Eimeria tenellla. 
Serum samples were received from Professor Teodora Georgieva, of Trakia 
University, Bulgaria. Samples were from three groups of chickens. In this study 
(approved by Trakia University Ethics committee) group 1 were challenged orally 
with E. tenella oocysts (n=5), group 2 were challenged with both oral E. tenella 
oocysts orally and E. coli via intraperitoneal injection (n=7) and group 3 were 
healthy controls (n=11). The experiment was conducted under the same 
conditions and applying the same methods described in Georgieva et al. (2010). 
Samples underwent SDS PAGE in a single dimension to separate the serum 
proteins to identify Ovt using mass spectrometry. The serum concentrations of 
Ovt and Cp were determined as previously described.  
From the 1DE gel bands of interest were excised for identification using mass 
spectrometry. Bands of interest were selected by identifying bands differentially 
present between samples. Selected individual protein bands were cut from the 
gel, trypsin digested into peptides and analysed using mass spectrometry and 
MASCOT database searching (Glasgow Polyomics, University of Glasgow).  
2.2.4 Statistics  
The results for studies 1 and 3 were analysed using GraphPad Prism v5. The data 
was evaluated using D'Agostino-Pearson omnibus normality test. Non-parametric 
analysis was selected based on the results with a Kruskal-Wallis with Dunn post-
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test analysis employed for all analysis except for study 1. For this study the 
initial analysis employs a student t-test. With assistance from Dr. Claire Walls 
(University of Glasgow) the results for study 2 were analysed as a general linear 
mixed models with the „R‟ statistical program v2.12.1. (Walls pers comm. 2012).  
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2.3 Results  
 
2.3.1 Investigating acute phase proteins in broiler chickens 
 
2.3.1.1 Study 1: Acute phase proteins in culled and healthy broilers 
The serum concentrations of the APPs Cp and PIT54 were determined from 
culled and healthy birds from a commercial farm. A t-test revealed a statistically 
significant (p=<0.05) difference in both Cp and PIT54 between serum from culled 
(n=18) and healthy birds (n=20) (GraphPad Prism v.5). Culled birds had increased 
serum concentrations of both APPs (Figure 2.3) when compared to apparently 
healthy birds within the same flock.  
 
Figure 2.3 : Scatter plot of Cp and PIT54 concentrations of culled (n=18) and healthy (n=20) 
birds from a commercial farm, with mean (horazontal bar) and ± SEM. Data was analysed 
using t-test (*p<0.05) using GraphPad Prism v5.  
 
Figure 2.4:  Scatter plot of Cp and PIT54 concentrations of lame (n=7), stunted (n=11) and 
healthy (n=20) birds from a commercial farm, with mean (horazontal bar) and ± SEM. Data 
was analysed using Kruskal Wallis test with Dunn post test analysis (*p<0.05) using GraphPad 
Prism v5. 
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When the birds culled were divided into those culled for stunting and those 
culled from lameness, a non-parametric Kruskel-Wallis test, with Dunn post test 
analysis was performed on the three groups. This revealed no significant 
difference in PIT54 concentration between the three groups. When the same 
test was applied to the Cp concentrations there was a significant difference 
between the three groups, the Dunn post test analysis revealing this to lie 
between the healthy and stunting. Figure 2.4 details graphically the serum 
concentrations of PIT54 and Cp in these three groups and Table 2.6 contains the 
descriptive statistics.  
Group APP N Min Max Mean Median SD 
Healthy 
PIT54 20 0 0.0550 0.0285 0.0330 0.01431 
Cp 20 0 0.0980 0.00815 0.0 0.02565 
Lameness 
PIT54 7 0 0.7510 0.1894 0.0310 0.2901 
Cp 7 0 2.491 0.4304 0.0 0.9174 
Stunting 
PIT54 11 0.0080 0.2380 0.07173 0.0400 0.07055 
Cp 11 0 4.516 0.6191 0.0 1.335 
 
Table 2.6: Descriptive statistics for APP concentrations for culled and healthy birds. Data 
calculated using D'Agostino-Pearson omnibus normality test (GraphPad Prism v5). 
 
2.3.1.2 Study 2: The effect of gait abnormality and NSAIDs on plasma acute 
phase protein concentration and plasma proteome. 
Serum concentrations of all three APPs were significantly associated with gait, 
with GS3 birds having significantly higher Cp (p≤ 0.001), PIT54 (p≤ 0.05) and Ovt 
(p≤ 0.05) than GS1 birds. These results are described in Table 2.7 and Figure 2.5. 
 Gate score 1 Gait score 3 
 lowest Highest Median lowest Highest Median 
Cp g/L 0.275 2.352 0.698 0.037 4.440 0.815 
PIT54 g/L 0.008 0.186 0.105 0.059 0.188 0.115 
Ovt g/L 0.750 3.668 2.210 0.413 11.903 2.065 
 
Table 2.7: Cp, PIT54 and Ovt concentration ranges and medians in GS1 and GS3 birds.  
 
Cp was significantly associated with weight with heavier birds tending to have 
higher Cp concentrations (p≤ 0.05). Birds treated with 5mg/kg of meloxicam 
(M5) had significantly increased Ovt concentrations, though no significant 
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increase was observed in birds receiving 2mg/kg of meloxicam (M2) (Figure 2.6). 
There were no significant associations between the APP concentrations and 
broiler breed or time when the meloxicam was administered.   
 
Figure 2.5: Scatter plot of Cp, PIT54 and Ovt plasma concentrations in GS1 (n=64) and GS3 
(n=68) birds. Mean (horizontal bar), ± SD and significance is indicated *p≤0.05/**p≤0.001 
(GLM,„R‟ v2.12.1).  
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Figure 2.6: Scatter plot of Ovt plasma concentrations in saline (n=43), meloxicam  at 2mg/kg 
(M2) (n=51) and 5 mg/kg (M5) (n=38) treated birds. Mean (horizontal bar), ± SD and 
significance is indicated *p≤0.05 (GLM,„R‟ v2.12.1).  
 
APP concentration was used to select plasma from the most acute phase reactive 
GS3 birds and compared to non-APRP from GS1 birds. Differences were found in 
a number of regions on the APRP and non-APRP gels, with many spots differing in 
presence and intensity. The 3 non-APRP samples gave consistent plasma 
proteomes (Figure 2.7 a).There was more variation in the proteomes of the 3 
APRP samples, with additional spots appearing and apparent differences in the 
intensity of spots (Figure 2.7b). 
  
 
 
 
 
APRP plasma                                                    Non-APRP 
Figure 2.7 a: Non-APRP and acute phase plasma                                        :  
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Figure 2.7 b: Six 2DE gels from APRP (left) and non-APRP (right). 
 
 
Figure 2.7: a) 2DE gels comparing non-acute phase reactive plasma (Non-APRP) (a) and 
acute phase reactive plasma (APRP). b) Comparison of three APRP and three non-APRP 
gels.  Separation was achieved over pi 3-10 and molecular weights of 10-200kDa. An IPG+1 
TGX precast midi 4-12% acrylamide gel (BioRad#567-1081). Protein is stained with Coomassie 
blue G dye (Sigma Aldrich).  
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Figure 2.8: Summary of proteins found in GS3 broiler, identified using mass spectrometry. 
Separation was achieved over pi 3-10 and molecular weights of 10-200kDa. An IPG+1 TGX precast 
midi 4-12% acrylamide gel (BioRad#567-1081). Protein is stained with Coomassie blue G dye 
(Sigma Aldrich). Spots were excised from the gel trypsin digested and identified using nanoflow 
HPLC-EPI-MS/MS with identities assigned using Mascot Science Daemon server to interrogate 
protein sequences in the NCBI Genbank database for Gallus gallus and boney vertebrates.      
Mass spectrometry and peptide fingerprinting identified proteins labelled in 
Figure 2.8. Established APPs Ovt and PIT54 were identified, however Cp was not 
identified on the 2DE gel. Other APPs identified included haemopexin (Hpx), AGP 
and fibrinogen (Fb). In contrasting the plasma proteomes of APRP from the GS3 
birds to the non-APRP of the GS1 birds, the areas corresponding to 
immunoglobulin (Ig) have increased while the Ovt spots are of a higher intensity 
in the APRP from the GS3 birds. The AGP spot was well defined in the APRP gels 
and was either faint or completely absent in the non-APRP gels. A full and 
comprehensive protein identification list for the gel in Figure 2.8 is contained in 
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Appendix 2.5, and corresponds to the same gel with the spots numbered (Figure 
2.8).  
 
Figure 2.9: Gait gel with numbered labels. Separation was achieved over pi 3-10 and molecular 
weights of 10-200kDa. An IPG+1 TGX precast midi 4-12% acrylamide gel (BioRad#567-1081). 
Protein is stained with Coomassie blue G dye (Sigma Aldrich). A full detailed list of results is 
available in Appendix 2.5 
 
2.3.1.3 Study 3: Serum Ovotransferrin and Ceruloplasmin in chickens 
infected with Escherichia coli and Eimeria tenellla 
A non-parametric Kruskal – Wallis test revealed the serum concentration of Ovt 
to be significantly affected by E. tenella and E. coli infection, with Dunn post-
hoc analysis indicating that the birds infected with both pathogens to have 
significantly higher Ovt than the control birds (Figure 2.10). Birds infected with 
E. tenella alone did not have significantly higher Ovt than the control birds. A 
highly significant association (p ≤0.0001) was found between infection group and 
serum Cp concentration, with Dunn post-hoc analysis revealing both the 
combination infection of E. tenella and E. coli and E. tenella alone groups to 
have significantly higher Cp than the control group with p values of ≤0.01 and  
≤0.05 respectfully.  
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From a 1DE gel loaded with a control sample, three serum samples from 
individual birds infected with E. tenella and four from birds infected with both 
E. tenella and E. coli; bands showing differential intensity in Coomassie staining 
were selected, excised and identified using mass spectrometry (Figure 
2.11/2.12). The proteins identified are listed in Table 2.8. Ovotransferrin was 
identified with a molecular weight of 77.7 kDa. This band was present in all 
infected samples and no band was identified in the control sample at this 
molecular weight.  
 
Figure 2.10: Boxplot graph describing serum Ovt and Cp from birds infected with 
E.tenella (n=5), E.tenalla and E.coli (n=7) and a control group (n=11). Data presented in 
median with 25 to 75 percentile range. Statistical significance (Kruskal-Wallis and Dunn post-
test analysis) is reported: *p<0.05, **p<0.01 (Graphpad Prism v5). 
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Figure 2.11: 1DE gel with serum from E. tenella and E. tenella and E. coli infected birds. 
Separation was achieved using a 4-12% CriterionTM Bis-Tris precast polyacrylamide gel 
(BioRad#345-0124). Protein is stained with Coomassie blue G dye (Sigma Aldrich). 
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  Name 
Protein Identification 
Score 
Theoretical 
Matched Sequence 
Coverage 
% UniProt 
Accession 
NCBI  
Identifier 
Mass Da PI 
1 fibronectin [Gallus gallus] P11722 gi|311213923 472 276669 5.43 14(3) 14(3) 6 
2 Alpha-2-macroglobulin 
precursor(Alpha-2-M) 
[Gallus gallus]* 
P98157 gi|118083282 
 
698 164165  15(7) 15(7) ** 
Ovotransferrin P02789 gi|1351295  70 79551  6.85 2(0) 2(0) 2 
3 Ovotransferrin P02789 gi|1351295  74 79551 6.85 2(0) 2(0) 2 
Serum albumin [Gallus 
gallus] 
P19121 gi|45383974 69 71868 5.51 2(0) 2(0) ** 
4 Serum albumin [Gallus 
gallus] 
P19121 gi|45383974 997 71868 5.51 32(8) 23(7) ** 
PIT 54 protein [Gallus 
gallus] 
Q98TD1 gi|46395491  82 52670 4.61 3(2) 2(1) 4 
Hemopexin (Gallus gallus) P20057 gi|118106467 71 16191 5.61 2(1) 2(1) ** 
5 serum albumin [Gallus 
gallus] 
P19121 gi|45383974  360 71868 5.51 14(3) 10(2) ** 
6 Fibrinogen beta chain Q02020 gi|399491 708  7.18 33(13) 13(8) 30 
Chain C, Crystal Structure 
Of Native Chicken 
Fibrinogen 
P14448 gi|8569623 146 47486 5.4 3(2) 3(2) 6 
7 Chain C, Crystal Structure 
Of Native Chicken 
Fibrinogen 
P14448 gi|8569623  370 47486 5.4 23(3) 10(2) 23 
8 complement component 3d 
[Gallus gallus] 
A6N9E0 gi|83655498 146 36820 9.11 4(1) 4(1) 11 
complement C3 precursor 
[Gallus gallus] 
P04210 gi|45382303 103 185510 6.69 4(0) 4(0) 1 
Ig light chain precursor V-J 
region – chicken 
* gi|104728 50 22769 5.36 2(0) 2(0) 9 
9 apolipoprotein A-I [Gallus 
gallus] 
P08250 gi|211159  576 30673 5.58 22(7) 13(5) 44 
Ig light chain [Gallus 
gallus] 
* gi|212058  192 23868 5.34 5(2) 4(2) 17 
Ig light chain precursor V-J 
region – chicken 
* gi|104728  190 22769 5.36 5(2) 4(2) 17 
complement C3 precursor 
[Gallus gallus] 
P04210 gi|45382303  149 185510 6.69 4(1) 4(1) 2 
1
0 
apolipoprotein A-I [Gallus 
gallus] 
P08250 gi|211159  236 30673 5.58 19(0) 8(0) 29 
pre-fibrinogen alpha 
subunit [Gallus gallus] 
P14448 gi|732995 215 56766 6.82 20(1) 6(1) 8 
Ig light chain precursor V-J 
region – chicken 
* gi|104728  60 22769 5.36 3(0) 2(0) 8 
*name has since changed to Low-density lipoprotein receptor-related protein 1 (P98157) 
**Mascot online database of results has moved this protein and original result.  
Table 2.8: Proteins identified from 1DE (Figures 2.11 and 2.12) identified by Mascot Gallus 
gallus peptide database. Bands were excised from the gel trypsin digested and identified using 
nanoflow HPLC-EPI-MS/MS with identities assigned using Mascot Science Daemon server to 
interrogate protein sequences in the NCBI Genbank database for Gallus gallus and boney 
vertebrates. Both NCBI and where Uniprot identifications are listed (immunoglobulins are not 
listed in Uniprot). The protein score is the sum of the highest ions score for each distinct 
sequence. The first number under matches is the count of MS/MS spectra that have been 
matched to peptides from this protein. The matches shown in the parenthesis indicating unique 
matches (scores above the significance threshold). The sequences column is the count of 
matches to distinct peptide sequences, the number in parenthesis is the count of sequences with 
significant matches (Matrixscience.com). The coverage percentage is proportion of the protein‟s 
entire sequence identified.  
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Figure 2.12: Excised bands identified with MS. The same, labelled, figure is shown in Figure 
2.11. Results are detailed in Table 2.8. Separation was achieved using a 4-12% CriterionTM Bis-
Tris precast polyacrylamide gel (BioRad#345-0124). Protein is stained with Coomassie blue G dye 
(Sigma Aldrich). 
 
 
 
 
 
 
 
96 
 
2.4 Discussion  
 
2.4.1 Study 1: Acute phase proteins in culled and healthy 
broilers 
Currently there is no published information available on the APP concentrations 
of broiler chickens from commercially sized poultry farms. There is a need for 
relevant reference ranges to compare experimental data and culled birds 
represent an accepted yet unnecessary economic loss to the poultry industry. 
This study determined the serum concentrations of PIT54 and Cp in healthy birds 
and birds culled for generalised ill health, namely stunted growth and lameness 
and found the concentrations to be significantly different, with culled birds 
having significantly higher concentrations of PIT54 and Cp.  
The healthy birds had maximum serum concentrations of 0.055 g/L and 0.0980 
g/L for PIT54 and Cp respectfully, with only two of the twenty healthy birds 
sampled having a serum Cp concentration within the detectable range of the 
assay, the rest fell below the minimal detectable limit (MDL) of the assay. The 
average PIT54 and Cp concentrations for healthy birds were 0.029 and 0.008 g/L 
respectfully. For PIT54 that is a 12 fold reduction on the average baseline of 
0.36 g/L reported for healthy control birds in a number of studies (Georgieva et 
al., 2010; Millet, et al., 2007; Nazifi, et al., 2010; Nazifi, et al., 2011). For Cp 
the healthy birds had an average Cp concentration that was 9 fold lower than 
the reported average baseline for Cp in healthy control birds (Disilvestro & 
Harris, 1985; Georgieva et al., 2010; Richards & Augustine, 1988).  
The lower PIT54 and Cp concentrations seen in the healthy birds from this study 
compared to those cited in the literature could be due to the variation that will 
inevitably exist between farms, studies, birds, assaying method and the wide 
time scale over which these studies were conducted. The serum Cp 
concentration of the healthy birds was less than the MDL in all but two birds. For 
both PIT54 and Cp many of the samples did not reach the MDL of the assay which 
could also be why there is variation in the serum concentrations in this study and 
those cited in the literature.  
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The age of the birds could have a strong effect on the serum concentrations of 
APPs. The ages of the birds in this study were of various ages ranging from 12 – 
25 days and similarly the ages of the birds from the literature vary considerably 
making comparisons problematic. Further studies would be needed to ascertain 
whether age effects APP serum concentrations.  
In this study birds were culled due to lameness or stunting, routine non-specific 
conditions that result in a birds removal from a flock. When the culled group was 
sub-divided into lameness and stunted, differences in PIT54 concentrations 
between these groups were detected. Dunn post hoc analysis revealed that 
PIT54 was significantly different between healthy and the stunted culled birds 
specifically, with no significant difference noted between PIT54 serum 
concentrations of the healthy and lame culled birds. Analysis of the culled bird 
Cp concentrations revealed no differences between the two culled groups.  
Previous studies measuring the APPs of birds with specific causes of lameness 
found that metabolic diseases that cause lameness, namely tibial 
dyschondroplasia and femoral head separation disorders did not show elevations 
in serum Ovt, because as well as inflammation, infection or tissue injury was 
needed in addition to inflammation to evoke a rise in OVT (Rath, et al., 2009). 
The results of this study suggest that the lame birds were not undergoing an 
APR. The presence of two outliers however, exhibiting much higher PIT54 
concentrations in the lameness group suggest that more than one disease is 
responsible for the lameness, or that the birds were at differing stages of a 
disease process, with one disease or stage resulting in an acute inflammatory 
response, as evidenced by the two high PIT54 outliers, one of which is also 
produces the single high Cp outlier for lameness. The stunted birds were shown 
to be undergoing an inflammatory response consistent with the presence of an 
APR the causes of which were unknown but likely to be associated with the 
stunting. 
2.4.2 Study 2: The effect of gait abnormality and NSAIDs on 
plasma acute phase protein concentration and plasma 
proteome. 
In a second study conducted in collaboration with SRUC into gait scored broilers 
from commercial farms, it was found that the APPs PIT54, Cp  and Ovt were all 
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significantly associated with gait, with GS3 birds having significantly higher Cp 
(p≤ 0.001), PIT54 (p≤ 0.05) and Ovt (p≤ 0.05) than GS1 birds. This study, unlike 
the previous smaller study, indicated that lameness was associated with an APR 
which significantly elevated all three APPs. The larger numbers of birds used in 
this study (GS3 n=68, GS1 n=64) compared with the smaller study (healthy n=20, 
culled n=18) gives increased statistical weight to these results. In addition the 
protocol based assessment of gait with an associated score is a more objective 
measure of lameness than that used in the first trial and may also have had an 
influence on these increased APP found with increasing GS. These results 
indicate that increased APP expression is associated with poor GS in broilers. 
Within the groups there was considerable variation in the APP concentrations 
which may indicate that sub-populations exist related to differing aetiologies of 
gait defect. All birds in this study were potential hosts to a wide variety of 
pathologies and conditions that cause leg weakness and affect gait.  
There were no significant associations between the APP concentrations and 
broiler breed and although no significance was identified between weight and 
gait score, Cp was significantly associated with weight with heavier birds from 
both GS1 and GS3 tending to have higher Cp concentrations (P≤ 0.05). Higher Cp 
in the heavier birds may indicate that increasing weight results in a series of 
events, inflammatory in nature, that result in higher plasma Cp concentrations. 
Alternative explanations for this finding may lie in the causes of the increased 
bodyweight in this group of birds such increased feed intake. 
Multiple studies have shown that both basal concentrations and acute phase 
concentrations of APPs can be affected by a variety of dietary supplements. 
Plasma Cp concentrations can be modulated by dietary copper concentrations 
(Song, et al., 2009) and supplementations such as conjugated linolenic acid can 
affect the serum concentrations of APPs including Cp during experimentally 
induced APR (Takahashi, et al., 2002). Protein supplementation can also illicit 
changes in the circulating concentrations of APPs. Takahashi, et al., (1995) 
found birds fed a high protein diet had higher plasma alpha-1-acid glycoportein 
(AGP) concentrations than those fed a low protein diet. Those on the high 
protein diet went on to generate smaller increases in AGP as a result of LPS 
challenge than the low protein group. Notably feed restriction has been shown 
to have no effect on APP concentrations (Najafi, et al., 2015). The significant 
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association between bodyweight and Cp concentration may be an inflammatory 
consequence of increase bodyweight, but this relationship requires further 
investigation. The findings of the aforementioned studies showing how the APR 
can be effectively modulated by changes in diet cannot be overlooked given the 
association between bodyweight and feed intake.  
When comparing the proteomic profiles of the acute phase reactive plasma 
(APRP) and the non-APRP of GS3 and GS1 birds, differences were found in a 
number of regions with many spots differing in presence and intensity. Many of 
the proteins identified in the gels were found previously in the chicken serum 
proteomes detailed by Huang et al. (2006) and Gilbert et al., (2011). The 
protein identifications reveal that a number of APPs were present in the 
proteomes of both acute phase and non-acute phase plasma (APRP/non-APRP) 
from GS1 and GS3 birds. Mass spectrometry and peptide fingerprinting identified 
the APPs OVT, PIT54, Hpx, AGP and Fb. Ceruloplasmin was not identified on any 
of the 2DE gels. The increased immunoglobulin (Ig) in the APRP from the GS3 
birds together with the higher intensity of the Ovt spots and a well defined AGP 
spot that was either faint or completely absent in the non-APRP gels is 
supportive of the assay results that also indicate that an acute inflammatory 
reaction is taking place in the GS3 birds. Further proteomic work looking at the 
effects of lameness on the proteome would benefit from the removal of albumin 
and immunoglobulin as these are dominant proteins within the serum/plasma 
proteomes and their removal would allow other less abundant proteins to be 
identified more easily.  A quantitative proteomic approach would also be of 
value in investigation of the APP in the chicken samples. 
Birds in this study were designated into one of three groups: those injected with 
saline and two groups that receiving 2mg/kg and 5mg/kg of the NSAID 
meloxicam intramuscularly. Ovotransferrin was the only APP to be affected by 
meloxicam, and only at the higher dose. Both Cp and PIT54 concentrations 
remained unaffected by the administration of meloxicam. The literature 
suggests that at therapeutic doses, in animals not undergoing an inflammatory 
reaction, NSAIDs are unlikely to induce an increase in APP expression. There are 
numerous studies of inflammatory diseases that investigate the effects of NSAIDs 
on APPs concentrations and the results are variable. Lewis, et al., (1998) for 
example found the NSAIDs to increase haptoglobin and Cp in experimental 
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models of rats with inflammation, whereas Bennett et al. (2013) found no 
changes in serum CRP in osteoarthritic dogs treated with NSAIDs. What has been 
established is that suprapharmacological doses of NSAISDs will affect the 
integrity of the intestine with the resultant translocation of bacteria and toxins 
into the systemic circulation which will stimulate an APR with resultant rises of 
APPs (Tugendreich, et al., 2006). Meloxicam is used, off license, in back yard 
chickens at a dose of 0.2-2mg/kg. At the 2mg/kg dose this study showed no 
significant increase of the measured APPs. At 5mg/kg, Ovt was shown to be 
significantly higher. It is highly probable that at this dose, the meloxicam had 
deleterious effects on the gastrointestinal tract – a recognised side effect of 
NSAIDs causing the increase in the moderate APP Ovt via the mechanism 
described above.  
2.4.3 Study 3: Serum Ovotransferrin and Ceruloplasmin in 
chickens infected with Escherichia coli and Eimeria 
tenellla 
The results of the study investigating the serum concentrations of Ovt and Cp 
during infection with E. tenella and E. coli revealed that E. tenella infection 
alone did not significantly increase the Ovt serum concentrations and that duel 
infection with E. coli was needed to evoke a significant rise in Ovt. This result 
contrasts with Rath et al., (2009) who found Ovt to increase significantly with E. 
tenella infection alone. This Eimeria species colonises the caecal pouches 
causing haemorrhaging and localised pathological changes that are amongst the 
most serious of the Eimeria infections, yet despite this a concurrent infection of 
E. coli was also needed to evoke a significant rise in Ovt.  
Eimeria tenella infection alone did significantly increase Cp concentrations as 
did the combination E. tenella and E. coli infection (p≤0.01 and p≤0.05 
respectfully). These findings compare with Georgieva et al., (2010) who also 
found Cp to significantly increase (p≤0.05) with both combination and E. tenella 
infection alone. Georgieva et al., (2009) also found the APP Fb increased during 
E. tenella infection, yet like Ovt, PIT54 only significantly increased during a 
combined infection of E. tenella and E. coli and not E. tenella alone. This study 
also found that E. coli when administered alone did significantly increase PIT54 
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and Cp. The results of Georgieva et al., (2010) and this study are suggestive of 
E. coli being a more effective stimulant of the APR.  
When E. tenella infection causes an APR, the aetiology probably follows a similar 
course to the suprapharmacological doses of NSAIDs. Eimeria tenella, 
compromising the integrity of the intestinal barrier, results in the translocation 
of intestinal bacteria into systemic circulation with a resultant APR. 
Furthermore, a number of factors that have been shown to affect the outcome 
of naturally occurring Eimeria infections could also affect the results during 
experimental infections. Genetic factors and the interference of simultaneous 
infection with different Eimeria species and interactions with other pathogens 
such as viruses and enteric bacteria will determine the severity of the disease 
(Vermeulen, et al. 2001). Managerial factors, like poor hygiene, presence of 
other animals on the farm, the use of in-feed medication and the occurrence of 
other infectious diseases in the present or previous flock all affect the spread of 
the disease and the severity of the infection (Graat et al., 1998) and as such will 
affect the severity and duration of an APR.  
A control sample and three samples of serum from birds infected with E. tenella 
and four samples from birds infected with both E. tenella and E. coli were 
subjected to 1D SDS gel electrophoresis. A number of bands appearing 
differentially present between infected and control samples were identified as 
APPs: Ovt, Fb, Fn and apo-AI. The proteins Complement 3 an activator of the 
innate immune system and alpha-2-macroglobin (low-density lipoprotein 
receptor-related protein 1) a major plasma protein were also found to be 
differentially expressed between samples though further work would be needed 
to assess the significance of these preliminary results.  
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Chapter  3 
The development of an ovotransferrin radial 
immunodiffusion assay  
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3.1 Introduction  
 
The competitive ELISA described in chapter 2 is an ovotransferrin (Ovt) assay 
detailed by Narayan Rath (Rath et al. 2009; 2010, pers comm.), modified and 
used to determine the concentration of Ovt. After applying this assay to a 
number of sample sets including the ones detailed in chapter 2, it was apparent 
that the repeatability, as represented by both intra- and inter-assay co-efficient 
of variants (CVs) were unsatisfactorily high. The intra-assay CV was 14% and the 
inter-assay CV was 32%. The reagent used in this assay, namely the rabbit α-
chicken transferrin antibody (Accurate Chemical AI-AG 8240) was also 
prohibitively expensive analysis of a large numbers of samples. The method was 
lengthy and required large numbers of repeated washes. 
To address the problem of an inadequate assay method for Ovt, an apt APP 
target in chickens, a new assay was developed. A radial immunodiffusion (RID) 
assay, using an antibody produced against egg derived Ovt as an antigen, was 
developed and applied to a number of samples sets.   
3.1.1 Radial Immunodiffusion 
The presence of a ring, formed in gels from the precipitation reaction between 
an antigen and anti-serum, was observed by early immunoscientists with 
Ouchterlony (1949) the first to detail the relationship between precipitate and 
anti-serum concentration and exploit single radial diffusion for quantitative 
purposes (Ouchterlony, 1949; Mancini, et al., 1965). A single-diffusion  
precipitation reaction is performed by incorporating one of the two partners of 
the reaction, usually the antibody into agarose gel at a uniform concentration, 
whereas the other reactant, usually the antigen is introduced into a well from 
which it is allowed to diffuse into the gel where it will react with the internal 
reactant. Radial immunodiffusion occurs when a gel is flat and the diffusion 
occurs radially starting from a circular well (Mancini, et al., 1965).  
Mancini et al., (1965) comprehensively detailed RID for the purposes of 
identification and quantification of a known antigen from whole serum, 
describing the linear relationship between the area of the precipitate and the 
concentration of the antigen. This method has been widely applied for research 
and diagnostic purposes, though its popularity has decreased since other assay 
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methods such as ELISAs, automated analysers and more recently quantitative 
proteomic methods have developed. Despite this, the RID method remains 
robust, straightforward, cost effective and reliable and as such, a good 
technique to measure and evaluate Ovt in chickens.  
3.1.2 Egg Ovotransferrin 
Ovotransferrin (Ovt) is synthesised both in the liver and the oviduct and is 
secreted into circulation or incorporated into the egg white respectfully. The 
antibody used in the assay described and modified from Rath, et al. (2009; pers 
comm. 2010) utilises rabbit α-chicken transferrin antibody (Accurate Chemical 
AI-AG 8240), a polyclonal antibody raised against chicken serum Ovt. Note that 
the difference between Ovt and transferrin is solely phraseologic, with most 
authors and databases such as Uniprot differentiating between types of 
transferrin and recommending the use of chicken ovotransferrin for the protein 
in an egg or in serum. Egg Ovt is available in a purified form (Conalbumin Sigma 
C0755) as a crystalline power derived from egg white. This was used as an 
antigen for antibody production.  
3.1.3 Aims of study  
The aims of this study were to produce an antibody using egg Ovt as an antigen, 
validate a RID assay and apply this assay to a number of studies to establish 
whether Ovt is a suitable APP target in chickens by applying it to a series of 
studies. Ovotransferrin was selected as an APP on which to focus further as it is 
a moderate APP in chickens. The availability of purified egg Ovt for use as an 
antigen for standards and antibody generation readily enables further assay 
development. It was hypothesised that the use of egg derived Ovt would enable 
the production of antibody that also cross reacts to chicken serum Ovt and that 
this antibody could be used to develop an assay that could be applied to a 
number of studies. The results of these studies are detailed in Chapters 4 and 5 
where Ovt is measured alongside other APPs.  
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3.2 Materials and Methods 
 
3.2.1 Reagents  
Chemicals and materials used were obtained from Sigma Chem. Co. Poole, UK 
and Bio-Rad Laboratories LtdHemel Hempstead UK. Unless otherwise stated. 
Double distilled water was used throughout. 
3.2.2 Egg Ovotransferrin 
Purified egg Ovt (Conalbumin Sigma C0755) was diluted with dH2O to a 
concentration of 5mg/ml and 1.25mg/ml and, alongside acute phase (AP) and 
non-acute phase (NAP) serum diluted 1:10, separated on a 1DE gel using the 
method describe in Chapter 2, Section 2.2.2.1. Pig serum and bovine foetal 
albumin (BFA) diluted 1:10 were also included on the gel. The gel was run in 
duplicate, enabling a western blot to be performed as described in Chapter 2, 
Section 2.2.2.2. The western blot used rabbit α-chicken transferrin antibody as 
the primary antibody diluted 1:5000 and goat α-rabbit IgG HRP (Ab 6721) as a 
secondary antibody diluted 1:20,000. Bands from the egg Ovt lanes were 
removed from the 1DE gel and trypsin digested, the proteins identified using MS 
as described in Chapter 2, Section 2.2.2.3.  
3.2.3 Sheep α-chicken ovotransferrin antibody 
To raise the antibody against egg Ovt, 1mg of egg Ovt dissolved in sterile saline 
together with 1.25ml of Freund‟s Complete Adjuvant in an emulsion of 2% Tween 
80 and saline was injected into a sheep and bleeds recovered on a monthly basis 
thereafter. Subsequent boosters employing Freund‟s Incomplete, were delivered 
monthly 7 days prior to the bleed (Scottish National Blood Transfusion Centre, 21 
Ellen's Glen Road, Liberton, Edinburgh). 
3.2.4 Immunoelectrophoresis (IEP) 
A 1% agarose gel was prepared by dissolving 0.17g of agarose (sigma A9539-log 
RK0015) in IEP buffer (0.08M Tris . 0.485mM Calcium lactate . 3.076mM Sodium 
azide . 0.02M Tricine). The liquid agarose was poured on an agarose film (Sigma 
Aldrich electrophoresis film for agarose gels b#110EO264-100EA), left to set at 
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room temperature before chilling at 4⁰C for 15 minutes.  „Wells and troughs‟ 
were punched into the gel for samples (wells) and antibody (troughs) to go into.  
To the sample wells 5µl of chicken serum either neat or diluted 1 in 4 was 
added. On each gel 5mg/ml egg Ovt was added to a well. To all wells 1µl of 1% 
bromophenol blue (BDH chemicals Ltd Prod 4430535534605) was added. The gel 
was run at 75V for 1.5 hours or until the bromophenol blue had migrated towards 
the anode but no further than the troughs end. The gel was transferred gel side 
up to humidity chamber. To the troughs, 150µl of antibody was added and the 
gels left at room temperature for 48 hours.  
Following the incubation the following wash protocol was undertaken. The gel 
was washed in 0.09% NaCl overnight, and the following day pressure dried, to 
remove all the liquid from the agarose. The gel was washed in 0.09% NaCl for an 
hour and pressure dried to remove liquid from the gel. This was repeated once 
further. For the fourth and final wash the gel was washed in dH2O for 1 hour, 
pressure dried and left to air dry over night. The following day the gel 
membrane was stained with Coomassie blue G dye (B0770, Sigma-Aldrich, 
Dorset, UK), prepared as 0.1% (w/v) Brillant Blue G, 25% (v/v) methanol, and 5% 
(v/v) acetic acid, for 20 minutes and de-stained in 10% (w/v) acetic acid in 25% 
(v/v) methanol for 1 hour. The gel was left to dry overnight. To determine the 
antigenicity of the sheep α-chicken ovotransferrin antibody and compare to the 
rabbit α-chicken transferrin antibody a series of IEP were performed.  
3.2.5 Western blot analysis  
To compare the reactivity of the antibodies to Ovt, western blots following 1DE 
were undertaken as previously described (Chapter 2, Sections 2.2.2.1 - 2.2.2.2). 
Three acute phase samples (AP) and three non-acute phase samples (NAP) were 
run alongside egg Ovt (1.25mg). The primary antibodies rabbit α-chicken 
transferrin (Accurate Chemical AI-AG 8240) and sheep α-chicken Ovt were used 
at a concentration of 1:200. Secondary antibodies, goat α-rabbit IgG HRP (Ab 
6721) and rabbit α-sheep IgG HRP (Ab 6747) were diluted 1:20,000.   
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3.2.6 Mass spectrometry  
From the 1DE gel selected bands of interest were removed, trypsin digested and 
the proteins identified using MS (Chapter 2, Section 2.2.2.3). Precipitates from 
the IEP membranes also underwent identification by the same method, by 
cutting the membrane and trpysin digesting the proteins contained within the 
precipitation arc.  
3.2.7 Radial immunodiffsion (RID) 
A single radial immunodiffusion gel contains antibody within the gel resulting in 
the formation of a precipitation ring when the antigen is added to a punched 
well. A 1% agarose gel was made by dissolving 0.17g of agarose (sigma A9539-log 
RK0015) in 17ml TBS. To establish a suitable antibody concentration 5ml of 
dissolved agarose was added to a conical tube and brought to temperature in a 
water bath at 56˚C. Rabbit anti-chicken transferrin antibody was pipetted into 
each of the 4 tubes at concentrations of 284µg/µl, 142µg/µl, 71µg/µl and 
35.5µg/µl. After gentle mixing at 56⁰C each of the agarose mixtures was poured 
onto a gel membrane and allowed to set at room temperature before 
transferring to a cold room where they remained for 15 minutes. Six wells were 
punched into the gels into which 8µl of Ovt standard at 5mg, 1.250mg/ml and 
0.3125mg/ml, two AP and one NAP serum samples were added. The RID gel was 
incubated in a humidity chamber overnight at room temperature. The gel 
underwent the same washing and staining process described in Section 3.2.4.  
The resulted ring diameters were measured and a standard graph produced from 
which the Ovt concentration of the samples could be determined.   
3.2.8 Ovotransferrin radial immunodiffusion assay 
To establish whether there was a difference in precipitation ring between the 
rabbit α-chicken transferrin antibody and the sheep α-chicken Ovt antibody a 
number of RIDs were undertaken to establish whether this method could be used 
as an assay and to validate the sheep α-chicken transferrin antibody Further RIDs 
comparing the two antibodies determined that the sheep α-chicken Ovt antibody 
produced good precipitation rings. To determine the optimal antibody 
concentration of the sheep α-chicken Ovt antibody, four mini RID gels were 
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produced, with 100μl, 150μl, 200μl and 250μl of sheep α-chicken Ovt antibody 
added to 20ml of agarose, with 200μl found to be the optimal for clear ring 
precipitate formation. For assay validation, the RID assay was applied to a 
sample group (n=44) and intra and inter assay CVs determined. 
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3.3 Results  
 
3.3.1 Egg Ovotransferrin 
To investigate the protein content of the egg derived Ovt (Conalbumin Sigma 
C0755) prior to its use as an antigen for antibody production a 1D SDS gel and 
western blot using rabbit-α-chicken transferrin was undertaken (Figure 3.1). 
 
  Figure 3.1 a.                                                                             Figure 3.1 b. 
Figure 3.1: 1D SDS gel: Proteins are separated with 4-12% CriterionTM Bis-Tris precast 
polyacrylamide gel (BioRad#345-0124) and stained with Coomassie blue G dye (Sigma Aldrich). 
Lane 1 and 2 contain chicken acute phase and non-acute phase serum respectfully (Figure 1a). 
Lanes 3 and 4 contain egg Ovt at concentrations of 5mg/ml and 1.25mg/ml respectfully. Lane 5 
contains acute phase pig serum and lane 6 bovine foetal albumin. The bands extracted for mass 
spectrometry identification are identified in the highlighted area to the right: bands i-iv. A 
western blot using rabbit α-chicken transferrin was undertaken on a duplicate gel and is detailed 
in figure 1 b.  
 
Figure 3.1 compares chicken acute phase serum with the purified egg Ovt (Figure 
3.1.a) with the western blot (Figure 3.1.b) showing high affinity of the rabbit α-
transferrin antibody with the egg Ovt as well as the serum Ovt. To identify 
proteins within the main double band at 75 and 76 kDa and also the lower 
molecular weight proteins, bands i – iv were excised from the 1D SDS PAGE gel 
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and identified using MS. The MS results identified Ovt as the protein present in 
all bands with the additional identification of ovalbumin in band i. (Table 3.1). 
 
 Name Locus 
Uniprot 
accession 
Score 
Mass 
Da 
PI Matched Sequence 
Protein 
coverage 
i 
Ovt TRFE_CHICK PO2789 401 79551 6.85 41(12) 21(11) 43% 
Ovalbumin OVALX_CHICK PO1013 87 263331 5.1 5(1) 4(1) 18% 
ii Ovt TRFE_CHICK PO2789 593 79551 6.85 56(21) 36(17) 47% 
iii Ovt TRFE_CHICK PO2789 604 79551 6.85 50(18) 28(14) 43% 
iv Ovt TRFE_CHICK PO2789 481 79551 6.85 41(10) 28(8) 41% 
 
Table 3.1: Mascot results of bands i-iv removed from lanes 3 and 4 of SDS PAGE gel in Figure 
3.1. a. Bands were excised from the gel trypsin digested and identified using nanoflow HPLC-EPI-
MS/MS with identities assigned using Mascot Science Daemon server to interrogate protein 
sequences in the NCBI Genbank database for Gallus gallus and boney vertebrates. Both NCBI and 
where Uniprot identifications are listed (immunoglobulins are not listed in Uniprot). The protein 
score is the sum of the highest ions score for each distinct sequence. The first number under 
matches is the count of MS/MS spectra that have been matched to peptides from this protein. 
The matches shown in the parenthesis indicating unique matches (scores above the significance 
threshold). The sequences column is the count of matches to distinct peptide sequences, the 
number in parenthesis is the count of sequences with significant matches (Matrixscience.com). 
The coverage percentage is proportion of the protein‟s entire sequence identified. 
 
3.3.1.1 Immunoelectrophoresis 
Immunoelectrophoresis was used to compare both antibodies and their reactivity 
with chicken serum diluted 1:4. Both antibodies precipitate protein in the serum 
with the exact mobility as the egg Ovt. In addition the sheep α-chicken Ovt 
antibody precipitates a second arc that is more mobile than the first and clearly 
visible in all the samples except the egg Ovt (Figure 3.2). Further work revealed 
that when serum is added without dilution the rabbit α-chicken transferrin 
antibody also precipitates a second arc that, although not identical to the 
second arc seen with the sheep α-chicken Ovt antibody, also shows continuity 
with the main arc (Figure 3.3). This indicates that the protein within the second 
arcs share immunological identity to the main arcs, and has increased sensitivity 
to the sheep α-chicken transferrin antibody. The second arcs differ between the 
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antibodies, with the second arc of the sheep α-chicken Ovt antibody having 
increased mobility relative to the second arc precipitate of the rabbit α-chicken 
transferrin antibody and as such could be the result of different degradation 
products of Ovt.  
 
Figure 3.2: IEP gel (1% agarose) comparing the two antibodies. Rabbit α-chicken transferrin 
and sheep α-chicken Ovt antibodies and their reactivity to chicken serum and egg Ovt antigen 
are compared. The area highlighted is the second arc, visible only with the Sheep α-chicken Ovt 
antibody. 
 
Figure 3.3: IEP gels (1% agarose) to compare rabbit α-chicken transferring and sheep α-
chicken Ovt antibodies on undiluted and diluted serum. 
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3.3.1.2 Mass spectrometry  
To investigate the nature of the second arc produced with the sheep α-chicken 
Ovt antibody and determine whether it was an isoform, fragment or degradation 
product of the main Ovt arc, MS was used to identify the proteins within the 
precipitate arcs. From the IEP gel eight sections were excised (on plastic 
membrane) for trypsin digestion (Figure 3.4). Table 3.2 details the proteins 
identified within each precipitate. The proteins identified in the precipitates as 
well as including Ovt, which is the most abundant, also include other major 
plasma proteins including apo-AI, Fb and ovoinhibitor. The most probable cause 
of the other proteins identified by mass spectrometry within the precipitates is 
that the washing of serum from the IEP gel was incomplete which together with 
a highly sensitive proteomic method of protein identification results in the 
identification of other plasma protein that remain on the IEP gel. 
 
 
Figure 3.4: IEP (1% agarose) membrane with excised areas labelled. Gel contains sheep α-
chicken Ovt antibody (trough) and serum samples (wells). Proteins identified are detailed in 
Table 3.2.  
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Arc    Protein ID 
          NCBI 
      Accession 
MW 
(Da) 
Pi 
Peptides 
matched 
Sequences  
Covera
ge  
Score 
1 Ovotransferrin  gi|1351295 79551 6.85 63(26) 29(16) 42 705 
 Chain A, Crystal Structure Of 
Aluminum-Bound 
Ovotransferrin  
gi|83754919 77518 6.70 63(26) 29(16) 44 705 
 ovotransferrin CC type  gi|71274077  79575 7.08 57(22) 28(15) 41 660 
 Fibrinogen beta chain gi|399491 53272 7.18 22(9) 16(8) 37 291 
 Chain C, Crystal Structure Of 
native Chicken Fibrinogen 
gi|8569623 
 
47486 5.40 17(7) 12(4) 26 175 
 pre-fibrinogen alpha subunit  gi|732995 56766 6.82 15(3) 8(3) 18 162 
2 Apolipoprotein B precursor  gi|113206052 524519 8.51 14(1) 12(1) 2 138 
 Titin isoform X3 gi|513193910 377391 6.02 49(0) 38(0) 1 97 
 Ovoinhibitor gi|513206786 59590 6.44 5(1) 4(1) 8 72 
 Lysosomal-trafficking 
regulator 
gi|513175724  433306 5.92 7(0) 7(0) 1 59 
3 fibrinogen alpha chain isoform 
1 precursor [Gallus gallus] 
gi|429484490 83139  6.86 24(14) 12(7) 37 494 
 Chain A, Crystal Structure 
Aluminum-Bound Ovt 
gi|83754919 77518 6.7 53(18) 27(13) 38 409 
 Ovotransferrin CC type gi|71274077 79575 7.08 50(16) 26(12) 36 376 
 Fibrinogen beta chain gi|399491 53272 7.18 22(7) 15(7) 39 271 
 Chain C, Crystal Structure Of 
Native Chicken Fibrinogen 
gi|8569623 47486 5.40 18(8) 13(8) 31 185 
4 Ovotransferrin (conalbumin) gi|1351295 79551 6.85 22(4) 17(4) 27 98 
 Chain A, Crystal Structure 
Aluminum-Bound Ovt 
gi|83754919 77518 6.70 22(3) 17(3) 28 98 
 Ovotransferrin CC type gi|71274077 79575 7.08 22(3) 17(3) 27 83 
 Ovoinhibitor [Gallus gallus] gi|513206786 59590 6.44 6(3) 5(2) 63 73 
 Chain C, Crystal Structure Of 
Native Chicken Fibrinogen 
gi|8569623 
 
47486 5.40 3(1) 3(1) 9 43 
5 Ovotransferrin  gi|1351295  79551 6.85 62(33) 28(21) 41 717 
 Chain A, Crystal Structure 
Aluminum-Bound Ovt 
gi|83754919  77518 6.7 62(33) 28(21) 43 717 
 Ovotransferrin BC type  gi|71274079 79588  28(29) 28(19) 44 651 
 Fibrinogen alpha chain gi|1706798 56766 6.82 24(9) 13(6) 26 322 
 Fibrinogen beta chain gi|399491 53272 7.18 20(12) 16(11) 44 303 
 Apolipoprotein A-I precursor gi|211146   30672 5.97 4(2) 4(2) 15 52 
6 Ovoinhibitor [Gallus gallus] gi|513206786 59590 6.44 2(1) 2(1) * 83 
 Apolipoprotein A-I precursor gi|211146 30672 5.97 2(1) 2(1) 7 47 
7 Chain A, Crystal Structure 
Aluminum-Bound Ovt 
gi|83754919   77518 6.7 71(29) 25(16) 41 963 
 ovotransferrin CC type  gi|71274077 79575 7.08 68(29) 24(16) 38 954 
 Ovotransferrin  gi|1351295 79551 6.85 70(28) 24(15) 36 898 
8 Ovotransferrin  gi|1351295 79551 6.85 10(3)   9(3) 14 100 
 Ovoinhibitor precursor gi|71895337 59590 6.44 8(1) 6(1) * 45 
 Apolipoprotein A-I precursor gi|211146   30672 5.97 3(1) 3(1) 10 39 
 Apolipoprotein AI gi|227016 28790 5.45 3(1) 3(1) 11 39 
Table 3.2: Mass spectrometry results from IEP (Figure 3.4). *Coverage data not available. The 
IEP membrane containing specified arcs were cut out and the membrane containing precipitated 
protein trypsin digested and identified using nanoflow HPLC-EPI-MS/MS with identities assigned 
using Mascot Science Daemon server to interrogate protein sequences in the NCBI Genbank 
database for Gallus gallus. Both NCBI and where Uniprot identifications are listed 
(immunoglobulins are not listed in Uniprot). The protein score is the sum of the highest ions 
score for each distinct sequence. The first number under matches is the count of MS/MS spectra 
that have been matched to peptides from this protein. The matches shown in the parenthesis 
indicating unique matches (scores above the significance threshold). The sequences column is 
the count of matches to distinct peptide sequences, the number in parenthesis is the count of 
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sequences with significant matches (Matrixscience.com). The coverage percentage is proportion 
of the protein‟s entire sequence identified. 
 
3.3.1.3 Fibrinogen and ovoinhibitor  
With a view to eliminating Fb and ovoinhibitor as proteins precipitating with the 
sheep α-Ovt antibody to form the second more mobile arc two further steps 
were taken. For fibrinogen an IEP was undertaken using both plasma and serum. 
Figure 3.5 shows the IEP gel and no difference in the arc patterns is notable 
between the two sample types.  
 
Figure 3.5: IEP membrane (1% agarose) with serum and plasma samples (wells) from the 
same individual chickens which is separated and precipitated with sheep α-chicken 
transferrin antibody (troughs).  
 
Similarly an IEP using ovoinhibtor (as trypsin inhibitor from chicken egg 
white/type II-O partially purified ovomucoid containing ovoinhibitor, Sigma 
T9253) resulted in no precipitation arc and a western blot using the ovoinhibitor 
also yielded a negative result (results not shown). Ovoinhibitor was included as a 
sample on a RID gel with both antisera in the agarose gel and in one of the two 
wells into which it was added yielded a very faint ring was seen with sheep a-
chicken Ovt (Figure 3.6).  
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Figure 3.6: RID gel comparing serum and ovoinhibitor (*as trypsin inhibitor from chicken egg 
white/type II-O partially purified ovomucoid containing ovoinhibitor, Sigma T9253) 
precipitation rings with sheep α-chicken Ovt and rabbit α-chicken transferrin antibodies. 
 
3.3.1.4 Validation of specificity of Sheep α-chicken ovotransferrin antibody 
To determine the specificity of the antiserum for Ovt  RIDs using the sheep α-
chicken Ovt antibody with serum samples showed clear merging of the outer 
precipitation ring of three samples of egg Ovt (standards) and the serum Ovt 
within three samples (Figure 3.7). The merger of the ring round a serum sample 
and purified egg Ovt demonstrates immunological identity and confirms the RID 
is specific.   
 
Figure 3.7: Ovt rings from three egg standards (top row) and three serum samples (bottom 
row) showing merging of precipitation rings, in an RID using the sheep α-chicken Ovt. 
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3.3.2 Ovotransferrin radial immunodiffusion assay 
Initial studies applying the rabbit α-transferrin antibody to a RID assay method 
established the optimal concentration at which the antibody should be diluted in 
agarose (Figure 3.8). A volume of 100µl in 5ml of agarose (a concentration of 
142µg/ml) produced the most optimal rings for measurement with this antibody.   
 
Figure 3.8: Mancini RID gel of three samples and the Ovt standards and different rabbit α 
chicken transferring antibody concentrations. The gel layout is detailed above.  
 
To optimise the dilutions of the serum a further RID was undertaken using 1:4 
and 1:8 serum dilutions. OVT standards were added starting at 1.250 mg/ml and 
serially diluted four fold. Figure 3.9 details the diluted serum and standard 
rings. Measuring the ring diameters and plotting diameter against concentration 
to produce a standard curve (Figure 3.10).  
 
Figure 3.9: RID with four diluted serum samples (top row of rings) and OVT standards 
(bottom row of rings). The serum is serially diluted.  
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Figure 3.10: Standard curve of OVT produced from RID ring diameters in previous figure. 
To compare the commercial rabbit α-chicken transferrin and the sheep α-
chicken Ovt antibodies, two RIDs using the same standard concentrations as 
previously used, but with undiluted serum samples were produced and are shown 
in Figure 3.10. The concentration of antibody for the sheep α-chicken Ovt RID is 
less than optimal and further work to optimise the concentration of this 
antibody for RID was undertaken. The two low samples (NAP) and the two high 
samples (AP) show good repeatability and a clear difference in ring size between 
the two acute phase status samples.  
  
3
3.1
3.2
3.3
3.4
3.5
3.6
3.7
3.8
3.9
4
4.1
4.2
4.3
4.4
4.5
0 0.2 0.4 0.6 0.8 1 1.2 1.4
mm
ring
OVT concentration mg/ml
118 
 
 
Figure 3.11: RIDs of Ovt standards and four samples using two antibodies. Both gels also 
contain ovoinhibitor (OvoI) as highlighted in Figure 3.6. 
Using the standard ring diameters standard curves for both antibodies were 
produced (Figure 3.12) from which Ovt concentrations of four chicken samples: 
two acute phase (high 1 and 2) and two non-acute phase (low 1 and 2) were 
calculated. Table 3.3 contains calculated concentrations and CVs to compare the 
two antibodies.  
 
Figure 3.12: Standard curve of RID using sheep α-chicken Ovt and rabbit α-chicken 
transferring antibodies.  
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Antibody Sample 
Ring 
diametre  
Calculated Ovt 
conc. mg/ml  
Average  SD CV 
Rabbit anti-
chicken 
transferrin  
Low 1 7 0.99 1.05 0.09 8.73 
Low 1 7.5 1.12       
Low 2 7.3 1.07 1.07 0.00 0.00 
Low 2 7.3 1.07       
High 1 8.9 1.48 1.51 0.04 2.44 
High 1 9.1 1.54       
High 2 9.2 1.56 1.60 0.06 3.45 
High 2 9.5 1.64       
      Mean Intra-assay CV 3.65 
Sheep anti-
chicken 
ovotransferrin  
Low 1 12 1.17 1.19 0.03 2.48 
Low 1 12.2 1.21       
Low 2 12.5 1.27 1.27 0.00 0.00 
Low 2 12.5 1.27       
High 1 13.5 1.48 1.49 0.01 0.99 
High 1 13.6 1.50       
High 2 13.8 1.54 1.53 0.01 0.96 
High 2 13.7 1.52       
      Mean Intra-assay CV 1.11 
 
Table 3.3: Calculated serum Ovt concentrations and CVs of high and low samples using RID. 
Low and high samples were ran in duplicate, and the average CV of all samples taken as total CV. 
 
Figure 3.13: Correlation of calculated Ovt concentrations from four samples using two RID 
assay utilising two different antibodies.  
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For further validation that the sheep α-chicken ovotransferrin antibody is indeed 
measuring serum Ovt in the chicken, Ovt concentrations of samples using both 
antibodies were plotted against each other to produce an R2 value of 0.96 
(Figure 3.13).  
3.3.2.1 Assay Validation  
Continuing with an RID method using only the sheep α-chicken Ovt antibody, a 
total of 44 samples were measured across 5 gels to validate the assay and 
determine its repeatability over a larger number of samples. Two quality control 
(QC) samples were used on each gel in triplicate. Standards were double diluted 
from 2.5 – 0.3mg/ml to produce a standard curve (Figure 3.14). The inter- and 
intra- assay coefficients of variants (CVs) were calculated. Table 3.4 contains 
the results of the intra-assay CV for each of the gels, calculated from the 
triplicate results of each sample.  
 
 
Figure 3.14: Standard curve using sheep α-chicken ovotransferrin, with standards 2.5, 1.25, 
0.6 and 0.3 mg/ml. Standard curve appears more linear at these standard concentrations.  
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RID gel  Intra assay %CV  
Ovt RID gel #11 4.88 
Ovt RID gel #12  8.30 
Ovt RID gel #13 5.56 
Ovt RID gel #14 9.62 
Ovt RID gel #15 7.97 
Mean           7.27 
 
Table 3.4: Intra-assay CV of replicate samples on each gel.CVs for each sample (ran in 
triplicate) were averaged to produce an intra-assay CV for that gel.  
The inter-assay CV was calculated by calculating the standard deviation of each 
of the average Ovt concentrations for each of the QC samples from all five gels 
and calculating the CV. Table 3.5 details the results of the QC samples. 
 
Gel Sample 
Average 
Ovt 
mg/ml 
SD CV 
11 
500 2.522 0.249 9.88 
493 2.325 0.038 1.63 
12 
500 2.016 0.057 2.83 
493 1.374 0.157 11.40 
13 
500 2.096 0.126 5.99 
493 1.641 0.068 4.12 
14 
500 2.115 0.068 3.21 
493 1.538 0.096 6.25 
15 
500 2.303 0.237 10.30 
493 1.842 0.237 12.88 
     
Sample  500 
Ovt mg/ml  
Sample  493 
Ovt mg/ml Gel 
 
Gel 
 11 2.522 
 
 11 2.325 
 12 2.016 
 
 12 1.374 
 13 2.096 
 
 13 1.641 
 14 2.115 
 
 14 1.538 
 15 2.303 
 
 15 1.842 
Mean 2.210 
 
Mean 1.744 
SD 0.203 
 
SD 0.366 
CV% 9.197 
 
CV% 20.999 
Table 3.5: Calculated inter assay CVs for QC samples. Quality control (QC) samples (high and 
low) ran on every gel, intriplicate used to produce a CV which was then averaged to produce a 
CV for the high and low QC, from which the mean CV was calculated.  
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3.4 Discussion  
The competitive Ovt ELISA, detailed in Chapter 2, was found to be expensive, 
time consuming and have poor repeatability. Given the availability of the egg 
derived Ovt that could serve as an immunogen for antibody production, the 
initiative was taken to produce an antibody that would cross react with the 
serum Ovt for use in an assay with higher precision and allow multiple analyses 
to be undertaken as described in Chapters 4 and 5.  Before using a commercial 
protein as an antigen it was important to assess its purity so that the antibody 
would be as specific as possible. Western blot analysis revealed that purified Ovt 
(Conalbumin Sigma C0755) consisted of a protein 75-76kDa that bound both 
antisera at the same molecular weight as serum Ovt and MS confirmed this to be 
Ovt. Bands present at lower molecular weights within the egg derived Ovt were 
also revealed to be Ovt. Ovalbumin, the major component of egg white (Awadé, 
et al., 1994) was also identified in a minor band, with one significant match to a 
peptide sequence made, making it likely that this was a minor contaminant of 
the purified Ovt. These results confirmed that the preparation could be used as 
an immunogen for antibody production.  
3.4.1 Validation of sheep α-chicken ovotransferrin antibody 
Initial IEP comparing rabbit α-chicken transferrin and sheep α-chicken Ovt 
antibody revealed the presence of a second more mobile precipitation arc, the 
result of a more mobile protein forming a precipitate between the sheep α-
chicken Ovt antibody and serum. The nature of the protein causing this second 
arc was investigated to determine whether it was an Ovt fragment or 
degradation product or a protein precipitating with a contaminant antibody 
within the sheep α-chicken Ovt antiserum. A contaminant was ruled out once the 
IEP was re-ran using undiluted serum, which revealed that the a similar arc was 
also present with the rabbit α-chicken transferrin antibody, meaning that the 
same or similar protein isoform or degradation product was also precipitating 
with the rabbit α-chicken transferrin antibody, albeit with less sensitivity, hence 
the need for more concentrated serum to identify it.  
Mass spectrometry results of the IEP precipitation arcs yielded large volumes of 
data and identified Ovt in all but one arc. The sensitivity of the MS together with 
123 
 
the inability of the IEP gel membrane to be washed clear of all but the 
precipitated proteins meant that despite the sensitivity of this method, the 
specificity was limited as other proteins, not necessary from the precipitate 
were also identified. Given the large Mascot Score for Fb and the presence of 
the protein ovoinhibitor in two of the second arcs, these were singled out for 
further analysis.   
The IEP to compare plasma and serum revealed no difference between the 
antibody reactions and excluded fibrinogen as a contaminant. Investigation of 
ovoinhibitor yielded mixed results. The IEP and western blot analysis reveal no 
arc or band respectfully, yet an RID well loaded with trypsin inhibitor from 
chicken egg white/type II-O partially purified ovomucoid containing ovoinhibitor 
(Sigma T9253) revealed a small faint ring. This finding is likely to be artefact (it 
was not identified in replicate wells) though further work, ideally using a more 
purified form of ovoinhibitor would be needed to confirm this conclusion. 
It is highly likely that the second precipitation arc is an Ovt fragment which by 
the nature of its structure and glycosylation pattern is more mobile than the 
parent protein from which it is derived. Initial work on the purified egg Ovt 
identified a number of bands with lower molecular weights than the main Ovt 
bands, and these were identified as Ovt. The presences of the second arc, seen 
with both antibodies, together with the Ovt bands of differing molecular weight 
seen on 1D SDS PAGE and western blots reveal that other Ovt products and 
fragments exist that are as immunologically sensitive as the parent protein. 
These fragments, evident as the second arc, merge with the major precipitated 
protein in IEP which demonstrate that there is immunological identify with Ovt 
so that the antiserum can be used in immunoassay to measure this protein in 
serum. To further investigate the nature of the second precipitation arc and 
fully determine the differences between the Ovt seen in the main and second 
arcs, immunoaffinity separation and MS could be employed.  
Further validation for the use of the sheep a-chicken Ovt came from the shared 
immunological identity with the egg Ovt which was observable when two RID 
rings, from egg and from serum merge together. This is indicative of a single 
protein precipitation product and was seen on numerous RID gels.  
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Further work to develop this assay for use on an automated analyser using an 
immunoturbidimetric format would allow increased throughput and widen the 
measurement of this APP into many other areas of poultry research. In its 
current form however it remains an economic and straightforward assay that is  
been utilised across many poultry research areas (Najafi et al., 2009; Shakeri et 
al., 2014; Najafi et al., 2015). 
3.4.2 Validation of ovotransferrin radial immunodiffusion assay 
Once the optimal dilutions of egg Ovt and antibody concentration within the 
agarose gel were determined, the results of samples measured using an RID 
assay using rabbit α-chicken transferrin antibody and an RID assay using sheep α-
chicken Ovt antibody were correlated. The R2 value of 0.96 was calculated 
which adds further validity to the sheep α-chicken Ovt antibody and the RID 
assay. The inter- and intra- assay CVs for the samples measured were 15.0% and 
7.3% respectively. Compared to the CVs for the competitive Ovt ELISA, which 
had inter- and intra- assay CVs of 32.0% and 14.9% respectively, the CVs for the 
Ovt RID have been halved and as such make this assay a more reliable, 
repeatable and precise measure of serum Ovt in chickens than the ELISA system 
as used in Chapter 2.  
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Chapter  4 
The measurement of chicken acute phase proteins and 
identification and measurement of other biomarkers of 
the acute phase response using a quantitative proteomic 
method. 
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4.1 Introduction 
Research on chickens APPs has largely focused on proteins previously identified 
in other veterinary species and humans, identifying and purifying an APP from 
plasma before measuring it in chickens during experimental infections. This 
approach, while successful in many respects has revealed that some APPs, for 
example (ovo-) transferrin do not respond in chickens as they do in mammals 
during an APR. Detailing the behaviour of known APPs in chickens during an APR 
is necessary as there are many APP, particularly the negative APPs that have 
received very little attention in chickens.  
This can be hindered by the fact that for many chicken APPs, specific and 
validated commercial immunoassays are not available. The limited knowledge of 
chicken APPs and in some cases the low abundance in serum, even during an APR 
is problematic for assay development. Developing immunoassays is also costly, 
time consuming and slow. Moving away from immunoassays, proteomic 
approaches can be utilised not only to identify differentially expressed proteins 
between healthy and diseased animals but also quantify them. Applying 
quantitative proteomic techniques to the field of APP research in chickens would 
allow identification of the major APPs and confirm the presence and behaviour 
of other APPs in this species.  
The major APPs in chickens are yet to be determined. The APPs serum amyloid A 
(SAA) and C-reactive protein (CRP) are major APPs in other species, and are used 
routinely in human and veterinary medicine. Serum amyloid A is a major 
candidate for a major chicken APP having been demonstrated to increase up to 
1000 fold in earlier studies (Upragarin, 2005). Although a pentraxin gene has 
been identified in chickens there are no reports of CRP being purified and 
identified in chicken plasma or sera though there are studies that have measured 
CRP in chickens and cite commercially available kits. Conclusive identification 
and measurement of this protein in chickens is needed. 
Other APPs targeted in this study are introduced here alongside SAA and CRP. In 
mammalian species the APPs apolipoprotein AI (Apo-AI) and transthyretin (Ttn) 
behave as negative APPs, their behaviour in chickens during an APR is unknown 
and as such these are appropriate targets in this study. Haemopexin (Hpx) is an 
established yet not widely measured APP in chickens while PIT54, Ovt and AGP 
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have been previously measured and are included here to complete the panel of 
APPs measured. Where these APPs have not been studied widely or at all in 
chickens, information has been gathered from mammalian studies with a view of 
contextualising these APPs in this study.  
The quantitative proteomic method employed in this study identifies all 
differentially abundant proteins between acute phase and non-acute phase 
samples in chickens and will thus allow identification of other proteins that may 
be biomarkers of the APR in this species. Moving away from the “one rule fits 
all” approach to investigating the chicken APR and identifying and measuring 
other proteins that show differential abundance in serum during the APR will 
determine whether other, novel, biomarkers of the APR exist in chickens.  
4.1.1 Serum Amyloid A 
Serum amyloid A (SAA) is a major vertebrate APP and in most species the most 
sensitive protein of the APR. The SAA family of APPs comprises a number of 
differentially expressed apolipoproteins, associated with high density lipoprotein 
(HDL),  including two isoforms of hepatic origin: SAA-1 and SAA-2, these are 
acute phase SAA proteins that can increase 1000 fold during an APR implying an 
important beneficial role in host defence (Eriksen et al., 1993; Uhlar & 
Whitehead, 1999; Röcken & Shakespeare, 2002). In mammals a constitutive SAA 
(SAA-4) is present as a minor HDL apolipoprotein that comprises over 90% of SAA 
during homeostasis and is not significantly increased in acute phase serum 
(Landman, 1998; Röcken & Shakespeare, 2002). In mammals multiple SAA genes 
and proteins, strongly induced during an APR, have been described (Uhlar and 
Whitehead, 1999; Upragarin et al., 2005). In chickens only one SAA gene has 
been identified (Ovelgönne et al., 2001). Extrahepatic synthesis of SAA (isoform 
SAA-3) has been documented to occur in a number of mammalian tissues, 
including intestine, kidney, endocrine organs, synovial fibroblasts and 
macrophages (Uhlar & Whitehead, 1999). In avian species, SAA is primarily 
synthesised in the hepatocytes. Extraheptic synthesis of SAA has been shown to 
occur in duck lung tissue (Guo et al., 1996) and chicken fibroblast-like 
synoviocytes (Upragarin et al. 2005).  
Serum amyloid A appears to be highly conserved within mammalian species and 
is present in other vertebrates including birds and fish as well as invertebrates 
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(Santiago-Cardona et al., 2003). This conservation of SAA together with the wide 
range of tissues where SAA is expressed and the dramatic induction of SAA 
production shortly after tissue damage, makes it evident that SAA plays an 
essential protecting role in the organism (Soler et al., 2013).  
4.1.1.1 Serum amyloid A structure and function  
Analysis of human and murine circulating SAA primary sequences reveal it to be 
a hydrophobic, amphipathic protein consisting of a N-terminal helical bundle 
that comprises the 80% of the protein and a remaining potentially disordered C-
terminus that might serve as ligand binding region (Stevens, 2004; Soler et al., 
2013). Modulating lipoprotein transport and metabolism during an APR appears 
to be a major function of SAA. Serum amyloid A allows cholesterol to remain in 
damaged tissues where it is needed for repair and regeneration of membranes 
and to transport cholesterol and clear lipid debris from bacteria and damaged 
areas of tissue (Eriksen et al., 1993; Landman, 1998). During an APR, SAA 
prevents oxidative tissue damage and can recruit immune cells to localised areas 
of inflammation (Uhlar and Whitehead, 1999). Serum amyloid A is 
immunomodulatory, inhibiting pyrexia and down regulating pro-inflammatory 
events during an APR (Shainkin-Kestenbaum et al., 1991; Uhlar and Whitehead, 
1999).  
4.1.1.2 Serum amyloid A and the acute phase in chickens 
In both mammals and birds persistently elevated serum SAA levels, together with 
ongoing inflammatory and/or infectious disease may result in the formation of 
AA amyloid protein. The accumulation of this proteinaceous SAA derivative in 
organs and tissues gives rise to the disease AA amyloidosis (Röcken and 
Shakespeare, 2002). AA amyloidosis in chickens and other Galliform species was 
rare until Landman et al., (1994) reported a new syndrome of avian amyloidosis 
in a flock of heavy breed brown layer chickens. Birds showed signs consistent 
with chronic arthritis, with inflammatory lesions in the joints and tendon 
sheaths. These lesions were found to be amyloid giving rise to a new 
arthropathic classification of amyloidosis in birds, of which Galliformes are 
predisposed (Landman, 1998). Serum amyloid A, when investigated in 
amyloidotic birds was found to be significantly higher than in healthy controls 
(Alasonyalilar et al., 2006).  
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Nazifi et al., (2010, 2011) found significant increases in SAA in chickens infected 
with IBDV and IBV. These studies show only mild 1.5- 2 fold increases in plasma 
SAA concentration in response to the viral infections. Similarly Seifi et al., 
(2014) found IBV Serotype 4/91 to increase SAA serum concentrations 2-fold to 
2.85±0.21 mg/L. By 5 days post inoculation, average serum concentration had 
returned to a level lower than the initial baseline concentration. Earlier work by 
Upragarin, (2005) also found SAA to increase as a result of turpentine and S. 
aureus injection with SAA levels increasing from undetectable levels pre-
injection to increases of 100-1000 fold 12 hours post injection. At 72 hours post 
injection the mean SAA concentration of injected birds was 77.23 mg/L. 
Alasonyalilar et al., (2006) found severely amyloidotic birds to have mean serum 
SAA concentration of 42.53 mg/L. However in this latter study control birds had 
serum concentrations of 8.48 mg/L, much higher than control levels reported in 
Nazifi et al., (2010, 2011) and Upragarin (2005).  
4.1.1.3 Quantification of serum amyloid A in chickens 
The study by Upragarin (2005) is the only one to use a specific chicken SAA 
antibody ELISA, the other studies use a Murine antibody. Previous work 
undertaken but not described in this chapter found a number of anti-SAA 
antibodies to show no cross reactivity with chicken acute phase serum. Rabbit 
anti-recombinant bovine SAA, rabbit anti-pig SAA, rabbit α - bovine SAA and 
sheep α - bovine SAA peptides all showed no cross reactivity.  
4.1.2  C-Reactive Protein  
C-reactive protein (CRP) is a member of the phylogenetically ancient and highly 
conserved „pentraxin‟ family of proteins, which also includes serum amyloid P 
component, a constituent of all amyloid deposits (Volanakis, 2001). This APP has 
been defined in humans as an exquisitely sensitive marker of inflammation and 
tissue damage. C-reactive protein is a major APP in humans, pigs and dogs and is 
the most frequently measured APP in veterinary species (Eckersall and Bell, 
2010).  
4.1.2.1 C-reactive protein structure and function  
C-reactive protein consists of five non-covalently associated protomers arranged 
symmetrically around a central pore (Volanakis, 2001). Canine CRP has a 
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molecular weight of 100kDa, with each of the five each protomers having a 
molecular weight of 20kDa, human CRP contains five 25kDa protomers. Examined 
by electron microscopy, canine CRP resembles human CRP, the main difference 
between the proteins is that two of the five subunits of canine CRP are 
glycosylated (Ceron et al., 2005) giving rise to two distinct bands at 25-27 kDa 
when examined by 1DE. 
Originally named for its ability to bind C-polysaccharide of Streptococcus 
pneumonia (Tillett & Francis, 1930), CRP has calcium ion dependent binding 
specificity for phosphocholine a constituent of many bacterial and fungal 
polysaccharides and most biological cell membranes including C- polysaccharide 
the teichoic acid of Streptococcus pneumoniae (Volanakis & Kaplan 1971). C-
reactive protein binds, in a calcium-dependent manner, a diverse array of 
ligands including phosphatidylcholine in membrane bilayers, fibronectin, 
laminin, chromatin, histones, and small nuclear ribonucleoprotein, implying a 
role in the clearance of cellular and nuclear debris (Kravitz et al., 2005). On 
binding to the surface of apoptotic cells there is amplification of the classical 
pathway of complement activation, reduced terminal complement component 
assembly, increased phagocytosis by macrophages and sustained production of 
transforming growth factor-β (Volanakis, 2001). As well as contributing to 
restoration of normal structure and function of injured tissues CRP‟s ability to 
recognize pathogens and to mediate their elimination by recruiting the 
complement system and phagocytic cells makes CRP an important constituent of 
the innate host defence (Volanakis, 2001). 
4.1.2.2 C-reactive protein and the acute phase response in chickens 
Patterson and Mora (1964) purified CRP from chicken serum and developed an 
assay to detect the presence or absence of CRP in chicken serum.  They found 
CRP to be present in birds with E. coli, Pasturella (P.) multocida and 
Staphylococcus (S.) aureus infection, as well as Histomoniasis and adjuvant 
injection. The authors also found CRP positive birds in a clinically normal 
population. These positive birds, on post mortem, had lesions consistent with 
chronic respiratory disease, highlighting the use of CRP as a potential biomarker 
for non-clinical disease. Whether CRP is a major APP in chickens as it is in 
humans and other veterinary species is yet to be established. Patterson and Mora 
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(1965) found that CRP did not rise in chickens as quickly as it is in humans, CRP 
was detectable 36 – 48 hours post infection in chickens, compared to 16 -18 
hours in humans. It was also noted that the CRP concentration, though not 
quantitated, appeared lower in chickens than in comparative human samples.  
Recent studies have found the percentage of CRP positive birds to increase 
during heat stress (Sohail et al., 2010) and  experimental infection with IBV 
(Seifi et al., 2014), Salmonella typhimurium lipopolysaccharide administration 
(Rauber et al., 2014) and Fumonisin toxicity (Rauber et al., 2013). Basal (pre-
innoculation) concentration of CRP were reported to be 1.3±0.014 mg/L 
increasing significantly to 1.65±0.011 mg/L two days post inoculation with IBV 
(Seifi et al., 2014). 
4.1.2.3 Quantification of the C-reactive protein in chickens 
Since the early work by (Patterson & Mora, 1964, 1965) no detailed investigation 
of CRP in chickens has been published. Recent studies have measured CRP in 
chickens using human detection kits (Sohail et al., 2010) or commercial ELISA 
kits (Rauber et al., 2013; Rauber et al., 2014; Seifi et al., 2014) described as 
being suitable for use in chickens, containing CRP-specific antibodies (USCNK – 
ELISA kit for C-Reactive Protein, 2016). 
C-reactive protein, having a known affinity for phosphorylcholine, a constituent 
of bacterial and fungal polysaccharides, can be separated, concentrated and 
purified using a phosphorylcholine affinity column on a fast protein liquid 
chromatography (FPLC) system. The CRP in acute phase serum will bind the 
phosphorylcholine in a calcium dependant fashion. The bound CRP can be eluted 
from the column using a ethylenediaminetetraacetic acid (EDTA) containing 
buffer, the EDTA binding the calcium ions preferentially, causing the CRP to 
disassociate from the column.  
4.1.3 Alpha-1-Acid Glycoprotein  
α1 – acid glycoprotein (AGP) is a constitutively expressed, highly glycosylated 
protein that is found mainly in blood in varying concentrations depending on the 
species (Ceciliani & Pocacqua, 2007; Murata et al., 2004). As well as increasing 
in concentration during inflammation, AGP also undergoes structural 
modifications of its oligosaccharide moiety, resulting in a change of both the 
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degree of branching and fucosylation, with the last phase of acute inflammation 
associated with a decrease in AGP branching to healthy levels while the  plasma 
concentration of the protein remains at high levels indicating that pathways for 
the expression of the protein and for the regulation of the modifications of the 
protein carbohydrate moiety differ (Ceciliani & Pocacqua, 2007).  
Alpha–1–acid glycoprotein protein is synthesised and secreted mainly by 
hepatocytes, though extrahepatic synthesis of AGP has been demonstrated in 
mammalian species. This local production of AGP is thought to contribute to 
maintenance of homeostasis by reducing tissue damage associated with the 
inflammatory process (Murata, et al. 2004). Alpha-1-acid glycoprotein has been 
extensively studied in humans as it is one of the most important binding proteins 
in plasma alongside albumin and is heavily involved in drug binding. As well as 
mouse and rat models, AGP has also been well documented in the domestic cat 
in which it is the major APP (Ceciliani & Pocacqua, 2007). In other veterinary 
species it has been less well documented but it does appear to have a significant 
role in the early stages of inflammation and infection in chickens and is 
described as moderate APP (O‟Reilly & Eckersall, 2014).  
4.1.3.1 Alpha-1-acid glycoprotein structure and function 
The very unusual chemical properties of AGP are summarized by its name: it 
migrates with the α-1 protein group in plasma protein electrophoresis, has a low 
pI (2.8-3.8) and a very high carbohydrate content (> 40%). The three dimensional 
structure of AGP clearly resembles the conformation of a transport protein, as it 
is rich in β-sheets. It has been demonstrated that AGP can bind, in non-
pathological circumstances, more than 300 different molecules and drugs 
(Ceciliani & Pocacqua, 2007). Alpha-1-acid glycoprotein is a natural anti-
inflammatory agent inhibiting neutrophil activation and increasing the secretion 
of IL-1 receptor antagonists by macrophages and it also helps with the clearance 
of LPS by binding directly and neutralising its toxicity (Murata, et al. 2004). This 
APP immunomodulates the inflammatory response, and, at the same time, act as 
a plasma transport protein (Ceciliani & Pocacqua, 2007) 
Human AGP is a 37 kDa single polypeptide with 183 amino acids and an 
isoelectric point of 2.7 (Ceciliani & Pocacqua, 2007). In contrast chicken AGP is 
22.3kD has a isoelectric point of 5.11 and contains 203 amino acids 
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(UniProt.org). Structurally the AGP protein in chickens, like mammals, is 
heterogeneous in its glycosylation differing in its reactivity to concanavalin 
(ConA), giving rise to a Con-A reactive and Con-A unreactive forms of AGP. 
Inoue, et al. 1997 investigated the changes in heterogeneity of chicken AGP in 
response to in experimental infection with IBDV. In control chickens there was 
47% Con-A-unreactive and 63% ConA-reactive AGP. This changed as a 
consequence of infection especially with inoculation of the highly virulent IBDV 
strain, where Con-A reactive increased to 80% in the early stages of infection. 
Infection with LPS resulted in an increase of 87% the Con-A reactive AGP. The 
biological effects of AGP are dependent upon its glycosylation type, with Con-A 
unreactive AGP exhibiting a stronger inhibitory effect of lymphocyte 
proliferation and mixed lymphocyte proliferation than the Con-A reactive. Also 
the inhibitory effects of AGP on neutrophil superoxide anion generation depends 
on the glycan structure with Con-A unreactive being less inhibitory that the Con-
A reactive (Inoue, et al. 1997). 
4.1.3.2 Alpha-1-acid glycoprotein and the acute phase in chickens 
A large number of studies have investigated AGP in chickens in response to both 
bacterial and viral infection. Following a single Escherichia (E.) coli LPS injection 
AGP plasma concentrations increased significantly 12 hours post injection with 
serum levels increasing 4 fold to peak 24 hours post injection (Takahashi et al., 
1998). Nakamura et al., (1998) found infection of E. coli LPS resulted in an 
increase in AGP that peaked 48 hours post infection with a return to normal 
levels over 7 to 14 days. Repeated injections of E. coli LPS was found to lower 
the responses of plasma AGP concentrations (Takahashi et al., 1995) while 
repeated injections of LPS at different concentrations resulted in different AGP 
profiles, with the higher concentration of LPS giving higher AGP values 
(Takahashi et al., 1998). Age and sex do not significantly alter AGP 
concentrations (Takahashi et al., 1995). Adler et al., (2001) using Salmonella 
serotype Typhimurium LPS and turpentine to illicit an APR found AGP levels 
increased 4 fold, peaking 24 hours post infection before returning to normal 
levels 6 days post infection.  
A number of studies have investigated AGP during viral infections both with and 
without vaccination. Experimental infection with infectious bronchitis (IB) and 
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infectious larygotracheitis virus (ILTV) increased AGP serum concentrations, with 
AGP higher in the IB than the ILTV infected birds (Nakamura et al., 1996). Inoue 
et al., (1997) found significant increases in serum AGP as a result of infection 
with a highly virulent infectious bursal disease virus (IBDV) strain and a virulent 
IBDV reference strain. The highly virulent strain increased AGP concentrations 
six fold and the virulent reference strain three fold. The chickens infected with 
the highly virulent strains also had extensive lesions in addition to the severe 
bursal lesions. Chickens receiving the attenuated vaccine strain of IBDV showed 
only a slight increase in AGP and no lesions in the bursa or liver (Inoue et al., 
1997). Chickens challenged with low pathogenic avian influenza (LPAI) showed 
increases in AGP up to 48 post infection; however those that received LPAI 
vaccine were shown to have significantly lower AGP concentrations than 
unvaccinated controls (Sylte and Suarez, 2012).  
As a result AGP measurement has been used in a wide variety of poultry research 
areas most notably in the area of nutrition where experimental diets are 
followed by an immunogen challenge usually in the form of a bacterial LPS and 
the AGP concentration determined. The changes in AGP concentrations as a 
result of nutritional changes have been particularly well documented by 
Takahashi et al. (1995; 2002; 2009). The use of APPs as a physiological marker 
for overall health and welfare is another potential use of APP measurement. In 
comparing different egg laying systems Salamano et al., (2010) compared the 
serum concentrations of AGP and albumin. Mean AGP serum concentrations, 
when measured at 2 weeks and 2 months post arrival at accommodation, were 
higher in hens kept in conventional and modified cages than hens in a free range 
system. However after 4 months the free range hens had higher mean AGP than 
both modified and conventionally caged groups, with the mean AGP of the free 
range hens having increased significantly from 2 months previously. AGP was 
used to evaluate stress and immunity of organically produced broilers compared 
to traditionally produced broilers. The organic broilers had serum AGP 
concentrations that were significantly higher (P=<0.001) than the conventionally 
produced broilers, this was attributed to restriction of prophylactic medicines 
coupled with access to the outside (Tuyttens et al., 2008).  
4.1.3.3 Quantification of alpha-1-acid glycoprotein in chickens 
135 
 
α1 – acid glycoprotein is one of the most widely measured APPs in chickens 
owing to the commercial availability of easy to use and chicken specific AGP kits 
(ECOS Institute, Miayagi, Japan). This kit contains anti-chicken α-1-acid 
glycoprotein antibodies of rabbit origin and commercial single RID test kits are 
available for measurement of AGP in chickens (Takahashi et al. 1994). Other 
immunoassay kits measuring AGP in chickens are now available.  
4.1.4 Apolipoprotein AI 
Plasma lipoproteins are water-soluble macromolecules composed of lipids and 
one or more specific proteins called apolipoproteins (apos) (Franceschini, 2003). 
There are several classes of lipoproteins: high density lipoprotein (HDL), low 
density lipoprotein (LDL), intermediate density lipoprotein (IDL), very low 
density lipoprotein (VLDL) and chylomicrons, classified on the basis of its 
floatation density or size (Tan et al., 2005). Avian HDL comprise more than 80% 
of plasma lipoproteins and their lipid and protein composition very closely 
resemble that of human HDL (Lamon-Fava et al., 1992). Apolipoprotein AI (Apo-
AI) is the major protein fraction of HDL in both birds and mammals (Kravitz et 
al., 2005).  
The pattern of tissue expression of the Apo-AI gene in birds is however very 
different from mammals in which Apo-AI synthesis is restricted to liver and 
intestine (Lamon-Fava et al., 1992). In chickens, Apo-AI synthesis occurs in a 
number of peripheral tissues in addition to the liver and intestine. In this 
respect, chicken Apo-AI closely resembles mammalian apolipoprotein E (ApoE), 
which is expressed at high levels in brain, kidney, lung, and other peripheral 
tissues. Since ApoE has not been detected in the plasma lipoproteins of chickens 
it is suggested that Apo-AI is the functional homologue of mammalian 
extrahepatic ApoE (Rajavashisth et al., 1987; Lamon-Fava et al., 1992). 
Comparing the total Apo-AI mRNA in the peripheral tissues, liver and intestine of 
chickens reveals that the peripheral tissues do not contribute a major portion to 
the circulating plasma Apo-AI functioning instead in cellular cholesterol 
metabolism or local lipid transport. On a cell basis, Apo-AI is most abundant in 
the intestine, whereas on a whole organ basis, the content of Apo-AI mRNA is 
very similar in liver and intestine, suggesting that both organs contribute almost 
equally to the whole body Apo-AI synthesis (Rajavashisth et al., 1987). 
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4.1.4.1 Apolipoprotein AI structure and function  
A prominent structural feature of apolipoproteins is an amphipathic α-helix in 
which the hydrophobic and hydrophilic faces are separated by positively charged 
residues, providing a hydrophobic side for interaction with lipids and a 
hydrophilic surface to interact with physiological fluids (Rajavashisth et al., 
1987; Franceschini, 2003). Chicken Apo-AI contains 264 amino acid and has a 
molecular weight of 30.6 kDa and an isoelectric point of 5.59 
(Uniprot.org/P08250) and shows 49% and 42% homology to human and rat Apo-AI 
respectfully (Rajavashisth et al., 1987). 
In mammals Apo-AI is an antioxidant incorporating esteriﬁed cholesterol into 
HDL and stabilising paraoxonase 1 and preventing lipid peroxidation (Kravitz et 
al., 2005). The cardioprotective role of high levels of HDL has been well 
described in humans with a strong inverse correlation between plasma HDL 
levels and coronary heart disease, and Apo-AI seems to the major factor in the 
anti-atherogenic activity of HDL because of the multiple roles it plays in reverse 
cholesterol transport (Franceschini, 2003; Kravitz et al., 2005). Reverse 
cholesterol transport is the process whereby excess cholesterol in peripheral 
tissues including the arterial wall is esterified in the plasma and transported to 
the liver for excretion (Kravitz et al., 2005). In birds, HDLs are responsible for 
the redistribution of cholesterol, cholesterol esters, and other nonpolar lipids 
from peripheral tissues to the liver for reuse or excretion in the bile (Roman et 
al., 2009).  
4.1.4.2 Apolipoprotein AI and the acute phase in chickens 
In mammals Apo-AI is a negative acute-phase protein decreasing by up to 25% 
during acute inflammation. Pro-inflammatory mediators IL-6, IL-1β, and TNF-α 
that usually stimulate the synthesis of positive APPs such as CRP and SAA, inhibit 
the synthesis of Apo-AI (Kravitz et al., 2005). In pigs Apo-AI is a negative APP, 
where it decreases in experimentally induced acute inflammation (Carpintero et 
al., 2005), African swine fever, Aujeszky's disease (Carpintero et al., 2007) and 
during road transport (Piñeiro et al., 2007). It also appears to reduce during the 
APR in cows infected with Salmonella Typhimurium (Oikawa et al., 1997).  
As a lipoprotein expressed widely in peripheral tissues chickens Apo-AI is 
regularly identified in both the serum and tissue proteomes of chicken (O‟Reilly, 
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2013). However its behaviour during an APR and possible use as a biomarker for 
infection and inflammation in chickens has not yet been determined. 
Apolipoprotein AI has been measured in a study on the effect of feeding regime 
on hepatic lipid metabolism in sexually mature broiler breeders, where it was 
found that the expression Apo-AI was significantly higher in birds reared using a 
SKP feeding regime compared to those reared on a everyday feeding regime 
(Ekmay et al., 2010).  
4.1.4.3 Quantification of apolipoprotein AI in chickens 
Kits for measuring chicken Apo-AI are widely available and use immunoassay 
methods with chicken specific antibodies. Despite this there are no reports in 
the literature of Apo-AI being measured in chickens. A mutant chicken (WHAM) 
identified and used as a model for spontaneous HDL deficiency has over a 90% 
reduction of HDL and Apo-AI compared to normal chickens. The serum 
concentrations of Apo-AI in the WHAM and normal chickens were 0.08±0.006 g/L 
and 0.95±0.21 g/L respectfully (Poernama et al., 1992). This normal Apo-AI 
concentration is lower than that reported for pigs, where the mean 
concentrations ranged from 2.3–3.08 g/L in pre-challenged groups in  the series 
of studies by Carpintero et al., (2005). 
4.1.5 Transthyretin  
Thyroid hormones (THs), lipophilic hormones that modulate growth and 
development, are bound to specific carrier proteins in plasma to ensure 
adequate distribution to target tissues (Yamauchi & Ishihara, 2009).  
Extracellular TH are distributed by thyroxine-binding globulin (TBG), 
transthyretin (Ttn) and albumin (Eguchi et al., 2008; Yamauchi & Ishihara, 
2009). In humans, 70–80% of THs in plasma are bound to TBG whereas in 
chickens, most THs are bound to Ttn and albumin as TBG is not synthesized in 
avian species (Eguchi et al., 2008). 
Hepatically synthesised Ttn is secreted alongside TBG and albumin into plasma. 
Transthyretin is also synthesised in the choroid plexus of the brain and secreted 
into the cerebrospinal fluid (CSF) of adult mammals, birds and reptiles 
(Yamauchi & Ishihara, 2009). In rats, Ttn constitutes 50% of the total protein 
secreted by the choroid plexus, with all Ttn made by choroid plexus secreted 
towards the brain (Chang et al., 1999). In chickens Ttn from circulation 
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accumulates in the yolk during oogenesis and is expressed embryonically before 
the vascular system and hypothalamic– pituitary–thyroid axis are established, 
where it plays a role in the transport and distribution of THs from the yolk to 
specific embryonic sites (Yamauchi & Ishihara, 2009). In adult chickens Ttn gene 
expression has been detected, by RT-PCR, in the kidney, lung, spleen and 
intestine (Yamauchi & Ishihara, 2009). 
4.1.5.1 Transthyretin structure and function  
Transthyretin has been detected in the plasma of fetal and adult eutherians, 
herbivorous (Australian) marsupials and some omnivorous (American) marsupials 
and birds (Chang et al., 1999; Yamauchi & Ishihara, 2009). It has been detected 
only at low levels, in the plasma of adult reptiles, amphibians and fish, in which 
the expression of Ttn is modulated in developmentally specific and species-
specific manners (Yamauchi & Ishihara, 2009); recent studies have suggested 
that the extrahepatic expression of Ttn is more predominant in lower 
vertebrates than in higher vertebrates (Yamauchi & Ishihara, 2009). 
Transthyretin is one of the most strongly conserved plasma proteins as 
sequences from mammals show 87 % sequence identity between species. Chicken 
and lizard Ttn show 75% and 66% sequence similarity with the human protein, 
respectively (Sunde et al., 1996). The sequence of amino acids in the thyroid 
hormone binding site regions of Ttn is totally conserved between species (Chang 
et al., 1999). Each molecule of Ttn is composed of four identical subunits (each 
composed of 127 amino acids) which coalesce non-covalently to generate a non-
glycosylated edifice with a molecular mass of 55 kDa and a central channel with 
two potential binding sites for the thyroid hormones (Chang et al., 1999; 
Ingenbleek & Bernstein, 2015).  
Transthyretin is described as being a negative acute phase reactant, decreasing 
in concentration in the plasma during an APR (Gruys et al., 2005). The decrease 
in plasma Ttn alongside cortisol-binding globulin and retinol-binding protein 
during an APR indicates an increased availability of the hormones bound to these 
proteins. The negative APPs are therefore described by some authors as „acute 
booster reactants‟ (Ingenbleek & Young, 1994). Used as a biomarker in human 
medicine Ttn has received strong support for assessing a broad array of diseases 
comprising metabolic and septic disorders though some researchers in the human 
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field have cast doubt on the clinical reliability of Ttn (Ingenbleek & Bernstein, 
2015). The exquisitely sensitive response of Ttn to the restriction of dietary 
amino acid supply, attributed to its small pool size, its short half life, and its 
high content of tryptophan (the narrowest of all indispensable amino acid pools 
in mammalian tissues) also make Ttn a biomarker of nutritional status and 
energy and protein adequacy (Ingenbleek & Bernstein, 2015). 
4.1.5.2 Transthyretin and the acute phase response in chickens 
As an acute phase reactant Ttn has not been studied in chickens and no 
information as to its behaviour or measurement during APR has been published. 
Transthyretin is a negative APP in pigs, where serum concentration of Ttn was 
shown to decrease rapidly and stay depressed during Streptococcus suis and 
Mycoplasma hyosynoviae infections (Campbell et al., 2005; Heegaard et al., 
2011). 
4.1.5.3 Quantification of transthyretin in chickens  
In pigs Ttn has been quantified using an in-house ELISA that utilised an anti-
human Ttn antibody (Campbell et al., 2005; Diack et al., 2011; Heegaard et al., 
2011). Reference ranges are reported as 174–610 mg/L in pigs (Diack et al., 
2011), and 300–330 mg/L and 250–270 mg/L in male and female humans 
(Ingenbleek & Bernstein, 2015). 
4.1.6 Haemopexin 
Haemopexin (Hpx) is a haem binding protein synthesised mainly by hepatocytes 
and has been detected in the plasma of all mammals to date and is an 
established APP in chickens and other birds. In mammals Hpx is synthesized 
mainly in the liver though extrahepatic synthesises has been demonstrated in 
skeletal muscle, retina, nervous system and kidney (Grieninger et al., 1986; 
Adler et al., 2001; Tolosano & Altruda, 2002; Wicher & Fries, 2010).  
4.1.6.1 Haemopexin structure and function  
Haemopexin has the highest affinity for iron of any known haem-binding protein 
and is important in the clearance of haem following haemorrhage, trauma, or 
infection (Ascenzi et al., 2005). During homeostatsis low concentrations of haem 
in the plasma occurs due to oxidation of haemoglobin, which is released during 
the enucleation of erythroblasts. This haemoglobin dissociates into αβ dimers 
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which are rapidly bound by haptoglobin (Hp) and metabolised. Plasma 
haemoglobin (Hb) that remains unbound to Hp is quickly oxidized into 
ferrihaemoglobin, before dissociation into globin and ferrihaem. The haem is 
first bound by albumin then transferred to Hpx for which it has a much higher 
affinity. Haemopexin binds to the non-protein pyrrole rings within the haem 
molecuIe and once bound undergoes a conformational change allowing for 
interaction with a specific Hpx receptor, mainly expressed on the hepatocyte 
membrane. It is internalised and the haem is catabolised (Tolosano & Altruda, 
2002; Tolosano et al., 2010). Haemopexin can then be released intact into the 
bloodstream and the haem is degraded and the iron is reutilised (Ascenzi, et al. 
2005). Receptors for haem–Hpx are expressed by liver parenchymal cells as well 
as retinal pigment epithelia cells, lymphocytes, and several cell lines (Tolosano 
& Altruda, 2002). 
Haemopexin is a multifunctional protein having involvement in iron homeostasis, 
antioxidant production and signalling pathways that promote cell survival and 
gene expression (Tolosano et al., 2010). The predominant function of Hpx 
however is to sequester and transport haem, preventing both haem catalysed 
oxidative damage and haem- bound iron loss (Tolosano & Altruda, 2002). In 
addition to its role during homeostasis, Hpx alongside Hp is also important for 
the clearance of haem following haemorrhage, trauma, infection or other 
haemolytic crisis (Ascenzi et al., 2005; Tolosano et al., 2010). During such times 
the presence of Hpx prevents haem-catalyzed oxidative damage, the pro-
inflammatory effects of free haem and limits the growth of many pathogens by 
preventing them from acquiring this readily available source of iron (Buyse et 
al., 2007) 
The structure of chicken Hpx differs significantly from mammalian Hpx being a 
larger, 52kDa protein with a different glycosylation pattern: possessing α1-
glycoprotein as oppose to a β1-glycoprotein seen in mammals. In keeping with 
the finding of a simpler carbohydrate structure, chicken Hpx exhibits a single 
band on 1DE under both non-denaturing and denaturing conditions whereas 
mammalian Hpx shows several bands. In contrast, the isoelectric focusing 
pattern of chicken haemopexin is very complex, revealing at least nine bands 
between pH 4.0 and pH 5.0  (Goldfarb et al., 1986).  
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4.1.6.2 Haemopexin and the acute phase response in chickens 
Barnes et al., (2002), using E. coli LPS to induce an APR found a 2.6 fold increase 
in Hpx. Adler et al., (2001) used Salmonella Typhymurium LPS and complete 
Freund‟s adjuvant and found Hpx levels to increase three fold 24 hours post 
infection, Hpx levels were still significantly higher than the control birds 14 days 
after the LPS challenge. Garcia et al,. (2009) found Hpx to increase by 
approximately 1.5 fold in response to intra crop Salmonella enterica serovar 
Gallinarum, with serum concentration decreasing from 7 days post infection.  
L-Carnitine, synthesized in vivo from methionine and lysine, is known to have 
immunomodulary properties. Buyse et al., (2007) found that while plasma Hpx 
(and AGP) were significantly increased in birds injected with LPS, the increase 
was more pronounced in the L-carnitine supplemented chickens, suggesting that 
extra L-carnitine in the diet of broiler chickens can enhance or advance the APR. 
In a similar study supplementation of Astragalus polysaccharide was found to 
attenuate the increase in Hpx (and AGP) induced by LPS challenge in chickens 
(Liu et al., 2015).   
4.1.6.3 Quantification of haemopexin in chickens  
Purification of Hpx from chicken serum is possible using a haem affinity 
chromatography. Purified chicken Hpx was used to raise a chicken specific 
antibody to Hpx which was used in rocket immunoelectrophoresis to determine 
Hpx concentrations (Adler et al., 2001; Buyse et al., 2007). Using this method a 
basal concentration of 0.15 g/L was reported by Buyse et al., (2007) which is 
lower than the basal concentration in humans of 0.5–1.2 g/l humans (Tolosano & 
Altruda, 2002). The administration of LPS resulted in Hpx concentrations 
increasing to approximately  0.3 – 0.6 g/L (Buyse et al., 2007).   
 
4.1.7 Quantitative Proteomics  
MS(MS) based quantitative proteomic approaches are well-suited to the 
discovery of protein mediators and biomarkers of disease (Cretu et al., 2015) 
which together with the introduction of new technologies in MS allows for the 
identification and quantification of thousands of proteins in a single experiment 
through different sets of approaches called shotgun proteomics (Wilson, 2013). 
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Shotgun proteomics, which is named for its analogy with shotgun genomics is 
conceptually accepted as the use of enzymes, usually trypsin, to digest proteins 
and characterise the proteins in the mixture by tandem MS, this is termed the 
bottom up approach. The top down approach is the characterisation of intact 
proteins, this approach is better for the determination of post translational 
modifications and the characterisation of isoforms, though there are 
disadvantages to this approach and methods are still under development. The 
middle down approach is the intermediate approach of using partial or limited 
proteolytic digests for protein identification (Nogueria & Domont, 2014).  
Descriptive proteomics, the identification of proteins, gives extremely important 
qualitative information on biological systems, however it is quantitative 
information on protein abundance that provides precise and richer results 
(Nogueria & Domont, 2014). Two main approaches are used in quantitative MS 
based proteomics: stable isotope labelling and label-free quantification (Arike & 
Peil, 2014) which is absolute quantification where the protein concentration or 
copy number is determined, or relative quantification respectfully (Nogueria & 
Domont, 2014). Quantification with stable isotopes is based on the mass 
difference between labelled and unlabelled ions in MS analysis. Proteins are 
chemically, metabolically, or enzymatically labelled with molecules that have a 
combination of light and heavy isotopes of 15 N, 13 C, 18 O, and 2 H in their 
composition.  After mixing, the peptides labelled with different isotopes are 
identified as pairs in the MS spectra or as reporter ions in the MS/MS and the 
intensity ratio between the isotope variants reflects the fold-difference between 
their abundances (Arike & Peil, 2014; Nogueria & Domont, 2014). 
 
For label-free quantification there are two basic approaches the first is by 
counting the number of spectra acquired for a given protein in a given sample. 
This method is termed spectral counting (Salvidor & Levin, 2014) and it is the 
most simple label-free quantification technique based on the observation that 
the more abundant the protein is the more peptides can be identified from it 
(Arike & Peil, 2014). Spectral counting implies a counting and a comparison of 
the number of fragment-ion spectra (MS/MS) acquired for peptides of a given 
protein. Due to the empirical observation that the number of tandem mass 
spectra of a particular peptide increases with an increasing amount of the 
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corresponding protein, a relative quantification of proteins between different 
samples is possible (Megger et al., 2013). The second method uses the 
measurement of chromatographic peak areas (also termed MS signal intensities) 
of peptide precursor ion intensity and this has been shown to produce a more 
accurate quantification (Salvidor & Levin, 2014). The quantification is based on 
the differential peak intensity of the peptides in each MS scan (Cretu et al., 
2015). Depending on the chromatographic method (e.g. reversed-phase liquid 
chromatography) the peptides are separated according to their particular 
physical properties (e.g. hydrophobicity, charge), subsequently ionized in an ion 
source and finally detected in a mass spectrometer. In the acquired mass 
spectrum each peptide of a particular charge and mass generates one 
monoisotopic mass peak. The intensity of this peak as a function of the retention 
time can be visualized in an extracted ion chromatogram (XIC) and the area 
under the curve (AUC) can be determined. The areas of chromatographic peaks 
have been shown to correlate linearly in a wide range with the protein 
abundance which makes their measurement feasible for quantitative studies 
(Megger et al., 2013). 
 
Label-free proteomics has emerged as a high-throughput method for quantitative 
clinical proteomics studies (Megger et al., 2013) as such experiments often 
result in tens to hundreds of candidate biomarkers, therefore, in the context of 
biomarker discovery, high-throughput MS-based proteomics is a powerful tool for 
obtaining disease-specific proteome profiles of biological materials (Cretu et al., 
2015). In the human field of biomarker identification, plasma is known to 
represent a diverse proteome and while an excellent source of potential disease 
markers, as proteins secreted by tissues are diluted in blood, and are often 
undetectable by current MS methods (Cretu et al., 2015). To aid protein 
identification samples can be pre-fractionated (e.g. via 1D-PAGE, isoelectric 
focussing, ion exchange chromatography, high-pH reversed-phase liquid 
chromatography) prior to reverse phase liquid chromatography and each fraction 
can then be analyzed in a single LC–MS/MS experiment. A clear advantage of 
such a 2D setup is a decomplexation of the sample leading to a higher proteome 
coverage as well as the possibility to select particular fractions of interest for 
the subsequent analysis (Megger et al., 2013). Depending on the MS used for a 
label-free analysis, different acquisition modes can be used, namely a data-
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dependent acquisition (DDA) and a data-independent acquisition (DIA). The 
former one includes the acquisition of a survey scan and a subsequent 
fragmentation of selected precursor peptide ions (Megger et al., 2013). 
4.1.7.1 Planning a quantitative proteomic study: pre-fractionation and 
sample preparation  
While shotgun proteomics has become the method of choice for identifying and 
quantifying proteins in large scale studies because of high data throughput and 
better protein detection sensitivity (Nesvizhskii, 2007), digesting all the proteins 
within a biological sample such as plasma into peptides will result in a very 
complex sample (Hu et al., 2007; Nesvizhskii, 2007). As a result the amount of 
mass spectra generated from shotgun analysis of complex samples such as serum 
is very difficult to interpret because of the large number of peptides generated 
from trypsin digestion (Fournier et al., 2007), the complexity of which is much 
higher than simply the sum of all the tryptic peptides from a mixed protein 
sample, as miscleavages and truncations occur during digestion giving rise to 
much higher than predicted numbers of peptides (Westermeier et al., 2008). The 
tens of thousands of peptides generated from a tryptic digestion of a sample will 
have a wide dynamic range of concentrations. These peptides may have similar 
m/z ratios and different levels of abundance, creating a challenge for the MS 
with respect to the detection and identification of low abundant proteins. 
Therefore powerful separation techniques are required to maximise the number 
of peptides for analysis for MS (Fournier et al., 2007).  
Within a complex protein sample such as serum or plasma the concentrations of 
proteins are not evenly distributed and it is very difficult for MS to detect and 
analyse very low abundant proteins. The protein concentrations of plasma span 
over ten orders of magnitude (Westermeier et al., 2008) which together with the 
generation of the tens of thousands of peptides mean that identifying a low 
abundant protein within a serum sample can be very difficult. To increase the 
chance of identifying peptides from the target proteins, enriching the source 
material to increase the concentration of a low abundant protein is often 
necessary. For serum this can simply be achieved by removing the high abundant 
proteins. In plasma approximately 90% of the proteins are albumin and IgG and 
just twenty-five high abundant proteins represent 99% of the total protein 
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content, however the remaining proteins are still spread over a huge 
concentration range (Westermeier et al., 2008). Other enrichment methods will 
target the proteome of particular cellular locations or organelles. 
The initial part of this study is concentrated on identifying the APPs SAA and CRP 
in chicken serum with a view of identifying suitably tryptic peptides from these 
APPs for quantification purposes. The molecular weights of SAA and CRP are 14.1 
kDa and 25.6 kDa respectfully, making these suitable candidates for enrichment 
by molecular weight fractionation prior to trypsin digestion. By fractioning based 
on molecular weight many of the high abundant proteins such as albumin and IgG 
will be excluded. Utilising CRP‟s strong affinity for phosphorylcholine an affinity 
column on a fast protein liquid chromatography (FPLC) system can separate and 
concentrate CRP from acute phase serum. This can be used as a further 
enrichment method for CRP. 
The shotgun proteomics method for this study is based on the coupling of high 
performance liquid chromatography (HPLC) and MS. The digested peptides from 
both whole serum and the enrichment samples will be analysed by 
multidimensional chromatography coupled to tandem MS/MS. Multidimensional 
separation can be performed over two independent separation techniques that 
can include ion exchange, size exclusion and reverse phase affinity (Fournier et 
al., 2007). This study will utilise reverse phase C18 chromatography for both 
dimensions, with high pH (pH10) and low pH (pH3) for the 1st and 2nd dimensions 
respectfully. The peptides are then sequenced using tandem MS (MS/MS) and 
automated database searching is then used to identify the proteins (Lange et 
al., 2008). This study will utilise the technologies of  the Q-Exactive Hybrid 
Quadrupole–Orbitrap mass spectrometer (Thermo Scientific) which allows both 
the targeted and untargeted screening (Thermo Scientific).  
The first stage of this study will utilise untargeted screening to identify all the 
proteins present in the whole serum of three acute phase pools and the enriched 
samples, using the peak area the MS/MS spectra which uses the area under the 
curve (AUC) to give a relative quantification of each protein following 
normalisation using intensity. 
When selecting peptides for each protein target it is critical that peptides are 
both detectable and unique to the protein of interest (proteotypic) and also 
146 
 
accurately represent the level of the protein (quantotypic) (Worboys et al., 
2014). Peptides that are quantotypic are readily ionized and observed in the 
mass spectrometer with no signal loss due to miscleavage or post translational 
modification. The proteolytic digestion of proteome proteins is frequently 
incomplete, and miscleavages are often generated in addition to or instead of 
the limit peptides produced. The goal of quantitative proteomic experiments is 
to quantify the proteins, not their peptides per se, so quantotypic peptides 
should be stoichiometric with the parent protein to enable accurate quantitation 
(Lawless & Hubbard, 2012). Several factors may impact the quantotypic 
properties of peptides such as differential post translational modification, 
alternative splicing and the completeness of proteolytic digestion. Selection of 
optimal quantotypic peptides is crucial to ensure accurate quantification of 
protein levels (Worboys et al., 2014). Once peptides of the targeted proteins 
have been identified and validated the Q-Exactive will be used with the targeted 
mode (single ion monitoring SIM/targeted MS/MS) screening to identify and 
quantify only the peptides of interest. The basic concept is to monitor the 
presence and intensity of specific transitions consisting of pairs of precursor ion 
m/z and its product ion m/z. Single ion monitoring (SIM) and targeted MS/MS 
analysis provide high sensitivity and high specificity for peptide selection since 
only desired peptides are selected and analysed in both MS and MS/MS mode and 
other signals are regarded as noise (Zhi et al., 2011).  
4.1.8 Aims of this study  
The purpose of this study is to utilise proteomic technologies to identify and 
quantify APPs in chickens, using enrichment methods where necessary to aid in 
the identification of low abundant APPs. Proteins found to be differentially 
abundant proteins between acute phase and non-acute phase samples were also 
targeted and measured with a view of identify novel biomarkers of the APR.  
Serum amyloid A was targeted as it is the only major APP described in chickens, 
while CRP was targeted as it is the major APP in many species, yet descriptions 
in chickens remain scant. Initially SAA and CRP were enriched using molecular 
weight fractionation and a phosphorylcholine affinity column for CRP. These 
enriched fractions together with whole serum from acute phase and non-acute 
phase samples underwent trypsin digestion and shotgun analysis using 
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untargeted screening with UPLC coupled to a Q-Exactive Hybrid Quadrupole–
Orbitrap mass spectrometer (Thermo Scientific). Known APPs together with 
differentially expressed proteins were targeted using the same method, this 
time using the Q-Exactive Hybrid Quadrupole–Orbitrap mass spectrometer in a 
targeted mode (data dependant single ion monitoring SIM/targeted MS/MS) 
screening to identify and quantify only the targeted peptides of interest. It was 
the hypotheses of these studies that SAA and CRP would be identified in 
enriched sera and subsequently quantified. Furthermore, identifying proteins, 
differentially expressed between three acute phase groups would also allow the 
targeting of other, novel, acute phase reactive proteins as well as the 
quantification and characterisation of other known APPs.  
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4.2 Method 
A diagram, detailing the experimental process and proteomic workflow is 
contained in Appendix 4.2.  
4.2.1 Enrichment and shotgun analysis of acute phase serum 
 
4.2.1.1 Identifying C-reactive protein in chicken serum 
Using an AKTA Fast Protein Liquid Chromatography (FPLC) (GE Healthcare, Life 
sciences) a pooled sample of acute phase chicken serum was injected on to an 
immobilized p-aminophenyl phosphoryl choline gel column (Thermo Scientific 
20307), following column equilibration with a binding buffer (0.1M Tris, 0.1M 
NaCl, 2mM CaCl2 pH8). Following one hour incubation at room temperature, the 
column was flushed with binding buffer to remove unbound proteins. An elution 
buffer containing ethylenediaminetetraacetic acid (EDTA) (0.1M Tris, 0.1M NaCl, 
10mM EDTA pH8) was pumped through the column and eluates collected over 
time in a fraction collector. Four elutions containing protein were pooled, 
dialysed overnight at 4˚C to and centrifuged in an Amicon centrifuge tube 
(Millipore Amicon Ultra centrifugal filters 0.5mL 3K UFC500324) to concentrate 
the protein for 1DE, which was undertaken using methods detailed in Chapter 2, 
Section 2.2.2.1. Western blotting using rabbit α-human CRP and sheep α-dog CRP 
at a 1:500 dilution, with Goat anti-rabbit IgG HRP (Abcam 6721) and Rabbit anti-
sheep IgG HRP (Abcam 6747) as secondary antibodies respectfully, was 
undertaken using methods detailed in Chapter 2, Section 2.2.2.2. Bands were 
excised and the proteins identified using nanoflow HPLC electrospray tandem 
MS(nLC-ESI-MS/MS) detailed in Chapter 2, Section 2.2.2.3. 
4.2.1.2 Sample collection  
To obtain acute phase serum with potentially high concentrations of SAA and 
CRP, a flock of broiler chickens of 25 days of age from a commercial farm in 
Scotland were accessed on site for poor growth, lameness and generalised signs 
of ill health. Within a single house 19 birds were selected, culled and blood was 
recovered immediately post-mortem into serum tubes. Three serum samples 
were obtained from a different company from sick birds that were later 
diagnosed with Adenovirus infection. Serum concentrations of AGP, was 
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determined using a chicken specific single immunodiffusion test kit (ECOS 
Institute, Miyagi, Japan). The Adenovirus infected birds showed up to a 10 fold 
increased AGP concentration and were categorised as being highly acute phase 
(HAP). Acute phase (AP) samples, showing up to 5 fold increase in AGP compared 
to healthy chicken and samples where the AGP was within the normal ranges and 
non-acute phase (NAP) were pooled to create two further  groups (Table 4.1).   
Group Acute phase status n 
Pool – 1 Highly acute phase (HAP) 3 
Pool – 2 Acute phase (AP) 6 
Pool – 3 Non- acute phase (NAP) 6 
Table 4.1: The acute phase status of three groups for shotgun analysis.  
 
4.2.1.3 Protein Quantification  
Serum was diluted 1:10 and 1:5 for acute phase and healthy samples respectfully 
and protein concentrations determined using RC DC protein assay kit (BioRad 
500-01190) as follows: Bovine serum albumin (BSA) (Thermo scientific Pierce BSA 
assay standards) was diluted 0 – 1.4 µg/µl, and 25µl of each used as standard. 
The standards and diluted samples were mixed with 125µl of RC reagent 1, 
vortexed and incubated for 1 minute at room temperature (RT). An equal 
volume of reagent 2 was added, the samples centrifuged at 15,000g for 10 
minutes at 4⁰C and the resultant pellet was dissolved in solution A (reagents S + 
A), vortexed and incubated at RT for 5 minutes. To this 1ml of reagent B was 
added, vortexed and incubated at RT for 15 minutes, before absorbance was 
measured at 750nm on a spectrophotometer. The absorbance for the standards 
were plotted to produce a curve from which the protein concentration of the 
samples was calculated.  
4.2.1.4 Trypsin digestion  
Three pools, as detailed in Table 4.1, containing equal quantities of protein from 
each sample was reduced with the addition of 10mM DTT in 50mM ammonium 
bicarbonate and heated in the dark at 56⁰C with agitation for 40 minutes. 
Samples were alkylated with 20mM iodoacetamide in 50mM ammonium 
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bicarbonate and left at RT in the dark for 30 minutes before undergoing a second 
10 minute RT reduction using 11mM DTT in 50mM ammonium bicarbonate to 
eliminate any excess iodoacetamide. Samples were precipitated using 2D clean 
up kit from GE Healthcare (80-6484-51) during which 300µl of precipitant was 
added to each sample, vortexed and incubated on ice for 15 minutes. The same 
volume of co-precipitant was added, vortexed and the tubes centrifuged at 
15,000g for 15 minutes at 4⁰C and the supernatant removed. To wash the pellet 
a further 40µl of co-precipitant was added to the undisturbed pellet, incubated 
on ice for 5 minutes, centrifuged at 15,000g for 5 minutes at 4⁰C and the wash 
removed. To the pellet 25µl of H2OmQ was added and vortexed to disturb the 
pellet and 1ml of -20⁰C acetone and 5µl of wash additive was added, the 
samples vortexed and the samples incubated at -20⁰C for 1 hour. The samples 
were centrifuged, and to the final pellet 90µl of 50mM ammonium bicarbonate 
was added. For the first of two trypsin digestions 1µg of trypsin in 25mM 
ammonium bicarbonate was added to each sample, vortexed and incubated at 
37⁰C overnight. The following day 0.5µg of trypsin in 25mM of ammonium 
bicarbonate with 80% acetonitrile was added to each sample and incubated at 
37⁰C for 3 hours at 600rpm. To halt the digestion 0.5% of TFA was added to the 
final volume to acidify the pH, inhibiting the activity of the trypsin enzyme. 
Samples were vacuum centrifuged and 100µl of 0.1% TFA was added to the 
resultant pellet. Thermo Scientific Pierce C18 tips (87782) were used as 
according to the manufacturers instruction on each sample to remove 3.5µg of 
digested peptide, which was recovered in a final elution buffer of ACN 50% TFA 
0.1%. This was vacuum centrifuged and the resultant pellet was re-suspended in 
3.5µl of Waters MassPREP Digestion Standard Mixtures (MPDS-mix) #1 for samples 
1 and 2 and into mixture #2 for sample 3. Into this the same volume of TFA and 
H2OmQ were added.  
4.2.1.5 Quantitative Proteomics 
Shotgun analysis was performed on each of samples using 2D nano UPLC system 
(RP x RP nano Acquity, Waters), coupled to a Q-Exactive hybrid Quadrupole-
Orbitrap mass spectrometer (Thermo Scientific), in conjunction with Dr. Gabriel 
Mazzucchelli and Professor Edwin De Pauw at the MS Laboratory at the 
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University of Liege, Belgium during a short term scientific mission of the COST 
Action on Farm Animal Proteomics.  
The peptides were added over two dimensions to the mass spectrometer using 
liquid chromatography. The Q-Exactive-Orbitrap Mass spectrometer (Thermo) 
then performed MS/MS spectra analysis, and comparisons were made to the 
Gallus gallus protein database (Uniprot) using Sequest (Thermo Scientific) and 
Mascot (Matrix Science). 
4.2.1.6 Protein fractionation  
To target SAA and CRP serum was fractionated by molecular weight to create a 
sample rich in low molecular weight proteins to increase the sensitivity of the 
shotgun analysis and identifying the target peptides. From pools 1 and 2, 500µg 
of protein underwent a (2D) protein clean up method as described earlier, in 
duplicate, so as fractionate two aliquots from each pools. The GE Healthcare 2D 
clean-up kit (80-6484-51) was used to precipitate the protein, using 450µl of 
precipitate and co-precipitate. After 1 hour at -20⁰C in acetone wash buffer, the 
resultant pellet was re-suspended in 8µl of 1M DTT, 30 µl of x5 Tris acetate 
sample buffer (42302) and 112µl H2OmQ. Vortex was used to ensure the pellet 
was dissolved and the samples heated at 50⁰C for 10 minutes.  
Protein Discovery GelFree® 8100 Fractional system (Expedeon, Cambridge, UK), 
utilising a 10% cartridge kit to fractionate proteins from 3.5 – 100kDa was used to 
fractionate proteins from pools 1 and 2. An initial fractionation examining the 
protein concentrations of 12 fractions collected using the recommended protocol 
revealed that the first five fractions to be very low in protein. Because the SAA 
protein would fractionate within these initial fractions, the programme was 
extended as detailed in Table 4.2 to separate the early fractions further.  
Step 1 2 3 4 5 6 7 8 9 10 11 12 13 
Voltage 50 50 50 50 50 50 100 100 100 100 100 100 100 
Time 16 34 2 2 3 4 3 4 5 7 10 15 20 
Fraction 
 
Action 
Add 
2ml 
RB 
1 2 3 4 
5 
RB 
Change 
6 7 8 9 
10 
RB 
Change 
11 12 
 
Table 4.2: The fractionation protocol with the additional step at the start. This method 
was followed during the molecular weight separation of the serum.  
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The cathode and anode reservoirs were filled with 6ml and 8ml of HEPS running 
buffer (RB) respectfully. The samples were added to a washed loading chamber, 
and 150µl of RB was added to the washed collecting chamber. The programme 
was started and after the 1st step, an additional 2ml of RB was added to the 
cathode reservoir, the loading chamber was washed twice with 200µl of RB and 
the programme continued. After each step, the resultant fraction was collected 
from the collection chamber, the chamber washed twice with 200µl of RB, re-
loaded with 150µl of RB and the programme continued. Where indicated in Table 
4.2, the RB was changed in both the anode and cathode reservoirs and the 
loading chamber also. After all the fractions were collected the cartridge was 
discarded. 
4.2.1.7 1D SDS PAGE (1DE) 
To evaluate the fractions a 1DE gel was performed on all fractions from the 
second duplicate fractionation, including the first three that were estimated to 
have low protein concentrations. Firstly 5µg of protein from fractions 4-12 and 
all of the protein within fractions 1-3 underwent a trichloroacetic acid (TCA), Na 
Deoxycholate (DOC) and acetone precipitation as follows. A 2% DOC solution was 
added to each sample to obtain a final concentration of 0.02% of the volume and 
left at RT for 15 minutes, before 100% TCA was added to obtain a final volume of 
10% TCA before vortexing and a 1 hour RT incubation. The samples were 
centrifuged at 4⁰C for 10 minutes, the supernatant removed and the pellet air 
dried. To each pellet 200µl of -20⁰C acetone was added on ice, the samples 
incubated for 15 minutes, centrifuged at 15,000g at 4⁰C for 10 minutes and the 
pellet air dried, after which the pellet was re-suspended in 10µl of Laemelli 
buffer. The samples were heated at 100⁰C for 10 minutes before being pipetted 
alongside side both molecular weight marker (Novex See Blue Plus standard 
1089578) and a whole serum sample of the fractionated sample containing 5µg 
of protein which underwent the same preparation as the fractions. The samples 
were loaded into different wells of a NuPAGE 4-12% Bis-Tris Midi gel (Novex Life 
Technologies WG1401BX10), the gels were loaded into a Introgen Novex Midi Gel 
system and ran in a Nu PAGE MED SDS running buffer (NP0002) for 1 hour at 
200V. The gels were then fixed with EtOH 50%, H3PO4 3% before being stained 
with a colloidal Coomassie (MeOH 34%, H3PO43% (NH4)2SO4 17%).  
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4.2.1.8 Fraction analysis 
The protein concentrations of fractions 1-12 (initial fractionation) and 4-12 
(second fractionation from pools 1 and 2 in duplicate) was ascertained using RC 
DC protein assay kit (BioRad 500-0119) as previously described though no 
dilutions of the fraction samples took place. Fractions 1-3 of the second 
fractionation experiment were not quantified owing to the low concentration 
seen on the initial fractionation, and the fact that the protein needed to be 
preserved for both gel electrophoresis and mass spectrometry. Fractions 1-6 of 
both groups 1 and 2 were trypsin digested as previously described, with volumes 
adjusted for protein concentration and the addition of 30µl of ammonium 
bicarbonate to the final pellet. Each fraction underwent shotgun analysis as 
previously described and the resultant protein matches pooled to create a 
description of all proteins identified in fractions 1 – 6 from pool-1 and pool-2.  
4.2.1.9 Shotgun analysis of immobilised p-aminophenyl phosphoyl choline 
gel elution 
Early attempts at identifying CRP using an immobilised p-aminophenyl 
phosphoyl choline gel, which uses the affinity of CRP isolate it from serum 
resulted in an elution containing a number of proteins including a 25kDa 
protein. This elution underwent the same preparation as the fractions and 
underwent shotgun analysis with the aim of identifying the proteins in this 
sample. 
4.2.2 Measurement of APPs and identification and 
measurement of other biomarkers of the acute phase 
response using quantitative proteomics 
 
4.2.2.1 Identification and measurement of acute phase proteins using 
single ion monitoring SIM targeted MS/MS  
 
4.2.2.1.1 Identifying acute phase proteins in initial shotgun analysis of 
pools 
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The shotgun analysis data, utilising the peaks from the MS/MS spectra was 
analysed. The peak area value derived from area under the curve (AUC) was 
used to give a relative quantification of each protein from each pool once the 
AUC values were normalised using intensity. Known APPs identified in the 
shotgun analysis of the HAP, AP and NAP pools (pools1-3) were targeted for 
quantification (with the exception of AGP, which was identified but not selected 
for measurement). The targeted APPs are detailed in Table 4.3. C-reactive 
protein was not selected as it was not identified in the initial shotgun analysis. 
Acute phase protein Abbreviation  
Serum Amyloid A SAA 
Apolipoprotein AI Apo-AI 
Ovotransferrin Ovt 
Transthyretin Ttn 
Haemopexin Hx 
PIT54 PIT54 
 
Table 4.3: Acute phase proteins targeted for quantification. These APPs, identified in the 
shotgun analysis, are known APPs and (with the exception of Apo-AI and Ttn) have been 
previously characterised in chickens. These were targeted for subsequent quantification.  
 
4.2.2.1.2 Measuring acute phase proteins using data dependant single ion 
monitoring targeted MS/MS in three acute phase groups 
Once the APP targets were selected, proteotypic peptides were assessed and 
quantotypic peptides identified. The samples from each pool were then assessed 
separately. Three HAP (pool-1) samples, and four AP and NAP (pools-2 and 3) 
samples were randomly selected. This shotgun analysis utilised the nano UPLC - 
Q-Exactive hybrid Quadrupole-Orbitrap mass spectrometre (Thermo Scientific) 
(data dependant single ion monitoring SIM/targeted MS/MS) in a targeted mode, 
targeting the peptides of each of the selected proteins, based on the results of 
the previous shotgun analysis. 
The MS data was collated and following normalisation, analysed using Skyline 
v.3.5 (MacCoss Lab software). The MS/MS peaks were integrated and the AUC for 
each peptide (peptide intensity) was determined. The peptide intensities (the 
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sum of all the fragment ions of that peptide) were used to determine the 
intensities of each APP in each sample. For each APP, two, three or four peptide 
intensities were used and non-parametric Kruskal-Wallis tests were used to 
compare the peptide intensity for each selected peptide across the three sample 
groups and identify significant differences. Spearman‟s correlations were used to 
calculate any correlation in the area generated from each peptide of each APP. 
Statistical analysis was undertaken using GraphPad Prism v.5 and v.6.  
4.2.2.1.3 Quantifying ovotransferrin and serum amyloid A by immunoassay  
Using a radial immunodiffusion method described in Chapter 3, Ovt was 
measured in the HAP, AP and NAP samples. Serum amyloid A was measured using 
a commercial kit, acquired from Life Diagnostics (3400-7 Life Diagnostics, Stoke-
on-Trent, UK) which utilises a chicken specific enzyme-linked immunoassay assay 
method (ELISA). This ELISA kit was used according to the manufacturer‟s 
instructions, with modifications to the initial serum concentrations, to reduce 
the volume of chicken sera used, and the serum was diluted 20 fold with the 
diluent, to obtain results that were measureable on the standard curve. By this 
stage of the work the third HAP sample was exhausted and as such no 
measurement is available for this sample. The results of the immunoassays were 
correlated with the peak area for each SAA and Ovt peptide generated from the 
targeted SIM/MS/MS results using a Spearman‟s correlation in GraphPad Prism 
v.6.  
4.2.2.2 Identification and  measurement of other biomarkers of the acute 
phase response using single ion monitoring targeted MS/MS 
 
4.2.2.2.1 Identifying novel biomarkers of the acute phase response in the 
initial shotgun analysis of pools 
Identification of other proteins in the serum that were differentially abundant 
between acute phase groups (pools) was undertaken to identify other possible 
biomarkers of the APR in chickens. To do this the peak AUC for all proteins 
identified in all three pools were normalised and the fold difference calculated 
between each pool for each protein and ranked to identify the most 
differentially abundant. From this shortlist proteins were further selected based 
156 
 
on the availability of suitable MS/MS data for targeted measurement generated 
from the shotgun analysis and the quantotypic nature of the constituent 
peptides of these proteins.  
4.2.2.2.2 Measuring novel biomarkers of the acute phase response using 
data dependant single ion monitoring targeted MS/MS in three 
acute phase groups 
Following the same protocol as detailed for APPs in 4.2.2.1.2, the novel 
proteins selected were quantified for the three highly acute phase and four 
acute phase and non-acute phase samples to determine whether these 
proteins were indeed differentially expressed between acute phase groups. 
The results were analysed as per Section 4.2.2.1.2. 
4.2.3 Statistics  
GraphPad Prism v.5 and v.6 were used for statistical analysis. All results were 
analysed using non-parametric tests: Kruskal-Wallis test with Dunn post-test 
analysis and Spearman‟s correlation, following data evaluation using D'Agostino-
Pearson omnibus normality test. Non-parametric analysis was selected based on 
the results together with the small number of replicates in each group.  
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4.3 Results  
 
4.3.1 Enrichment and shotgun analysis of acute phase serum 
 
4.3.1.1 Initial attempts at identifying C-reactive protein in chicken serum 
With the aim of purifying and identifying CRP in chicken serum, Western blotting 
using two α-CRP antibodies to identify any binding to chicken acute phase and 
non-acute phase serum was undertaken and the Western blot is shown in Figure 
4.1. 
 
Figure 4.1: Western blot to detect cross reactivity of rabbit anti-human CRP and sheep anti-
dog CRP antibodies to chicken serum (lanes 1-4 and 8-11). Both acute phase chicken serum 
(lanes 1-2 and 8-9) and non-acute phase serum (lanes 3-4 and 10-11) were used. Pig serum (lanes 
5-6) and dog serum (lane 12) were also included on the western blots for the anti-human CRP 
and sheep anti-dog CRP antibodies respectfully. Separation of proteins was achieved using a 4-
12% CriterionTM Bis-Tris precast polyacrylamide gel (BioRad#345-0124). 
 
The western blots revealed no reactivity between the rabbit anti-human CRP 
antibody and the proteins in chicken serum. The human antibody shows cross 
reactivity with the pig serum and unspecific binding as well. The sheep anti-dog 
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CRP antibody has shown unspecific binding, most likely immunoglobulin within 
the chicken serum but no binding was seen at 25kDa the molecular weight of 
CRP.     
Acute phase serum was injected onto an immobilized p-aminophenyl phosphoryl 
choline gel column (Thermo Scientific 20307) and following concentration of the 
eluted protein ran on a 1DE gel, alongside purified dog CRP. In Figure 4.2 a 
number of bands, typical in appearance of unspecific binding can be seen in the 
elution in lanes (1-6), including a single band at 25kDa. In lanes 7-9 the purified 
dog CRP can be seen as a double bands as two of the five CRP subunits are 
glycosylated and appear separately from the other subunits (Ceron et al., 2005). 
 
Figure 4.2:  1DE of concentrated eluate from FPLC and concentrated canine CRP. Separation 
was achieved using a 4-12% CriterionTM Bis-Tris precast polyacrylamide gel (BioRad#345-0124). 
Protein is stained with Coomassie blue G dye (Sigma Aldrich). 
  
This band of interest from the elution together with 6 other bands were excised 
from the gel and identified using mass spectrometry. The excised bands and the 
identified proteins are detailed in Figure 4.3 and Table 4.4 respectfully. 
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 Figure 4.3: Bands present and excised from 1DE shown in Figure 4.2. 
 
ID Protein ID  Accession Mr (da) PI 
Peptides 
matched 
Sequences 
Coverage 
% 
Mascot 
Score 
1 
Apolipoprotein AI (G. 
gallus) 
gi|211159 30673 5.58 15(4) 14(4) 51 145 
PREDICTED C-reactive 
protein (Canis lupis 
familiaris) 
gi|345797697 
  
 25367 - 2(0) 2(0) - 42 
3 
Predicted alpha 
tectorin like isoform 1 
(G.gallus) 
gi|363745877 29865 5.19 4(0) 4(0) 15 42 
4 
Serum albumin 
precursor (G.gallus 
gi|45383974  69872 - 13(0) 11(0) - 53 
Immunoglobulin (G. 
gallus) 
gi|118088308  53607 6.84 4(1) 3(1) 6 50 
Plasminogen (G. gallus) gi|118088308  49206 5.26 3(1) 3(1) 3 49 
 
Table 4.4: Proteins identified in bands 1, 3 and 4 from Figure 4.3. Bands 2, 5, 6 and 7 were 
contaminants (human keratin). Proteins were identified by Mascot Gallus gallus peptide 
database (Blanks exist where Mascot updates have deleted original data). Bands were excised 
from the gel trypsin digested and identified using nanoflow HPLC-EPI-MS/MS with identities 
assigned using Mascot Science Daemon server to interrogate protein sequences in the NCBI 
Genbank database for Gallus gallus and boney vertebrates. Both NCBI and where Uniprot 
identifications are listed (immunoglobulins are not listed in Uniprot). The protein score is the 
sum of the highest ions score for each distinct sequence. The first number under matches is the 
count of MS/MS spectra that have been matched to peptides from this protein. The matches 
shown in the parenthesis indicating unique matches (scores above the significance threshold). 
The sequences column is the count of matches to distinct peptide sequences, the number in 
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parenthesis is the count of sequences with significant matches (Matrixscience.com). The 
coverage percentage is proportion of the protein‟s entire sequence identified. 
 
Band 1, the most intense band was identified as apolipoprotein AI (Apo-AI), the 
major protein fraction of high-density lipoproteins (HDL). There were no 
matches for CRP or other pentraxans to Gallus gallus. When the search was 
widened to include all boney vertebrates there was a predicted match to canine 
CRP identification for two peptides. Given the low score and the presence of 
purified and highly concentrated dog CRP on the gel, this is highly likely to be 
contamination. Other bands excised were identified as human keratin a gel 
contaminant. 
4.3.1.2 Protein fractionation  
Two fractionations were undertaken using the Protein Discovery GelFree® 8100 
Fractional system (Expedeon, Cambridge, UK) to enrich the lower molecular 
weight proteins within HAP (pool-1/HAP) and AP (pool-2/AP) pooled serum 
samples to identify low abundant SAA and CRP by shotgun analysis. Initially a 
single sample from pool-1/HAP was fractionated and the protein concentrations 
of each fraction determined. Table 4.5 contains the estimated molecular weight 
of each fractionation based on the manufactures instructions. Figure 4.4 is the 
1DE gel containing the 12 fractions produced from pool – 1/HAP. Overlaid in 
graphical form are the protein concentrations of each fraction. Owing to the low 
concentration of protein at the lower molecular weights and because the protein 
concentrations did not appear to correlate with the band intensity this 
experiment was repeated, this time using both pools 1 and 2 in duplicate to 
assess the reproducibility of the method.  
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Fraction Estimated molecular weight of proteins (kDa) 
1 6 – 14 
2 8-15 
3 15-19 
4 18-26 
5 23-31 
6 28-34 
7 34-38 
8 37-50 
9 40-53 
10 50-55 
11 Around 60 
12 Around 66 
Table 4.5: Estimated molecular weight of each fraction according to Protein Discovery 
GelFree® 8100 Fractional system instructions (Expedeon, Cambridge, UK). 
 
 
Figure 4.4: 1DE gel containing the 12 fractions collected from the fractionation of pool-1 
serum. The superimposed graph shows protein concentration of each fraction. Protein 
separation was achieved using NuPAGE 4-12% Bis-Tris Midi gel (Novex Life Technologies 
WG1401BX10) and protein concentrations determined using RC DC protein assay kit (BioRad 500-
01190).  
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No protein quantification was undertaken for the first three fractions of the 
second fractionation experiment as it was previously determined that the 
protein concentrations of these fractions was very low and would need to be 
preserved for the following shotgun analysis. Based on the estimated molecular 
weight expected from the initial fractions, the 1st fraction of the second 
fractionation experiment was split into two and recovered separately and the 
final fraction was omitted. Figure 4.5 shows the protein concentrations of each 
of the 8 fractions from pools 1 and 2 in duplicate. All four sample fractions show 
a similar trend, albeit the first duplicate from pool-2 appears to show the same 
trend but one fraction prematurely to the other fractions, indicating that the 
method of separating proteins according to their molecular weight was 
effective.    
 
Figure 4.5: Protein concentrations of fractions 4-12 of pool-1 and pool-2 duplicate 
fractionations. Protein concentrations, determined using RC DC protein assay kit (BioRad 500-
01190), were plotted (y-axis) against fraction number (x-axis) for each of the two samples, ran in 
duplicate.  
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4.3.1.3 Shotgun analysis: Identifying Serum amyloid A and C-reactive 
protein  
 
4.3.1.3.1 Serum 
Shotgun analysis was performed on three acute phase status serum pools: HAP 
(pool-1), AP (pool-2) and NAP (pool-3). The results were analysed using both 
Mascot (Matrix Science) and SEQUEST (Thermo Finnegan) software. A total of 
671, 591 and 592 proteins from pools 1, 2 and 3 were identified. Figure 4.6, a 
Venn diagram comparing proteins identified in each pool, reveals that each pool 
contains a significant number of proteins not shared with the other two pools 
and 242 proteins were common between all three pools. Serum amyloid A was 
identified in pool-1, the HAP serum from viraemic birds and pool-2 from AP 
birds. Serum amyloid A was not detected in pool 3, the NAP pool. Table 4.6 
details the SAA peptides isolated from the pool-1 and pool-2 serum. The protein 
results were filtered and a minimum of two peptides required for a significant 
protein identification. When filter criteria was relaxed a single CRP peptide was 
identified in pool-2. This however is not sufficient to make a positive 
identification of CRP in the serum.  
 
 
Figure 4.6: Venn diagram of proteins identified by shotgun analysis of pools 1-3 (HAP, AP and 
NAP). Of the total number of proteins identified 242 were the same, with the HAP (pool-1) 
having the largest number of unique proteins.  
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Pool Peptide sequence Accession Protein Missed 
cleavages 
Database 
Pool-1 
EANYIGADKYFHAR 
F1NW65 
 
SAA 
1 
SEQUEST 
LDQEANEWGR 0 
GPGGAWAAK 0 
FRPAGLPNK 0 
FRPAGLPNKY 1 
Pool-2 
EANYIGADKYFHAR F1NW65 
 
SAA 
1 
SEQUEST  
LDQEANEWGR 0 
Pool-3 SYTDLTRPHSLFSYATK Q2EJU6 CRP 0 SEQUEST  
Table 4.6: Peptides identified from SAA and CRP from whole serum shotgun analysis.   
 
4.3.1.3.2 Fractions 
The shotgun analysis results for the first six fractions from pool-1 and pool-2 
were consolidated for each pool. To compare the numbers of proteins identified 
in the whole serum and fractionated serum to assess whether the fractionation 
process did indeed enrich lower molecular weight proteins, proteins over 38kDa 
from both shotgun result sets were excluded and a comparison made. Figure 4.7 
contains the Venn diagrams for each pool. 
 
                   Pool-1                   Pool-2 
Figure 4.7: Venn diagrams comparing the number of proteins that are less that 38kDa 
identified in whole serum and fractionated serum, in pool-1 (left) and pool-2 (right). 
 
The fractionated serum, enriched to exclude higher molecular weight proteins, 
including highly abundant albumin and IgG, and increase the concentration of 
the lower molecular weight proteins within a sample, resulted in a further 158 
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and 94 proteins being identified from the pool-1 and pool-2 samples respectfully, 
indicating that the enrichment technique was successful. It is clear that the 
fractionation was especially successful on pool-1, the HAP sample, with the 
identification of 233 proteins in this pool compared to the 139 identified from 
pool-2. It was also evident that the fractionation process resulted in the loss of 
lower molecular weight proteins, with 67 and 50 proteins identified only in the 
whole serum of pools 1 and 2 respectfully. Analysis of the proteins present in the 
fractionated samples from pools 1 and 2 resulted in the identification of a larger 
number of SAA peptides being identified in the pool-1 and 2 samples.  
Pool Peptide sequence 
Missed 
cleavages 
Accession Protein Database 
Pool  -1 GAEDTRLDQEANEWGR 1 F1NW65 
 
SAA SEQUEST 
LDQEANEWGR* 0 
EANYIGADKYFHAR* 1 
EANYIGADK 0 
VSGRGAEDTRLDQEANEWGR 2 
RGPGGAWAAK 1 
FRPAGLPNK* 0 
GPGGAWAAK* 0 
LDQEANEWGRR 1 
FRPAGLPNKY* 1 
DAAGGARDMWRAYR 2 
Pool - 2 GAEDTRLDQEANEWGR+ 1 F1NW65 
 
SAA SEQUEST 
LDQEANEWGR** 0 
EANYIGADKYFHAR** 1 
RGPGGAWAAK+ 1 
YFHARGNYDAARR 2 
DAAGGARDMWRAYR 2 
GNYDAARRGPGGAWAAK 2 
FRPAGLPNKY** 1 
Table 4.7: SAA peptides identified by shotgun analysis of fractions 1-6 of Pools 1 and 2. 
*Also identified in the serum shotgun analysis of pool-1. **Also identified in pool-1 serum. 
+Also seen in pool-1 fractionated results. 
No CRP peptides were identified in the fractionated shotgun results from pool-1 
or pool-2, even when the search criteria was relaxed. Table 4.7 lists the 
identified peptides from the fractionation shotgun analysis.  
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4.3.1.4 Shotgun analysis of immobilised p-aminophenyl phosphoyl choline 
gel elution 
With the aim of identifying CRP in chicken serum, the elution from the 
immobilised p-aminophenyl phosphoyl choline gel underwent shotgun analysis 
alongside the fractions. No CRP or pentraxin peptides were identified.  
 
4.3.2 Measurement of APPs and identification and 
measurement of other biomarkers of the acute phase 
response using quantitative proteomics 
 
4.3.2.1 Identification and measurement of acute phase proteins using 
single ion monitoring SIM targeted MS/MS 
 
4.3.2.1.1 Identifying acute phase proteins in initial shotgun analysis of pools 
The data from the shotgun analysis on the whole serum from pool-1 and pool-2 
was used to calculate relative quantification of the SAA protein. Using the peak 
area and normalising using intensity, the relative concentrations between pools 
1, 2 and 3 were determined. Pool-3 samples from the NAP birds contained no 
peptides from SAA. Pool-1 from the HAP viraemic birds was shown to be 5.8 fold 
higher than in the pool-2 samples from AP birds making this a target for further 
investigation and quantification. 
Other known APPs were identified from the shotgun analysis results and the fold 
difference between the quantity of these proteins between the HAP, AP and NAP 
pools determined. Table 4.8 and Figure 4.8 detail the fold differences between 
the pools of each of these APPs.  
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Acute phase Protein  HAP/ AP AP/ NAP HAP/ NAP 
Haemopexin -1.063 1.147 1.079 
Transthyretin -3.070 1.106 -2.775 
α- 1-Acid glycoprotein  1.318 2.143 2.824 
PIT 54 -1.097 1.270 1.158 
Ovotransferrin 2.158 1.025 2.211 
Apolipoprotein A-I -2.499 1.326 -1.885 
SAA 5.891 * * 
 
Table 4.8: Acute phase proteins identified and the fold difference in peak area between 
these APPs in the three acute phase pools. * SAA was not detected in AP and NAP pools 
therefore no fold difference calculation could be made.  
  
 
 
 
Figure 4.8: APP fold differences between three acute phase pools. Each point indicates the 
fold difference between the pool listed left in the legend relative to the pool listed right in 
the legend.  
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4.3.2.1.2 Measuring acute phase proteins using data dependant single ion 
monitoring targeted MS/MS in three acute phase groups 
The APPs SAA, Ovt, Apo-AI, Hx, Ttn and PIT54 were selected to be measured by 
targeted SIM MS/MS to determine whether these APPs could be measured using 
this method and to measure the relative differences in abundance between each 
of the acute phase groups. A minimum of three peptides are required for 
significant identification and measurement of an APP, for Hx only two suitable 
peptides were identified but this APP was still included for analysis. Table 4.9 
details the statistical analysis of the peak areas for all measured peptides for 
each APP. A Kruskal-Wallis test was applied to each of the APP peptides with 
Dunn‟s post test analysis. Figure 4.9 gives a graphical representation of the 
results of each APP. To assess the success of the SIM targeted MS/MS method for 
measuring these chicken APPs, a Spearman correlation between each of the 
peptide results was made for each APP.  
 
Protein Statistical test 
Peptides 
Peptide 1 Peptide 2 Peptide 3 Peptide 4 
 
Serum Amyloid A F1NW65 
R.EANYIGADK.Y 
[47, 55] 
R.EANYIGADKYF
HAR.G [47, 60]  
R.LDQEANEWGR
.R [100, 109]  
 
 Kruskal-Wallis test (p-value) 0.0158 0.0465 0.0078 
Dunn 
post-test  
analysis 
High AP vs AP  Ns ns  *  
High AP vs Non-AP  * *  *  
AP vs Non-AP  Ns ns  ns  
 
Spearman Correlation 
 
p-value 
 
r2-value 
 
 *Peptide 1 and 2 0.0225 0.6707 
**Peptide 1 and 3 0.0010 0.9106 
*Peptide 2 and 3 0.0121 0.776 
 
Ovotransferrin P02789 
R.GAIEWEGIESG
SVEQAVAK.F 
[154, 172] 
K.VEDIWSFLSK.A 
[278, 287] 
K.YFGYTGALR.C 
[539, 547] 
K.FYTVISSLK
.T [679, 
687] 
 Kruskal-Wallis test (p-value) 0.0116 0.1551 0.0163 0.0282 
Dunn 
post-test  
analysis 
High AP vs AP  Ns ns Ns Ns 
High AP vs Non-AP  ** ns * * 
AP vs Non-AP  ns ns Ns Ns 
 
Spearman Correlation 
 
p-value 
 
r2-value  
 ****Peptide 1 and 2 <0.0001 0.9545 
 
 ****Peptide 1 and 3 <0.0001 0.9229 
**Peptide 1 and 4 0.0253 0.6788 
***Peptide 2 and 3 0.0004 0.8793 
*Peptide 2 and 4 0.0371 0.6424 
**Peptide 3 and 4 0.0010 0.8454 
 
Apolipoprotein AIP08250 
K.DAIAQFESSAV
GK.Q [50, 62] 
K.LADNLDTLSAA
AAK.L [68, 81] 
K.WTEELEQYR.Q 
[130, 138] 
 
 Kruskal-Wallis test 0.0406 0.0282 0.0346 
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Dunn 
post-test 
analysis 
High AP vs AP  * * * 
High AP vs Non-AP  ns ns Ns 
AP vs Non-AP  ns ns Ns 
 
Spearman Correlation  
 
p-value 
 
r-value   
 
  ****Peptide 1 and 2 <0.0001 0.9636 
 
****Peptide 1 and 3 <0.0001 0.9636 
****Peptide 2 and 3 <0.0001 0.9727 
 
Haemopexin H9L385 
R.QDHPEEHQSLY
LFQDEK.V [68, 
84] 
K.VFSFDLELR.V 
[136, 144] 
 
 
 
Kruskal-Wallis test (p-value) 0.1137 1.0000 
Dunn 
post-test 
analysis 
High AP vs AP  ns ns 
High AP vs Non-AP  ns ns 
AP vs Non-AP  ns ns 
 
Spearman Correlation  
 
p-value 
 
r2-value 
  Peptide 1 and 2 ns 0.5182  
 
Transthyretin P27731  
K.AADGTWQDFA
TGK.T [58, 70] 
R.VEFDTSSYWK.
G [93, 102] 
R.HYTIAALLSPFSY
STTAVVSDPQE.- 
[126, 149] 
 
 Kruskal-Wallis test (p-value) 0.0400 0.0697 0.1400 
Dunn 
post-test  
analysis 
High AP vs AP  * Ns Ns 
High AP vs Non-AP  * Ns Ns 
AP vs Non-AP  * Ns Ns 
 
Spearman Correlation  p-value r2-value  
  ****Peptide 1 and 2 <0.0001 0.9455 
 
*Peptide 1 and 3 0.0128 0.7182 
**Peptide 2 and 3 0.0062 0.7636 
 
PIT54 H9KZK6 
 
R.VEVLHNDVWG
TVCDEGWDLR.E 
[79, 98] 
K.QLGCGDAVLA
PIAAK.F [216, 
230] 
 
R.VEVLHNNVWGT
VCDDNWDLR.E 
[299, 318] 
R.GPDVIWLD
DVNCEGTEE
SIFDCK.A 
[454, 476] 
 Kruskal-Wallis test (p-value) 0.4169 0.2335 0.4060 0.8401 
Dunn 
post-test 
analysis 
High AP vs AP  ns Ns ns ns 
High AP vs Non-AP  ns Ns ns ns 
AP vs Non-AP  ns Ns ns ns 
 
Spearman Correlation 
 
p-value 
 
r2-value  
  *Peptide 1 and 2 0.0289 0.6545 
 
 ****Peptide 1 and 3 <0.0001 0.9091 
*Peptide 1 and 4 0.0146 0.7091 
**Peptide 2 and 3 0.0020 0.8091 
**Peptide 2 and 4 0.0085 0.7455 
*Peptide 3 and 4 0.0146 0.7091 
 
Table 4.9: Statistical results of SIM/targeted MS2 of acute phase proteins in three acute 
phase groups: HAP (n=3), AP (n=4) and NAP (n=4). (ns = no significance, *<0.05, **<0.01, 
***<0.001, ****<0.0001). For each protein the quantitypic peptides are listed to the right in 
columns, underwhich the statistical results of the Kruskal-Wallis test are listed (p-value). The 
results of the Dunn post-test analysis, conducted to identify, where present, between which of 
the acute phase groups the significant difference lies are detailed in the rows underneath. 
Underneath is the result of the Spearman correlation, undertaken between the peptides for each 
protein across all the samples to determine whether the peptide peak areas (intensities) for each 
peptides, tryptically digested from the target protein correlate with each other. Asterisks to the 
the left of the peptide correlation indications level of significance, with p-value and r2-value 
listed alongside.  
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All three of SAA‟s peptides were found to be significantly different between the 
three acute phase groups, and all three peptides correlated significantly with 
each other. Of the four peptides measured for Ovt, peptide 2 had no significant 
correlation with any other peptide and this peptide was the only peptide found 
not to be significantly different between the three acute phase groups. 
Apolipoprotein A-1 in this study behaves as a negative APP, with all three 
peptides showing significantly different peak areas, with the HAP Apo-AI 
peptides having significantly lower peak area than AP and NAP groups. These 
results suggest Apo-AI is a negative APP in chickens. Only two peptides were 
quantified for Hx and both revealed no changes in peak area between the acute 
phase groups. The HAP group had lower peak areas for all three Ttn peptides, 
with peptide one significantly lower than the other two groups. PIT54 was the 
only APP measured that shown no significant differences of peak area between 
any of the acute phase groups for any of the four peptides measured. Conversely 
this APP showed the greatest correlations between measured peptides indicating 
that while no significant differences between groups were found, the peptides 
measured were consistent in their peak area. 
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Figure 4.9: Peak area (± SD of the mean) of each APP, divided within bar by peptide in three 
different acute phase status groups: highly acute phase (HAP) (n=3), acute phase (AP) (n=4) 
and non-acute phase (NAP) (n=4). Statistical analysis was undertaken using Kruskal-Wallis with 
Dunn post-test analysis (GRaphPad Prism v5). Significance between groups (as detailed in Table 
4.9) is indicated by asterisk *<0.05, **<0.01, ***<0.001, ****<0.0001, the colour of the asterisks 
corresponds to same coloured peptide as indicated in legend. 
 
172 
 
4.3.2.1.3 Quantifying serum amyloid A and ovotransferrin by immunoassay 
Using the method described in Chapter 3 and a commercially available ELISA kit 
(3400-7 Life Diagnostics, Stoke-on-Trent, UK), Ovt and SAA was measured in the 
HAP, AP and NAP samples (with the exception of the third HAP sample, which 
had become exhausted). Non-parametric Kruskal-Wallis test was performed 
between each group and Spearman‟s correlations between the assay results and 
each of the peptides of the two proteins was performed and the results detailed 
in Table 4.10 and Figure 4.10. 
 
Serum Amyloid A ELISA 
Kruskal-Wallis (p-value) 0.0019 
Dunn post test paired 
analysis 
HAP – AP Ns 
HAP – NAP * 
AP - NAP Ns 
Spearman‟s correlation p-value r-value 
 **Peptide 1 0.0028 0.8128 
 *Peptide 2 0.0500 0.6487 
 *Peptide 3 0.0222 0.7006 
Ovotransferrin RID 
Kruskal-Wallis (p-value) Ns 
Spearman‟s correlation p-value r-value 
 Peptide 1 0.0816 0.5836 
 Peptide 2 0.1150 0.5350 
 Peptide 3 0.0138 0.7599 
 Peptide 4 0.1144 0.5335 
 
Table 4.10: Statistical results of Ovt and SAA assays, together with correlations of each 
peptide to the assay results. For both SAA and Ovt the statistical results of the Kruskal-Wallis 
test is listed (p-value) together with the result of the Dunn post-test analysis, conducted to 
identify, for SAA, between which of the acute phase groups the significant difference lay. 
Underneath is the result of the Spearman correlation, undertaken between each peptide of SAA 
and Ovt and the ELISA and RID result respectfully. Asterisks to the the left of the peptide 
correlation indications level of significance, with p-value and r2-value listed alongside. 
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Figure 4.10: Scatterplots of SAA and Ovt concentrations in HAP (n=2), AP (n=4) and NAP 
(n=4), determined by ELISA and RID respectfully (first row). X-Y scatterplots of SAA and Ovt 
immunoassay result (x-axis) and the peak area of each peptide (y-axis) as determined by 
targeted SIM MS/MS (second row).  
 
4.3.2.2 Identification and measurement of novel biomarkers of the acute 
phase response using single ion monitoring targeted MS/MS 
 
4.3.2.2.1 Identifying novel biomarkers of the acute phase response in the 
initial shotgun analysis of pools 
The results of the initial shotgun analysis of the three acute phase pools were 
used to identify other proteins that were differentially abundant between acute 
phase groups. A total of 1187 proteins were identified across the three acute 
phase pools of which 242 were identified in all three pools. The fold differences 
between the shared 242 proteins were ranked according to fold change. Figure 
4.11 plots the fold differences between each of the 242 proteins between pools 
showing that smaller numbers of proteins are associated with larger fold 
differences between acute phase pools and the majority of shared proteins are 
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present in the three pools in similar quantities. Appendix 4.3 lists the proteins 
that show a greater than four-fold difference between each of the pools. A 
moderate APP shows a greater than four-fold difference during an APR and as 
such this was used as a cut off point to indicate that a protein could be 
differentially present. As this analysis excludes proteins that are absent from 
one of the three pools (such as SAA, which was absent from pool-3 the non-acute 
phase group), a further list was generated that included proteins present in the 
acute phase groups only (pools 1 and 2) but absent in the non-acute phase group 
(pool-3). This enabled the identification of proteins that are absent in a healthy 
non-acute phase state and as such potentially good biomarkers for the APR. 
Appendix 4.3 lists proteins that show greater than four-fold difference between 
these acute phase groups that are absent from pool-3. From this shortlist a 
selection was made based on availability of suitable MS/MS data for targeted 
measurement generated from the earlier shotgun analysis and the quantotypic 
nature of the constituent peptides of these proteins. Using this selection criteria 
11 proteins were selected for targeted quantification, to determine whether 
these results were reflective of all samples within the pools and as such whether 
these were, as differentially expressed proteins, potential biomarkers of the 
APR. Two further proteins: myeloid protein (P08940) and an uncharacterised 
protein with no close homologies (FIP580), with smaller fold differences between 
groups were also selected given the availability of good MS/MS data. Table 4.11 
lists the selected proteins. 
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Figure 4.11: The fold difference of each protein identified from pools 1-3.The data from the 
shotgun analysis conducted on the three acute phase pools was normalised using intensity, and 
the fold difference for proteins identified in all three pools (n=242) was calculated. This was 
plotted (x-axis) between each of the groups.  
 
Protein Accession 
Beta-2-Microglobulin P21611 
Coronin Q5ZI60 
Cathepsin D Q05744 
Matrilin-3 O42401 
Myeloid Protein P08940 
Tenascin P10039 
Putative ISG12(2) protein Q6IEC5 
Hsp90 co-chaperone Cdc37 O57476 
*Mannan-binding lectin associated serine 
protease 2 
F1NAP7 
*Alpha-2-HS-glycoprotein/fetuin-A E1BZE1 
*Major facilitator superfamily domain- 
containing protein 10 
E1C932 
*Complement C1r subcomponent F1NAB7 
No close homologies F1P580 
Table 4.11: Proteins selected for further quantification. *indicates an uncharacterised 
protein, the name of which is inferred from close homology. 
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4.3.2.2.2 Measuring novel biomarkers of the acute phase response using data 
dependant single ion monitoring targeted MS/MS  in three acute 
phase groups 
To investigate whether these differences are significant between individual 
samples the samples constituting the three pools were measured individually 
with all three HAP samples and four AP and four NAP samples selected randomly 
from the six samples included in pools 2 and 3. These underwent the same 
preparation and were measured in the same way as described for the APPs in 
Section 4.3.2. Table 4.12 details the results of the statistical analysis of the 
peak areas of the measured peptides of each of the selected proteins a 
Spearman correlation between each of the peptide results for each protein was 
also made. Figure 4.12 graphically details the results of each protein.  
 
Protein Statistical test 
Peptides 
Peptide 1 Peptide 2 Peptide 3 Peptide 4 
 
Beta-2-Microglobulin P21611 
R.LVHADFTPSSGS
TYACK.V [84, 
100] 
 
 
 Kruskal-Wallis test (p-value) 0.0406 
Dunn 
post-test  
analysis 
High AP vs AP  ns 
High AP vs Non-AP  * 
AP vs Non-AP  ns 
 
Coronin Q5ZI60  
K.NDQCYDDIR.V 
[19, 27] 
K.SDLFQDDLYPDT
AGPEAALEAEEWF
EGK.N [353, 380] 
K.NADPLLISLK.H 
[381, 390] 
 
 Kruskal-Wallis test (p-value) 0.6276 0.7004 0.6181 
Dunn 
post-test  
analysis 
High AP vs AP  ns Ns ns  
High AP vs Non-AP  ns Ns ns 
AP vs Non-AP  ns Ns ns 
 
Spearman Correlation p-value r2-value 
  
 Peptide 1 and 2 ns 0.4273   
**Peptide 2 and 3 0.0022 0.8364 
Peptide 1 and 3 ns 0.4455 
  
Cathepsin D Q05744 
K.LGFADLAEPTPE
ILK.N [56, 70] 
R.DPTAQPGGELL
LGGTDPK.Y [223, 
240] 
K.GGCEAIVDTGT
SLITGPTK.E 
[275, 293] 
  Kruskal-Wallis test (p-value) 0.0308 0.0308 0.0463 
Dunn 
post-test 
analysis 
High AP vs AP  * Ns ns 
High AP vs Non-AP  ns * * 
AP vs Non-AP  ns Ns * 
 
Spearman Correlation p-value r2-value  
 
Peptide 1 and 2 ns -0.1273 
 
**Peptide 2 and 3 0.0086 07636 
Peptide 1 and 3 ns -0.2182 
 
Matrilin-3 O42401 
K.NRPLDLVFIIDSS
R.S [49, 62] 
K.VVIIVTDGRPQD
QVENVAANAR.T 
[160, 181] 
R.TAGIEIYAVGVG
R.A [182, 194] 
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Kruskal-Wallis test (p-value) 0.0487 0.0764 0.0498 
Dunn 
post-test 
analysis 
High AP vs AP  * ns * 
High AP vs Non-AP  ns ns * 
AP vs Non-AP  ns ns ns 
  
Spearman Correlation p-value r2-value 
   ****Peptide 1 and 2 <0.0001 0.9729 
**Peptide 2 and 3 0.0022 0.8364 
**Peptide 1 and 3 0.0055 0.7909 
 
Myeloid Protein P08940 
 
K.GVDVICTDGSIVY
APFSGQLSGPIR.F 
[68, 92] 
K.GVDVICADGAT
VYAPFSGELSGPV
K.F [218, 242] 
K.FFHNGNAIDDG
VQIR.G [243, 
257] 
R.VFPGIISHIH
VENCDR.S 
[292, 307] 
 Kruskal-Wallis test (p-value) 0.1217 0.1217 0.0487 0.3423 
Dunn 
post-test 
analysis 
High AP vs AP  ns ns * ns 
High AP vs Non-AP  ns ns * ns 
AP vs Non-AP  ns ns ns ns 
 
Spearman Correlations  p-value r2-value  
     ****Peptide 1 and 2 <0.0001 0.9818 
 
****Peptide 1 and 3 <0.0001 0.9522 
**Peptide 1 and 4 0.0018 0.8455 
****Peptide 2 and 3 <0.0001 0.9704 
***Peptide 2 and 4 0.004 0.9000 
***Peptide 3 and 4      0.0007 0.8793 
 
Tenascin P10039 R.ESAPATINAGTDL
DNPK.D [943, 959] 
K.DLEVSDPTETT
LSLR.W [960, 
974] 
R.VSYVPITGGTPN
VVTVDGSK.T 
[1348, 1367] 
R.APVTDYL
LTYESIDGR.
V [1518, 
1533] 
 Kruskal-Wallis test (p-value) 0.9738 0.8401 0.8401 0.6276 
Dunn 
post-test 
analysis 
High AP vs AP  ns ns ns ns 
High AP vs Non-AP  ns ns ns ns 
AP vs Non-AP  ns ns ns ns 
 
Spearman Correlation p-value r2-value 
 
  ****Peptide 1 and 2      <0.0001 0.9455 
****Peptide 1 and 3 <0.0001 1.000 
****Peptide 2 and 3 <0.0001 0.9455 
 
Putative ISG12(2) protein 
Q6IEC5 
R.GSLASSIMSGEAK
.S [18, 30] 
K.SFGGGVPSGG
TTATLQEMGAK.
G [31, 51] 
  Kruskal-Wallis test (p-value) 0.0455 0.5232 
Dunn 
post-test  
analysis 
High AP vs AP  * ns 
High AP vs Non-AP  * ns 
AP vs Non-AP  ns ns 
 
Spearman Correlation p-value r2-value 
   Peptide 1 and 2 ns 0.4455 
 
Hsp90 co-chaperone Cdc37 
O57476 
K.ELEVAEPGGGS
GGGR.G [69, 83] 
 
 Kruskal-Wallis test (p-value) 0.0282 
Dunn 
post-test 
analysis 
High AP vs AP  * 
High AP vs Non-AP  ns 
AP vs Non-AP  Ns 
 
Uncharacterised protein+ 
F1NAP7 (Mannan-binding 
lectin associated serine 
protease 2)  
K.YICSDDGFWK.
N [407, 416] 
K.NDLVNFDNDIALI
K.L [523, 536] 
  
 Kruskal-Wallis test(p-value) 0.0406 0.0764   
Dunn 
post-test 
analysis 
High AP vs AP  * ns   
High AP vs Non-AP  * ns   
AP vs Non-AP  Ns ns   
 p-value r2-value  
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Spearman Correlation  
  Peptide 1 and 2 Ns -0.300 
 
Uncharacterised protein
+
 
E1BZE1 (alpha-2-HS-
glycoprotein/fetuin-A) 
K.VNGQFSVLASK
.C [117, 127 
K.NPDVYLMLLEIGR
.A [171, 183] 
K.DNLAACQLLPE
DQSNFGFCTAK.
M [212, 233] 
K.ISHNNPVAS
ESSSSEFPSLL
SAK.S [283, 
305] 
 Kruskal-Wallis test(p-value) 0.0478 0.0455 0.0487 0.0455 
Dunn 
post-test  
analysis 
High AP vs AP  * * * * 
High AP vs Non-AP  * * * * 
AP vs Non-AP  ns ns ns ns 
 
Spearman Correlation p-value r2-value 
 
      *Peptide 1 and 2 0.0144 0.7273 
***Peptide 1 and 3 0.0001 0.9273 
**Peptide 1 and 4 0.0015 0.8545 
**Peptide 2 and 3 0.0074 0.7727 
Peptide 2 and 4 Ns 0.5636 
**Peptide 3 and 4      0.0086 0.7636 
 
Uncharacterised protein+ 
E1C932 (Major facilitator 
superfamily domain-
containing protein 10) 
R.SFGVFLLSR.M 
[138, 146] 
K.EAPSDQNLQNLK
.I [270, 281] 
  Kruskal-Wallis test(p-value) 0.3850 0.0487 
Dunn 
post-test 
analysis 
High AP vs AP  ns * 
High AP vs Non-AP  ns * 
AP vs Non-AP  ns ns 
 
Spearman Correlation  p-value r2-value 
 Peptide 1 and 2 ns -0.209 
 
Uncharacterised protein+ 
F1NAB7 (Complement C1r 
subcomponent) 
K.AVDLDECDPDN
AAEDDEGLR.C 
[115, 134] 
K.SNEVDILFFTDES
GYSR.G [254, 270] 
 
 Kruskal-Wallis test(p-value) 0.4618 0.3749 
Dunn 
post-test  
analysis 
High AP vs AP  ns ns 
High AP vs Non-AP  ns ns 
AP vs Non-AP  ns ns 
 
Spearman Correlation  p-value r2-value 
 Peptide 1 and 2 Ns 0.02727 
 
Uncharacterised protein+ 
F1P580   
(No close homologies) 
R.LIWILK.D [63, 
68] 
K.DTLNLLQPVQDK
.F [69, 80] 
K.GYDFSFLR.R 
[117, 124]  
 
 Kruskal-Wallis test (p-value) 0.9306 0.7004 0.2577 
Dunn 
post-test   
analysis 
High AP vs AP  ns ns ns 
High AP vs Non-AP  ns ns ns 
AP vs Non-AP  ns ns ns 
 
Spearman Correlation p-value r2-value  
 
***Peptide 1 and 
2 0.0001 0.9273  
**Peptide 1 and 3  0.0069 0.7745  
**Peptide 2 and 3 0.0018 0.8428  
 
Table 4.12: Statistical results using SIM/targeted MS2 of selected proteins proteins in three 
acute phase groups: HAP (n=3), AP (n=4) and NAP (n=4). (ns = no significance, *<0.05, **<0.01, 
***<0.001, ****<0.0001, +Uncharacterised protein, homology given in brackets). For each protein 
the quantitypic peptides are listed to the right in columns, underwhich the statistical results of 
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the Kruskal-Wallis test are listed (p-value). The results of the Dunn post-test analysis, conducted 
to identify, where present, between which of the acute phase groups the significant difference 
lies are detailed in the rows underneath. Underneath is the result of the Spearman correlation, 
undertaken between the peptides for each protein across all the samples to determine whether 
the peptide peak areas (intensities) for each peptides, tryptically digested from the target 
protein correlate with each other. Asterisks to the the left of the peptide correlation indications 
level of significance, with p-value and r2-value listed alongside. 
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Figure 4.12 a 
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Figure 4.12b 
 
 
Figure 4.12a and 4.11b: Peak area (± SD of the mean) of each targeted protein, divided 
within bar by peptide in three different acute phase status groups: highly acute phase (HAP) 
(n=3), acute phase (AP) (n=4) and non-acute phase (NAP) (n=4). Statistical analysis was 
undertaken using Kruskal-Wallis with Dunn post-test analysis (GRaphPad Prism v5). Significance 
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between groups (as detailed in Table 4.8) is indicated by asterisk *<0.05, **<0.01, ***<0.001, 
****<0.0001. Colour of asterisks corresponds to same coloured peptide as indicated in legend.  
 
 
For the proteins beta-2-microglobulin and HSP90 co-chaperone Cdc37, only a 
single peptide was successfully measured. For these two proteins the peak area 
of the measured peptide was found to be significantly different between the 
HAP and NAP and HAP and AP respectfully. Coronin, tenescin, complement C1r 
subcomponent and the uncharacterised protein showed no significant differences 
between the peak areas of the three acute phase groups, indicating that these 
proteins were not affected by the acute phase status of these birds when 
examined over individual samples as oppose to pools. Of these proteins, tenescin 
and the uncharacterised protein have good degree of correlation between the 
peak areas of the measured peptides, with tenescin particularly having all three 
peptides correlating with each other with p-values of <0.0001. For complement 
C1r component there was no significant correlation between the two peptides 
measured and as such one or both represent poor quantitypic peptides.  
 
For the other selected proteins significance was found between at least two of 
the three acute phase groups, usually between the HAP and NAP. A number of 
the proteins appear to be negative biomarkers, reduced in abundance in the HAP 
group. Myeloid, matrilin-3, putative ISG12(2), mannan binding lectin associated 
serine protease-2, α-2-HS-glycoprotein/fetuin-A and major facilitator 
superfamily domain-containing protein 10 all show significant differences in 
abundance between the HAP and NAP group and the HAP and AP group, with the 
AP and NAP groups appearing closer in abundance. Of these proteins myeloid 
protein and putative ISG(12)2 are positively associated with the acute phase, the 
other proteins are negatively associated, being significantly less abundant in the 
HAP group. The protein cathepsin D, positively associated with the acute phase 
groups was significantly higher in both HAP and AP groups, indicating that of all 
the proteins targeted in this protein appears to have the most potential as a 
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biomarker of the acute phase, as it was significantly increased in the AP as well 
as the HAP group.  
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4.4 Discussion  
Taking a quantitative proteomic approach to identifying and measuring 
recognised APPs allows for their confirmation as acute phase responders in 
chickens, allowing for the cost effective measurement of a wide number of 
proteins within a single study. This is an appropriate approach in this species as 
previous work has focused of mammalian APPs, which if transferred to chicken 
could result in many biomarker candidates being overlooked because they are 
not known as acute phase responders in mammalian species.    
4.4.1 Enrichment and shotgun analysis of acute phase serum 
Using protein fractionation to enrich the lower molecular weight proteins to 
identify SAA and CRP peptides resulted in the identification of more SAA 
peptides than shotgun analysis of whole serum alone. Of the SAA peptides that 
were identified with no miscleavages, three were identified in the whole serum 
and the same three together with one further peptide was identified in the 
fractionated serum. The fact that SAA was not identified in the NAP serum and 
that all three of SAA peptides were significantly higher in the HAP samples 
confirms previous findings that this is a major APP in chickens and as such should 
command the primary position in APP panels for this species.   
 
C-reactive protein in contrast was not conclusively identified at any step of this 
investigation. Using a phosphorylcholine gel affinity column to isolate and purify 
chicken CRP was not successful, with only Apo-AI and immunoglobulin identified 
in the elution. Using MS to identify the proteins within the elution bands from 
1DE resulted in the identification of one peptide for canine CRP when the search 
criteria was extended. This is likely to be a contaminant from the highly 
concentrated canine CRP included on the gel for comparative purposes. 
Furthermore when the same elution had undergone trypsin digestion and 
SHOTGUN proteomics no CRP or other pentraxin was identified. Using the 
molecular weight fractionation to enrich the lower molecular weight proteins 
resulted in the identification of a single CRP peptide from pool-3, the NAP pool. 
As a minimum of two peptides are required for the positive identification of a 
protein, this falls below the threshold and as such a positive identification could 
not be made. Searches were made on subsequent shotgun results of individual 
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samples and again no further CRP peptides were identified. Although it may be 
that peptides from trypsinisation of chicken CRP are not ideal candidates for 
flight in a MS, these results were generated from a range of samples: HAP, AP, 
NAP and enriched samples and suggest that CRP is not an APP in chickens. A CRP 
gene is present in the chicken genome however there is evidence of the protein 
only at transcript level (Uniprot, 2016). Further work is necessary to confirm the 
absence of CRP in the chickens. 
 
4.4.2 Identification and measurement of acute phase proteins 
using data dependant single ion monitoring targeted 
MS/MS 
The APPs SAA, Ovt, Apo-AI, Hpx, Ttn and PIT54 were all successfully identified 
and quantified using shotgun analysis and targeted SIM MS/MS. Although AGP was 
also identified it was not selected for further measurement given the 
widespread availability of immunoassays. This study confirmed SAA as a major 
positive APP in chickens, the results also validated by a commercially available 
immunoassay. While no significance was identified between the acute phase 
groups for Ovt, this is considered to be a result of the low samples numbers. 
Three of the four quantified peptides significantly correlated with the results of 
the RID assay established in Chapter 3 offering further validation of this 
immunoassay. Apolipoprotein AI was shown to behave as a negative APP, with 
significantly lower abundance detected in the HAP samples for all three 
peptides. Transthyretin appeared to also behave as a negative APP, although 
only one of the three peptides was significantly different between the three 
acute phase groups. Neither Hpx or PIT54 appeared to act as acute phase 
responders, in contrast to previous findings. Given the widespread measurement 
of PIT54 in a number of studies further validation of commercially available 
immunoassays is warranted, though again the small number of samples in each 
of the three groups may be an issue, particularly for minor APPs. This method 
identified quantotyptic peptides for six APPs, and the availability of this data 
enables this method to be employed in future studies of the chicken acute 
phase, allowing a large number of APPs to be measured without the limitations 
of immunoassay availability.  
 
186 
 
4.4.3 Identification and measurement of novel biomarkers of 
the acute phase response using data dependant single ion 
monitoring targeted MS/MS   
Normalising and comparing the shotgun results for the HAP, AP and NAP serum 
samples allowed differentially abundant proteins to be identified by ranking the 
fold difference in abundance of each protein. This analysis was performed on 
pooled samples, and while this proved to be successful in identifying some 
proteins that went on to show significant differences between acute phase 
groups when analysed on individual samples; there were a number of proteins 
for which no significance was found when measured on individual samples. 
Coronin, a highly conserved regulator of the actin cytoskeleton responsible for 
phagocytosis and macropinocytosis (de Hostos, 1999), tenascin, a major 
extracellular matrix glycoprotein that shows a very dynamic occurrence during 
embryonic development, in tumours and healing wounds (Spring et al., 1989) 
and an uncharacterised protein with close homology to complement C1 whose 
biological functions include innate immune response, complement activation and 
proteolysis (Uniprot.org); were all found to show no significant differences 
between acute phase groups when quantified on individual samples. A further 
protein with no close homology, targeted because it was not present in the NAP 
group and showed 18 fold higher abundance in HAP compared to AP, was also 
found to exhibit no significant differences in abundance between acute phase 
groups when samples were evaluated individually. This could be an affect of 
small sample numbers in each group but more likely this demonstrates the need 
for analysing individual samples to determine whether a protein is a biomarker 
candidate.  
For complement C1 only two peptides were identified, ideally three peptides 
require quantifying to make a comparative analysis on the quantity of the 
protein from which they were digested. For five other proteins: β-2-
microglobulin, putative ISG12(2), HSP90 co-chaperone Cdc37, mannan binding 
lectin associated serine protease-2 and major facilitator superfamily domain-
containing protein 10  only one or two peptides were quantified, making any 
conclusions as to their behaviour between the acute phase groups difficult. 
Analysis of the measured peptides does however provide an initial insight into 
the behaviour of the protein during an APR. 
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For β-2-microglobulin a single quantotypic peptide was identified and measured, 
revealing a significantly higher abundance in the HAP. β-2-microglobulin is a 
light chain that is non-covalently bound to the heavy chain of major 
histocompatibility complex (MHC) class I, the presence of which is an important 
prerequisite for the binding of small ligands by MHC class I molecules and 
maintaining complex stability (Hee et al., 2012). The kidneys play a key role in 
the catabolism of β-2-microglobulin and blood and urine levels are useful 
indicators of renal function (Cooper & Plesner, 1980). Many tumours can be 
associated with an elevated serum β-2-microglobulin but it is most widely used 
as a tumour biomarker in lymphoid malignancies (Cooper & Plesner, 1980). Given 
the significance identified in this study and the wide use as a biomarker in 
human medicine, the inclusion of its quantotypic peptide in future studies would 
be recommended and further evidence of its potentiality as a biomarker in 
chickens may prompt development of immunoassay. Interferon stimulated gene 
12 (ISG12) expression sensitizes cells to apoptotic stimuli and influences the 
innate immune responses of interferons (Cheriyath et al., 2011). ISG12 gene 
expression is unregulated during infectious disease, inflammatory bowel disease 
and cancer (Uhrin et al., 2013). In this study two putative chicken ISG12(2) 
peptides were quantified and one was found to have significantly higher 
abundance in the HAP group than AP and NAP. For HSP90 co-chaperone Cdc37, 
only a single peptide was identified and measured and this was significantly 
lower in abundance in the HAP. Cdc37 (cell division cycle protein 37) is an 
essential co-chaperone of Hsp90 (90 kDa heat-shock protein), a molecular 
chaperone that manages protein folding and quality control in the cell 
environment (Grover et al., 2011). In chickens mannan binding lectin (MBL) is 
described as a mild positive APP increasing two-fold with infectious bronchitis 
virus, ILV and IBDV (Laursen & Nielsen, 2000). Mannan binding lectin is part of 
the lectin pathway an important component of innate immunity providing a first 
line of defence during the lag phase that precedes the onset of an adaptive 
response (Degn et al., 2012; Lynch et al., 2005). The lectin pathway is an 
antibody independent route of complement activation (Lynch et al., 2005). This 
pathway is activated by multi-molecular complexes that recognize and bind to 
microbial polysaccharides. These complexes comprise a multimeric carbohydrate 
recognition subunit either MBL or ficolin and in chickens, the MBL-associated 
serine proteases-2 (Lynch et al., 2005). In this study, MBL was not identified in 
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the shotgun analysis of any of the acute phase pools or individual samples. 
However the MBL-associated serine proteases-2 was found and two peptides 
were measured. One peptide showed significantly lower abundance in the HAP 
compared to both the AP and NAP, indicating it is negatively associated with the 
APR. Consideration must be given to the fact that only a single peptide is being 
evaluated as opposed to the recommended three, however this is an interesting 
results and its quantification in future studies, particularly alongside the APP 
MBL would provide useful insight into the avian lectin pathway. Major facilitator 
superfamily domain-containing protein 10 is a member of the  major facilitator 
superfamily (MFS) the largest groups of secondary active transporters that play a 
pivotal role in multiple physiological processes (Yan, 2013). Only one of the two 
peptides measured from this protein was found to be significant between acute 
phase groups, with lower abundance in the HAP group.  
 
The protein that appears to show the most potential as a biomarker of the APR is 
cathepsin D. The major function of cathepsin D is an aspartate protease involved 
in intracellular catabolism and is found within the acidic fraction of the 
lysosomal compartment (Dean, 1975; Fusek & Vetvicka, 2005). It is also involved 
in the processing of antigens, hormones, and neuropeptides as well as tissue 
remodelling and apoptosis. Cathepsin D serves as an independent prognostic 
factor in many types of cancers as pro-cathepsin D has the ability to stimulate 
growth and cancer cell proliferation to form metastases (Fusek & Vetvicka, 
2005). All three peptides showed significant differences between the acute 
phase groups, with increased abundance of all three cathepsin D peptides 
positively associated with the APR. Furthermore cathepsin D was significantly 
higher in the AP compared to the NAP, and as such appears to be a more 
sensitive protein showing significant increases in this middle acute phase group. 
Other proteins showed significance between the HAP and NAP or HAP and AP 
groups only. Matrilin-3 is an extracellular matrix (ECM) protein that connects 
matrix components in the cartilage to form macromolecular networks (Shahzad 
et al., 2014). In humans a strong correlation exists between enhanced matrilin-3 
protein expression with the extent of tissue damage in cartilage of osteoarthritis 
patients, suggesting that matrilin-3 expression is essential for maintenance of 
the cartilage ECM microenvironment (Shahzad et al., 2014). In chickens matrilin-
3 is mainly expressed in growth plates with reduced expressions of matrilin-3 
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mRNA and protein during TD in chickens (Shahzad et al., 2014). In humans 
matrilin-3 can be measured in synovial fluid and serum and its measurement in 
serum can be used as a biomarker for osteoarthritis  (Vincourt et al., 2012). In 
this study three matrilin-3 peptides were identified and measured and two of 
the three were found to be significantly lower in the HAP. Myeloid protein-1 
precursor is expressed specifically by cells of hematopoietic origin. It is also 
abundant in osteoclasts which are derived from myeloid precursors and it is 
postulated to be important in bone remodelling (Falany et al., 2001). In birds 
myeloid protein-1 has also been found to be a novel chemoattractant factor for 
heterophils and has been associated with the host response to Salmonella 
infection (Sadeyen et al., 2006). One out of the four quantified myeloid protein-
1 peptides showed a significant difference between acute phase groups, being 
significantly higher in the HAP group.  
 
Fetuin, also called α-2-glycoprotein, is a multifunctional plasma protein and a 
member of the cystatin superfamily of protease inhibitors identified in humans, 
rodents, sheep, pigs and cows (Gangneux et al., 2003; Dabrowska et al., 2015).  
The name fetuin (or fetuin-A in humans and rats where a paralog called fetuin-B 
also exists) has been suggested as the universal nomenclature for this protein in 
every species (Olivier et al., 2000; Gangneux et al., 2003). During foetal 
development fetuin is abundantly synthesized by multiple tissues, in adults it is 
secreted predominantly by the liver (>95%) (Dabrowska et al., 2015). Fetuin-A is 
a key protein in several metabolic pathways and accumulates in bones and teeth 
as a major fraction of non-collagenous bone protein. It is involved in 
osteogenesis and bone resorption, this function ascribed to the ability of fetuin-
A to regulate calcium metabolism and growth factor-β activity required for bone 
mineralization (Olivier et al., 2000; Gangneux et al., 2003; Dabrowska et al., 
2015). Fetuin-A is an anti-inflammatory mediator that participates in 
macrophage deactivation preventing the overproduction of pro-inflammatory 
cytokines (Gangneux et al., 2003). It appears to be a key partner in the recovery 
step of an APR to systemic inflammation (Olivier et al., 2000). The behaviour of 
fetuin-A during an APR varies between species: in humans, rats and guinea pigs 
fetuin(-A) is reported as a negative APPs, whereas in mice and cattle it is 
described as a positive APP (Olivier et al., 2000). In cattle fetuin decreases by 30 
% in pregnancy but increases up to 10-fold in some trauma cases (Dziegielewska 
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et al., 1992). Given its crucial role in the pathogenesis of type 2 diabetes 
mellitus, obesity, nonalcoholic fatty liver disease, dyslipidemia, atherosclerosis 
and cardiovascular disease in humans fetuin-A is regarded as a useful biomarker 
in clinical practice (Dabrowska et al., 2015). In chickens feutin has been 
identified in bone (Gotoh et al., 2002) though there is no reference in the 
literature to its role during the APR. In this study an uncharacterised protein 
with close homology to alpha-2-HS-glycoprotein/fetuin-A was identified. Four 
peptides were quantotypic and all four peptides had significantly lower 
abundance in the HAP group. The abundance of all peptides were similar and 
insignificant between the AP and NAP, but the levels detected in the HAP were 
dramatically lower. In the pooled samples the abundance in the HAP pool was 44 
and 56 fold lower than the AP and NAP pools respectfully. This dramatic 
difference is highly suggestive of this being a negative APP in chickens.  
 
It is notable that matrilin-3 (a protein of the ECM in cartilage), myeloid protein-1 
(associated with bone remodelling) and fetuin (involved in the regulation of 
osteogenesis and calcium metabolism) are all significantly different in the HAP 
group. This suggests that in the HAP group further changes associated with bone 
homestasis are occurring. Mireles et al., (2005) found that inducing an APR by E. 
coli LPS injection in chickens caused marked changes in bone metabolism, 
evidenced by a loss of tibia breaking strength. Bone homeostasis was severely 
disturbed as a result of the inflammatory response possibly as a result of changes 
in the ECM or in the mineral matrix due to changes in calcium or phosphorus 
metabolism during the APR (Mireles et al., 2005). In mammals, LPS activates 
osteoclasts and causes bone resorption via pro-inflammatory cytokines (Roux and 
Orcel, 2000). The significant differential expression of proteins associated with 
bone and cartilage metabolism in chickens that are highly acute phase should 
prompt further studies into the effects of the APR on bone metabolism, as the 
resultant changes in the associated plasma biomarkers may elude to more 
information on both the APR and skeletal health in chickens.  
 
 
4.4.4 Identifying acute phase biomarkers – future perspectives  
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While this study was successful in identifying a number of chicken APPs and 
novel biomarkers of the APR, it highlighted a number of areas to be considered 
in future studies. While the initial analysis concentrated on identifying proteins 
with the largest fold difference between the three pools, this was presumptive 
as it was only identifying and ranking proteins that were found in all three pools. 
There were a number of proteins, including SAA that were absent in the NAP 
pool yet highly expressed in the AP and HAP pools, and as such excellent 
candidates for further study and subsequent analysis took this into 
consideration. While many studies use well established models to induce an APR, 
this study incorporated samples from farm culls that were classified according to 
the serum concentration of the APP AGP. This is a well established APP and the 
most widely studied APP in chickens to date and this resulted in three clearly 
defined acute phase groups. This also had the potential however to shape the 
subsequent findings, particularly as the NAP, while having normal AGP 
concentrations were culled for stunting or lameness and as such could have 
underlying non-inflammatory pathologies. Furthermore the HAP group were a 
viraemic group with extremely high serum AGP concentrations reflecting this 
particularly sick group of birds. While surveying for biomarkers as this study has 
done, these may not be relevant issues, further studies may benefit from 
utilising samples from more controlled and established models of APR.  
 
Although identifying biomarkers such as APPs in very sick birds or those 
challenged with LPS in trials provide information on how APPs respond to 
pathogens; identifying and measuring more „subtle‟ biomarkers of the acute 
phase may allow early detection of disease and ill health in a flock and separate 
the healthy and unaffected from the (apparently) healthy and mildly/early 
infected. Using untargeted quantitative shotgun method as employed in this 
study is an excellent way of comparing groups and individuals by identifying all 
the proteins in plasma that show differential expression. In this study many 
proteins were found to be differentially expressed in the HAP group when 
compared to the AP and NAP groups. If the study was repeated with birds 
challenged with LPS, again major differences in the plasma proteome would 
likely be detected. Future studies should aim to identify protein biomarkers 
expressed in the early and mild APR to allow for the early detection of disease, 
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allow more of distinction to be made between birds during low levels of 
infection and as such be of greater diagnostic value. 
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Chapter  5 
Biomarkers of intestinal health, satiety and the acute 
phase response in chickens challenged with re-used litter 
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5.1 Introduction 
The consequences of intestinal disease in production animals are wide ranging, 
affecting welfare, productivity and potentially human health. Identifying areas 
where the application of proteomics and immunoassays could serve to improve 
understanding of disease processes and be useful for diagnosis and monitoring 
flock health are welcomed. In poultry production intestinal health and function 
is paramount to achieving efficient feed utilisation and growth. Maintaining a 
high level of enteric health within a flock allows for the profitable production in 
a high welfare environment, of meat products that are safe for the consumer.  
 
This Chapter investigates, in more depth, areas of interest highlighted during 
previous studies. In Chapter 2, the mapping of the 2D proteome of chicken 
plasma revealed a distinct spot that varied in size between samples (Figure 2.8, 
spot 18). This spot was identified as apolipoprotein AIV (apo-AIV), an intestinally 
derived antioxidant protein that associates with HDL and functions in reverse 
cholesterol transport, lipid transport and lipoprotein metabolism (Franceschini, 
2003; Vowinkel et al., 2004; Navarro et al., 2005). Apolipoprotein AIV has also 
been shown to function as a satiety protein to control food intake and gastric 
function in mammals (Tso & Liu, 2004; Vowinkel et al., 2004). Apolipoprotein 
AIV is associated with the APR, being an endogenous anti-inflammatory protein 
with anti-atherogenic properties (Vowinkel et al., 2004). These findings make 
apo-AIV both a relevant and interesting target for study in chickens.  
 
Previous work identifying differentially expressed jejunal proteins in chickens 
receiving a microbial challenge in the form of re-used poultry litter, revealed 
the intestinal protein villin to be differentially expressed over time between 
challenged and control groups, decreasing in the challenged birds significantly 
over time (O‟Reilly, 2013). Figure 5.1, taken from this study, details the 
decrease in expression of villin over time. These results, together with the 
measurement of serum villin in humans and identification of villin as a biomarker 
for intestinal dysfunction (Wang et al., 2008) make villin an appropriate target 
for further research. Gelsolin, a member of the gelsolin super family of actin 
binding proteins to which villin belongs, was also selected for measurement 
using quantitative proteomics. 
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Figure 5.1: The decrease in the abundance of spots 525 and 526, both identified as villin, 
from day 12 (pre-challenge) to day 22, in birds challenged with re-used poultry litter 
(O’Reilly, 2013). Proteins were seperated and quantified using DiGE.  
 
 
 
5.1.1 Apolipoprotein AIV 
In humans and rats apo-AIV is synthesised in the proximal small intestine, the 
liver and the hypothalamus and is present in plasma, interstitial fluid and lymph 
(Tso, et al. 1999; Navarro et al., 2004; Pardina et al., 2009). In chickens apo-AIV 
synthesis occurs in the intestine and liver, with the intestine being the primarily 
site of synthesis, the highest level of expression seen in the proximal intestine  
with only minor expression in the ileum and rectum. No apo-AIV mRNA has been 
detected in other organs investigated, including the brain (Steinmetz et al., 
1998). Small intestinal apo-AIV synthesis is stimulated by active lipid absorption 
with triglyceride feeding an potent stimulus for intestinal secretion of apo-AIV 
(Tso et al., 1999). Following synthesis in the enterocytes, apo-AIV enters the 
circulation on the surface of nascent chylomirons but thereafter dissociates from 
their surface and circulates primarily as a lipid-free protein (Weinberg et al., 
2000; Weinberg, 2002). An important difference between mammalian and avian 
apo-AIV is that in birds apo-AIV it is not delivered to a lymphatic system but is 
secreted into the portal vein as a so-called „porto-microns‟ which are subject to 
rapid uptake by the liver (Steinmetz & Schneider, 1999).  
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5.1.1.1 Apolipoprotein AIV structure 
Apolipoprotein AIV is a 46kDa protein that has several distinctive structural 
features. Like all plasma apolipoproteins it contains multiple amphipathic α-
helices, in apo-AIV however, these are very hydrophilic and cannot deeply 
penetrate lipid surfaces resulting in weak lipid binding affinity (Weinberg, 2002). 
In contrast the 38-kDa avian homolog of mammalian apo-AIV is a much more 
hydrophobic protein with longer α-helical hydrophobic domains and shorter 
hydrophilic domains and is predicted to contain multiple amphipathic α-helical 
domains and therefore binds lipid more readily (Weinberg et al., 2000).  
Sequence analysis reveal that apo-AIV is the most recently evolved 
apolipoprotein, probably originating from the intra-exonic duplication of the 
apo-AI gene, 270–307 million years ago. The C terminus of human apo-AIV 
contains a unique and highly conserved region that is the site of genetic 
polymorphisms that affect apo-AIV structure, plasma lipid levels, and the 
response to diet in mammals (Weinberg et al., 2000). The primary structure of 
chicken apo-AIV contains 347 amino acids and displays 57% sequence identity 
with human apo-AIV. The chicken apo-AIV protein does not appear to be 
significantly glycosylated and the isoelectric point is 4.65, considerably more 
acidic than human apo-AIV (Steinmetz & Schneider, 1999). Avian apo-AIV lacks 
the highly conserved mammalian C-terminal region suggesting that chicken apo-
AIV could be the molecular ancestor of mammalian apo-AIV and that the 
mammalian C-terminal domain may be a structural adaptation that evolved to 
confer a new physiologic function to this apolipoprotein (Weinberg et al., 2000).  
5.1.1.2 Apolipoprotein AIV function 
 
5.1.1.2.1 Lipoprotein metabolism and reverse cholesterol transport 
Evidence suggests that one of the primary roles of apo-AIV is the regulation of 
intestinal lipid absorption and chylomicron assembly (Weinberg et al., 2000). 
During subsequent plasma passage and metabolism of lymph chylomicrons about 
25% of apo-AIV is transferred to HDL and the remaining 75% is found in the 
lipoprotein-free fraction of plasma (Vowinkel et al., 2004). Apolipoprotein AIV 
plays an important role in reverse cholesterol transport by stimulating 
lecithin:cholesterol acyltransferase activity which causes apo-AIV to associate 
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with HDL in a reaction that causes depletion of HDL surface lipids and stabilizes 
HDL (Navarro et al., 2005).  
5.1.1.2.2 Satiety 
Apolipoprotein AIV has been proposed to physiologically control food intake and 
this inhibitory effect is centrally mediated (Tso & Liu, 2004). It is synthesised in 
the hypothalamus and the hypothalamic apo-AIV level is reduced by food 
deprivation and restored by lipid feeding (Tso & Liu, 2004). In rodent models, 
apo-AIV administered either intravenously or into the intra-cerebroventricular 
space suppresses food intake in a dose dependant manor, the potency of intra-
cerebroventricular administration fifty times greater than the intravenous 
administration (Fujimoto et al., 1992; Fujimoto & Fukagawa, 1993). Conversely 
administration of apo-AIV antiserum into the intracerebroventricular space 
causes increased feeding and decreases the hypothalamic apo A-IV mRNA level, 
implying that feeding is normally limited by endogenous apo-AIV (Tso & Liu, 
2004). 
The stimulation of intestinal synthesis and secretion of apo-AIV by lipid 
absorption is rapid  (Tso & Liu, 2004). In rats a gastric bolus of lipid causes a 
significant increase of plasma apo-AIV within 15 minutes with the increment 
remaining significant until 30 minutes after the meal, indicating that the 
increase in plasma levels of apo-AIV produced were sufficiently quick and large 
enough to produce satiety (Rodriguez, et al. 1997) and that apo-AIV is capable of 
short-term regulation of food intake. Evidence also suggests apo-AIV‟s 
involvement in the long-term regulation of food intake and body weight. Chronic 
ingestion of high fat blunts the hypothalamic apo-AIV response to lipid feeding 
and may therefore explain why chronic intake of high fat predisposes animals 
and humans to obesity (Tso & Liu, 2004). 
In humans genetic polymorphisms of apo-AIV are well documented and may be a 
factor that mediates the heterogeneous response of plasma lipids to diet in 
humans. Only two of the reported polymorphisms however demonstrate altered 
biophysical properties that include either an increased or decreased postprandial 
hypertriglyceridemia, LDL response to dietary cholesterol in the setting of a 
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moderate fat intake, HDL response to changes in total dietary fat content and 
higher or lower body mass and adiposity (Weinberg, 2002). 
In veterinary species apo-AIV has not been well documented, the pig however is 
the notable exception. Pigs are regarded as one of the best models for human 
lipid metabolism because their lipoprotein profile is similar to that of humans 
(Navarro et al., 2004) and as such it is the veterinary species in which apo-AIV 
has been most widely studied, albeit as a inflammation model.  
It is only the cow and dog in which apo-AIV has been studied in relation to 
feeding and satiety. In cows, following the successful development of an ELISA, 
serum apo-AIV was found to be significantly higher in lactating cows compared 
to non-lactating with average apo-AIV concentrations of 102 and 64mg/L 
respectfully and apo-AIV concentrations of fasted calves increased significantly 
once fed (Takahashi et al., 2004). In dogs cholesterol feeding was found to 
increase plasma apo-AIV three fold (Sloop et al., 1983).  
5.1.1.2.3 Apolipoprotein AIV and the acute phase response  
Besides changes in APP, the APR is also associated with systemic alterations in 
lipids and lipoproteins. During infection and inflammation serum triglyceride 
levels increase and small dense LDL appear and HDL cholesterol levels decrease 
(Khovidhunkit et al., 2004). Apolipoprotein AIV has antioxidant and anti-
inflammatory activity (Vowinkel et al., 2004) and is a potent endogenous 
inhibitor of lipid oxidation (Qin et al., 1998). In a murine model of colitis, apo-
AIV significantly and specifically delays the onset and reduces the severity and 
extent of inflammation. Apolipoprotein AIV significantly inhibits leukocyte and 
platelet adhesive interactions (Vowinkel et al., 2004). Over expression of human 
or mouse apo-AIV in transgenic mice protects against the formation of diet-
induced aortic lesions (Navarro et al., 2004). In mice injected with endotoxin, 
increased levels of apo-AIV in acute phase HDL and apo-AIV hepatic mRNA are 
detected both of which indicate that this protein is a positive APP (Khovidhunkit 
et al., 2004). Clinically it has been observed that in horses apo-AIV significantly 
increases in horses with both acute and chronic laminitis, a debilitating disease 
of the equine foot associated with insulin resistance, obesity and gastrointestinal 
inflammation (Steelman & Chowdhary, 2012).  
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In contrast, rat models of rheumatoid arthritis, that demonstrate changes to 
serum proteins similar to that seen during an APR, show a down regulation of 
apo-AIV (Eberini et al., 2000) and during a turpentine oil induced APR in pigs, a 
decrease in hepatic apo-AIV mRNA expression is observed, though this does not 
correlate with the plasma protein levels. The distribution of plasma apo-AIV 
experiences a shift from HDL to larger particles. The well-known HDL decrease 
found in the APRs appears, in the pig, due to the decreased expression of apo-AI 
and the enlargement of the apo-AIV containing HDL (Navarro et al., 2005).  
There is evidence that the protective anti-inflammatory effects of apo-AIV are 
independent of the effects of this protein on lipoprotein metabolism and food 
intake, a study finding that the over expression of apo-AIV in transgenic mice 
whilst conferring increased protection against atherosclerosis, did not affect 
their feeding behaviour (Qin et al., 1998). Figure 5.2 summarise the functions 
and the sites of synthesis of apo-AIV. 
 
 
 
 
 
Figure 5.2: The sites of synthesis and functions of apo-AIV (*described for mammals, not 
demonstrated in the chicken). 
 
 
5.1.2 Villin 
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In cells the actin cytoskeleton plays a central role in many fundamental cellular 
processes involving the generation of force and facilitation of movement. The 
assembly and three-dimensional organisation of actin filaments is controlled 
through interactions with a large number of functionally distinct actin binding 
proteins (Li et al., 2012). In the intestine, epithelial cells have a brush border 
composed of numerous membrane extensions called microvilli, fingerlike 
extensions that increase the absorptive function of these specialized cells. The 
core of each intestinal microvillus is a rigid bundle of 20–30 parallel actin 
filaments extending from the microvillus tip down into the cell cortex (Athman 
et al., 2002). Villin is the actin binding protein expressed in the brush border of 
the intestinal epithelium. It is also found to be highly expressed in the gall 
bladder and kidney (Athman et al., 2002; Nag et al., 2013). Villin belongs to 
gelsolin superfamily of actin-binding proteins which includes gelsolin, severin, 
fragmin, adseverin/scinderin and actin crosslinking proteins such as dematin and 
supervillin (Khurana & George, 2008) 
5.1.2.1 Villin structure and function  
Villin was first isolated from chicken intestinal epithelial cells and later from 
mammalian species. It has a globular protein with a molecular mass of 92.5 kDa 
and occurs in monomeric form, present as two eqimolar variants with isoelctric 
points 6.2 and 6.3 (Alicea & Mooseker, 1988). Villin can be highly phosphorylated 
with ten tyrosine phosphorylation sites identified in human villin (Khurana & 
George, 2008). All actin binding proteins in the gelsolin superfamily require 
calcium to function with two major calcium-sensitive sites present in villin that 
induce conformational changes (Khurana & George, 2008). Villin however, unlike 
the rest of the gelsolin superfamily, requires micromolar to millimolar levels of 
calcium to function as tyrosine phosphorylation lowers the threshold to the 
nanomolar range, suggesting that tyrosine phosphorylation may be the primary 
mode of regulation of villin activity under physiological conditions (Nag et al., 
2013).  
As a versatile actin modifying protein able to both polymerize and depolymerize 
actin filaments and cap, sever, nucleate and bundle actin filaments (Li et al., 
2012), villin is able to regulate epithelial cell morphology, actin reorganisation, 
apoptosis, cell motility and wound healing of intestinal enterocytes (Wang et al., 
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2008; Nag et al., 2013). This is necessary for the intestinal epithelium to 
function as a physiological and structural barrier as intestinal epithelial cells 
have a high rate of cell turnover accompanied by an equally high rate of 
apoptosis (Li et al., 2012).  
5.1.2.2 Villin as a biomarker  
Normal apoptosis is essential for the hierarchical organisation of the intestinal 
epithelium and apoptosis is a key regulator of the very high cellular turnover 
rate seen in the gastrointestinal epithelium (Li et al., 2012; Wang et al., 2012). 
Abnormalities associated with apoptosis in the epithelium have been linked to 
most major gastrointestinal disorders, including ischemia reperfusion injury, 
inflammatory bowel disease, necrotising enterocolitis, coeliac disease, 
gastrointestinal infections and colorectal cancer (Wang et al., 2012). Increased 
apoptosis in the intestinal epithelium contributes to the tissue damage and the 
severity of colonic inflammatory response (Li et al., 2012). A decrease in the 
levels of villin expression in enterocytes has been noted in several inflammatory 
diseases of the gastrointestinal tract including Crohn‟s disease and ulcerative 
colitis (Wang et al., 2008; Li et al., 2012).  
As well as changes to villin expression in the intestine, the presence of villin in 
the serum is also indicative of the pathological state of the gastrointestinal 
tract, with significant associations between serum villin and stage, severity and 
type of gastrointestinal disease found (Dudouet et al., 1990). Because villin 
expression is maintained in neoplasic tissues, villin is also a useful marker for 
primary tumors or metastases deriving from tissues that normally express villin. 
Its presence in the blood of patients presenting colorectal carcinomas makes it a 
diagnostic adjunct for the detection of these cancers (Athman et al., 2002). 
5.1.3 Gelsolin  
Gelsolin is a member of the gelsolin superfamily of actin binding proteins all of 
which are calcium dependant multi-domain regulators of the actin cytoskeleton 
(Nag et al., 2013). In mammals villin shares 50% sequence homology with gelsolin 
and has a similar proteolytic cleavage pattern (Nag et al., 2013). In chickens 
gelsolin and villin share 40.3% sequence homology (Uniprot.org). Gelsolin is a 
highly abundant, calcium dependent actin binding protein and there is increasing 
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evidence that gelsolin is also a multifunctional regulator of cell metabolism that 
involves multiple mechanisms independent of its actin regulatory functions (Li et 
al., 2012). Gelsolin is the most widely studied actin regulatory protein, however 
the roles of gelsolin are disputed in terms of its involvement in contrasting 
activities such as oncogenic, anti-oncogenic, pro-apoptotic and anti-apoptotic 
(Khurana & George, 2008). While both members of the same functional family, 
gelsolin unlike villin is not tissue specific. Gelsolin exists in two forms: a plasma 
form and a cytoplasmic form and cytoplasmic gelsolin is ubiquitously expressed 
in cells and tissues (Li et al., 2012).   
Plasma gelsolin depolymerises and sequesters actin released into the vasculature 
as a result of lysis of injured or dead cells and tissues, averting pathological 
blockages of the microvasculature (Li et al., 2012; Nag et al., 2013). This 
scavenging role of gelsolin involves the binding and inactivation of bioactive 
inflammatory mediators. Gelsolin plays a protective role against inflammation 
and can enhance or inhibit apoptosis depending on the nature of the 
pathological conditions, the identity of the cell types, and the specific tissues 
that are involved (Li et al., 2012).  
5.1.3.1 Gelsolin as a biomarker 
Gelsolin has a variety of roles in the pathology of many diseases and as such is 
reported in humans to have biomarker and therapeutic target potential (Li et 
al., 2012; Nag et al., 2013). Increased plasma gelsolin expression has been 
detected in acute liver failure, myocardial infarction, septic shock, muscle 
necrosis and acute respiratory distress syndrome. Gelsolin is observed to be 
down regulated in most cancers, except a small sub-set of lung cancers and in 
the transition from non-invasive to invasive tumours. The levels of gelsolin in a 
cancer setting may give an index of metastatic potential and is thought to be an 
independent marker for tumour recurrence and progression in urothelial tumors, 
particularly for high-grade variants. Gelsolin may also be used as a biomarker in 
cardiovascular disease, with its abundance an indicator of chronic heart failure 
(Li et al., 2012). Gelsolin is involved in a wide range of cellular processes, 
influencing actin dynamics in multiple and sometimes contradictory ways. As 
such, while gelsolin is regarded as an assayable peripheral blood biomarker for 
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several disease conditions, the changes in plasma gelsolin concentrations are 
regarded as context sensitive (Li et al., 2012; Nag et al., 2013). 
 
5.1.4 Aims of this study 
Apolipoprotein AIV is a multifunctional protein, reported to be an acute phase 
reactant in mammals. No studies characterising apo-AIV during an APR in 
chickens have been undertaken and apo-AIV does not appear to have been 
targeted in poultry nutritional or feed behaviour studies. The development of an 
ELISA to measure plasma/serum apo-AIV in chickens would therefore be of great 
value to many poultry research areas and develop a better understanding of how 
this lipoprotein functions in the chicken. It was hypothesised that, once 
quantifiable and measured, apo-AIV would be affected by the addition of re-used 
litter to challenged pens. Furthermore it was also hypothesied that apo-AIV 
would also change during an APR.  
Using re-used litter provides a microbial challenge to broilers that is 
representative of the commercial growing environment. Re-used litter changes 
the intestinal microbiota and its increased microbial complexity acts as an 
immunological challenge to the chicks and negatively affect growth rates (Torok, 
et al., 2009; Cressman et al., 2010; Lee et al., 2011). Acute phase proteins, 
using both immunoassays and quantitative proteomics, will be measured to 
determine whether the addition of re-used litter causes an APR, the hypothesis 
being that the litter could evoke an immune response sufficient enough to 
increase serum concentrations of APPs. Having already established that the 
introduction of re-used poultry litter negatively affected growth rates and 
causes differential expression of a number of intestinal proteins, including villin 
(O‟Reilly, 2013), it was the aim of this Chapter to validate the change in villin 
over time in the intestinal lysate and investigate whether villin could be a 
biomarker for intestinal health in the broiler chicken by identifying, and if 
possible, quantifying this protein in the plasma of chickens using quantitative 
proteomics and immunoassay methods. The hypothesis being that villin, having 
been demonstrated to decrease in the intestinal proteome of challenged birds, 
would also show a similar change in the serum of these birds.   
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5.2 Methods 
 
5.2.1 Intestinal challenge study 
This study was undertaken at the Scotland‟s Rural College (SRUC) in 2012 for an 
M.Sc. project investigating the intestinal proteome of broiler chickens (O‟Reilly, 
2013) in collaboration with Professor Nick Sparks. During this experiment, blood 
was also recovered for the purposes of studying the APR. The experimental 
model was approved by the SRUC animal experimentation committee and SRUC 
standard operating procedures (SOPs) were employed throughout the experiment 
to ensure the welfare of the birds was maintained. At day-old, 120 male Ross 
308 broiler chicks were randomly divided into two groups: control and 
challenged. Birds were divided into 6 replicates per group, housed in individual 
pens containing 10 birds per pen in an environmentally controlled room 
(standard temperature profile). Chicks were fed a commercial starter ration 
until 10 days of age after which they were moved onto a grower ration for the 
remainder of the study. On day 12 litter from a commercial unit housing broilers 
aged 35 days was recovered from the top layer, manually broken down and 1 kg 
was added to each of the challenge pens. An aliquot of the challenge litter was 
submitted to the Avian Science and Research Centre (ASRC) microbiology 
laboratory‟s (SRUC, Auchencruvie, UK) for microbial analysis. On day 12 and days 
15, 18 and 22 (3, 6 and 10 days post addition of the reused litter) the chicks in 
each pen were bulk-weighed and one bird from each pen was randomly selected 
and following cervical dislocation blood was recovered via intra-cardiac puncture 
into lithium containers. Following centrifugation, plasma was removed, 
aliquoted and stored at -80˚C until use. Figure 5.3 gives an overview of 
experimental design. 
 
5.2.2 Measurement of acute phase proteins  
 
5.2.2.1 Immunoassays 
The APPs SAA and Cp were measured using commercially available ELISAs (3400-7 
(SAA), 2610-3 (Cp) Life Diagnostics, Stoke-on-Trent, UK). Both ELISA‟s utilise 
chicken specific antibodies and although used according to the manufacturer‟s 
instructions, plasma was diluted 20 fold and 40,000 fold with diluent for the SAA 
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and Cp ELISAs respectfully, to obtain results that were measureable on the 
standard curve. For the SAA ELISA a smaller volume of plasma was also used with 
resultant adjustments to diluent volumes, to accommodate the small volumes of 
plasma available. For Ovt the RID method described in Chapter 3 was used. 
Mann-Whitney non-parametric tests (GraphPad Prism v.5) were used at each 
time point to determine whether the plasma concentrations of these APPs were 
significantly different between challenged and control groups. A Krusal-Wallis 
test was used to identify significance over the four time points for the challenge 
and control samples separately.   
 
 
Figure 5.3: Overview of intestinal challenge experimental design. 
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5.2.2.2 Quantitative proteomics   
The APPs SAA, Ovt, ApoA1, Hpx, Ttn and PIT54 were measured using the 
quantitative proteomic method detailed in Section 4.2.2. Measurement of these 
samples was undertaken at the same time as those detailed in Chapter 4. For 
this analysis three replicates per group were randomly selected for measurement 
owing to cost constraints, as oppose to the six replicates used for the 
immunoassay measurements.  
5.2.3 Apolipoprotein A4 indirect ELISA 
 
5.2.3.1 Western blotting  
Western blotting, as described in Chapter 2, Section 2.2.2.2 comparing acute 
phase and non-acute phase serum samples was undertaken using rabbit anti-
APO4 antibody (abcam 113108) at 1 in 10,0000 and 1 in 20,000 dilutions. Jejunal 
samples, recovered from the birds sampled in the intestinal challenge study 
were flushed on recovery and frozen immediately. They were individually ground 
in liquid nitrogen and 0.2g was vortexed in a Tris buffer (20mM, pH7.4). The 
samples were centrifuged and the supernatant recovered. A 1DE gel with 
intestinal lysate or serum diluted 1:10 with dH2O from two challenge samples 
and two control samples from days 18 and 22 were run. Western blots performed 
as previously described using was goat α-rabbit IgG HRP (Ab 6721) diluted 
1:20,000 as a secondary antibody.  
5.2.3.2 Indirect ELISA  
Samples were diluted at 1:10,000 or 1 in 20,000 in coating buffer (50mM Sodium 
hydrogen carbonate, pH 9.4) and 100μl was added in triplicate to a 96 Maxisorp 
96 MicroWell™ plate (Nunc International, Rochester, NY). The standard was a 
previously determined high sample that was double diluted 1:4,000 – 1:64,000, 
of which 100μl was added in triplicate to the same plate. The plate was 
incubated overnight at 4˚C. Following removal of the coating buffer, the plate 
was blocked with 200μl of 5% (w/v) Marvel milk protein diluted in TBS-T (0.05%) 
over an hour at room temperature with rocking. The plate was washed with TBS-
T (0.05%) - 1% (w/v) Marvel milk protein three times, each wash consisting of 
agitation followed by thorough removal of wash. Following the final wash, the 
plate was patted dry and rabbit anti-chicken APO4 antibody (abcam 113108), 
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was diluted 1:500 with TBS- 1% (w/v) Marvel milk protein and 100μl was added 
to each well. The plate was incubated at room temperature for 1 hour with 
agitation. The plate was washed three times as previously described and 100μl 
of goat anti-rabbit IgG-HRP (abcam ab6721) diluted 1:2000 with TBS - 1% (w/v) 
Marvel milk protein was added to each well. The plate was again incubated at 
room temperature for 1 hour with agitation. The plate was washed three times 
again as previously described before 100µl of IMB peroxidase substrate (KPL 50-
76-00) was added. Following a 5 minute incubation at room temperature which 
was halted with the addition of 100µl 1M HCl, the absorbance was measured at 
420nm on a FLUOstar absorbance microplate reader and analysed using 
associated MARS data analysis software (both BMG LABTECH, Ortenburg 
Germany). A standard curve using 4-parametre fit curve was used to determine 
Apo-AIV concentrations as arbitrary units (AU) with 100 AU being the value 
obtained with the standard at a 1:4000 dilution. 
 
5.2.4 Biomarkers for intestinal health 
 
5.2.4.1 Quantitative proteomics  
Using the quantitative proteomic methods described in Chapter 4, Section 4.2.2, 
apo-AIV and villin, proteins previously determined to be of interest as potential 
biomarkers of intestinal health were targeted in the initial shotgun analysis. 
Villin however was only identified in the AP pool (pool-2) and no quantotypic 
peptides were identified. Instead the protein gelsolin was targeted. Gelsolin was 
present in all three pools and given the functional similarity and presence of 
four quantotypic peptides, gelsolin was targeted instead. Plasma apo-AIV and 
gelsolin were measured by quantitative proteomics in the intestinal challenge 
study and in the three acute phase groups detailed in Chapter 4, HAP, AP and 
NAP, to determine whether the serum concentration of these intestinally 
derived proteins change during an APR.  
5.2.4.2 Villin as a serum biomarker for intestinal health 
A series of western blots, using mouse anti-chicken villin (MCA292 AbD serotec, 
Oxford, UK) a monoclonal antibody, were undertaken on both plasma and 
intestinal lysate. Western blots were undertaken as described in Chapter 2 
Section 2.2.2.2, except visualisation of immunoreactivity was undertaken using 
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Pierce ECL to detect HRP activity (#32209 Thermo Scientific, Paisley, UK) 
according to the manufacturer‟s instructions. The NCP was trimmed and 
wrapped in Saran Wrap and exposed to radiographic film for approximately 3 
minutes and the resultant radiographic films scanned.  
5.2.5 Statistical analysis  
GraphPad Prism v.5 and v.6 were used for statistical analysis. All results were 
analysed using non-parametric tests: Kruskal-Wallis test with Dunn post-test 
analysis, Mann-Whitney test and Spearman‟s correlation, following data 
evaluation using D'Agostino-Pearson omnibus normality test. Non-parametric 
analysis was selected based on the results together with the small number of 
replicates in each group.  
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5.3 Results 
 
5.3.1 Intestinal challenge study 
As reported in O‟Reilly (2013), there were no mortalities during the study though 
by day 18 it was evident that the introduction of the challenge litter at day 12 
had affected the growth of the challenged pens with uneven growth evident. 
The mean weight for the challenged birds, when compared to un-challenged 
controls at day 22 was significantly lower (P<0.05), with mean body weights of 
374g (± 41g) and 441g (± 34g) for the challenged and control birds respectively. 
A representative sample of the re-used litter, submitted for microbial analysis 
on the day of collection identified Clostridium perfringens, Lactobacillus and 
Campylobacter. The oocyst count from the re-used litter was 27,000 oocyst per 
gram which corresponding to a lesion score 1 (Janseen Pharmaceutica, 1990). 
This oocyst count is within the expected range for a poultry unit at 35 days 
(O‟Reilly, 2013). 
 
5.3.2 The effect of intestinal challenge on the plasma 
concentration of acute phase proteins 
 
5.3.2.1 Immunoassays 
Plasma concentrations of SAA and Cp were determined using commercially 
available immunoassays and Ovt concentrations were determined using RID as 
detailed in Chapter 3. None of these APPs were found to be significantly 
different between the challenged and control groups at any time point and the 
plasma concentrations of these APPs were not significantly affected by time. 
Figure 5.4 details graphically the results of these APP immunoassays. Using the 
same samples serum AGP concentrations were also determined in an earlier 
study, and were not significantly different between treatment groups at each 
time point but were significantly affected but time, increasing significantly over 
time in both treatment groups (O‟Reilly, 2013).  
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Figure 5.4: Boxplot graphs describing serum concentrations of SAA, Ovt and Cp, determined 
by immunoassay, over time in challenge (n=6 per time point) and control groups (n=6 per 
time point). Data was analysed using Kruskal-Wallis with Dunn post test analysis to identify any 
significant effect of time for both control and challenged groups (analysed separately). At each 
timepoint a Mann-Whitney test was performed to identify any significant difference between the 
control and challenged birds at that time point (GraphPad Prism v5). Data presented in median 
with 25 to 75 percentile range. 
 
5.3.2.2 Quantitative Proteomics 
The same methods, used successfully in Chapter 4, Section 4.2.2, were used to 
quantify the APPs SAA, Ovt, ApoA1, Hpx, Ttn and PIT54 in three replicate 
samples from the challenge and control samples at each time point. No 
significant differences between the challenge and control samples was seen for 
any of the APPs at any time point except for Hpx where peptide-1 in the control 
group was significantly different over the four time points, increasing from day 
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12 to day 22. A similar, but non-significant trend was seen in the challenge group 
and in both challenge and control groups for peptide-2.  
 
5.3.3 Apolipoprotein AIV  
 
5.3.3.1 Western blotting 
The western blots worked at both antibody concentrations with specific binding 
producing a distinct band at 38kDa and no noted background binding. The 
molecular weight of chicken apo-AIV is reported to be 40.8 kDa. There were no 
detectable difference between the acute phase and non-acute phase samples at 
either dilution. Figure 5.5 shows the western blot, at a 1:10,000 dilution it is 
possible to detect a second slightly heavier band. A negative control was 
undertaken and no binding was identified. 
 
 
 
Figure 5.5: Western blot comparing apo-AIV in acute and non-acute phase samples using 
rabbit anti-chicken apoIV antibody diluted 1:10,000 and 1:20,000. Serum proteins were 
separated with 4-12% CriterionTM Bis-Tris precast polyacrylamide gel (BioRad#345-0124) prior to 
western blotting. 
 
Western blotting was also undertaken with intestinal lysate with bands apparent 
at the 38kDa, the same molecular weight as the serum apo-AIV. The bands 
however were not as intense (hence image not shown). There were no obvious 
differences between the size and intensity of the bands between the lysate 
samples from the two days (18 and 22) and between the challenge and control.  
 
212 
 
5.3.3.2 Apolipoprotein AIV indirect ELISA  
 
5.3.3.2.1 ELISA validation  
To develop and validate an indirect ELISA for the measurement of apo-AIV in 
serum and plasma, a number of steps were undertaken to determine the optimal 
serum and antibody concentrations. The optimal antibody concentrations for the 
rabbit anti-chicken apo-AIV antibody were determined by diluting the antibody 
1:100, 1:500, 1:2000 and 1:8000. Figure 5.6 plots the OD of five serum samples, 
serially diluted fourfold from 1:4000 to 1:256,000, calculated from standard 
curves produced at four different antibody concentrations. The samples show 
linearity but plateau at both high and low dilutions. Based on these findings a 
1:500 antibody dilution was selected as the most optimal antibody concentration 
producing the best standard curve. The same high sample double diluted from 
1:4,000 to 1:64,000 was used to produce all subsequent standard curves used to 
calculate apo-AIV concentrations in this study. Arbitrary units (AU) (in the 
absence of a purified sample of known concentration) were used to record the 
concentration of each sample. The calculated standard curve is based on 1:4000 
equalling 100% through to the 1:64,000 sample equalling 6.3%, using a 
logarithmic scale along the X axis (Figure 5.7, Table 5.1). The apo-AIV 
concentration of two samples (previously determined as containing relatively 
high and low apo-AIV) were diluted 1:10,000 and 1:20,000 and apo-AIV 
concentrations determined, the results presented in Table 5.2. From this data 
samples were measured at a 1:10,000 dilution, though in later studies this 
increased to 01:20,000 owing to higher apo-AIV serum concentrations.   
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Figure 5.6: Optimisation of antibody concentration for apo-AIV ELISA.  Serum was serially 
diliuted from 1:1000 to 1:256000 and the OD recorded for each sample using 1:100, 1:500, 
1:2000 and 1:8000 chicken anti-apo AIV antibody.   
 
Figure 5.7: Example standard curve using a 1:500 antibody dilution (MARS data analysis, BMG 
LABTECH). Using the 1:500 antibody (that appeared to give the optimal response as detailed in 
Figure 5.6), the ELISA was re-ran and the standard curve plotted using a 4-parametre fit, widely 
recommended for ELISAs 
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Absorbance 
     Formula: Y = Bottom + (Top-Bottom) / (1+(EC50/x)^Slope) 
 
Fit results are based on OD values 
 Wavelength: Top 3.528287 
   450 Slope 1.646091 
   
 
EC50 10.96318 
   
 
log(EC50) 1.039936 
   
 
Bottom 0.148144 
   
 
R 0.999981 
   
 
r² 0.999962 
    
Table 5.1: Standard curve fit results (MARS data analysis, BMG LABTECH). 
 
 
1:10,000 1:20,000 
Sample Results  SD Results  SD 
High 38.56 3.93 35.55 4.74 
 
38.83 
 
42.90 
 
 
31.89 
 
34.04 
 
Low 22.83 5.40 21.98 5.04 
 
19.95 
 
17.75 
 
 
12.38 
 
11.94 
 
 
Table 5.2: Apo-AIV results from a high and low sample replicated three times at a 1:10,000 
and 1:20,000. 
 
5.3.3.2.2 Inter and intra-assay precision   
The inter- and intra-assay coefficient of variants (CVs) were calculated using 107 
samples from two preliminary studies and the intestinal challenge study (only high QC) 
and are contained in Table 5.3. The average inter- and intra-assay CVs are 4.71% and 
3.61% respectfully, making this a particularly precise and repeatable ELISA method. 
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 High QC Low QC 
 Inter-assay CVs Plate 
Mean 
ApoA4 
Plate 
Mean 
ApoA4 
Preliminary study - 1 
Plate 1 51.32 Plate 1 28.20 
Plate 2 53.06 Plate 2 30.71 
Plate 3 49.96 Plate 3 27.99 
mean 51.44 mean 28.97 
sd 1.55 sd 1.51 
CV 3.02 CV 5.22 
Preliminary study - 2 
Plate 1 42.64 Plate 1 38.43 
Plate 2 48.92 Plate 2 42.85 
Plate 3 44.60 Plate 3 39.91 
mean 45.39 mean 40.40 
sd 3.21 sd 2.25 
CV 7.08 CV 5.57 
Intestinal challenge 
study 
Plate 1 43.67 
  
Plate 2 42.18 
  
Plate 3 44.43 
  
mean 43.43 
  
sd 1.14 
  
CV 2.63 
  
Average Inter-assay CV 4.71% 
  
Intra-assay CV plate CV% 
 
Preliminary study -1  
Plate 1 3.95 
 
Plate 2 4.53 
 
Plate 3 4.37 
 
Preliminary study-2 
plate 1 3.20 
 
plate 2 2.68 
 
plate 3 5.02 
 
Intestinal challenge 
study 
plate 1 3.09 
 
plate 2 2.45 
 
plate 3 3.21 
 
Average Intra-assay CV 
 
3.61% 
 
 
Table 5.3: Inter and Intra-assay CVs of Apo-AIV indirect ELISA. The inter-assay CV was 
calculated from running 107 samples in duplicate from three seperate studies, across nine 
plates. The intra-assay CV was calculated using the same studies, measureing all samples in 
duplicate.  
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5.3.3.2.3 Limit of detection  
The minimum detection limit was taken as the apo-AIV concentration at 3 SD 
from the mean of blank samples (n=20). This resulted in a limit of detection of 
1.56 AU. 
5.3.3.2.4 Plasma apolipoprotein AIV in intestinal challenge study 
 
Using the indirect ELISA, the plasma concentrations of apo-AIV was determined 
in all the samples in the intestinal challenge study. Figure 5.8 shows the 
concentration of apo-AIV over time in challenged and control samples. A Mann-
Whitney non-parametric test was performed between the challenge and control 
groups at each time point and revealed no significant difference in Apo-AIV 
plasma concentrations. Kruskal Wallis tests, performed between the four time 
points for the challenge and control groups revealed however that for the 
control group there was a significant effect of time (P=0.0441), with Dunn post 
test analysis revealing the significance to lie between day 12 and 15 (P=<0.05). 
No significance was detected over the four time points for the challenge group. 
 
Figure 5.8: Boxplot graphs describing plasma concentration of Apo-AIV, determined using 
indirect ELISA, in challenge (n=6 per time point) and control groups (n=6 per time point). 
Data was analysed using Kruskal-Wallis with Dunn post test analysis to identify any significant 
effect of time for both control and challenged groups (analysed separately). At each timepoint a 
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Mann-Whitney test was performed to identify any significant difference between the control and 
challenged birds at that time point (GraphPad Prism v5). Data presented in median with 25 to 75 
percentile range. 
 
5.3.4 Targeting biomarkers for intestinal health 
 
5.3.4.1 Quantitative proteomics  
The same quantitative methods detailed and presented in Chapter 4 were used 
to target apo-AIV and gelsolin in the intestinal challenge study, with a view of 
identifying possible biomarkers of intestinal health. Table 5.4 details the 
quantotypic peptides targeted. For apo-AIV no significance was noted between 
challenge and control groups at any of the time points. When examining the 
challenge and control groups over time however a Kruskal-Wallis test showed a 
significant difference between the time points (P=<0.05) in the challenge group, 
Dunn post-test analysis revealing this to lie specifically between days 12 and 18 
(P=<0.01) and days 15 and 18 (P=<0.05). The corresponding test for the control 
group revealed no significance. For gelsolin no significant difference between 
the challenge and control groups at any time point for any of the four peptides. 
No significance was identified in the control or challenge groups over the four 
time points for any of the gelsolin peptides. Figure 5.9 shows the peak area of 
each peptide for each group for both apo-AIV and gelsolin.  
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 Peptide 1 Peptide 2 Peptide 3 Peptide 4 
Gelsolin O93510 
K.NLYGDFFTGDSYL
VLNTIR.Q [79, 97] 
K.VPVDPATYGQFY
GGDSYIILYDYR.H 
[453, 476] 
R.AVELDPAASQLNS
NDAFVLK.T [573, 
592] 
R.GSNSAELSGAQEL
LK.V [604, 618] 
Apo-AIV O93601 
R.LVPFATELQAQLV
QDSQR.L [78, 95] 
K.LAPYADEVHQQIG
TNIR.E [111, 127] 
R.AQLSPLAQELQEA
LR.G [263, 277] 
 
Spearman’s correlations  r2-value p-value  
 *Peptide 1 and 2 0.4791 0.0178  
Gelsolin Peptide 1 and 3 0.3122 ns  
 Peptide 1 and 4 0.3035 ns  
 *Peptide 2 and 3 0.4800 0.0176  
 Peptide 2 and 4 0.3017 ns  
 ***Peptide 3 and 4 0.7391 <0.0001  
 ***Peptide 1 and 2 0.8162 <0.0001  
Apo-AIV **Peptide 1 and 3 0.5583 0.0056  
 Peptide 2 and 3 0.3557 ns  
Apo-AIV ELISA 
Peptide 1 0.3350 ns  
Peptide 2 0.2935 ns  
**Peptide 3 0.4575 0.00282  
 
Table 5.4: Quantotypic peptides targeted for apo-AIV and gelsolin quantification and results 
of Spearman’s correlations between each peptide and between each apo-AIV peptide and the 
results of the apo-AIV ELISA. ns = no significance, *<0.05, **<0.01, ***<0.001, ****<0.0001, 
(GraphPad Prism). For both proteins the quantitypic peptides are listed to the right in columns, 
underwhich the result of the Spearman correlation, undertaken between the peptides for each 
protein across all the samples to determine whether the peptide peak areas (intensities) for each 
peptides, tryptically digested from the target protein correlate with each other. Asterisks to the 
the left of the peptide correlation indications level of significance, with p-value and r2-value 
listed alongside.  
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Figure 5.9: Peak area (± SD of the mean) of apo-AIV and gelsolin for challenged (n=6 per time 
point) and control (n=6 per time point) groups over four time points, divided within bar by 
peptide. Significance is indicated by asterisk *<0.05, **<0.01. Colour of asterisks corresponds to 
same coloured peptide as indicated in legend. Data was analysed using Kruskal-Wallis with Dunn 
post test analysis to identify any significant effect of time for both control and challenged groups 
(analysed separately). At each timepoint a Mann-Whitney test was performed to identify any 
significant difference between the control and challenged birds at that time point (GraphPad 
Prism v5). Data presented in median with 25 to 75 percentile range. 
 
A Spearman‟s correlation was performed on the results of the apo-AIV ELISA and 
the peak area value of apo-AIV peptides within each sample. Spearman‟s 
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correlations were performed between each peptide to determine whether the 
quantitative measure of each peptide was relative to the others and as such a 
good quantotypic peptide. The results of these correlations are contained in 
Table 5.4 and Figure 5.10. There was no significant correlation between the apo-
AIV assay and peptides 1 and 2 from the quantitative proteomics. However for 
peptide 3 there was a highly significant correlation (p=<0.01). For the peptides 
themselves there was significance between 1 and 2 and 1 and 3 only.   
 
Figure 5.10: X-Y scatterplot of apo-AIV ELISA result (x-axis) and the peak area of each apo-
AIV peptide (y-axis) as determined by targeted SIM MS/MS (GraphPad Prism v5). 
 
5.3.4.2 Apolipoprotein AIV and gelsolin during an acute phase response  
To determine whether the APR had an effect on plasma concentrations of apo-
AIV or gelsolin, these proteins were also measured in the HAP, AP and NAP 
samples detailed in Chapter 4, using the same quantitative proteomic method. 
In the same samples apo-AIV was also measured using the ELISA. None of the 
peptides quantified for apo-AIV or gelsolin were found to be significantly 
different between the acute phase groups. When measured with the ELISA, the 
results were the same, no significant differences were observed between the 
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three acute phase groups. Figure 5.11 details the findings for the ELISA 
measurement. To investigate further apo-AIV in the context of the APR a 
Spearman‟s correlation between the of the immunoassay results of SAA, AGP, 
Ovt and Cp and the apo-AIV ELISA results from the intestinal challenge study was 
calculated and the results described in Table 5.5 and Figure 5.12. A significant 
correlation between apo-AIV and Cp was identified. No other significant 
correlations between apo-AIv and the other APPs were identified. 
 
Figure 5.11: Boxplot graph describing apo-AIV concentrations in HAP (n=2), AP (n=4) and NAP 
(n=4) groups. Data are presented in of median range. Data analysed using Kruskal-Wallis test 
(GraphPad Prism v5), no significance between the tree groups was detected. 
 
Apolipoprotein –AIV SAA AGP Ovt Cp 
Spearman’s correlation 
p-value 0.6606 0.1283 0.3363 0.0442 
r-value -0.06808 -0.2356 0.1484 -0.3049 
 
Table 5.5: The results of a Spearman’s correlation between apo-AIV and four APPs, measured 
by immunoassay (GraphPad Prism v5).  
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Figure 5.12: X-Y scatterplot of the APPs SAA, AGP, Ovt and Cp (y-axis) and apo-AIV ELISA (x-
axis) results for each sample from the intestinal challenge study (GraphPad Prism v5). *The 
concentrations of these APPs have been adjusted to fit all points clearly on graph: SAA = μg/ml, 
AGP*=mg/mlx10, Ovt=mg/ml and Cp*=mg/mlx10.  
5.3.4.3 Villin as a serum biomarker for intestinal health 
Western blotting was carried out on both plasma and intestinal lysate, with a 
view of demonstrating that the mouse anti-chicken villin antibody was specific 
and to determine whether it would validate the differential expression of villin 
in the intestine and also whether villin was detectable and quantifiable in the 
plasma. Figure 5.13, a western blot of pooled intestinal lysate derived from 
challenged and control samples over the four time points, shows clearly that this 
antibody works well with no non-specific binding evident with samples or the 
negative control. The day 12 control sample did not work well because of 
difficulties ascertaining protein concentrations in this lysate sample. In plasma, 
despite multiple attempts with a variety of plasma and serum samples, no villin 
was identified on western blotting. 
 
Figure 5.13: Western blot of pooled intestinal lysate from days 12 to 22 for challenged (Ch) 
and control (Cx) groups with mouse anti-chicken villin antibody. 
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5.4 Discussion  
 
5.4.1 The effect of an intestinal challenge on acute phase 
proteins 
The results from both the immunoassays and the quantitative proteomics show 
that the introduction of re-used poultry litter at day 12, was not sufficiently 
immunogenic to evoke a rise in the APPs SAA, Ovt, Cp, Apo-AI, Ttn and PIT54. 
For Hpx both peptides appeared to increase over time in both the control and 
challenged groups, with one of the two peptides measured found to be 
significantly higher between day 12 and 22 in the control group. An increase over 
time in both treatment groups was identified with the APP AGP, which increased 
in all groups over time regardless of treatment group (O‟Reilly, 2013). While no 
studies have sought to determine the normal age related changes in APP 
concentration in chickens, it is possible that an increase in some APPs during the 
early growth period is a normal finding in chickens. Most maternally derived 
antibodies for vaccinated parent flocks are depleted by day 10 (Gharaibeh et 
al., 2013), which together with the exposure to an environment that is becoming 
more microbiology complex could cause a normal, protective and non-
pathological rise in some APPs. For SAA there is also an upward trend in both 
treatment groups, which could possibly have become significant if the trial 
continued. A further consideration in this study is the experimental model 
employed. Adding re-used poultry litter, while providing immunogenic 
stimulation sufficient enough to cause decreased and uneven growth is a 
generalised challenge and was not sufficient enough to stimulate an APR. Other 
enteric models however could be more stimulatory to the APR. In an 
experimental model of sub-clinical necrotic enteritis, Cp was found to increase 
significantly in challenged birds compared to unchallenged controls, increasing 
significantly from 1 day to 4 days post-infection (Saleem, 2013). As such it is 
possible that APPs could be suitable biomarkers for some enteric diseases, 
though the behaviour of APPs in normal, healthy growing chickens needs to be 
established.  
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5.4.2 Apolipoprotein AIV 
The apo-AIV antibody was determined to be a highly specific antibody producing 
no background noise and excellent ELISA repeatability, detecting apo-AIV in both 
the plasma and intestinal lysate. While the apo-AIV bands were faint with the 
intestinal lysate, moving to an ECL method which uses the chemiluminescence 
reaction of HRP to detect the secondary antibody would allow this band to be 
visualised better on scanning. One notable downside of the apo-AIV ELISA was 
the high antibody concentration required for the ELISA to be optimal, which 
made it expensive to perform. It is possible that further work to optimise this 
ELISA to work equally well at with lower antibody concentrations may yield it to 
be a more financially viable ELISA which can be applied to large numbers of 
samples. Shotgun proteomic analysis revealed three apo-AIV peptides to be 
quantotypic and these were targeted not only in the intestinal challenge samples 
but also in the HAP, AP and NAP samples from Chapter 4, with a view of 
determining whether apo-AIV is an acute phase responder in chickens. There was 
no significant difference between the challenged and control groups or over 
time for both groups for peptides 1 and 2. Peptide 3 however was significantly 
lower in the challenged group at day 18, than at day 12 and day 15. The apo-AIV 
ELISA showed no significance between the challenged and control groups at each 
time point, though for the control group, apo-AIV was significantly higher at day 
15 than at day 12. When examining the correlations between the three peptides 
and the ELISA results, only peptide 3 was significantly correlated with the ELISA 
results (p=<0.01).  
There are a number of possible reasons as to why the results from the ELISA and 
the quantitative proteomics differed. The most likely explanation is the number 
of samples used in each of the analysis. The ELISA used all six replicates from 
both the challenged and the control group, while the quantitative proteomic 
study used only three because of resource constraints. This difference could 
affect the results. Furthermore, 25% of apo-AIV in plasma is reported to transfer 
to HDL, the rest found in the lipoprotein-free fraction of plasma (Vowinkel et 
al., 2004). It is possible that HDL binding could affect antibody binding, as it is 
reported to do so in SAA and thus affect the detectable levels of apo-AIV in the 
ELISA. 
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Despite the differing results, it is clear that the introduction of the litter had an 
effect over time on the apo-AIV concentrations of either group or both groups. It 
is also possible that both results are correct, given that they are not 
contradictory and a significant correlation, at least between one of the peptides 
and the ELISA was observed. In the control group the increase observed between 
days 12 and 15, if a normal finding at this age group, is absent in the challenged 
group. The presence of a higher apo-AIV is indicative of satiety, the ingestion of 
lipid having triggered the synthesis and release of apo-AIV. The increase seen in 
the control birds could be normal, indicative of the birds growing and feeding 
normally. The absence of a similar increase between the same time points in the 
challenged group could therefore be indicative of reduced feed intake, digestion 
or absorption which resulted in reduced plasma apo-AIV, the absence of a 
significant increase between days 12 and 15, the uneven growth observed at the 
later stages and the significant difference in pen weights between the two 
treatment groups at day 22. While not possible to draw too much from the 
quantification of just one peptide, the significant changes in and the correlation 
with the ELISA; together with the significant correlation of peptide 3 with both 
peptides 1 and 2, mean that the results of this peptide warrant discussion. From 
days 12 to 18 peptide 3 is significantly reduced in the challenge group, which 
when taken together with the rest of the results is further evidence that plasma 
apo-AIV was affected by the intestinal challenge.  
There is accumulating evidence indicating that lipoprotein metabolism is 
strongly influenced by inflammation, infection, and sepsis, with both sepsis and 
LPS specifically affecting plasma lipoprotein levels by modulating lipoprotein 
production and clearance through their effect on apolipoproteins, lipolytic 
enzymes, lipid transfer factors, and lipoprotein receptors (Berbée et al.,2005). 
Apolipoprotein AIV, confirmed to have antioxidant and anti-inflammatory 
activity (Vowinkel et al., 2004), varies in its response between species. In this 
study no significant differences between the three acute phase groups was 
detected, either by ELISA or using quantitative proteomics. Correlating the 
concentrations of apo-AIV with the APPs SAA, Ovt, AGP and Cp across all the 
samples in the intestinal challenge study revealed Cp and apo-AIV concentrations 
to be significantly correlated. In obese humans Cp is higher and concentrations 
of Cp are strongly correlated with serum triglyceride and cholesterol levels 
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(Cignarelli et al., 1996), which suggests that the correlation seen in this study 
could be associated with lipid absorption. Measuring apo-AIV using the 
established model of LPS injection to induce an APR would conclusively 
determine whether apo-AIV is an acute phase reactive lipoprotein in chickens. 
The evidence from this study however is suggestive of apo-AIV not being an APP 
in chickens. 
More research has still to be undertaken to fully understand the role of apo-AIV 
in both mammals and birds. The wide ranging functions performed by apo-AIV 
during homeostasis and during inflammation may make its use as a biomarker 
problematic. Transgenic apo-AIV negative mice show no significant abnormalities 
in lipid absorption or feeding behaviour and exhibit normal food intake, although 
they do take up more food after a long fast (Simon et al., 2011). Apolipoprotein 
AIV deficiency does not impact on total fat absorption instead there is an 
increase in secreted triglyceride-rich apoB-containing lipoproteins. Conversely 
the transgenic over expression of human apoAIV increases serum VLDL 
cholesterol and triglycerides in the fed state. The subtle effects of apoAIV 
deficiency or excess on lipid absorption appear discernible under certain 
conditions (Simon et al., 2011; Pan et al., 2013).  
Despite these concerns, apo-AIV may be a useful biomarker in particular areas of 
poultry research. Its role as a satiety protein in mammals is established and its 
measurement during feed trials or behaviour studies may be informative and 
elude to the physiological role apo-AIV has in birds. It has been shown that 
serum and intestinal apoAIV protein and mRNA levels exhibit circadian rhythms, 
being higher in the dark, indicating that apoAIV is involved in the diurnal 
regulation of lipid absorption and plasma lipid levels (Pan et al., 2013). If apo-
AIV in chickens is similarly affected the affect of rearing environment and 
lighting on feeding and growth could be more complex than previously 
understood. 
Further work is necessary to understand fully the role of apo-AIV in chickens. 
The circadian expression, its expression during feeding and effect on satiety 
together with its described role as an anti-inflammatory protein mean that there 
are many areas in poultry research where the measurement of this protein could 
be applied. The methods described here, particularly the ELISA, give a validated 
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mode of measurement by which the function of this protein and use as a 
biomarker in chickens can be fully determined. 
5.4.3 Gelsolin  
Villin was only detectable in pool-2 (AP pool) during the initial shotgun analysis 
and it was not possible to identify any quantotypic peptides and an alternative 
protein was selected for further assessment. As a member of the same actin 
binding family as villin, its role as a biomarker in humans and the identification 
of four quantotypic peptides, gelsolin was targeted as a possible biomarker. 
Despite its role in humans as a biomarker, no significance was identified in this 
study. Four quantotypic peptides from gelsolin were identified and quantified, 
both in the intestinal challenge study and in the three acute phase groups. 
Gelsolin was not found to be significantly affected by the introduction of the 
litter, or the time course of the study. Similarly there was no significant 
difference in the abundance of gelsolin in the three acute phase groups for any 
of the four peptides. It appears that in the chicken, gelsolin is not a biomarker 
of intestinal dysfunction or the APR.  
5.4.4 Villin  
Plasma villin was targeted for quantitative proteomics due to the changes seen 
in villin expression in the intestine in birds receiving re-used litter as an 
immunogenic challenge. Intestinal villin reduced significantly over time when 
compared to the unchallenged controls appearing to be negatively associated 
with the challenged group (O‟Reilly, 2013). It was the aim of this study to use 
quantitative proteomics, a sensitive method of detecting peptides and 
identifying proteins, to measure villin in the plasma in the birds from the same 
study to correlate the intestinal expression of villin and abundance of villin in 
the plasma. While villin is synthesised in the intestine, leakage of this protein 
into the systemic circulation resulting in detectable levels in the plasma and 
sera is reported (Dudouet et al., 1990). Unfortunately villin was only detected 
by shotgun analysis in one of the acute phase pools, pool-2 (AP). A mouse anti-
chicken villin antibody was used for western blotting of both intestinal lysate 
and plasma from the intestinal challenge study. While villin was clearly 
detectable in the intestinal lysate, it was not detectable in the plasma. The 
results of the western blots indicate that villin is unlikely to be present as a 
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plasma protein derived from the intestine in chickens that are healthy or receive 
re-used litter as an immunogenic stimulation. It was detected however in the 
plasma of the AP pool. Despite none of the six identified peptides being suitably 
quantotypic, its presence in the serum of chickens mean that it was detectable 
and is potentially measurable in some intestinal diseases or during an APR. In the 
intestinal challenge study, there was reduced expression in the intestine and 
villin may only be detectable (as it is in humans) in the plasma or serum during 
disease processes that increase the intestinal expression of villin. The AP pool 
was derived from on farm culled birds with high concentrations of AGP. It is 
possible that one or more of the samples in this pool originated from a bird with 
an intestinal disease that increased expression of villin. Using shotgun 
proteomics to identify villin for quantification would benefit from an enrichment 
process and given the high presence of villin in the intestine (as determined 
from the western blotting) the use of intestinal lysate for this purpose could 
allow many more peptides to be identified.  
Until villin is differentially identified in the plasma or serum it cannot be 
regarded as an intestinal biomarker. Its identification in the serum of an AP pool 
and its role in maintaining intestinal integrity and function mean that methods 
to quantify this protein in both intestinal lysate and the plasma of diseased and 
healthy chickens should be pursued. Its notable differential expression in the 
jejuna of chickens as a result of the introduction of re-used poultry litter and its 
identification in serum mean that villin should continue to be a protein of 
interest in chicken intestinal health.  
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Chapter 6 
Proteomic investigation of gastrocnemius tendon rupture 
in broiler chickens 
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6.5 Introduction 
 
Proteomic investigation of diseased and healthy tissue has lead to a major 
advance in biomarker identification and elucidation of the way in which 
infectious agents cause diseases in their hosts. Although this advancement is 
most notable in the area of human health and disease there is increasing 
momentum in the animal health sciences towards utilising proteomic methods to 
investigate animal diseases as well as identify biomarkers. Uncovering the 
proteomic changes between diseased and healthy tissues allows for a deeper 
understanding of animal diseases and the way different species respond to 
pathogens. Studying disease at the protein level is challenging and proteins, as 
mediators of phenotype, require complete understanding if the molecular 
mechanisms of disease are to be fully understood (Friedman & Lilley, 2008).  
Moving forward from plasma proteomics, methods can also be used on whole 
tissues that have been collected from experimental or clinically affected 
animals. Tissues are collected, homogenised and the proteins compared. 
Furthermore, advancement in the way tissues and cells are prepared has allowed 
for the identification of proteins in tissues or sub-cellular fractions by mass 
spectrometry methods (Lilley & Friedman, 2004). Sub-cellular fractionation is 
undertaken to reduce the protein complexity and to pre-select for biologically 
associated proteins. By separating cell organelles, cytosol and membranes, these 
different proteomes can be targeted, resulting in a less complex proteomic 
picture and identification of low abundant proteins (Miller, 2011).  
By applying proteomic approaches to the poultry sciences it is possible to closely 
detail bird responses to disease, dietary interventions and vaccination, and yield 
useful molecular information. This could assist with disease control by 
identifying the mechanisms by which pathogens infect birds and have their most 
deleterious effects.  
There are many areas within the poultry sciences that have harnessed the use of 
proteomics to investigate bird response to diseases, avian pathogens and poultry 
food products though none to date have examined the tendon proteome of 
chickens.  
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6.5.1 The Gastrocnemius tendon  
The gastrocnemius muscle (GM) consists of three muscle bellies that lie on the 
caudal aspect of the tibiotarsal bone. The GM is the main extensor of the 
intertarsal joint, inserting by a single tendon: the gastrocnemius tendon (GT) 
onto the hypotarsus, a proximal extremity on the plantar aspect of the 
tarsometatarsal bone (Figure 6.1) (King & McLelland, 1984).   
 
Figure 6.1: Hind limb anatomy of chicken (Duff & Randall, 1986). 
 
6.5.2 Rupture of the gastrocnemius tendon in chickens 
Rupture of the GT has long been recognised as a cause of lameness in broiler and 
broiler breeder chickens with both viruses and bacteria implicated in the 
aetiology (Duff & Randall, 1986). Avian reoviruses are regarded as the principal 
aetiological agent, causing tenosynovitis (Jones, et al., 1975, Jones et al., 
1981), inflammation of tendons, tendon sheaths, joints and synovial bursae (van 
Walsum et al., 1981), which causes the GT to rupture. Bacteria and 
mycoplasmas colonise tendons already damaged by viral tenosynovitis, with 
staphylococcal infection the most frequent predisposing factor causing 
secondary GT rupture (Duff & Randall, 1986; Crespo & Shivaprasad, 2011). The 
aetiological picture of GT rupture however is not completely clear.  
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Figure 6.2: Lame broiler chicken with ruptured GT (Crespo & Shivaprasad, 2011). 
Gastrocnemius tendon rupture has been found to occur with no evidence of 
tenosynovitis and studies involving viral isolates tend to induce lesions in 
tendons other than the GT and are not always re-isolated from lesions, it is 
therefore suggested that reoviruses do not provoke ruptures alone but do so with 
the involvement of other predisposing factors (Duff & Randall, 1986; Dinev, 
2008). Similarly Staphylococcus aureus, considered to be a secondary invader 
exacerbating a primary reovirus lesion, shows no virulence and tropism for 
tendon tissue in experimental studies (Kibenge et al., 1983). 
Gastrocnemius tendon rupture can occur without the presence of infectious 
agents with non-infectious causes, such as deficiency states, obesity, congenital 
causes, variations in tensile strength and glucoaminoglycan content hypothesised 
as causes of GT rupture (Duff & Randall, 1986; Dinev, 2008). Inherited factors 
resulting from genetic selection for fast growth and increased body weight are 
reputed to be contributing factors (Duff & Randall, 1986) as GT tendon rupture is 
seen predominantly in broiler chickens and broiler breeders. Studies into this 
predisposition are wide ranging and exacting, yielding mixed results. The 
presence of a avascular area of tendon just above the hock that is the usual site 
of rupture is a predisposing factor (Duff & Anderson, 1986) and the tensile 
strength of the GT, an indicator of predisposition to tenosynovitis, has been 
found to be markedly higher in birds resistant to tenosynovitis (white leghorn 
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hens) compared to those breeds that are susceptible (broiler breeder cocks). 
The GT of the resistant birds contain relatively more collagen with collagen 
fibres showing better alignment and a higher degree of cohesion, this finding 
particularly observable on the plantar side of the gastrocnemius tendon (van 
Walsum et al., 1981).  
The feeding practices of broiler breeders has also been associated with the 
incidence of GT rupture with studies finding birds fed ad libitum to be affected 
by GT rupture whereas birds feed restricted diets were not (Riddell, 1983). 
Conversely Duff & Anderson, (1986) found spontaneous GT rupture to occur in 
feed restricted birds. Regarding body weight, a case study of an outbreak of GT 
rupture in broiler breeder hens found no association between body weight and 
GT rupture, instead associating the GT rupture outbreak with a traumatic 
aetiology (Crespo & Shivaprasad, 2011). In one experimental study broilers are 
reported to spend 76% of their time lying down with time spent lying increasing 
significantly with age (Weeks et al., 2000). The effect of this behaviour and its 
effect on the GT has been investigated using an immobility model to investigate 
the effect of disuse on the mechanobiology of broiler GT, revealing that 
immobility reduces structural strength and toughness of the GT while increasing 
its material strength and toughness (Foutz et al., 2007).       
6.5.3 Difference Gel Electrophoresis (DiGE) 
There are a number of issues associated with 2DE such as reproducibility and 
analytical problems associated with gel to gel variation and a limited dynamic 
range, all of which severely hamper a quantitative differential display study 
(Lilley & Friedman, 2004; Friedman & Lilley, 2008). These issues have been  
circumvented with the development of 2D Difference gel electrophoresis (DiGE) 
technique, first described by John Minden‟s lab (Unlu et al. 1997). 
The DiGE method involves labelling proteins with spectrally distinct fluorescent 
dyes prior to electrophoretic separation. Cyanine dyes (CyDyes) are chemically 
modified so that they bind protein and co-migrate with the protein through the 
gel media (Westermeier, et al. 2008) and there are three spectrally distinct 
CyDyes available: Cy2, Cy3, and Cy5 (DiGE CyDye Fluor CyTM GE Healthcare). Up 
to three samples can be bound to each of the three CyDyes, these can then be 
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electrophoresed on a single gel. The gel is then scanned with a fluorescent 
imager at different wavelengths and each of the samples on the single gel are 
then visible separately. Having been ran together under identical condition with 
proteins migrating under the exact conditions the problems of reproducibility 
are overcome (Lilley & Friedman, 2004; Unlu & Minden, 2002; Westermeier et 
al. 2008). The sensitive binding of the Cy dyes to the protein together with the 
use of large 24 cm gels results in a more detailed proteomic image.  
6.5.4 Aims of this study 
This study aimed to detail the tendon proteome of broiler chickens and to 
investigate GT rupture in broilers. This GT rupture outbreak appeared 
unconnected to previously detailed risk factors and no infectious agents had 
been isolated from affected birds and tendons. The ruptured tendons used in 
this investigation had previously been examined histologically and a fibrinoid 
material was found to be associated with the ruptured tendons (R. Bailey Pers. 
Com.). Studies were undertaken to assess whether the tendon material was 
malleable to proteomic investigations and to optimise the buffers and extraction 
methods needed to extract soluble protein and separate the proteins according 
to their molecular weight and isoelectric point. A difference gel electrophoresis 
(DiGE) method was applied to improve the 2-D separation of the proteins within 
the tendons samples with a view of detailing the tendon proteome of chickens 
and establishing whether there are any differences between the proteomes 
which could elude to the reason as to why the incidence of tendon rupture 
appears to differ between different groups of birds. It was the hypothesis of this 
study that proteins, differentially abundant between healthy tendons, ruptured 
tendons and those from a line of birds with known incidence of tendon rupture, 
would be identified enabling further elucidation to the aeitiology of GT rupture 
in broilers.  
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6.6 Method 
 
6.6.1 Tendon samples 
To extract the soluble protein from the tendons, 50g of tendon was cut into 
small pieces and homogenised using a IKA T25 basic S1 ultra-turrax laboratory 
homogenizer  with 2.5ml of buffer (20mM Tris HCl • 4%CHAPS pH 8.2) for at 
17,000 m-1 for 1 minute (Figure 6.3). The tendon was left over night at 4°C to 
allow the solution to become liquid given the high level of foam formation 
throughout the homogenate. The homogenate was centrifuged to sink the large 
tendon pieces and the supernatant recovered. The protein concentration, 
determined using a Bradford assay as described in Chapter 2, Section 2.2.1.2 
found the protein concentrations of the tendons to be low in all samples. To 
increase the protein concentration the proteins within the supernatant were 
concentrated using Amicon Ultra centrifugal filters, which have a 3kDa 
molecular weight cut off  (UFC500324, Millipore (U.K.) Limited, Livingston, UK) 
according to the manufacturer‟s instructions.  
6.6.2 Sample preparation  
This study was conducted in association with Aviagen Ltd, a poultry breeding 
company from where all samples were sourced. The GT of four groups of 
chickens were studied: ruptured tendons (RT), intact tendon from the opposite 
leg of the ruptured tendon (IT), healthy tendons from a line of birds known to 
have incidences of tendon rupture (IR) and control tendons, from a line of birds 
with no history of tendon rupture (CX). The ruptured tendon samples were from 
broiler breeder farms. The GTs were recovered from culled birds unable to stand 
and walk the cause of which was found to be either uni- or bilateral GT rupture. 
Where the bird was found to be unilaterally affected, the opposite tendon was 
also sampled and allocated to group 2 (IT). Groups 3 and 4 were taken during 
routine post mortems of the two lines.  
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Figure 6.3: Preparing the tendon samples. Control tendons (a) and Ruptured tendons (b) whole 
before preparation. Control tendons (c) ruptured tendons (d) and known incidence of rupture 
tendons (e) after weighing. All tendon samples diced and in tendon buffer prior to homogenation 
(f).  
 
6.6.3 1D and 2D SDS PAGE (1DE/2DE)  
To compare the protein profiles of the different tendons, the tendon 
supernatant, diluted 1:10 with distilled H2O underwent the same preparation 
and separated using 1DE and 2DE as described in Chapter 2, Section 2.2.2.1 and 
where additional steps or deviations to these methods occurred, these are 
described here. For 2DE gels 180 µg of protein was diluted in rehydration buffer 
(BioRad 163-2106) and loaded onto 11cm 3-10 pH non-linear IPG strip (BioRad 
ReadyStripTM) and focused overnight (PROTEIN IEF cell protocol, BioRad). The 
method for the second dimension is the same as described in Chapter 2, Section 
2.2.2.1. 
a b 
f 
d 
e 
c 
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6.6.4 DiGE 
 
6.6.4.1 Sample preparation  
For this study the ruptured tendons (RT) (n=7), tendons from the line with a 
known incidence of rupture (IR) (n=6) and control tendons (CX) (n=6) were 
prepared as detailed above and pooled to form three pools. To remove organic 
salts and other impurities that would affect gel quality each of the three pools 
underwent an acetone precipitation. Pools were diluted 1:6 with DIGE lysis 
buffer (7M urea, 2M thiourea, 4% CHAPS 25mM Tris) to make a total volume of 
200µl. To this 800µl of 100% Acetone at -20°C was added and the samples 
incubated overnight at -20°C. The pools were briefly centrifuged to sink the 
hard visible pellet and the supernatant removed. The pellet was re-suspended in 
200µl of 80% Acetone at -20°C and the pellet vortexed. This was then 
centrifuged and the supernatant removed. This wash was repeated twice more. 
After the final centrifuge the pellet was re-suspended in 200µl lysis buffer. 
Following the acetone precipitation the protein concentration was measured and 
adjusted to a concentration of 5mg/ml using a Bradford assay.     
6.6.4.2 Preparative gels   
Protein spots were picked from the preparative gels. Loaded with a greater 
concentration of protein, these gels are matched to DiGE gel and spots removed 
for identification. The preparative gels were produced by mixing 500µg of 
protein from each three pool with 350µl of rehydration buffer (6M urea, 2M 
thiourea, 4% CHAPS, 0.002% (w/v) bromophenol blue) into which 3.5mg of 
dithiothreitol (DTT) and 1.75 µl IPG pH 4 - 7 buffer (GE healthcare biosciences 
17-6000-86) was added. These were mixed for 30 minutes, applied to a 24cm 4-7 
IPG strip (GE Healthcare Life Sciences 17-6002-32), covered with 1ml of mineral 
oil and focused to 8000 Volts over 27 hours. Following the focusing the IPG strips 
was washed in two IEF equilibrium buffer washes for 15 minutes each. The first 
with 10mg/ml DTT added and the second with 25mg/ml of 2-
Iodoacetamide added. For the second dimension the IPG strip was placed onto a 
24cm 12.5% SDS-PAGE gel with 1ml of 0.5% agarose with bromophenol blue was 
added on top of the gel to seal the strip to the gel and to serve as a dye front for 
monitoring the progress of the gel. The gel was ran in a ETTAN DALT system with 
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2% SDS running buffer at 1V per gel for 18 hours. The gels were fixed for 1 hour 
in 40% ethanol / 10%acetic acid, washed twice for 10 minutes in dH2O and 
stained in colloidal Coomassie for 48 hours. 
6.6.4.3 DiGE Gels  
The DiGE experimental protocol for the pools and gels are detailed in Figure 6.4. 
For each of the three tendon pools 50μg of tendon lysate was labelled to both 
Cy3 and Cy5 DiGE Fluors by mixing 50μg of tendon lysate with 1µl of Cy dye, 
these were incubated in the dark on ice for 30 minutes. To this 1µl of 10mM 
lysine was added to stop the Cy‟s reaction with the protein. For each gel a Cy3 
bound sample and a Cy5 bound sample were mixed together, as detailed in 
Figure 6.4, with rehydration buffer (6M urea, 2M thiourea, 4% CHAPS, 0.002% 
(w/v) bromophenol blue) into which 3.5mg of dithiothreitol (DTT) and 1.75 µl 
IPG pH 4 - 7 buffer (GE healthcare biosciences 17-6000-86) was added. These 
were mixed for 30 minutes, applied to a 24cm 4-7 IPG strip (GE Healthcare Life 
Sciences 17-6002-32), and focused, washed and ran in the second dimension as 
described for the preparative gels. Gels were scanned on a Typhoon 9400 laser 
scanner.  
6.6.5 Identification of proteins using mass spectrometry  
All spots that were matched from the prep gel to the DiGE gels were picked for 
protein identification with a view of detailing the tendon proteome of broiler 
chickens. Spots were removed from the preparative gel and underwent in gel 
digestion as described in Chapter 2, section 2.2.2.3.1. Similarly proteins were 
identified using nanoflow HPLC electrospray tandem mass spectrometry (nLC-
ESI-MS/MS), in Glasgow Polyomics, in collaboration with Dr R Burchmore. Details 
of which are described in Chapter 2, section 2.2.2.3.2. 
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Figure 6.4: Sample labelling and gel layouts. Cy Dye labelling of each of the samples and gel 
layout of each of the three gels containing two samples with opposite Cy binding. 
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6.3 Results 
 
6.3.1 1D SDS-PAGE (1DE) 
The 1D separation of the tendon lysate was successful, yielding clear bands 
showing good separation of the proteins by molecular weight. There appeared to 
be a high degree of homology within each of the groups (Figure 6.5). 
 
 
Figure 6.5:  Initial IDE gel of four tendon groups. This gel also includes haemolysed serum to 
confirm the suspicion that the large bands at 15 kDa in the ruptured tendons is indeed 
haemoglobin. Separation was achieved using a 4-12% CriterionTM Bis-Tris precast polyacrylamide 
gel (BioRad#345-0124). Protein is stained with Coomassie blue G dye (Sigma Aldrich). 
 
 
There were also differences between the groups, the most notable of which was 
intense staining band at 15 kDa for all the ruptured tendons. This was thought to 
be haemoglobin, from the haemorrhage and inflammation associated with the 
rupture of the GT. The RT showed gross haemorrhage (Figure 6.3) and this 
finding on the 1D gel was likely to be haemoglobin, the small molecular weight 
oxygen transport molecule found with red blood cells. To confirm this 
haemolysed serum was also ran on a 1D gel and a highly intense band was seen 
at the same molecular weight in the haemolysed serum, making it highly likely 
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that this band in the RT is haemoglobin. Gel to gel repeatability was poor for the 
larger molecular weight proteins within the samples and further gels (not shown) 
indicated that repeatability to be satisfactory if limited freeze thaw cycles were 
maintained and the supernatant was well mixed.  
6.3.2 2D SDS-PAGE (2DE) 
Using 2D SDS-PAGE to separate the proteins within the supernatant over both 
molecular weight and isoelectric dimensions was achieved. However, the 
resultant gels were less than optimal, with the gel shown in Figure 6.6 being a 
more successful example. 
 
 
 
Figure 6.6: 2DE gel of the tendon lysate. Separation was achieved over pi 3-10 and molecular 
weights of 10-200kDa. An IPG+1 TGX precast midi 4-12% acrylamide gel (BioRad#567-1081). 
Protein is stained with Coomassie blue G dye (Sigma Aldrich).  
 
Despite repeated attempts and changes designed to optimise the protocol, the 
repeatability was less than satisfactory. Gels frequently had poor isoelectric 
focusing resulting in streaking and the control group protein spots were 
extremely faint. Despite attempts to increase the protein concentration in these 
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samples stained spots appeared ill defined and flat. To overcome these 
difficulties, it was apparent that other 2D proteomic methodologies needed to 
be utilised.  
 
6.3.3 DiGE gels  
 
All the DiGE gels worked well, giving clear, well defined protein separation in 
both dimensions. Each of the samples, ran in duplicate with a different Cy dyes, 
exhibited good repeatability. The prep gels, were not as clear and showed some 
of the problems experienced with the previous 2D method. Figure 6.7 shows 
each of the DiGE images for each pool with both Cy3 and Cy5 dyes. Gel 1 (Figure 
6.7b and f) when scanned was much lighter resulting in less protein detail for 
both Cy dyes. The preparative gel for CX is shown in Figure 6.8 and this 
illustrates the less than optimal separation on 2DE gels with higher protein 
concentrations and Coomassie staining. This resulted in a limited number of 
spots matched to the DiGE spot maps and therefore identified. A total of 31 
spots were excised and identified across the 3 preparative gels. Table 6.1 details 
the mascot results for the 31 spots excised.  
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Figure 6.7: DiGE gels in Cy3 and Cy5 for each of the three groups RT (a, b) IR (c, d) CX (e, f). 
Separation was achieved by binding tendon lysate to Cy3 and Cy5 dyes. Proteins were separated 
over a pi range of 4-7 using 24cm IPG strip (GE Healthcare 17-6002-32) following reduction and 
alkylation steps. Following isoelectric focusing the proteins were separated in the second 
dimension on a 12.5% SDS-PAGE gel.   
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Figure 6.8: Preparative gel for CX. For separation 500μg of tendon was focused over a pi range 
of 4-7 using 24cm IPG strip (GE Healthcare 17-6002-32) following reduction and alkylation. The 
proteins were then separated in the second dimension on a 12.5% SDS-PAGE gel.  Following spot 
matching to the DiGE gels, spots were excised from the preparative gels, manually trypsin 
digested and identified using nanoflow HPLC-EPI-MS/MS with identities assigned using Mascot 
Science Daemon server to interrogate protein sequences in the NCBI Genbank database for 
Gallus gallus and boney vertebrates.       
  
ID Protein ID (Gallus gallus) 
NCBI 
Accession 
Mr (da) PI 
Peptide 
matches 
Coverage 
% 
Mascot 
score 
1 
14-3-3 protein episilon GI|55741616 29326 4.63 62 (27) 64 714 
14-3-3 protein beta/alpha GI| 57529350 28004 4.76 9 (3) 10 76 
2 
14-3-3 protein theta GI|55741594 28050 4.68 61 (32) 54 627 
14-3-3 protein beta/alpha GI|7529350 28004 4.76 9 (6) 35 204 
14-3-3 protein zeta GI|71897035 27929 4.73 30 (11) 33 188 
14-3-3 protein epsilon GI|55741616 29326 4.63 12 (5) 17 126 
14-3-3 protein eta GI|56119054 28495 4.18 14 (6) 21 118 
3 
14-3-3 protein zeta GI|71897035 27929 4.73 50 (28) 57 633 
14-3-3 protein beta/alpha GI|7529350 28004 4.76 33 (14) 41 308 
14-3-3 protein theta GI|55741594 28050 4.68 28 (13) 39 269 
14-3-3 protein eta GI|56119054 28495 4.81 18 (6) 23 160 
14-3-3 protein epsilon GI|55741616 29326 4.63 12 (4) 14 79 
4 
Vimentin GI|114326309 53167 5.09 73 (35) 38 500 
Desmin GI|118453 53304 5.45 5 (2) 6 114 
5 
Vimentin GI|114326309 53167 5.09 32 (19) 20 427 
Desmin GI|118453 53304 5.45 7 (2) 4 88 
6 Vimentin GI|114326309 53167 5.09 31 (22) 29 534 
7 
Vimentin GI|114326309 53167 5.09 60 (44) 31 852 
Desmin GI|118453 51689 5.3 11 (5) 7 120 
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8 Vimentin GI114326309 53167 5.09 6 (4) 8 110 
9 
Vimentin GI114326309 53167 5.09 33(24) 26 529 
tubulin beta-2 chain GI|363730444 50377 4.78 2(1) 6 95 
Desmin GI|118453 51689 5.3 4 (2) 7 70 
10 
Full=Myosin regulatory light chain 2B, 
cardiac muscle isoform 
GI|143811419 18834 4.85 23 (15) 66 339 
11 Vimentin GI|114326309 53167 5.09 25 (17) 24 482 
12 Vimentin GI|114326309 53167 5.09 24 (16) 22 322 
13 
myosin light chain 1, cardiac muscle GI|45384044 22096 5.22 38(24) 60 623 
myosin a1 light chain (partial) GI|212347 19525 4.72 7 (3) 24 129 
myosin alkali light chain GI|212395 17200 4.63 8 (3) 16 129 
ras-related protein R-Ras2 GI|57530014 23508 5.74 3 (2) 18 111 
apolipoprotein A-I GI|211159 30673 5.58 5(3) 21 102 
NADH dehydrogenase [ubiquinone] 
iron-sulfur protein 8, mitochondrial 
GI|118090950 24379 5.84 4 (2) 24 71 
14 
rho GDP-dissociation inhibitor 1 GI|124249432 23317 5.22 26(8) 58 251 
THY1 GI|30316401 18391 7.6 3 (2) 24 60 
immunoglobulin lambda chain 
variable region [Gallus gallus] 
GI|1536804 10883 4.72 2(1) 23 50 
15 
apolipoprotein A-I GI|211159 30673 5.58 25 (16) 70 1105 
Ig light chain precursor V-J region – 
chicken 
GI|104728 22769 5.36 9(3) 24 90 
PREDICTED: gamma-interferon-
inducible lysosomal thiol reductase 
GI|363743852 28395 5.56 2(2) 12 80 
16 
myosin light chain 1, cardiac muscle GI|45384044 22096 5.22 57 (32) 76 1085 
heat shock protein beta-1 GI|45384222 21715 5.77 7(4) 38 120 
apolipoprotein A-I GI|211159 30673 5.58 7(3) 26 119 
calpain small subunit GI|2506056 24014 5.05 3(3) 20 109 
17 
 
Chain A, Transthyretin GI|1633502 14209 5.10 30 (19) 76 405 
15 kDa selenoprotein precursor GI|143771685 18272 5.28 1(1) 10 110 
Chain B, R-State Form Of Chicken 
Hemoglobin D 
GI|4699641 16496 8.85 7(4) 43 101 
18 
Chain A, The Siderocalin Ex-Fabp 
Functions Through Dual Ligand 
Specificities (fatty acid binding 
protein) 
GI|365813051 18276 5.94 24(16) 53 527 
marker protein(fatty acid binding 
protein) 
GI|211503 20204 5.37 21(13) 41 422 
19 
PREDICTED: cartilage oligomeric 
matrix protein 
GI|118103279 86065 4.27 79(34) 47 874 
PREDICTED: prolargin GI|118102574 43288 9.11 10(4) 23 137 
decorin precursor GI|71896943 40061 8.71 5(1) 17 88 
20 
apolipoprotein A-I GI|211159 30673 5.58 93(47) 71 1063 
Ig light chain precursor V-J region – 
chicken 
GI|104728 22769 5.36 6(2) 24 78 
PREDICTED: cartilage oligomeric 
matrix protein 
GI|118103279 86065 4.27 3(2) 4 64 
21 
Chain A, Crystal Structures Of 
Chicken Annexin V In Complex With 
Ca2+ (Annexin A5) 
GI|62738641 36159 5.61 61(43) 60 856 
F-actin capping protein subunit beta 
2 
GI|291084676 30820 5.69 7(4) 33 121 
22 
fatty acid-binding protein, adipocyte GI|45383556 14999 6.34 41(21) 81 651 
adipocyte-type fatty acid binding 
protein 
GI|33668025 5759 9.37 10(6) 78 151 
Chain B, R-State Form Of Chicken 
Hemoglobin D 
GI|4699641 
 
16496 8.85 3(2) 24 84 
23 fatty acid-binding protein, adipocyte GI|45383556 14999 6.34 30(14) 81 509 
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Chain B, R-State Form Of Chicken 
Hemoglobin D 
GI|4699641 16496 8.85 11(8) 49 231 
adipocyte-type fatty acid binding 
protein 
GI|33668025 5759 9.37 8(4)  220 
epsilon globin GI|71895591 16469 9.2 7(4) 34 157 
24 
Chain A, Transthyretin GI|1633502 14209 5.10 14(8) 70 226 
Chain B, R-State Form Of Chicken 
Hemoglobin D 
GI|4699641 16496 8.85 6(5) 50 112 
25 
alpha-enolase GI|46048768 47617 6.17 147(75) 70 1943 
hypothetical protein RCJMB04_24e12 GI|53135040 23833 6.97 71(42) 63 1046 
beta-enolase GI|46048765 47566 7.28 44(21) 23 638 
pre-fibrinogen alpha subunit GI|732995 56766 6.82 15(5) 35 206 
PREDICTED: cytochrome b-c1 
complex subunit 1, mitochondrial 
GI|50754375 53410 6.58 10(5) 25 169 
elongation factor 1-alpha 1 GI|54020687 50449 9.10 19(7) 30 167 
ecName: Full=Fibrinogen beta chain GI|267844833 53272 7.18 21(6) 47 156 
hemoglobin subunit alpha-A GI|2829707 15533 8.54 12(6) 65 136 
6-phosphogluconate dehydrogenase, 
decarboxylating 
GI|57529439 53771 6.51 6(3) 16 129 
26 
apolipoprotein A-I GI|211159 30673 5.58 221(82) 81 1517 
alpha-enolase GI|46048768 47617 6.17 5(2) 10 106 
Ig light chain precursor V-J region – 
chicken 
GI|104728 22769 5.36 12(4) 24 71 
Ig light chain GI|212060 23868 5.34 12(4) 22 71 
PREDICTED: gamma-interferon-
inducible lysosomal thiol reductase 
GI|363743852 28395 5.56 2(1) 12 49 
27 
apolipoprotein A-I GI|211159 30673 5.58 192(74) 74 1630 
cathepsin B precursor GI|46195455 38475 5.74 8(7) 25 248 
Ig light chain precursor V-J region – 
chicken 
GI|104728 22769 5.36 11(4) 24 110 
Ig light chain GI|212060 23868 5.34 10(4) 22 110 
alpha-enolase GI|46048768 47617 6.17 2(2) 6 86 
immunoglobulin lambda chain 
variable region 
GI|1536804 10883 4.72 4(2) 38 70 
28 
serum albumin precursor GI|45383974 71868 5.51 244(72) 65 1557 
heat shock cognate 71 kDa protein GI|45384370 71011 5.47 11(55) 22 128 
heat shock protein 70 GI|30962014 70098 5.56 10(2) 15 77 
29 
actin, cytoplasmic type 5 GI|56119084 42151 5.3 128(43) 76 915 
actin, cytoplasmic 1 GI|45382927 42052 5.29 122 (43) 72 915 
actin, alpha cardiac muscle 1 GI|118405200 42334 5.23 93(4) 46 813 
actin, alpha skeletal muscle GI|71894831 42366 5.23 92(38) 46 784 
actin, aortic smooth muscle GI|71895043 42367 5.23 80(36) 46 720 
PREDICTED: actin, alpha skeletal 
muscle B isoform 2 
GI|50803534 42386 5.16 72(32) 38 650 
serum albumin precursor GI|45383974 71868 5.51 20(6) 37 176 
phosphoglycerate kinase GI|45384486 45087 8.31 6(4) 18 127 
beta-actin GI|348167222 16060 5.04 8(3) 26 90 
30 
Vimentin GI|114326309 53167 5.09 212(85) 66 1615 
creatine kinase M-type GI|45382875 43529 6.5 13(7) 25 241 
phosphoglycerate kinase GI|45384486 45087 8.31 9(5) 23 170 
beta-actin GI|63018 42080 5.29 17(6) 34 162 
Chain B, Crystal Structure Of The 
Chicken Actin Trimer Complexed 
With Human Gelsolin Segment 1 
GI|28373640 
 
42340 5.17 13(4) 24 125 
PREDICTED: actin, alpha skeletal 
muscle B isoform 2 
GI|50803534 42386 5.16 11(3) 26 113 
31 
Vimentin GI|114326309 53167 5.09 33(26) 38 753 
hemoglobin subunit alpha-A GI|52138655 15533 8.54 11(7) 57 208 
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alpha-globin-A GI|211114 15492 9.1 11(5) 57 142 
apolipoprotein A-I GI|211159 30673 5.58 5(3) 23 113 
 
Table 6.1: Proteins identified in DiGE gels and picked from preparative gels (Figures 6.7 and 
6.8). Spots were excised from the gel trypsin digested and identified using nanoflow HPLC-EPI-
MS/MS with identities assigned using Mascot Science Daemon server to interrogate protein 
sequences in the NCBI Genbank database for Gallus gallus and boney vertebrates. Both NCBI and 
where Uniprot identifications are listed (immunoglobulins are not listed in Uniprot). The protein 
score is the sum of the highest ions score for each distinct sequence. The first number under 
matches is the count of MS/MS spectra that have been matched to peptides from this protein. 
The matches shown in the parenthesis indicating unique matches (scores above the significance 
threshold). The sequences column is the count of matches to distinct peptide sequences, the 
number in parenthesis is the count of sequences with significant matches (Matrixscience.com). 
The coverage percentage is proportion of the protein‟s entire sequence identified. 
 
Figure 6.9 details the protein results on a typical spot map to give a clearer 
picture of where the identified proteins are on the gel spot map and to detail 
the chicken GT proteome.  Figure 6.10 is the same image with the spot numbers 
shown. 
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Figure 6.9: Proteome of chicken gastrocnemius tendon (white labels are used for clarity 
only). Table 6.1 lists and details the proteins identified from the tendon 2D DiGE gel, Figure 6.10 
is the same gel with numbered labels. Separation was achieved by binding tendon lysate to Cy3 
and Cy5 dyes. Proteins were separated over a pi range of 4-7 using 24cm IPG strip (GE Healthcare 
17-6002-32) following reduction and alkylation steps. Following isoelectric focusing the proteins 
were separated in the second dimension on a 12.5% SDS-PAGE gel. Protein identifications were 
made from spots identified in the DiGE gels and matched from the preparative gels (Figures 6.7 
and 6.8). Excised spots were trypsin digested and identified using nanoflow HPLC-EPI-MS/MS with 
identities assigned using Mascot Science Daemon server to interrogate protein sequences in the 
NCBI Genbank database for Gallus gallus and boney vertebrates.  
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Figure 6.10: Proteome of chicken gastrocnemius tendon (as shown in Figure 6.9) with 
numbered labels that correspond to proteins listed in Table 6.1. 
 
6.3.4 Proteins of interest  
 
To determine whether there were any differences in the proteomes of the RT, IR 
and CX tendons visual inspection of the gels was undertaken as statistical 
analysis could be applied owing to absence of standards on the gels. Despite this 
two areas of difference between the RT gels and the gels of the IR and CX were 
clear and are detailed in Figures 6.11 and 6.12.  
The entire left quarter of the gel is highlighted in Figure 6.11. The most intense 
protein spot / spot cluster is spot 30, identified with a very high score as 
vimentin. Spots 1,2 and 3 are identified as 14-3-3 proteins, of various isoforms 
and spots 4 – 12 at a lower molecular weight were also identified as vimentin 
(apart from spot 10). It is clear from the gels that the spots identified as 
vimentin, both in the major spot and at the lower molecular weights are 
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distinctly lighter in the RT gels compared to the IR and CX gels. Unfortunately 
the Cy3 gel for RT was gel 1 which as detailed early scanned at a lighter 
resolution, however even on this gel on which the CX sample was also ran, 
showed the vimentin spots were much more intense than on the RT gel. In Figure 
6.12 Apolipoprotein A1 (ApoA1) was found in all 4 spots detailed in Figure 6.12, 
with mascot scores the highest in spots 15, 26 and 27.  
 
Figure 6.11: Significant area of interest is spot 30, showing a clear difference in expression 
between RT and IR and CX. The large mass of spots was identified as vimentin. The middle spot 
cluster was identified as 14-3-3 protein epsilon and the lower cluster as predominantly vimentin. 
Both the large top spot mass and the lower cluster of spots identified as vimentin are reduced in 
the RT. 
 
251 
 
 
Figure 6.12: Area of interest and mascot results from the mid-section of the gel. Clear 
difference between the apo-AI spots between RT and CX and IR are evident.  
Looking at the gene ontologies (GO) for the proteins identified in the tendon 
proteome, Figure 6.13 compared molecular function, cellular component and 
biological process, to give an overall view of the proteins identified with mass 
spectrometry, with an large number of the identified proteins functioning as 
binding proteins.  
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Figure 6.13: Gene ontology view of proteins identified in the tendon proteome (GO terms 
and data: UniProt.org). For all proteins identified from spots excised from the preparative gels, 
the GO terms were determined and compared using UniProt‟s GO tool for comparison of 
molecular function, cellular component and biological regulation of proteins.  
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6.4 Discussion 
 
6.4.1 Proteomic methods targeting tendon proteins 
Very few proteomic studies of tendons have been undertaken, and there are 
none reported in chickens. Of the proteomic studies available, comparisons are 
difficult because studies have been in vitro or used in vivo models of healing. 
Collagen, the main structural protein of connective tissue, is the most abundant 
protein in tendons forming 70-80% of the dry matter, with type I collagen 
forming 95% of the total collagen content and 5% consisting of type III and V 
collagens (Moussa et al., 2008). Despite its abundance no collagen proteins were 
identified in any of the spots identified by mass spectrometry. This is due to the 
insolubility of collagen protein and a preparation buffer and homogenisation 
method that targeted only the soluble proteins. As a result it was the non-
collagenous proteins that were identified in this study. Non-collagenous proteins 
are derived from the extra cellular matrix (ECM). The ECM of the tendon 
contains proteoglycans and their associated glycoaminoglycans chains and other 
non-collagenous proteins. The non-collangenous matrix proteins provide the 
interfibrillar links that bind the collagen fibrils one to another in a molecular 
bridge allowing force transfer (Moussa et al., 2008).. For the purposes of this 
study it was the non-collagenous proteins which are of special interest, as it has 
previously been established that the GT of birds resistant to GT rupture contain 
relatively more collagen with collagen fibres showing better alignment and a 
higher degree of cohesion (van Walsum et al., 1981). Other areas of proteomic 
research are hampered by the presence of highly abundant protein, so it is 
arguably preferable to have a method that by design and the nature of the 
target tissue results in the exclusion of the most abundant proteins.  
The initial 2DE utilising the BioRad system with Coomassie staining was not 
successful, Figure 6.6 being a single good example of a gel produced using this 
method. Gels produced lacked repeatability the same samples producing vastly 
different results often with streaking or no result at all. The proteomic analysis 
of tendon is known to be problematic, even with the absence of insoluble 
protein such as collagen, the presence of highly anionic macromolecules causes 
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extreme charge density that can interfere with protein separations (Önnerfjord 
et al., 2012; Little et al., 2014).  
Other studies have employed better methods to target this tissue, such as in 
Little et al., (2014), where heating, pulverisation and sonication were used and 
trypsin digestion of the tendon protein took place in situ, resulting in 100% 
solubilisation of the protein before identification took place using quantitative 
two-dimensional liquid chromatography – tandem mass spectrometry. More 
proteins, including the insoluble proteins were therefore identified in this study. 
When investigating the literature, only Sato et al., (2012), for a preliminary 
study, has targeted the tendon proteome using the DiGE method. The current 
study was successful in identifying DiGE as a suitable method for identifying and 
mapping proteins within a tendon proteome finding separation of the proteins to 
be very good. The preparative gels, from which the spots were picked however, 
were subject to the same limitations as the SDS-PAGE gels, and as such matching 
to the DiGE gels was limited, resulting in many DiGE spots not being identified. 
The difference in the results of these two methods using the same tendon 
samples, make it highly probable that protein concentration is also a factor, 
with the lower concentration used on the DiGE (a tenth of that used on the 
preparative gel) resulting in much better separation. Any future studies could 
utilise the alternate DiGE method of loading additional unbound protein (which 
would normally be loaded on to a preparative gel) alongside the Cy-bound 
protein onto a DiGE gel. This would allow for Coomassie staining after the DiGE 
gel had been scanned and spots picked from the original gel, thus avoiding any 
possible problems with a large protein concentrations and also spot matching.  
6.4.2 The tendon proteome 
As a preliminary study which excluded a Cy2 labelled standard, no statistical 
analysis could be performed yet it was clear that parts of the RT proteome 
differed with differential expression of a number of spots highlighted in Figures 
6.11 and Figure 6.12. Figure 6.11 shows two areas with multiple identifications 
for vimentin: the large mass of protein labelled as spot 30 and a cluster of spots 
below it (spots 4-9 and 11-12). In both areas the vimentin spots are much 
smaller in the RT indicating reduced expression. These two areas flank a cluster 
of spots (1-3), which were all identified as various isoforms of the protein 14-3-
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3, a class of highly conserved proteins involved in regulating signal transduction 
pathways, apoptosis, adhesion, cellular proliferation, differentiation and survival 
(Mhawech, 2005). Protein 14-3-3 does not differ in intensity between the 
different tendon groups, adding weight (in the absence of internal standard) to 
the differential expression of vimentin.  
Vimentin is the major intermediate filament (IF) protein found in mesenchymal 
cells and is frequently used as a developmental marker of cells and tissues. 
Intermediate filaments represent the main cytoskeletal and nucleoskeleton 
systems found in virtually all vertebrate cells (Eriksson et al., 2009). Vimentin 
sequences show a high degree of homology among species implying important 
and evolutionary conserved physiological roles. Vimentin is involved in several 
critical cellular processes related to the organization and regulation of proteins 
involved in adhesion, migration, and cell signalling (Eriksson et al., 2009). 
Vimentin also has a role in the mechanotransduction of shear stress and studies 
on resistance in arteries has shown vimentin to be sensitive to mechanical 
stresses, including shear stress (Henrion et al., 1997). This, together with what 
appears to be differential expression between the tendons in this study, points 
towards a possible role in the aetiology of ruptured GT. Desmin, also identified, 
alongside vimentin, in spots 4, 5, 7 and 9, is also a IF found at myotendinous 
junction (Tidball, 1992).  
Heat shock protein was identified in two spots: 16 and 28. Spot 16 as detailed in 
Figure 6.12 showed differential expression between RT and CX and IR. Spot 28 is 
a large mass of spots that dominants all the gels but on visual inspection it does 
appear less intense in the RT compared to the other two groups. Heat shock 
proteins are a group of proteins synthesised in response to physical, chemical or 
biological stresses, including heat exposure (Gu et al., 2012). They are 
molecular chaperones responding to stress related events in a variety of organs. 
Heat shock proteins protect against environmental stresses and are considered 
important for adaption to environmental changes (Otaka et al., 2009). Heat 
shock proteins protects against ischemic and reoxygenation mediated injury and 
inhibits apoptosis induction (Cohly et al., 2002). Jielile et al., (2011) found that 
heat shock protein increased in expression between early motion rabbits and 
immobile rabbits post gastrocnemius tenotomy, and attribute this to the 
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increase in cellular stress. Heat shock B1 is also believed to be a collagen 
binding chaperone involved in the maturation of collagen (Jielile et al., 2011).  
As a vascular tissue, proteins from blood bathe tendon or ligament extracellular 
matrix in intravascular and extravascular interstitial fluid, but are not typically 
interrogated as part of tendon or ligament extracellular matrix. Nonetheless, 
they may play a role in tendon and ligament homeostasis and disease and may 
be enriched in different tendon and ligament structures (Little et al., 2014). 
Albumin is present in serum at concentrations of 20–50 mg/mL, and is one of the 
most abundant blood proteins, thus as a conservative estimate any blood, serum 
or amyloid protein present in a vascularised tissue at similar or higher levels 
than albumin would be expected to be preferentially enriched within the tissue 
(Little et al., 2014). In the current study albumin was identified in spots 28 and 
29. Spot 28 is a large band rather than a spot with albumin forming the main 
protein, with a high mascot score of 1557, and as such it is clear that blood 
components form part of the tendon proteome in this study. Differences in blood 
derived proteins were expected between RT and other tendons given the degree 
of tissue haemorrhage seen in the RT during preparation (Figure 6.3.a.) and spot 
(band) 28 is larger in the RT tendons compared to the RT and IR tendons. Jielile 
et al., (2011) in a study of post tenotomy healing in rabbit GT, found albumin 
was increased in expression in the immobile group compared to the early motion 
group. Should the current study be repeated in addition to the inclusion of Cy2 
bound internal standards to allow for statistical analysis, when comparing groups 
the quantitative differences in the GO terms relating to blood/plasma between 
two or more groups in relation to albumin could be applied as described in Little 
et al., (2014) to give an indication as to what blood proteins are present at 
enriched concentrations within the tendon. In addition to albumin, 
transthyretin, haemoglobin and fibrinogen were all identified in the tendon 
proteome. 
Of the spots shown in Figure 6.12 two large spots, 26 and 27 in the RT appear 
absent in the IR and CX tendons. Apolipoprotein A1 (ApoA1) was found in all 4 
spots detailed in Figure 6.12, with mascot scores the highest in spots 15, 26 and 
27. Spots 26 and 27 are large spots and also contain α-Enolase, a protein not 
identified in the IR and CX tendons. Apolipoprotein A1, a major component of 
high density lipoprotein (HDL) in plasma, is involved in lipid transport and 
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metabolism. Apolipoprotein A1 has anti-inflammatory properties (Kravitz et al., 
2005) and in avian species ApoA1 is expressed in numerous other tissues other 
than the liver, the primary site of synthesis in mammals (Doherty et al., 2004). 
ApoA1 is thought to act as a local lipid transporter (Doherty et al., 2004) and its 
presence in the RT could be due to the increase in cellular debris, brought about 
by the damaged tissue. α-Enolase, a highly conserved glycolytic enzyme, is a 
multifunctional protein that serves as a plasminogen receptor on the surface of a 
variety of haematopoetic, epithelial and endothelial cells playing an important 
role in the intra-vascular and pericellular fibrinolytic system. Additionally it 
functions as a heat shock protein, binds cytoskeletal and chromatin structures 
playing a crucial role in transcription and a variety of pathophysiological 
processes. It also increases in a variety of auto- immune diseases (Pancholi, 
2001). Enolase enzymes have not been identified as being differentially 
expressed in other studies of the tendon proteome. 
Annexin is a calcium-dependent phospholipid-binding protein that plays a role in 
the regulation of cellular growth and in signal transduction pathways and is also 
involved in a number of biochemical processes, including cell proliferation, ion 
channel activation, and cell– cell interactions (Jielile et al., 2011). Annexin has 
been identified as being associated with tendinopathy and is known to be 
involved in the proposed mechanisms of tendinopathy, including hypoxia or 
apoptosis (Little et al., 2014). Annexin was identified in this study, but it was 
unclear whether there were any differences between the groups.  Annexin was 
found to be higher in the early motion group than the immobilised group in 
Jielile et al., (2011), the authors postulating whether the presence of annexin 
A2 in the samples of the early motion group could facilitate proliferation of 
tendon cells and an increase in the circumference of collagen fibers and as such 
be involved in many normal and pathological processes which accelerate GT 
healing (Jielile et al., 2011). 
Other proteins that appear differentially expressed between groups include 
cathepsin B precursor, found exclusively in the RT group. Cathepsin B is a papain 
family cysteine protease that is normally located in lysosomes where it is 
involved in maintaining normal metabolism of cells. This protease has been 
implicated in many pathological conditions including tumour formation, osteo- 
and rheumatoid arthritis (Yan & Sloane, 2003). Myosin light chain 1 was 
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identified in spot 16 on the IR and CX gels but appeared absent in RT gels. 
Myosins are a large superfamily of proteins that interact with actin, hydrolyse 
ATP to produce movement (Sellers, 2000).  
To expand this investigation beyond this preliminary study the protocol would 
benefit from a number of changes in addition to the ones already described. A 
more localised approach, to focus on the fibrocartilage attachment area at the 
hypotarsus where the GT rupture occurs may yield more informative results. 
Further DiGE work should involve more replication and the use of internal 
standards that would allow the associated DiGE software to determine which 
proteins are statistically different between groups, and this may allow for subtle 
differences between the gels to be identified. With a view of identifying 
proteins that increase the risk of GT rupture, concentrating on the IR and CX 
tendons may be preferable, so as to exclude proteins present as a result of the 
traumatic tissue damage caused by GT rupture. As described earlier the 
adoption of a protein extraction method that achieves 100% solubilisation of the 
tendon protein could be advantageous, as would a comparative study to 
determine whether leaving the insoluble protein out of the study does in fact 
enhance protein identification of less abundant proteins. The results of this 
study, as well as identifying problems with and improving the described method 
does at this preliminary stage suggest that differentially expressed proteins, 
particularly vimentin play a role in the aetiology of GT rupture in broiler 
chickens.  
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Chapter 7 
General Discussion 
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The aims of this thesis were outlined in Chapter 1 and the results of the work 
discussed in each of the chapters that followed. This chapter will summarise and 
discuss the most significant of these findings and elaborate on possible areas of 
future study.  
 
Chickens are the most populous farm animal in the word, with an estimated 
worldwide flock of 21 billion (Blake & Tomley, 2014). The human world 
population is growing, there is a demand for more affordable protein rich foods 
in regions with increasing population and this is a major driver for this change 
(Lassaletta et al., 2014). Expansion of the poultry industry is predicted to 
continue for at least 30 years with Africa and Asia accounting for the most 
growth (Blake & Tomley, 2014). Management practices, biosecurity, nutritional 
improvements, R&D investment and advancements in genomics enable the 
poultry industry to maintain and grow their industry in a challenging economic 
and microbial environment. Commercial poultry production is only possible with 
the support of effective pathogen control, chemoprophylaxis and vaccination 
(Blake & Tomley, 2014). The trend of increased consumer demand in an era 
where antimicrobial prophylaxis and treatment is under close scrutiny requires 
novel strategies to maintain flock health and combat disease. Bacteria and 
viruses are the major variables, constantly evolving to cause antimicrobial 
resistant pathogens that lead to outbreaks of disease that are difficult to treat. 
Low level, sub-acute disease with non-specific, often undiagnosed causes can 
greatly affect bird health and growth, and impact enormously on productivity. 
 
The concept of this research was borne out of a need to identify ways in which 
the early IIR of the chicken could be measured and assessed. As an early non-
specific response the APR is a highly suitable target for biomarker investigation. 
While the immune system of the broiler chicken has been a long standing area of 
research interest, translating this interest into actionable methods that can be 
applied to diagnostics or as a tool for selection have been shortcoming. As 
quantifiable mediators of the APR, APP have been studied alongside disease 
research in chickens, however the limited availability of anti-sera and ELISAs has 
resulted in a lot of information on only a few APPs. 
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Many of the studies follow the same approach, measuring APPs in specific 
disease models or injecting birds with LPS. While these deliver informative 
results initially, the publications regarding APPs in chickens over the last 10 
years have offered no new insights into identifying and confirming other APPs in 
chickens or methods to measure them. No studies have measured any APP in 
normal chickens from commercial farms and none have sought to measure APPs 
during generalised poor growth and performance as a method to characterise 
general chicken robustness. For APPs to be used diagnostically and as selection 
tools then this information is needed in order to address these data deficient 
areas.  
  
The lack of baseline data was addressed with the first study measuring PIT54 and 
Cp in healthy and culled birds from a commercial flock. Baseline data has 
previously been derived from the control groups of challenge studies and 
therefore not representative of normal populations. The results for the healthy 
birds were 12 and 9 fold lower serum concentrations for PIT54 and Cp 
respectfully than the average reported control results in published reports. It 
would appear that healthy chickens on commercial units have lower baseline 
concentrations of PIT54 and Cp than what would be deduced from the published 
data. The low concentration of PIT54 and Cp was also seen in a number of 
samples and studies that were investigated during this research. As minor APPs 
with small fold changes, the concentrations of these APPs are low and 
sometimes undetectable. The PDP oxidation method for measuring Cp was 
problematic owing to the relatively quick rate of oxidation observed, which 
limited the number of samples measured at any one time and also increased the 
inter-assay CV to over 20% which is undesirable. 
 
While measuring other more moderate and major APPs may reveal more 
information, as a starting point this was informative. This area would benefit 
from being revisited, measuring a wider variety of APPs on a larger numbers of 
samples. This type of study will always be difficult owing to the fact that 
producers are unwilling to sacrifice healthy birds. Moving sampling to the 
slaughterhouse would overcome this issue, yet transport stress is known to 
increase APPs in pigs (Piñeiro et al., 2007) and as such would not be reflective of 
normal concentrations.  
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Measuring APPs in broiler chickens at differing ages is suggested for future 
studies. Measuring APPs by both immunoassay and quantitative proteomics in 
chickens challenged with re-used litter from day 12 to 22 found that AGP 
increased significantly from day 12 to 22 in all chickens, irrespective of 
challenge (O‟Reilly, 2013). The present study found SAA and Hpx to increase 
over the same time period, although not significantly. The plasma 
concentrations of the other APPs measured Ovt, Cp, Apo-AI, Ttn and PIT54 did 
not change overtime. Further studies to fully characterise the changes in APP 
expression over the normal production life of broilers and broiler breeders would 
provide valuable reference material.  
 
The early part of this thesis looked at the effect of gait score on APP 
concentrations and measured APPs in birds culled from commercial farms for 
lameness. Lameness is an issue for the broiler industry in terms of animal 
welfare and economic loss, however there are 15 separate conditions in broiler 
chickens that can result in lameness (Neeteson, 2010). Many of the culled lame 
birds had APP profiles comparable to the healthy birds and although GS3 birds 
were found to have significantly higher PIT54, Cp and Ovt than sound GS1 birds, 
the multiple aetiologies of lameness, including those known to not cause 
elevations in APPs, namely tibial dyschondroplasia, make using APPs as a 
biomarker for lameness difficult. The significant association between bird weight 
and Cp concentrations across all birds is an interesting but unexplainable 
finding. There are a number of possible reasons that could account for this 
finding, the most basic being that bigger birds produce more Cp, with increased 
dietary intake enabling increased synthesis of Cp and increased growth.  
  
While not strictly relevant to the poultry industry, the higher 5mg/kg dose of 
meloxicam, significantly increased plasma Ovt concentrations. This suggests that 
the NSAID had a deleterious effect on the gastrointestinal tract which resulted in 
the translocation of bacteria and a resultant APR, as described in humans and 
rodent models (Tugendreich et al.,2006). This finding is highly relevant to 
backyard and pet chickens that receive meloxicam off licence and caution 
should be applied to prescribing dosages above 2mg/kg.  
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These early studies uncovered a number of difficulties with the competitive Ovt 
ELISA, prompting the development, validation and subsequent use of an Ovt RID 
assay. Unlike the competitive ELISA the RID assay had good CVs, was easy and 
straightforward to use and more economical. This assay can also be undertaken 
in the most basic of labs with no need for specialist equipment. Developing an 
automated turbidimetric assay with the same antibody would increase 
throughput of this assay enabling many more samples to be measured and 
allowing full characterisation of Ovt in broiler chickens to be made. Further 
validation of this assay and antibody was achieved in Chapter 4, using 
quantitative proteomics, where the relative concentrations of three of the four 
Ovt peptides, found were significantly correlated with the results of the RID 
assay. Table 7.1 summarises the results of all the studies that have quantified an 
APP in this thesis. Results are listed by APP with the method of measurement 
detailed also. Table 7.2 summarises chicken APPs providing an updated 
classification of APPs in this species.  
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APP 
(method) 
Chapter 2 Chapter 4 Chapter 5 
Culled bird study Gait score study NSAID Coccidiosis study Quantitative proteomics Gut litter challenge study 
Healthy Culled GS1 GS3 Saline NSAID Control Challenged 
Non-
acute 
phase 
Acute phase day Control 
Litter 
challenged 
Ovt 
(ELISA) 
g/L 
  2.15 (0.73) 2.44 (1.73)* 2.20 (0.75) 
2mg/ml = 
2.05 (0.79) 
 
5mg/ml  = 
2.75 (2.15)* 
2.165 
(0.1435) 
E. tenella  
= 3.86 (1.56)* 
 
E. tenella & E. coli  
=4.70 (1.54)* 
    
Ovt 
(RID+) 
g/L 
      
1.34 
(0.36) 
Highly acute phase  
= 4.31 (1.8) 
 
Acute phase 
= 1.63 (0.55) 
12 1.49 (0.26) 1.55 (0.34) 
15 1.36 (0.29) 1.28 (0.25) 
18 1.34 (0.21) 1.29 (0.32) 
22 1.39 (0.14) 1.56 (0.26) 
Cp  
(PPD) 
g/L 
0.00 
(0.03) 
Lame  
= 0.43 (0.91) 
 
Stunting 
=  0.07 (0.07)* 
0.72 (0.28) 0.98 (0.68)** 2.20 (0.75) 
2mg/ml = 
0.90 (0.67)  
 
5mg/ml  = 
0.86 (0.50) 
0.002 
(0.007) 
E. tenella  
= 0.15 (0.14)* 
 
E. tenella & E. coli  
=1.67 (2.09)** 
  
 
 
Cp 
(ELISA) 
g/L 
       
12 0.13 (0.07) 0.14 (0.02) 
15 0.13 (0.01) 0.17 (0.07) 
18 0.11 (0.06) 0.16 (0.05) 
22 0.21(0.07) 0.19 (0.06) 
PIT54  
g/L 
0.10 
(0.01) 
Lame  
= 0.19 (0.29) 
 
Stunting  
= 0.62 (1.33) 
0.10 (0.03) 0.12 (0.023)* 2.20 (0.75) 
2mg/ml = 
0.11 (0.03) 
 
5mg/ml  = 
0.10 (0.03) 
    
SAA 
(ELISA) 
ng/µl 
      
0.05 
(0.04) 
Highly acute phase 
= 0.43 (0.01)* 
 
Acute phase 
= 0.24 (0.10) 
12 0.66 (0.28) 0.89 (0.20) 
15 1.28 (0.99) 0.79 (0.65) 
18 1.15 (0.62) 1.45 (0.71) 
22 2.31 (0.90) 1.89 (1.22)  
AGP 
(RID) 
µg/ml 
      
247.79 
(38.28) 
Highly acute phase 
= 1344.32 (583.02)* 
 
Acute phase 
= 880.68 (154.98)* 
12‡ 155.45 (68.37)  120.19 (69.0) 
15‡ 172.88 (22.95) 193.31 (41.49) 
18‡ 198.08 (92.71) 210.94 (55.34) 
22‡ 217.68 (50.76) 343.45(184.42 
Table 7.1: Summary of all the APPs measured throughout thesis over a number of different studies, with chapter containing full details of the studies and 
methods of measurement indicated. Value shown is the mean (±SD). Where significant differences relative to the control/healthy were observed this is indicated 
Table 7.1. 
265 
 
(*p=<0.05, **p=<0.01). + Developed in Chapter 3. ‡While no significance was detected between challenge and control samples. The AGP was found to increase 
significantly over time in both control and challenged.   
Acute phase protein Classification Method In agreement with literature? 
Serum amyloid A Major positive Immunoassay & Quantitative proteomics  
Alpha-1-acid glycoprotein Moderate positive Immunoassay  
Ovotransferrin Moderate positive Immunoassay & Quantitative proteomics  
PIT54 Minor Biochemical reaction   
Ceruloplasmin Minor Immunoassay & Biochemical reaction  
Apolipoprotein-AI Negative Quantitative proteomics Novel finding 
Apolipoprotein AIV Not an APP in chickens*  Immunoassay & Quantitative proteomics Novel finding 
Haemopexin  Minor positive Quantitative proteomics X 
Transthyretin Negative Quantitative proteomics Novel finding 
Fetuin Negative  Quantitative proteomics Novel finding 
CRP Not an APP in chickens 
Table 7.2: An updated tabl classifing APPs in chickens. Both immunoassays and quantitative proteomics were used in a series of experiments on experimental 
studies on gait score, NSAIDs study, Coccidiosis study and a reused litter challenge study and also more general investigations such as that undertaken on culled 
birds. A quantitative proteomics approach was also used to identify and relatively quantify APPs between acute phase groups.   
*Further work to fully characterise needed.
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While APPs such as Ovt, PIT54 and Cp are covered widely in the literature, there 
are many reputed APPs that have not been studied in chickens, and this is 
because of limited anti-sera availability and the reduced chances of successfully 
appropriating anti-sera from other species. To overcome these issues and 
identify and characterise the full spectrum of APPs in chickens, a quantitative 
proteomic approach was taken. The APPs SAA and CRP were particular targets 
owing to the previous work reporting SAA as a major APP in chickens (N 
Upragarin, 2005) and because of C-reactive protein‟s prominent position as the 
major APP in humans, dogs and pigs and subsequent inclusion in a number of 
publications on chickens. As the early work on these proteins was unsuccessful 
(not included in thesis) it was clear that enrichment steps would need to be 
undertaken on both of these proteins prior to shotgun analysis. Molecular weight 
fractionation was successful in enriching acute phase serum sufficiently to 
identify more SAA peptides but despite both molecular weight enrichment and 
the affinity chromatography, CRP was not identified. Relaxing the search criteria 
resulted in one peptide being matched to CRP but this was not sufficient for an 
identification to be made. From these results it is clear that CRP is not an APP in 
chicken. Further steps to validate these findings could be undertaken, but the 
given the sensitivity of the MS and the enrichment steps undertaken and the 
number of samples this was applied to, it is strongly suspected that CRP is not 
present at all at a protein level chickens. It is therefore frustrating to see 
multiple papers using non-specific, commercially acquired ELISA kits to measure 
“CRP” in chickens. While there is a CRP gene present, it would appear that it 
does not result in the expression and secretion of CRP. A recent paper using 
qPCR to look at expression of immune genes in the spleen of chickens infected 
with parasite Ascaridia galli, targeted CRP finding expression to increase less 
that 2 fold at one time point, the authors noting that „few reports exist on 
chicken CRP‟ (Dalgaard et al., 2015).  
 
The APPs Apo-AI and Ttn were confirmed as negative APPs in this study. There 
are no reports that detail these APPs in chickens, the findings here confirm that 
they are present at lower quantities in HAP and AP birds during at APR and as 
such classified as negative APPs. Negative APPs and other biomarkers are often 
not as „popular‟ as positive ones. An increasing biomarker has an infinite 
possibility, whereas a negative one cannot get any less than zero. However the 
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decrease of constitutive proteins during an APR is a significant event that should 
draw more interest than it currently does. Often referred to as “acute booster 
reactants” to highlight the cascade of helpful events (Ingenbleek & Bernstein, 
2015) generated by their reduced synthesis, increased breakdown or loss of 
these proteins, the decrease in their concentration has to confer a benefit to the 
animal.  
 
It has been postulated that the decrease in the major negative APP albumin 
during an APR is to allow for the unused pool of amino acids to instead be used 
to generate positive APP and other important mediators of inflammation (Cray 
et al., 2009). This is possible as the fractional synthesis rate of total liver 
proteins (stationary and exported), equals approximately 25% of the liver protein 
content daily (Barle et al., 1997). Further still, in humans the amount of albumin 
synthesised per day (absolute synthesis rate) is calculated to be 109 ± 21 mg per 
kg of body weight (Barle et al., 1997). While not completely comparable, if this 
was to be extrapolated for a 2kg chicken, it would equate to over 1.5g of 
albumin in a week during homeostasis. During an APR, the decrease of albumin 
and negative APPs, apo-A1 and Ttn for the partitioning of amino acids towards 
synthesis of positive APPs and other mediators of the immune system, if 
insufficient to meet the needs of the APR, results in redirection of other 
energies towards the immune system which results in the problem surrounding 
the „costs‟ of the immune system that were discussed in Chapter 1. Focusing on 
the negative APPs may prove insightful when considering this issue, the negative 
APPs should perhaps be considered “constitutive APPs”. If proteins such as 
albumin, apo-A1 and Ttn provide the building blocks of the early IIR, ensuring 
these plasma proteins remain at optimal levels in the healthy bird may reduce 
the mounting costs associated with an effective APR. 
 
Having established the value of using quantitative proteomics, this method was 
employed to identify proteins that were differentially abundant between three 
acute phase pools. The advantages of using quantitative shotgun methods for 
identifying and measuring proteins cannot be over stated. It allowed a broad 
approach to be taken that moved away from the „looking for what you‟re 
expecting to find‟ approach that had previously dominated the APP work in 
chickens. Figure 7.1 is a well circulated cartoon that illustrates this point well. 
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Acute phase proteins are known to behave differently between species so 
looking for the same targets across species is not a good approach.  
 
 
Figure 7.1: Shotgun proteomics: a more effective way of identifying biomarkers (Image: 
Fields, 2001). 
 
The data collected during the shotgun proteomics, namely the quantotypic 
peptides for each protein and their retention times, can be used again and will 
save considerable time on future studies. As the data accumulates for chickens 
and technologies develop and preparative methods simplify, quantitative 
proteomics will become more widespread. It is an apt method for measuring a 
large number of proteins on a limited number of samples.  
 
Many of the proteins targeted for quantitative measurement were differentially 
abundant between the HAP and NAP or the HAP and the AP groups. It is not 
desirable to have a biomarker that shows massive increase or decrease between 
the HAP group and the other acute phase groups. On a farm the HAP birds would 
be evidently very ill or dead, negating the need for a biomarker! Biomarkers 
need to identify birds that are not obviously unwell or infected. The protein 
cathepsin looks to be the most promising protein identified as it is only protein 
that showed a significant difference between the NAP and the AP. None of the 
APPs targeted showed a significant difference between these two AP groups.  
 
Biomarkers of intestinal health were targeted in this study. The intestinal health 
of broilers is a large and important area of research because of the important 
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role the gastrointestinal tract has in nutrient absorption, growth and maintaining 
the overall health of the bird. Plasma biomarkers for intestinal health and 
function would provide a non-invasive measure that, used in conjunction with 
other parameters, could aid in many areas of poultry health and nutritional 
research. Apo-AIV was identified as a protein of interest due to its clear 
differential expression on 2DE gels and its reported wide range of functions. An 
apo-AIV ELISA was successfully developed and validated. This ELISA was used to 
measure apo-AIV in HAP, AP and NAP samples and the intestinal challenge study. 
Apo-AIV was not significantly associated with the APR. This protein was also 
measured using quantitative proteomics. Apo-AIV in the intestinal challenge 
study was not significantly different between the challenge and control groups 
at any time point, however apo-AIV concentrations were significantly different 
over time for the control group (when measured using the ELISA) and the 
challenge group (when quantified using quantitative proteomics). The 
development of the apo-AIV ELISA means that this assay can be applied to a wide 
variety of studies where the behaviour and function of apo-AIV in chickens can 
be fully characterised. The protein villin, previously identified as a differentially 
expressed protein in the intestine of birds challenged with reused litter was 
found not to be present in the plasma of chickens. The introduction of the re-
used litter was not sufficient to elicit an enteric disease that would cause villin, 
an intestine specific protein to move into the plasma. Villin is unlikely to be a 
suitable biomarker for intestinal health in chickens. A proteomic approach was 
also undertaken to evaluate the incidence of tendon rupture. The chicken GT 
proteome had not been studied previously and given the mixed aetiology and 
breed associated differences in incidence of GT rupture it was a good proteomic 
target. Because of the fibrous nature of tendon, it was a difficult tissue to work 
with and any future work would benefit from using liquid nitrogen to powderise 
the tendon before suspension in buffer. The inclusion of a Cy2 standard would 
also allow DeCyder software to identify spots that are statistically different in 
abundance.  
 
This study has aimed to utilise samples and target tissues that closely reflect the 
normal production environment. Using tissues from naturally occurring disease 
(tendons) and realistic models of microbial challenge that affect growth (re-used 
litter), mean that when biomarkers are identified and later validated, they are 
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readily applicable to the poultry industry. It is relatively easy to identify 
differentially expressed proteins between samples, whether these translate into 
a useful biomarkers depends on a number of factors. Having the correct samples 
and study design from the outset makes the path from proteomics to biomarker 
development to industry application clear. 
 
Moving forward, suggested areas for future work include focusing further on 
lipoproteins. SAA, apo-AI and apo-AIV have revealed themselves to be proteins of 
interest in this study and while SAA is difficult to work with it is the only major 
APP in chickens. Moving quantitative methods of APP measurement from the 
laboratory to the farm is also an area of future development. The development 
of lateral flow systems enabling quick on-site measurement of APPs with small 
volumes of blood would open up the field of APP biomarkers considerably. While 
it is recognised that relying on single trait criteria to select for improved 
immune competence has adventitious results, multi-trait selection criteria still 
requires measureable parameters of the early IIR and APP are suitable targets. 
While referring to APPs it must be considered that APPs are a collection of highly 
variable proteins, whose only commonality is that they are secreted by the liver 
and change in serum concentration during an APR. They have wide ranging 
functions and should, as possible selection parameters for breeding programs, be 
considered separately, as they are likely to have considerably different 
potentials as selection targets.  
 
7.1        Conclusion  
The results in this thesis have contributed novel and interesting information on 
the APR in chickens. Apo-AI and Ttn are both negative APP and SAA appears to 
be the only major positive APP present in chickens. The moderate APPs Ovt and 
AGP are readily measureable and good targets on which to focus future studies 
and developments. The evidence from this work reveals CRP not be an APP in 
chickens and is likely not present at a protein level during both homeostasis and 
during an APR. Quantitative shotgun approaches were used to identify proteins 
that were differentially abundant as a result of the APR and this lead to a 
targeted measurement of a number of potential biomarker targets, of which 
cathepsin appears the most promising.  
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An anti-Ovt antibody was produced using the egg derived antigen that works 
successfully in a developed and validated RID immunoassay. An ELISA for 
measuring apo-AIV was developed and validated and applied to a number of 
studies. Apo-AIV in chickens appears not to behave as an APP and while the 
results are mixed, apo-AIV does appear to be affected by the introduction of re-
used litter. Villin was not identified in the serum or plasma of chickens and as 
such an unlikely biomarker for intestinal disease. The tendon proteome was 
evaluated in ruptured and normal tendons, where the application of the DiGE 
revealed a number of differentially expressed proteins.  
 
The information presented in this thesis has expanded the knowledge of chicken 
APPs and developed further methods of measurement that will allow the study 
of APPs in chickens to continue beyond this work. Using the latest proteomic 
technologies to identify and quantify APPs and investigate other biomarkers is, 
for this species novel and has resulted in a long overdue update on APPs in 
chickens.  
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Appendix A 
Publication 
O‟Reilly, E. L.  & Eckersall, P. D. (2014) Acute phase proteins: a review of their 
function, behaviour and measurement in chickens World‟s Poultry Science Journal 70 
(1) 27 – 44 
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Appendix 2.1 (section 2.2.1.2) 
Bradford reagent (5X concentrate) 
- 100 mg Coomassie Brilliant Blue G-250  
- 47 ml Methanol (100%)  
- 100 ml Phosphoric Acid (85%)  
- QS to 200 ml with H2O  
- Dissolve Coomassie in the methanol first then add other ingredients.  
 
Appendix 2.2 (section 2.2.1.3) 
Ceruloplasmin assay 
- Sodium acetate buffer: 20.8g sodium acetate (trihydrate) dissolved in 
250ml dH2O, adjust pH to 6.3 with acetic acid 
- Add 0.0615g of P-phenylenediamine (PDP) 
- Cover with tin foil, light sensitive.  
 
Appendix 2.3 (section 2.2.1.5) 
Ovt competitive ELISA coating buffer 
-  8.4g Sodium hydrogen carbonate dissolve into 500ml dH2O 
- Dissolve conalbumin at concentration of 1μg/μl for coating wells 
 
Appendix 2.4 (section 2.2.2) 
Tris Buffered Saline (x10) 
- Tris 22g 
- NaCl 72g 
- Dissolve in 1L dH2O and adjust to pH 7.6 with concentrated HCl 
Transfer buffer (x1) 
- Tris 6.06g 
- Glycine 28.8g 
- Dissolve in 1600mldH2O add 400ml methanol 
- Check pH, do not adjust should be pH8. 
 
 
Appendix 2.5 (section 2.3.1.2) 
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Spo
t 
Name 
Protein Identification*  
Score 
Theoretical 
Matched Sequence 
Cover
age % UniProt 
Mascot Protein 
ID 
Mass Da PI 
1 PIT 54.- Gallus gallus Q98TD1 562 52670 4.6 25(17) 12(10) 38 
Vitronectin.- Gallus gallus O12945 121 52345 5.17 3(2) 2(1) 6 
Uncharacterized protein-(Predicted pantetheinase precursor [Gallus gallus]*) Q5ZHM4 107 56105 6.33 3(3) 2(2) 5 
Serum albumin - chicken P19121 73 71868 5.51 9(1) 8(1) 17 
2 Alpha 1-acid glycoprotein - chicken JC7879 212 22535 5.11 9(5) 6(5) 32 
PIT 54.- Gallus gallus (Chicken). Q98TD1 144 52670 4.6 6(3) 6(3) 27 
3 Apolipoprotein AIV.- Gallus gallus (Chicken). O93601 47 40828 4.8 3(0) 3(0) 10 
PIT 54.- Gallus gallus (Chicken). Q98TD1 42 52670 4.6 2(0) 2(0) 8 
4 Immunoglobulin lambda chain variable region (Fragment).- Gallus gallus  * BAA11099 50 10993 6.78 1(1) 1(1) 16 
5 transthyretin precursor - chicken  P27731  S17827 735 16356 5.11 24(15) 6(6) 62 
Immunoglobulin lambda chain variable region (Fragment).- Gallus gallus   * BAA11099 98 10993 4.72 1(1) 1(1) 16 
Hemoglobin subunit beta (Hemoglobin beta chain) (Beta-globin).- Gallus gallus  P02112  HBB_CHICK 89 16496 8.84 2(2) 2(2) 17 
6 transthyretin precursor - chicken   P27731 S17827 366 16356 5.11 9(4) 6(4) 62 
PIT 54.- Gallus gallus  Q98TD1  54 52670 4.6 1(1) 1(1) 2 
7 transthyretin precursor - chicken  P27731  S17827 440 16356 5.11 14(8) 6(6) 62 
Hemoglobin subunit beta (Hemoglobin beta chain) (Beta-globin).- Gallus gallus  P02112 HBB_CHICK 61 16496 8.84 2(1) 2(1) 14 
8 apolipoprotein A-I precursor - chicken P08250 LPCHA1 1045 30661 5.58 68(32) 17(8) 52 
IG LIGHT CHAIN V-J REGION (FRAGMENT).- Gallus gallus  * AAA48870  87 10502 5.04 2(2) 2(2) 29 
Immunoglobulin lambda chain variable region (Fragment).- Gallus gallus  * BAA11099 68 10993 4.72 2(1) 2(1) 32 
9 apolipoprotein A-I precursor - chicken LPCHA1 P08250 389 30661 5.58 32(9) 15(6) 55 
IG LIGHT CHAIN V-J REGION (FRAGMENT).- Gallus gallus (Chicken). * AAA48870  195 10502 5.04 7(3) 2(2) 39 
Immunoglobulin lambda chain variable region (Fragment).- Gallus gallus  * BAA11099 177 10993 4.72 6(3) 3(3) 45 
10 retinol-binding protein precursor - chicken P41263 I50675 232 22843 5.93 11(5) 9(4) 52 
apolipoprotein A-I precursor - chicken P08250 LPCHA1 119 30661 5.58 13(3) 9(3) 33 
Immunoglobulin lambda chain variable region (Fragment).- Gallus gallus  * BAA11099 72 10993 4.72 1(1) 1(1) 16 
11 IGL PROTEIN (FRAGMENT).- Gallus gallus  * AAA48901 214 10422 8.17 8(5) 4(4) 66 
Immunoglobulin heavy chain variable region (Fragment).- Gallus gallus  * BAA11105  159 10717 5.13 3(2) 3(2) 43 
Immunoglobulin lambda chain variable region (Fragment).- Gallus gallus  * BAA11099 157 10993 4.72 4(2) 3(2) 40 
apolipoprotein A-I precursor - chicken P08250 LPCHA1 144 30661 5.58 13(4) 10(4) 36 
Ig light chain precursor V-J region - chicken (fragment) *  A21177  135 22769 5.36 13(3) 5(2) 32 
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12 IGL PROTEIN (FRAGMENT).- Gallus gallus (Chicken). * AAA48901  184 10422 8.71 5(3) 3(3) 44 
CHICKEN IG REARRANGED LAMBDA-CHAIN GENE 18D-2 V1J-REGION, PARTIAL CDS 
(FRAGMENT).- Gallus gallus  
* CAB25124  
151 30661 5.58 4(3) 3(3) 43 
  IG LIGHT CHAIN V-J REGION (FRAGMENT).- Gallus gallus  * AAA48883 149 10238 8.00 4(2) 3(2) 43 
13 Immunoglobulin lambda chain (Fragment).- Gallus gallus  * BAB47289  138 11226 5.99 3(3) 2(2) 28 
Immunoglobulin heavy chain variable region (Fragment).- Gallus gallus  * BAA11105  135 10717 4.72 4(3) 3(2) 45 
Phosphoglycerate mutase 1 (EC 5.4.2.1) (EC 5.4.2.4) (EC 3.1.3.13) (BPG-
dependent PGAM 1).- Gallus gallus (Chicken). 
  Q5ZLN1 PGAM1 
112 28920 7.21 5(2) 5(2) 30 
Ig light chain precursor V-J region - chicken (fragment) *  A21177  111 22769 5.36 4(2) 4(2) 23 
Immunoglobulin lambda light chain (Fragment).- Gallus gallus (Chicken). * BAB71891  90 11175 9.00 2(2) 2(2) 28 
apolipoprotein A-I precursor - chicken 
P08250 
 
LPCHA1 
70 30661 5.58 4(2) 4(2) 16 
14 Immunoglobulin lambda light chain (Fragment).- Gallus gallus (Chicken). * BAB71911 163  11410     8.78 4(3) 3(3) 41 
AB233021 NID: - Gallus gallus (immunoglobulin light chain variable region) * BAE80151  155 12497 7.98 5(2) 3(2) 37 
CHICKEN IG REARRANGED LAMBDA-CHAIN GENE 18D-3 V1J-REGION, PARTIAL CDS 
(FRAGMENT).- Gallus gallus (Chicken) 
* CAB25125   
138 10827 8.98 3(3) 3(3) 43 
  IG LIGHT CHAIN V-J REGION (FRAGMENT).- Gallus gallus (Chicken). * AAA48883 136 10238 8.00 3(3) 3(3) 50 
Immunoglobulin heavy chain variable region (Fragment).- Gallus gallus  * BAA11105  109 10717 4.72 3(3) 3(3) 43 
apolipoprotein A-I precursor - chicken P08250 LPCHA1 105  11410     8.78 9(2) 7(2) 21 
15 apolipoprotein A-I precursor - chicken P08250 LPCHA1 377  11410     8.78 9(4) 9(4) 35 
Ig light chain precursor V-J region - chicken (fragment) *  A21177  219 22769 5.36 5(4) 4(3) 23 
CHICKEN IG REARRANGED LAMBDA-CHAIN GENE 3W-1 V1J-REGION, PARTIAL CDS 
(FRAGMENT).- Gallus gallus (Chicken). 
* CAB25129   
167 10362 4.39 4(2) 3(2) 55 
Immunoglobulin heavy chain variable region (Fragment).- Gallus gallus  * BAA11105  139 10717 4.72 3(2) 2(2) 30 
16 Immunoglobulin lambda light chain (Fragment).- Gallus gallus (Chicken). * BAB71911 183  11410     8.78 4(4) 3(3) 41 
 Ig light chain precursor V-J region - chicken (fragment) *  A21177  165 22769 5.36 7(3) 4(3) 37 
 AB233021 NID: - Gallus gallus (immunoglobulin light chain variable region) * BAE80151  122 12497 7.98 3(2) 2(2) 27 
17 Ig light chain precursor V-J region - chicken (fragment) *  A21177  254 22769 5.36 8(6) 5(4) 37 
 Immunoglobulin lambda light chain (Fragment).- Gallus gallus (Chicken). * BAB71911 124  11410     8.78 4(2) 4(2) 48 
 Immunoglobulin lambda chain variable region (Fragment).- Gallus gallus  * BAA11101 111 10883 4.72 4(3) 3(2) 45 
18 Apolipoprotein AIV.- Gallus gallus (Chicken). O93601  1232 40828 4.8 37(20) 21(14) 60 
19 transthyretin precursor – chicken  P27731 S17827 402 16356 5.11 10(9) 6(6) 62 
20 Hemopexin (Fragment).- Gallus gallus (Chicken). Q90WR3  438 29765  5.92 15(10) 9(6) 52 
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21 serum albumin – chicken P19121 ABCHS  1206 71868 5.51 66(32) 32(20) 62 
 Vitronectin.- Gallus gallus O12945  89 52345 5.17 3(2) 3(2) 11 
 Immunoglobulin heavy chain (Fragment).- Gallus gallus (Chicken). * BAA10003   64 12975 4.97 1(1) 1(1) 9 
24 serum albumin – chicken   P19121 ABCHS 1595 71868 5.51 80(42) 33(20) 64 
GGIGMUCH NID: - Gallus gallus (Ig mu chain C region) * CAA25762  177 48827 6.07 7(4) 5(3) 15 
ovoinhibitor precursor [validated] – chicken  P10184 A26730 100 54394 6.16 8(2) 7(2) 21 
IG HEAVY-CHAIN V REGION (FRAGMENT).- Gallus gallus (Chicken). * AAA48835  60 11933 7.88 2(1) 2(1) 29 
25 serum albumin – chicken   P19121 ABCHS 1404 71868 5.51 73(33) 31(19) 58 
 
30 
serum albumin – chicken   P19121 ABCHS 486 71868 5.51 17(4) 16(3) 34 
Mannose-binding lectin precursor protein.- Gallus gallus (Chicken). Q98TA4   143 27758 5.85 5(1) 4(1) 21 
31 Ovotransferrin BB type.- Gallus gallus (Chicken). Q4ADJ7   1018 79606 6.85 48(24) 31(17) 52 
ovotransferrin– chicken P02789 TFCHE 906 79551 6.85 41(21) 27(16) 51 
33 Ovotransferrin BC type.- Gallus gallus (Chicken). Q4ADG4  1704 79588 7.08 83(39) 35(20) 57 
ovotransferrin – chicken P02789 TFCHE 1699 79551 6.85 81(39) 34(20) 56 
34 Ovotransferrin BC type.- Gallus gallus (Chicken). Q4ADG4  989 79588 7.08 57(23) 32(18) 55 
35 Ovotransferrin BC type.- Gallus gallus (Chicken). Q4ADG4  298 79588 7.08 11(4) 11(4) 23 
ovotransferrin– chicken P02789 TFCHE 297 79551 6.85 10(4) 10(4) 23 
Ig gamma chain (clone 36) - chicken (fragment) * S00390  77 54436 6.84 4(0) 4(0) 13 
36 Ig gamma chain (clone 36) - chicken (fragment) * S00390 180 54436 6.84 6(4) 5(4) 15 
IG HEAVY-CHAIN V REGION (FRAGMENT).- Gallus gallus (Chicken). * AAA48844 148 11878 7.86 4(2) 4(2) 50 
37 Ig gamma chain (clone 36) - chicken (fragment) * S00390 312 54436 6.84 20(6) 11(6) 28 
Immunoglobulin heavy chain variable region (Fragment).- Gallus gallus 
(Chicken). 
* BAA11100  
147 13188 8.44 4”) 3(2) 33 
IG HEAVY-CHAIN V REGION (FRAGMENT).- Gallus gallus (Chicken). * AAA48844 130 11878 7.86 5(2) 4(2) 42 
40 Ig gamma chain (clone 36) - chicken (fragment) * S00390 198 54436 6.84 12(5) 7(5) 16 
IG HEAVY-CHAIN V REGION (FRAGMENT).- Gallus gallus (Chicken). * AAA48837 168 11894 8.45 4(3) 2(3) 42 
41 fibrinogen beta chain - chicken (fragment)  Q02020 A38463 858 53272 7.18 70(23) 27(16) 68 
GGFIBA5 NID: - Gallus gallus (pre-fibrinogen alpha subunit [Gallus gallus])  P14448 AAB60685 177 56766 6.82 9(5) 7(4) 18 
Vitamin-D binding protein.- Gallus gallus (Chicken). Q9W6F5  110 55362 6.47 7(2) 7(2) 19 
42 fibrinogen beta chain - chicken (fragment) Q02020 A38463  1184 53272  7.18 47(18) 27(15) 68 
GGFIBA5 NID: - Gallus gallus(pre-fibrinogen alpha subunit [Gallus gallus])  P14448 AAB60685 820 56766 6.82 22(14) 16(10) 45 
44 fibrinogen beta chain - chicken (fragment)  Q02020 A38463 828 53272 7.18 26(8) 20(7) 45 
45 GGFIBA5 NID: - Gallus gallus(pre-fibrinogen alpha subunit [Gallus gallus])  P14448 AAB60685 829 56766 6.82 31(19) 12(12) 57 
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Ig gamma chain (clone 36) - chicken (fragment)  S00390 63 54436 6.84 3(2) 2(1) 6 
46 fibrinogen beta chain - chicken (fragment)  Q02020 A38463 840 53272  7.18 59(23) 26(16) 60 
GGFIBA5 NID: - Gallus gallus(pre-fibrinogen alpha subunit [Gallus gallus])  P14448 AAB60685 216 56766 6.82 11(7) 8(6) 21 
Vitamin-D binding protein.- Gallus gallus (Chicken). Q9W6F5   120 55362 6.47 8(2) 8(2) 20 
47 Vitamin-D binding protein.- Gallus gallus (Chicken). Q9W6F5  402 55362 6.47 23(8) 17(6) 47 
ovoinhibitor precursor [validated] - chicken P10184 A26730 127 54394 6.16 14(3) 9(3) 20 
fibrinogen beta chain - chicken (fragment)  Q02020 A38463 125 53272  7.18 8(4) 8(4) 20 
48 GGFIBA5 NID: - Gallus gallus(pre-fibrinogen alpha subunit [Gallus gallus])  P14448 AAB60685 139 56766 6.82 4(2) 4(2) 11 
49 Trypsin/Keratin (no Gallus gallus protein)         
50 Trypsin/Keratin (no Gallus gallus protein)         
51 keratin         
52 chicken hemoglobin d (EC 2.3.1.61), chain C - chicken  P02001 1HBRC 835 15586 6.58 35(22) 9(5) 82 
Hemoglobin subunit alpha-A (Hemoglobin alpha-A chain) Gallus gallus (Chicken). P01994 HBA_CHICK  580 15402  8.56 20(11) 8(5) 65 
Hemoglobin subunit beta (Hemoglobin beta chain) (Beta-globin).- Gallus gallus  P02112 HBB_CHICK  136 16496 8.85 10(4) 8(3) 66 
hemoglobin beta-H chain - chicken  Q90864 I50248 109 16469 9.20 6(2) 4(1) 29 
cystatin precursor - chicken  P01038 UDCH 56 15562 7.60 2(1) 2(1) 20 
53 Hemoglobin subunit alpha-A (Hemoglobin alpha-A chain) Gallus gallus (Chicken).   P01994 HBA_CHICK 469 15402  8.56 14(8) 6(5) 51 
Hemoglobin subunit beta (Hemoglobin beta chain) (Beta-globin).- Gallus gallus  P02112 HBB_CHICK  242 16496 8.85 19(7) 9(3) 73 
chicken hemoglobin d (EC 2.3.1.61), chain C - chicken  P02001 1HBRC 104 15586 6.58 4(3) 3(2) 37 
54 Hemoglobin subunit alpha-A (Hemoglobin alpha-A chain) Gallus gallus (Chicken).   P01994 HBA_CHICK 613 15402  8.56 30(16) 10(6) 89 
Hemoglobin subunit beta (Hemoglobin beta chain) (Beta-globin).- Gallus gallus  P02112 HBB_CHICK 197 16496 8.85 9(5) 7(5) 61 
serum albumin – chicken P19121 ABCHS  157 71868 5.51 14(4) 12(4) 22 
55 Hemoglobin subunit alpha-A (Hemoglobin alpha-A chain) Gallus gallus (Chicken).   P01994 HBA_CHICK 355 15402  8.56 12(7) 7(5) 60 
Hemoglobin subunit beta (Hemoglobin beta chain) (Beta-globin).- Gallus gallus    P02112 HBB_CHICK 302 16496 8.85 27(10) 11(6) 78 
hemoglobin beta-H chain - chicken  Q90864 I50248 173 16469 9.20 19(4) 8(2) 46 
56 Hemoglobin subunit beta (Hemoglobin beta chain) (Beta-globin).- Gallus gallus    P02112 HBB_CHICK 107 16496 8.85 4(1) 4(1) 39 
Hemoglobin subunit alpha-A (Hemoglobin alpha-A chain) Gallus gallus (Chicken). P01994 HBA_CHICK 90 15402  8.56 2(1) 2(1) 19 
58 serum albumin – chicken P19121 ABCHS 263 71868 5.51 8(1) 8(1) 15 
IGL PROTEIN (FRAGMENT).- Gallus gallus (Chicken). * AAA48901  235 10422 8.71 4(4) 3(3) 44 
Ig light chain precursor V-J region - chicken (fragment) *  A21177  212 22769 5.36 4(3) 3(3) 23 
Immunoglobulin lambda light chain (Fragment).- Gallus gallus (Chicken). * BAB71891  210 11175 9.00 3(3) 3(3) 40 
Immunoglobulin heavy chain variable region (Fragment).- Gallus gallus  * BAA11105  201 10717 5.13 3(3) 3(3) 43 
*Uniprot Accessions are given. Where Mascot identifier is different this is listed on the right. Note that Immunoglobulins are not listed in UniProt. The Mascot link reference can be 
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Bands were excised from the gel trypsin digested and identified using nanoflow HPLC-EPI-MS/MS with identities assigned using Mascot Science Daemon server to 
interrogate protein sequences in the NCBI Genbank database for Gallus gallus and boney vertebrates. Both NCBI and where Uniprot identifications are listed 
(immunoglobulins are not listed in Uniprot). The protein score is the sum of the highest ions score for each distinct sequence. The first number under matches is the 
count of MS/MS spectra that have been matched to peptides from this protein. The matches shown in the parenthesis indicating unique matches (scores above the 
significance threshold). The sequences column is the count of matches to distinct peptide sequences, the number in parenthesis is the count of sequences with 
significant matches (Matrixscience.com). The coverage percentage is proportion of the protein‟s entire sequence identified. 
 
 
 
 
 
 
 
 
 
 
 
 
 
opened in UniParc, the UniProt archive. 
**Mascot online database of results has deleted/moved this protein and original result of coverage not available. 
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Appendix 3.1 (section 3.2) 
IEP buffer  
- Tris 9.8g 
- Calcium lactate 0.106g 
- Sodium azide 0.2g 
- Tricine 4.3g  
- Dissolve in 1L dH2O 
RID gel  
- Dissolve 0.17g agarose in 17ml TBS  
- While in water bath (56˚C) add antibody, mix and pour immediately  
 
Appendix 4.1 (section 4.2.1.1) 
CRP Binding buffer 
- Tris 12.114g 
- NaCl 5.844 
- CaCl2 0.22g 
- pH 8-8.5 
CRP Elution buffer 
- Tris 12.114 
- NaCl 5.884 
- EDTA 0.586g 
- pH 8-8.5 
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Appendix 4.2 (section 4.2.2.2.2) 
 
Work flow chart summarising the work process of Chapter 4.   
 
 
  298 
 
Appendix 4.3 (section 4.3.2.2.1) 
Pools       Protein Accession 
Fold 
change 
H
ig
h
 a
c
u
te
 p
h
a
se
: 
A
c
u
te
 p
h
a
se
 
Uncharacterized protein E1BZE1 -44.05 
Uncharacterized protein E1BS56 -26.57 
Uncharacterized protein R4GJ67 -20.06 
Vinculin (Metavinculin) P12003 -19.70 
Uncharacterized protein F1NKD4 -18.78 
Matrilin-3 O42401 -18.41 
Uncharacterized protein F1P4C5 -9.22 
Uncharacterized protein F1P4N9 -8.59 
Uncharacterized protein E1C6J4 -8.12 
Uncharacterized protein F1NEQ4 -8.06 
Neuronal-glial cell adhesion molecule (Ng-CAM) Q03696 -7.96 
Uncharacterized protein E1C7H6 -6.79 
Uncharacterized protein (Fragment) F1NUF8 -6.35 
Lumican (Keratan sulfate proteoglycan lumican) (KSPG  lumican) P51890 -6.21 
Uncharacterized protein E1C544 -5.02 
Uncharacterized protein (Fragment) F1NRM4 -4.85 
Uncharacterized protein F1NHT5 -4.63 
Protein NEL (93 kDa protein) Q90827 4.04 
Fructose-bisphosphate aldolase (EC 4.1.2.13) R4GM10 4.07 
Uncharacterized protein R4GMH4 4.16 
Non-specific serine/threonine protein kinase (EC 2.7.11.1) E1BWY7 4.64 
Uncharacterized protein F1N8D4 5.10 
Uncharacterized protein (Fragment) F1NSD3 5.20 
Uncharacterized protein (Fragment) F1NLZ2 5.36 
Uncharacterized protein (Fragment) F1NXB6 5.39 
14-3-3 protein theta Q5ZMD1 5.71 
Uncharacterized protein  F1P2W2 6.24 
Uncharacterized protein R4GG01 7.31 
Docking protein 3 (Downstream of tyrosine kinase 3) A3R064 8.02 
Uncharacterized protein (Fragment) F1NJD5 8.59 
Uncharacterized protein F1NTF4 10.33 
Tenascin (TN) (Cytotactin)  P10039 10.61 
Clusterin (51.5 kDa protein)  P14018 10.62 
Uncharacterized protein E1BV78 11.38 
Beta-2-microglobulin P21611 11.76 
L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) P00337 17.18 
Sixth complement component (Uncharacterized protein) B8ZX71 18.89 
Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A;  P14448 21.34 
A
c
u
te
 p
h
a
se
 –
 N
o
n
-a
c
u
te
 p
h
a
se
 
Putative ISG12(2) protein (Uncharacterized protein) Q6IEC5 -42.70 
Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate 
dehydrogenase) 
Q5ZME2 -12.79 
Lamin-A P13648 -11.70 
Uncharacterized protein (Fragment) F1NJD5 -9.86 
Docking protein 3 (Downstream of tyrosine kinase 3) A3R064 -9.78 
Uncharacterized protein E1C1F2 -9.50 
Uncharacterized protein E1C8B4 -7.60 
Uncharacterized protein E1BWG1 -6.58 
Cadherin-5 (Vascular endothelial cadherin)  F1P1Y9 -6.49 
Uncharacterized protein (Fragment) F1NLZ2 -5.87 
Serum albumin (BSA) (allergen Bos d 6) P02769 -4.78 
Uncharacterized protein R4GMH4 -4.34 
Uncharacterized protein F1N869 4.45 
Uncharacterized protein (Fragment) F1NAB7 5.20 
Keratin, type I cytoskeletal 9  P35527 5.76 
L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) P00340 6.15 
Neuronal-glial cell adhesion molecule (Ng-CAM) Q03696 6.98 
Uncharacterized protein (Fragment) F1NCH8 7.09 
Uncharacterized protein E1C6J4 7.93 
Uncharacterized protein R4GJ67 9.20 
Plasminogen (EC 3.4.21.7) R4GMH5 10.73 
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Uncharacterized protein F1NNW0 13.08 
Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) 
(Phosphopyruvate hydratase) 
P07322 14.12 
Cathepsin D (EC 3.4.23.5)  Q05744 22.64 
Coronin Q5ZI60 59.85 
H
ig
h
 a
c
u
te
 p
h
a
se
: 
N
o
n
-a
c
u
te
 p
h
a
se
 
Uncharacterized protein E1BZE1 -52.65 
Matrilin-3 O42401 -20.99 
Putative ISG12(2) protein (Uncharacterized protein) Q6IEC5 -18.39 
Uncharacterized protein E1C1F2 -15.28 
Uncharacterized protein F1NKD4 -14.98 
Uncharacterized protein F1P4N9 -14.23 
Cadherin-5 (Vascular endothelial cadherin) (VE-cadherin) F1P1Y9 -11.54 
Uncharacterized protein F1NEQ4 -11.14 
Uncharacterized protein R4GGS2 -10.97 
Uncharacterized protein E1BWG1 -10.94 
Uncharacterized protein E1BS56 -10.76 
Ovocleidin-116 (OC-116) F1NSM7 -10.76 
Uncharacterized protein F1NYP5 -9.02 
Uncharacterized protein E1BWN2 -8.30 
Histone-lysine N-methyltransferase SETD1B (EC 2.1.1.43)  Q5F3P8 -7.69 
Vinculin (Metavinculin) P12003 -6.88 
Serum albumin (BSA) (allergen Bos d 6) P02769 -6.53 
Uncharacterized protein E1C8B4 -5.66 
Uncharacterized protein E1BX43 -5.42 
Uncharacterized protein (Fragment) F1NSF6 -5.42 
Uncharacterized protein F1P4C5 -5.36 
Malate dehydrogenase, cytoplasmic (EC 1.1.1.37)  Q5ZME2 -5.31 
Uncharacterized protein F1NHT5 -5.13 
Uncharacterized protein E1BYT9 -4.88 
Lamin-A P13648 -4.87 
Uncharacterized protein (Fragment) F1NUF8 -4.43 
Uncharacterized protein E1BTX1 4.28 
Uncharacterized protein E1C7M0 4.49 
Uncharacterized protein F1NTF4 4.64 
Ribonuclease homolog (EC 3.1.27.-) (RSFR) P30374 4.74 
Uncharacterized protein F1NDJ8 4.79 
Uncharacterized protein F1P2W2 5.14 
Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) 
(Phosphopyruvate hydratase) 
P07322 5.33 
Uncharacterized protein F1NNW0 5.62 
L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) P00340 5.99 
Uncharacterized protein (Fragment) F1NSD3 6.11 
Uncharacterized protein F1P587 6.42 
Uncharacterized protein E1C4F1 6.51 
Uncharacterized protein E1BV78 7.89 
Plasminogen (EC 3.4.21.7) R4GMH5 8.17 
Uncharacterized protein R4GG01 9.42 
Tenascin (TN) (Cytotactin) P10039 10.39 
Clusterin (51.5 kDa protein)  P14018 13.17 
Cathepsin D (EC 3.4.23.5)  Q05744 17.65 
Uncharacterized protein (Fragment) F1NAB7 18.25 
Fibrinogen alpha chain  P14448 20.48 
L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) P00337 21.31 
Sixth complement component (Uncharacterized protein) B8ZX71 22.91 
Beta-2-microglobulin P21611 25.68 
Coronin Q5ZI60 25.89 
Proteins identified in all three acute phase pools (pools 1-3), ranked by fold 
difference between pools and excluding proteins with less than 4 fold 
difference. Highlighted proteins were selected for further measurement in 
section 4.3.2.2.2. 
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Appendix 4.4 (section 4.3.2.2.1) 
Protein ID Accession 
Fold 
change 
Uncharacterized protein  E1C932 -61.56 
Uncharacterized protein R4GL55 -7.16 
Uncharacterized protein R4GHQ6 -6.62 
Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Retinal 
pigment epithelium-specific 65 kDa protein) (Retinol isomerase) 
Q9YGX2 -5.89 
Uncharacterized protein F1NAP7 -5.89 
Signal recognition particle subunit SRP68 (SRP68) F1P0P4 -4.71 
Uncharacterized protein F1NGF6 -3.47 
Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) 
(p50Cdc37) 
O57476 -3.14 
Uncharacterized protein F1NJN2 5.37 
Serum amyloid A protein* F1NW65 5.62 
Ras-responsive element-binding protein 1 (RREB-1) O57415 6.21 
Proteins present only in acute phase groups (pools 1 and 2) that show more than a 4 fold 
difference between these pools. Highlighted proteins were selected for further measurement in 
section 4.3.2.2.2, with the exception of serum amyloid A which was measured in section 
4.3.2.1.2. 
Appendix 5.1 (section 5.3.3.2) 
Apo-AIV indirect ELISA coating buffer 
- 50mM sodium hydrogen cardonate  
- 4.2g into 1L dH2O, pH 9 
TBS-tween 0.05% (stock): 1L TBS + 0.5ml tween 
TBS-tween 0.05%/5% Marvel (blocking): 100ml TBS-tween0.05%+5g Marvel 
TBS-tween 0.05%/1% Marvel (washing): 1L TBS-tween (0.05%) + 10g Marvel 
TBS-1% Marvel (diluting antibodies): 100ml TBS + 1g Marvel 
Appendix 6.1 (Section 6.2.4) 
DiGE Lysis buffer  
- 6M urea  
- 2M thiourea  
- 4% CHAPS  
- 25mM tris base  
Equilibration buffer I  
- 1.5M Tris HCl 
- 216.21 g urea  
- 180ml glycerol  
- 12g SDS  
- 100mg DTT  
- pH8.8 
Equilibration buffer 2 
- 1.5M Tris HCl  
- 216.21 g urea  
- 180ml glycerol  
- 12g SDS 280  
- pH8.8 
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